The differential effects of MDMA (ecstasy) use on executive and memory processes by Montgomery, C A
THE DIFFERENTIAL EFFECTS OF MDMA (ECSTASY) USE ON EXECUTIVE AND MEMORY 
PROCESSES. 
Catharine Anne Montgomery 
A thesis submitted in partial fulfilment of the requirements of Liverpool John Moores 
University for the degree Doctor of Philosophy. 
February 2006 
Acknowledgements 
I would like to thank the School of Psychology at Liverpool John Moores University 
for their support and funding over the last three years. In particular, I would like to 
thank Dr John. E. Fisk for steering me in the right direction. Without all of his help 
and mentorship during this period, and his suggestions on drafts of endless papers and 
chapters, this thesis would probably not have come together as soon as this. 
I would also like to thank Mrs Anne Montgomery and especially Mr Neil Clarke for 
their financial and emotional support during the last three years. 
2 
Abstract 
The purpose of this thesis was to examine the nature of executive function deficits in 
ecstasy users, and the contribution of these executive functions to performance on 
other cognitive tasks. Using recent theoretical models of executive functioning 
recreational ecstasy-polydrug users were tested in laboratory settings on measures of 
mental set switching, response inhibition, memory updating and access to semantic 
memory. It was found that ecstasy users performed significantly worse than nonusers 
on measures of updating and access, although cocaine also emerged as an important 
factor in deficits in access. The contribution of access and updating to performance on 
more complex executive function tasks was then assessed. It was found that while 
associative learning is relatively independent of access and updating, the same was 
not true for everyday memory and syllogistic reasoning. Ecstasy group related deficits 
in syllogistic reasoning were slightly attenuated following control for access and 
substantially following control for updating. It emerged that everyday memory 
deficits were more related to the use of cannabis than the use of ecstasy. The results of 
this thesis have serious implications for those who use ecstasy and should be used in 
educating such individuals. Outside the area of Psychopharmacology this thesis 
provides further support for the nature of executive functions and their relationship 
with syllogistic reasoning and everyday memory. Future research should assess 
executive functions along the same paradigm and seek to recruit polydrug control 
groups. 
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Chapter 1: Overview of Thesis 
This Chapter provides a brief overview of each Chapter of this thesis. 
Chapter 2 provides a brief introduction to the study of executive functions in ecstasy 
users and gives an overview of the theoretical models of working memory and 
executive functioning upon which this thesis is based. The chapter provides a 
rationale for studying executive functions as separable in ecstasy users. 
Chapters 3,4, and 5 are literature review chapters. Chapter 3 is a review of 
studies of aspects of cognition in ecstasy users. This chapter outlines areas that are in 
need of more research and further clarification, and thus provides a basis for the areas 
of intended study in this thesis. It is proposed that the use of ecstasy affects cognitive 
functioning via degradation of the serotonin system, thus Chapter 4 reviews studies in 
human ecstasy users that use objective measures of serotonergic functioning. This 
includes functional and structural brain imaging studies and measures of serotonin 
and glucose metabolism. The final literature review chapter is related to the use of 
cannabis and cocaine. Chapter 5 reviews some studies that have assessed cognitive 
functioning in cannabis and cocaine users, as it is possible that the use of these drugs 
may also contribute to cognitive deficits in ecstasy users. 
Chapters 6,7,8,9,10 and 11 are the empirical chapters of this thesis with the 
first three assessing the four postulated executive functions. Chapter 6 assesses 
memory updating performance in ecstasy users via a running memory task. Chapter 7 
assesses performance of ecstasy users and nonusers on measures of mental set 
switching and response inhibition. Chapter 8 assesses performance of ecstasy users 
and nonusers on a task of access to semantic memory. 
The results from these three Chapters revealed that ecstasy users are impaired 
in measures of memory updating and access, although switching and inhibition appear 
to be relatively unaffected. The final three empirical chapters assessed the 
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contribution of executive processes to performance on higher-level cognitive tasks 
and everyday memory tasks. Chapter 9 assesses the contribution of updating and 
access to syllogistic reasoning performance. Chapter 10 assessed the contribution of 
executive processes to associative learning performance. In Chapter 10 the underlying 
processes involved in associative learning performance are also investigated. Chapter 
11 examines the contribution of updating and access to everyday memory processes. 
The final chapter is a general discussion of the results. Chapter 12 evaluates 
the results in terms of the implications for drug users and the implications for the 
structure of executive functions and cognitive processes in general. 
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Chapter 2: The structure of Working Memory and Executive processes 
2.1 Chapter Overview 
This chapter briefly provides a theoretical basis for studying the executive 
components that are explored in more depth in Chapter 3. Baddeley's model of 
working memory is referred to followed by recent advances of research in to 
executive processes and the fractionation of the central executive. 
Theory of working memory and executive functions in relation to ecstasy studies 
A key construct in cognitive psychology is Baddeley's (1986) model of 
working memory. The model consists of two "slave" systems, one that is involved in 
the processing of verbal sequences (the phonological loop) and one that is involved in 
the processing of visuo-spatial sequences (the visuospatial sketchpad) and a modality 
free central executive. Recent research from the same laboratory (Baddeley, 2000) 
proposes a new component of the working memory model: the episodic buffer. 
Baddeley assumes that the episodic buffer is a modality-free short-term store, under 
the control of the central executive. Baddeley proposes that the episodic buffer plays 
an important role in both transfer into- and retrieval from- long-term eip sodic 
memory. In light of this it is unclear how the episodic buffer component may be 
related to this thesis (indeed the concept was not as well-received in the literature as 
the previous model) and it is thus not discussed further. Figure 1 below shows a 
diagram of Baddeley's most recent conceptualisation of working memory. 
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Figure 1: Working Memory Model (reproduced from Baddeley, 2000). 
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There is a growing body of research suggesting that the central executive may 
not be a unified structure, with different tasks tapping different processes that are to 
some extent independent. Most studies in ecstasy users to date refer to executive 
functions as a unitary concept, using archaic clinical models of executive functioning, 
and until now there has been no systematic investigation of the nature of executive 
process deficits in ecstasy users. Indeed, it was unclear why ecstasy users exhibited 
deficits on some "executive function" tasks, but not others. For example, Fox, Parrott 
and Turner (2001) assessed the performance of a group of ecstasy users who reported 
experiencing cognitive deficits, and those who did not report such problems. 
Paradoxically, non-problem users were found to have significantly longer Tower of 
London (TOL) planning times than the problem users and the control group. Both 
ecstasy groups made significantly more errors than controls on a spatial working 
memory task, while higher use of ecstasy was associated with longer TOL planning 
times. Testing executive function and spatial working memory, Fox, McLean, Turner, 
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Parrott et al. (2002) found that ecstasy users performed worse than controls on verbal 
fluency, spatial working memory, attention shifting and pattern recognition. Moving 
on to verbal working memory, Wareing, Fisk, Murphy and Montgomery (2004b) 
found that previous and current users of ecstasy were impaired on a computation span 
task, requiring the concurrent processing and updating of information in working 
memory. The main effect of ecstasy remained significant after control for the use of 
other drugs. However, no ecstasy related deficits were observed on the reading span 
task, which supposedly uses the same mechanism. Wareing, Fisk and Murphy (2000) 
also found ecstasy users to be impaired in a random letter generation task, but no such 
effect was found in a subsequent study (Fisk, Montgomery, Wareing and Murphy 
2004). While the results of such studies suggest global executive function deficits in 
ecstasy users, some studies fail to find ecstasy related cognitive deficits. Turner, 
Godolphin and Parrott (1999) found that ecstasy users were unimpaired on the 
Wisconsin Card Sort Task (WCST) (replicated by Fox et al. 2001), while Morgan, 
McFie, Fleetwood and Robinson (2002) found ecstasy users to be unimpaired in word 
fluency, Stroop, and Subtracting Serial Sevens among other tests. Alting von Geusau, 
Stalenhoef, Huizinga, Snel et al. (2004) also found that ecstasy users were unimpaired 
on the stop signal reaction time task (believed to measures response inhibition). One 
possible reason for such disparate results is that the central executive of working 
memory is not a unified structure, and ecstasy use differentially impairs its 
components. The next section of this Chapter discusses the separability of executive 
processes. 
Recent theoretical models of executive functioning postulate that the central 
executive is fractionated, with its different components performing separate tasks with 
varying degrees of competence. Lehto (1996) found that while more complex memory 
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span tasks (involving concurrent processing and storage of information) were 
correlated with memory updating tasks, the correlations between these tasks and other 
executive function tasks such as the Tower of Hanoi and the Wisconsin Card Sort 
Task were not significant. Lehto (1996) argued that this demonstrates the fractionated 
nature of the central executive. In a more recent study, Miyake et al. (2000) studied 
the separability of three supposed executive functions: mental set shifting ("shifting"), 
information updating and monitoring ("updating"), and inhibition of pre-potent 
responses ("inhibition"), and how they contributed to executive tasks. Structural 
equation modelling revealed that the three executive functions were moderately 
correlated with each other, but clearly separate, and they contribute differently to 
performance on various executive prefrontal tasks. For example, the Wisconsin Card 
Sort Task (WCST) was linked to the shifting component, the Tower of Hanoi to the 
inhibition component, random number generation to both the inhibition and updating 
components, and operation span to the updating component. That is not to say that 
these three are the only executive functions, and it is possible that Miyake et al only 
found these as this is all they aimed to find. Thus one aim of the present study was to 
assess these three target functions in ecstasy users. However, in a study of age-related 
differences in executive functioning, Fisk and Sharp (2004) administered a number of 
executive tasks to assess the target functions of updating, shifting, inhibition, and 
another executive function: the temporary activation of long-term memory/access to 
long-term memory (Baddeley, 1996). Fisk and Sharp (2004) found that the three 
target functions proposed by Miyake et al. (2000) loaded on to distinct factors, but 
there was a clear separable factor which word fluency and "redundancy" (the extent to 
which each letter is said with the same overall frequency in the random letter 
generation task) mapped on to. 
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To date there has been no systematic investigation of whether or not ecstasy 
users are impaired in the different aspects of executive functioning identified by 
Miyake et al (2000). Existing research findings are piecemeal and have not always 
made use of the traditional measures of the different executive subcomponents 
identified by Miyake et al (2000). Therefore, one aim of this thesis is to ascertain the 
nature of executive function deficits in a sample of recreational ecstasy users. We 
aimed to use "pure" measures of each of the four postulated executive functions 
(updating, shifting, inhibition and access), and provide further clarification of the 
nature of executive deficits in ecstasy users. 
The next Chapter reviews studies of cognitive deficits in ecstasy users. 
Although previous studies have assessed the central executive as a unified structure, 
in the following Chapter studies targeting the same executive functions have been 
grouped under sub-headings to enable the literature review to follow the same 
structure as the thesis. 
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Chapter 3: Review of Scientific Literature on Cognitive Deficits in ecstasy Users 
MDMA, or "ecstasy" is a ring substituted monoaminergic agonist producing 
both the release and inhibiting the reuptake of Serotonin-5HT (Schmidt, 1987), and 
Dopamine (Yamamoto & Spanos, 1988). The ever-increasing recreational use of 
ecstasy is of great concern, with an estimated 2,097,000 adult users in the UK alone 
(British Crime Survey, 2004-05). Ecstasy has been associated with memory/cognitive 
deficits, and problems with psychological affect, which are thought to be due to the 
drug's neurotoxic effects on the serotonin system. However, research into the long- 
term effects of ecstasy does not yet yield conclusive results. 
In addition to evidence of ecstasy-related memory deficits in rats and non- 
human primates, a growing number of studies are reporting persistent deficits in 
human working memory, compared to drug-naive controls. The present chapter will 
summarise the research evidence in a number of specific aspects of cognition, 
including intelligence, recall, verbal learning, non-verbal learning, switching, 
inhibition, updating, access to long-term memory, visuo-spatial functioning, and 
recognition. Table 1 which is found at the end of the chapter contains summaries of 
the ecstasy use variables from the studies reviewed. 1 
3.1 Intelligence: 
A number of studies have assessed intelligence in ecstasy users, rarely as a 
between groups factor but as a control method to match the groups in the study. Some 
studies have used measures of crystallised intelligence (e. g. the National Adult 
Reading Test) while some studies have assessed fluid intelligence (e. g. the Wechsler 
Abbreviated Scale of Intelligence, Raven's Progressive Matrices). Both Fluid and 
Crystallised Intelligence scores are correlated with higher cognitive capabilities, so it 
1 Specific dosages have not been referred to throughout the Chapter; this would involve much 
repetition. 
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is important that studies adequately match their groups on Intelligence scores, 
otherwise apparent ecstasy-related effects might in fact be attributable to group 
differences in intelligence. 
Croft, Mackay, Mills and Gruzelier (2001a) used the National Adult Reading 
Test (NART), a list of 50 words that are of decreasing frequency in the English 
language, and of atypical phonology, meaning that pronunciations cannot be derived 
from standard grammatical rules. Estimated IQ was not significantly different 
between the groups (ecstasy users 116.2, cannabis users 115.2 and non-users 115.2). 
In Curran and Verheyden's (2003) study, NART IQ scores were not significantly 
different between current ecstasy users (111.38), previous users (111.27) and controls 
(113.54). In a correlational study with no control group, Dafters, Duffy, O'Donnell 
and Bouquet (1999) found that NART scores were not significantly associated with 
extent of ecstasy use (number of tablets used in a year), and a further study by 
Dafters, Hoshi and Talbot (2004) found that NART scores were not significantly 
different between the groups (as did Morgan et al. 2002 and Fox et al. 2002). Morgan 
(1998) also matched IQ via the NART; in Study I IQ was not significantly different 
between the groups (ecstasy users 114.9, polydrug users 112.3 and nonusers 113.5); 
but in study 2, estimated IQ was lower for ecstasy users than polydrug and nonusers 
(113.1,116.1, and 115.1 respectively). Morgan (1999) also found that NART scores 
were significantly different between the three groups tested: 35.9 for ecstasy users, 
39.1 for polydrug users and 37.5 for drug naive controls. Although the groups were 
not matched for IQ in this study, the NART scores did not correlate with either 
immediate or delayed recall scores, where the performance differences lay between 
the groups. Semple et al. (1999) also matched their two groups using the NART. 
Groups did not differ significantly on this test (ecstasy user average IQ: 107.6; 
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nonuser: 109.7). Gouzoulis-Mayfrank, Daumann, Tuchtenhagen, Pelz et al. (2000) 
used the German language version of the WAIS-R Mosaic test to assess fluid 
intelligence (participants have to reproduce patterns using cubes: measuring fluid 
intelligence and assessing visuomotor performance and problem solving ability), the 
Wechsler Adult Intelligence Scale- Revised (WAIS-R) general knowledge test (to 
measure crystallised intelligence) and the LPS-4 abstract logical thinking test (in 
which participants are required to discover the rule for a series of letters or digits and 
indicate the incorrect element, testing fluid intelligence). On the LPS-4, mosaic and 
general knowledge test cannabis users and controls performed better than ecstasy 
users, indicating that ecstasy users in this study had a lower IQ. Krystal, Price, 
Opsahl, Ricaurte et al. (1992) also used the general intelligence scale of the WAIS-R. 
Estimated IQ was within the normal range (115), as were performance and verbal IQ. 
Zakzanis and Young (2001 a) used the WAIS-R vocabulary (to measure verbal IQ) 
and block design (to measure performance IQ) subtests. Participants were tested on 
two occasions a year apart, while self-administering ecstasy in the year between 
testing sessions. Although there were no differences between performance at baseline 
and follow up for either test, there was a significant negative correlation between the 
vocabulary change score (score at second session subtracted from score at first 
session) and the frequency of use indicating that vocabulary performance declined 
with increasing use of ecstasy. Gouzoulis-Mayfrank, Thimm, Rezk, Hensen et al. 
(2003) again used the WAIS-R general knowledge (crystallised intelligence) task. 
Intelligence was significantly different between the groups, with moderate ecstasy 
users and controls performing better than heavy users. Moreover, control for 
differences in intelligence reduced some of the memory deficits to below statistical 
significance (see later sections). 
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Simon and Mattick (2002) again used the vocabulary subtest of the WAIS-R 
and the Kaufman Brief Intelligence Test (K-BIT), which consists of both verbal and 
nonverbal elements to form a composite IQ score. No differences were apparent on 
the K-BIT task, but ecstasy users did score significantly lower on the vocabulary test 
of the WAIS-R (which was a significant contributor to most of the memory deficits 
observed in this sample). Zakzanis, Young and Radkhoshnoud (2002) used the 
Wechsler Abbreviated Scale of Intelligence (WASI) performance and verbal IQ 
subtests. The performance IQ subtest involved matrix reasoning (participants have to 
conceptualise spatial, design and numerical relationships of varying difficulty) while 
the vocabulary subtest involved providing definitions of words in an incremental 
order of difficulty. Intelligence was not significantly different between the groups and 
correlations with dosage and usage (occasions) were non-significant. Wareing, Fisk, 
Murphy and Montgomery (2004a; 2004b) used sets D and E of Raven's Progressive 
Matrices, a test of fluid intelligence which requires participants to identify the next 
element in a sequence and indicate the correct answer from a choice of 8 possible 
answers (matrix reasoning). Scores were not significantly different between the 
groups in either study. Using the, quick test Bhattachary and Powell (2001) assessed 
both fluid and crystallised Intelligence. Participants were required to examine line 
drawings and decide which was the most appropriate referent for a particular word. 
The words are of increasing abstractness and it is believed the test taps both 
crystallised (knowing the meaning of the words) and fluid (abstracting and comparing 
meanings of pictures) intelligence. Neither cannabis use nor ecstasy use was related to 
performance. In addition, neither recency of ecstasy use nor lifetime consumption 
predicted IQ scores in either the combined group of ecstasy users (novice, regular, 
currently abstaining), or the current users (novice, regular). Thomasius, Petersen, 
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Buchert, Andresen et al. (2003) assessed premorbid IQ via a German multiple choice 
test of vocabulary knowledge, while current IQ was assessed via performance on the 
"observation" and "calculation" subtests of the German Wilde Intelligence Test, and 
the reverse digit recall component of the Hamburg-Wechsler Intelligence Scale. No 
ecstasy-group related differences were observed on any of the IQ tests and all groups 
had similar premorbid IQ (current users: 102.5; ex-users: 106.48; polydrug: 104.28; 
drug-naive: 104.97). 
In summary, most studies have attempted to control for differences in IQ, and 
the majority of studies have found no between group differences in IQ scores, and 
little relationship between IQ scores and performance. In the four studies that did find 
between group differences in IQ scores (Gouzoulis-Mayfrank et al. 2000; Gouzoulis- 
Mayfrank et al. 2003; Morgan 1999; Simon & Mattick. 2002), three found that the 
effects of ecstasy on some other cognitive domains were reduced to below statistical 
significance following control for IQ. One study (Zakzanis et al. 2002) also found that 
IQ change over a year was negatively correlated with indices of ecstasy use, which 
raises the possibility that ecstasy may adversely affect IQ (although this area needs 
further clarification). In light of this evidence, every study that is researched in this 
thesis will adequately control for both premorbid and fluid intelligence. 
3.2 Speed of Processing 
Speed of processing is a much-researched area in ecstasy users. Tasks used 
include simple and choice reaction time tasks, the Trail Making Test-A (TMT-A), the 
Digit Symbol Substitution Task (DSST), Stroop-A, and some novel measures. On the 
whole, it appears that ecstasy users are not impaired on tasks that assess speed of 
processing, although some studies report increased incidence of errors. 
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Parrott, Lees, Garnham, Jones et al. (1998) assessed processing speed via 
simple and choice reaction time tasks. In the simple reaction time task, participants 
were required to press a key as soon as the target word ("YES") appeared on the 
screen, while choice reaction time involved pressing either the "yes" key when "yes" 
appeared on the screen or the "no" key when "no" appeared on the screen. Response 
latency was recorded. Regular and novice ecstasy users did not differ significantly 
from controls on these tasks. Fox, Parrott and Turner (2001) used a similar task in 
which fifty crosses appeared on a computer screen at random intervals and 
participants had to respond to them. Reaction times were not significantly different 
between controls and the three dosage groups (low, medium, high) but those who 
complained of ecstasy-related problems were significantly slower than those not 
complaining of problems (both groups had similar lifetime doses 372: 357 tablets 
respectively, although the abstinence period for problem users was slightly longer, 
7.8: 2.5 months respectively) and controls. To assess processing speed, Thomasius et 
al. (2003) used the Trail Making Test-A (TMT-A) which consists of the numbers 1-25 
encircled and spread randomly across a sheet of paper. The object of the task is to 
connect the numbers in order, beginning at 1 and ending at 25 in as little time as 
possible. The task requires visual scanning, numeric sequencing and psychomotor 
speed. No significant group differences were observed in psychomotor speed in this 
sample. This finding was replicated by McCardle, Luebbers, Carter, Croft et al. 
(2004) using the TMT-A test, in a sample of 17 recreational ecstasy users compared 
to 15 nonusers, and Morgan, McFie, Fleetwood and Robinson (2002) with a sample of 
18 current heavy ecstasy users, 15 former heavy users, 16 polydrug controls, and 15 
drug-naive participants. Two of the nine participants tested by Krystal et al. (1992) 
showed mild impairment on the TMT test, but these results should be treated with 
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some caution as the sample size was so small. Semple et al. (1999) also used the 
TMT-A task and the CANTAB simple reaction time tasks. Again, no differences were 
observed between the groups regarding reaction time, but again sample sizes were 
relatively small and comprised of males only. 
Wareing et al. (2000) measured information processing speed via a visual 
search match to sample task in which participants were required to indicate whether 
two sets of letters were the same or different, at three list lengths of three-, six-, or 
nine-letters. Participants were scored on number of targets classified and number 
correct at each list length. While nonusers had a higher percentage correct than 
previous and current users at the longest list length, there were no group differences in 
total number completed or numbers correct at the three and six item lengths. The 
sample size in this study is however rather small (N=10 per group), so the findings 
should be treated with some caution. In a conference paper Wareing, Fisk, Murphy 
and Montgomery (2003) reported that there were no ecstasy-related deficits on a 
pattern recognition match-to-sample processing speed task. On the letter comparison 
task (as used by Wareing et al. 2000) ecstasy users performed marginally worse than 
nonusers (which just attained statistical significance), although there was no 
interaction between complexity and user group. After controlling for differences in 
years of education the effect was reduced to below statistical significance. 
Rodgers (2000) measured visual and auditory reaction time via a computerised 
task in which participants had to press spacebar after seeing/hearing a target (which 
was a white circle for visual reaction time, and a simple tone for auditory reaction 
time), and complex reaction time in which participants had to press the number that 
corresponds to the number presented on the computer screen (1-9). Ecstasy users, 
cannabis users and nonusers performed similarly on all tests of reaction time 
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(however ecstasy users had used on an average of 20 times over 5 years, which is 
perhaps a little low compared to other studies: see Table 1). Verkes, Gijsman, Pieters, 
Schoemaker et al. (2001) assessed reaction time to simple auditory and visual stimuli, 
and a binary choice task. Reaction time was longest in heavy users and shortest in 
nonusers (with moderate users performing between the two). After control for group 
differences in education level and Beck Depression Inventory (BDI) scores, group 
differences in reaction time were no longer significant. In a clinical study (Cami, 
Farre, Mas, Mas et al. 2000), simple visual reaction time was not affected after 
administration of 75/125mg of MDMA. 
A number of studies have used the Matching Familiar Figures-20 (MFF-20) 
task in which participants view a sample geometric shape and attempt to identify a 
matching choice figure from a displayed selection as quickly as possible: 20 trials are 
implemented. In Dafters et al's (2004) study time and errors were not significantly 
different between the four groups (heavy ecstasy and cannabis, light ecstasy and 
cannabis, cannabis only and nonuser). Morgan et at (2002) also used the MFF-20, and 
a digit cancellation task (in which participants were required to mark every 
occurrence of the number "5", which was distributed randomly among 400 two-digit 
numbers in a 20x20 layout) to assess speed of processing. Performance between 
current ecstasy users, previous ecstasy users, polydrug users and nonuser controls was 
not significantly different on the digit cancellation task. There were however 
significant ecstasy-related group differences on the latency to first response, total 
number of errors and composite I score (calculated by subtracting the standardised 
score of the mean latency from the standardised score of the number of errors 
committed) on the MFF-20 task. The number of errors on the MFF-20 task was 
positively correlated with the reported average dose of ecstasy consumed by all 
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ecstasy users, and stepwise regression analyses revealed that MFF-20 errors, mean 
latencies to first response, and I scores were only significantly predicted by the 
average dose of ecstasy. This was interpreted as an ecstasy-related deficit in 
impulsivity (with ecstasy users being more impulsive and thus having faster response 
latencies and more errors). Using the Digit Symbol Substitution Task (DSST) a 
sample of 22 ecstasy users had similar digit symbol scores to a group of nonusers 
(Back-Madruga, Boone, Chang, Grob et al. 2004). Likewise, Thomasius et al. (2003) 
failed to find differences in DSST performance between 30 current users and 31 
former users, compared to 29 polydrug users and 30 controls. McCardle et al. (2004) 
also failed to detect any differences using this test with 17 ecstasy users and 16 
cannabis users. Similarly, Halpern, Pope, Sherwood, Barry et al. (2004) found no 
ecstasy group related difference between 23 users compared to a light polydrug 
control group (N=16). In a clinical study Cami et al. (2000) found that administration 
of either placebo, 40mg of amphetamine, 75 mg of MDMA or 125mg of MDMA did 
not impair reaction time on the DSST (although 125mg of MDMA was associated 
with slightly increased errors and reduced number of correct responses) at any of the 
testing periods (over 30 minutes to an hour for the 24 hours after administration). 
Halpern et al. (2004) also used the Stroop task to measure information- 
processing speed. In Stroop A, colour words (e. g. RED) are all printed in black ink, 
and participants are required to read them aloud. In Stroop B, colour words are printed 
in same and different coloured ink, and participants have to name the colour ink. 
While Stroop A measures speed of processing, Stroop B measures speed of 
processing under interference. Although Halpern et al. failed to find group related 
differences on the Stroop task in this sample, when the ecstasy group was split into 12 
moderate users (fewer than 50 occasions) and 11 heavy users (50+ occasions), it was 
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found that greater lifetime ecstasy use was associated with poorer performance on the 
Stroop interference task. However, Back-Madruga et al. (2004) failed to find any 
differences in Stroop performance between ecstasy users and nonusers. Croft et al. 
(2001 a) used the Stroop task A and B (interference). Stroop B performance was not 
significantly different between drug users and nonusers. Conversely, a combined 
ecstasy and cannabis user and cannabis only user group performed worse than 
nonusers on Stroop A, and performance was correlated with total ecstasy use (at . 31) 
and frequency of ecstasy use (at . 24). McCardle et al. (2004) also failed to find any 
ecstasy related differences on the Speed of Comprehension Test (SCT). Verbaten 
(2003) published a Meta analysis examining ten studies of ecstasy users that had 
abstained for at least a week prior to the studies, and concluded that ecstasy use was 
not associated with impaired information processing speed. 
The majority of studies have failed to detect ecstasy-related differences in 
information processing speed, although a small number of studies that did find 
differences were not limited to one type of test (most of the types of test reported had 
one study finding an effect). While Fox et al. (2001) found that problem ecstasy users 
(lifetime dose of 372.3 tablets) were slower than non-problem users (356.9 tablets), 
another study that did find a significant effect found that it was dose related: Morgan 
et al. (2002) found that current and former users of ecstasy (with a lifetime dose for 
men and women of 513/93 and 336/577 respectively) performed worse than polydrug 
users and controls; Verkes et al. (2001) found that heavy users (lifetime dose of 741 
tablets) took longer than light users (although this was reduced to below statistical 
significance after control for education and BDI scores). One study also found that 
performance was more related to ecstasy-polydrug use or cannabis use (Croft et al. 
2001 a) rather than ecstasy use. This area has been much researched in ecstasy users 
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with studies generally yielding few between group differences; it is likely that deficits 
in higher level cognitive functions are separable from deficits in information 
processing (e. g. Wareing, Fisk, Murphy, Montgomery & Chandler, 2005), and this 
area will thus not be investigated further in this thesis. 
3.3 Executive Tasks 
3.3.1 Switching 
"Switching" or "shifting" refers to a participant's ability to switch their 
attention between different tasks or different elements of the same task. It therefore 
requires greater temporal cost than a task in which no switching is required. Some 
studies in ecstasy users utilised the Trail Making Test-B, a novel Go/No-Go task and 
classification tasks (e. g. Wisconsin Card Sort Task). Again, most results in this area 
are equivocal. 
To measure mental set switching, Krystal et al. (1992) used the Trail Making 
Test-B (TMT-B). This is more complex than TMT-A as it requires the participant to 
connect numbers and letters in an alternating pattern (e. g. 1-A-2-B-3-C etc. ) in as 
little time as possible. As TMT-$ requires attentional switching between the letters 
and numbers, it is more cognitively demanding and thus requires more time. In 
Krystal et al. 's study, only 1 participant showed mild impairment, and one moderate 
impairment on the TMT-B test. However, the sample size in this study was very 
small, so the results should not be generalised to the population (N=9). Semple et al. 
(1999) also failed to find any ecstasy-related differences between 10 regular ecstasy 
users and 10 polydrug users matched for age, education and IQ using this task. Again 
comparing a sample of 30 current heavy ecstasy users, 31 former ecstasy users, 29 
polydrug controls (with significantly higher lifetime exposure to cannabis, psilocybin 
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mushrooms and amphetamine, and having used significantly more cannabis and 
amphetamine in the last year) and 30 drug naive controls who were matched for age 
and IQ, Thomasius et al. (2003) observed no significant differences using the TMT-B 
task. This was supported by McCardle et al. (2004) who found no ecstasy-related 
group differences on the TMT-B in a sample of 17 ecstasy users compared to 15 non- 
ecstasy user controls. Morgan et al. (2002) used the TMT-B task to assess executive 
function in four groups: 18 current ecstasy users, 15 former ecstasy users, 16 
polydrug controls (with similar drug use histories to the ecstasy groups) and 15 drug 
naive controls who were matched for age and IQ. Although completion times for 
TMT-B did not differ significantly between the groups, ecstasy users did commit 
significantly more errors on this task (current users committed slightly more than 
previous users although this was non-significant). Performance on TMT-B was not 
significantly correlated with observed differences in General Health Questionnaire 
(GHQ) scores, Impulsiveness Venturesomeness Empathy (NE) scores or any of the 
Symptom Check List-90 (SCL-90) scores. However, regression analysis using 
measures of previous ecstasy and other drug use revealed that TMT-B errors were 
only predicted by the number of LSD trips and the number of psilocybin mushrooms 
consumed in the year prior to testing. Following control for these other drugs via 
ANCOVA, the group differences in TMT-B errors were reduced to below statistical 
significance. 
McCann et al. (1999) used the Serial Add and Subtract Task from the Walter 
Reed Army Institute of Research Performance Assessment Battery (WRAIR-PAB). 
This is a computer based mental arithmetic task requiring sustained attention. Two 
random digits and a "plus" or "minus" sign flash rapidly on a computer screen. The 
participant has to perform the addition or subtraction and enter the least significant 
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digit of the result. If the answer is negative, the participant has to add 10 to obtain the 
correct response. The 22 ecstasy users were matched for age, gender, education level 
and use of other drugs with 23 nonusers (although no values of amounts are reported 
for the use of other drugs, ecstasy users reported using other drugs more frequently, 
and greater numbers reported trying other drugs), and both groups reported being 
abstinent from psychoactive drugs for three weeks prior to testing. There were no 
differences between the groups at baseline (day 1), but ecstasy users were slower than 
nonusers on days 2 and 3 although errors were similar between the groups. 
Furthermore performance was not related to decreased 5HIAA in the cerebrospinal 
fluid of ecstasy users. 
Fox, McLean, Turner, Parrott et al. (2002) compared 20 ecstasy users with 20 
controls matched for age (27.3: 27.5 years), and intelligence (estimated PMI 
100.3: 103). One measure of switching used was a go/no go task consisting of 10 
separate blocks, each of which involved 18 symbols appearing rapidly at the centre of 
a computer screen. Half of the symbols were "targets" and half were "non-targets" 
and comprised either letters (A-G) or numbers (2-9). Participants were told to tap the 
space bar as quickly as possible only when they saw the target for that block. The 
target was switched from letters to numbers (or vice versa) following every two 
blocks. The initial two blocks were practise blocks where the target was 
counterbalanced across participants. All participants were scored for mean number of 
errors made across trials (i. e. failure to tap the spacebar), mean number of 
"distractors" (i. e. the number of times they had responded to a non-target) and mean 
reaction time. No between group differences were observed in distractor errors or 
latencies, and as both groups scored predominantly zero on the omission errors, these 
were not included in the analysis. Fox et al. (2002) also used the 3-D IDED 
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attentional shift task, based on the CANTAB battery task, which assesses ability to 
form, maintain, and shift attentional set. Participants were requested to learn a series 
of two alternative forced choice discriminations and their reversals. The stimuli used 
varied along three possible dimensions (one relevant, and two irrelevant). In the 
simple visual discrimination stage, the stimuli differed on only one of the possible 
three dimensions, and in the following reversal stage, the previously incorrect 
stimulus became the correct one. In the compound visual stage, the contingencies 
from the previous stage remained the same (i. e. colour); however, the stimuli differed 
along all 3 possible dimensions. In the "intra-dimensional shift" stage, the relevant 
dimension (i. e. colour) still remained unchanged despite the introduction of two novel 
stimuli. In the final "extra-dimensional shift" stage, participants were required to 
"shift" response set to a previously irrelevant dimension (i. e. shape). Each of the four 
stages also preceded a reversal stage where the previously non-reinforced stimulus 
became the reinforced target. In order to proceed along each stage, participants were 
expected to achieve six correct successive discriminations in a row. If these were not 
achieved following 50 attempts, the task was terminated. Errors and response 
latencies for each stage were recorded. There were no significant between group 
differences in the number of errors committed (although for the reversal trials, the 
group x difficulty interaction approached significance, with ecstasy users making 
more errors on the simple and compound reversal trials, but slightly fewer on the 
extra-dimension reversal). Ecstasy users also performed worse than controls on the 
reversal latencies at all levels. 
One study that did find ecstasy-related deficits in task switching (in male users 
only) used a novel task to assess switching performance. Alting von Geusau, 
Stalenhoef, Huizinga, Snel et al. (2004) used the "dots-triangles" task involving the 
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maintenance and switching of response set. In a 4x4 grid on a screen, varying 
numbers of either dots or triangles appear. In the first block, dots appear and 
participants have to decide whether there are more dots in the left or right part of the 
screen; in the second block, triangles appear and participants have to indicate if there 
are more in the top or bottom part of the screen. In the third block, participants had to 
alternate between blocks of dots and triangles. The local-global task was also used 
requiring participants to respond to randomly presented rectangles or squares by 
pressing a left or right response button respectively. Larger (global) 
rectangles/squares consist of smaller (local) rectangles/squares. In blocks one and 
two, participants respond only to the local or global elements. In the third block, the 
participants had to switch between local/global responses. Switch costs were 
calculated as the time taken to complete block three, minus the average times of 
blocks one and two for both tasks. Male ecstasy users showed greater temporal switch 
costs, but were actually more accurate than male nonusers on the dots triangles task. 
Male ecstasy users were slower than nonusers in the locallglobal task, but did not 
differ in their accuracy. 
Fox et al, (2001) used a computerised version of the Wisconsin Card Sorting 
Task (WCST) in which participants must earn a rule in order to establish which one of 
three dimensions a pack of 128 cards are being sorted under (i. e. colour, shape and 
number). Once 10 consecutive cards were placed successfully into the correct pile, the 
rule was changed. Six trials were implemented whereby relevant dimensions were 
changed from colour to shape to number and then repeated. The task was terminated 
if a trial was not complete within 50 attempts. Participants were scored for number of 
trials taken to complete the first category, percentage number of perseverative and 
non-perseverative errors and failure to maintain set. There were no significant 
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differences between dosage groups (control, low, medium, high) or problem versus 
non-problem users. Thomasius et al. (2003) also used the WCST task in a sample of 
30 current ecstasy users, 31 former ecstasy users, 29 polydrug controls with illegal 
drug use similar to that of the ecstasy users (with the exception of ecstasy), and 30 
drug-naive controls. Only the measure of perseverative errors (i. e. giving the same 
incorrect response twice) was significant, with polydrug controls scoring significantly 
higher than either ecstasy group. Although failing to find an overall ecstasy-related 
effect, Alting von Geusau et al. (2004) found that when the groups were split by 
gender, 17 male ecstasy users performed less well on the WCST (by making more 
perseverative errors, making more errors on ambiguous trials, and having an impaired 
conceptual level response) than 12 male non-ecstasy users. Female users were not 
significantly impaired on this task (possibly because of the smaller lifetime dose). 
Halpern et al. (2004) also reported that a group of 23 ecstasy users did not perform 
significantly worse on the WCST than a group of 16 light drug-using controls. When 
the ecstasy group was further divided into moderate (fewer than 50 occasions of use) 
and heavy (more than 50 occasions of use) users, the heavy users performed less well 
on the "categories" score of the WCST. As both samples were infrequent users of 
other drugs, it is suggested that this relates to some parameter of ecstasy use. Back- 
Madruga et al. (2004) also failed to find ecstasy related differences in a sample of 22 
ecstasy users compared to 28 nonuser controls (no differences in perseverative 
responses, which are believed to be an index of switching ability). Two research 
groups also used tasks similar to the WCST to assess mental set shifting. Dafters et al. 
(1999) used the Behavioural Assessment of Dysexecutive Syndrome (BADS) Card 
Sort Task also involving a sudden change in the rules of card sorting. Twenty-three 
ecstasy users were split into 12 low users (less than 20 tablets across their lifetime) 
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and 11 high users (20+ tablets across their lifetime). Although no control group was 
incorporated in this study, correlations indicated that extent of ecstasy use was 
associated with a decrease in performance on the BADS card sort task. In a further 
study Dafters et al. (2004) found no significant ecstasy-related differences on this task 
when comparing non-ecstasy users (18), cannabis users (n=15; lifetime cannabis dose 
of 1023 joints), cannabis and light ecstasy users (n=19; lifetime cannabis dose of 1252 
joints) and cannabis and heavy ecstasy users (n=16; lifetime cannabis dose of 1680 
joints). Another study (Zakzanis and Young 2001b) also failed to find any ecstasy 
related differences on this task in 24 ecstasy users compared to 24 controls. Finally, 
Verkes et al. (2001) used the classification task, a derivative of the WCST where 
participants have to identify the sorting criteria for four stimuli cards through a trial 
error process through feedback with a computer. Heavy users and moderate users did 
not differ from nonuser controls on this task. 
Six of the reviewed studies have found a difference between the groups in 
switching. Two of these studies found that either ecstasy related deficits were more 
related to use of hallucinogens (Morgan et al. 2002) or that polydrug users performed 
worse than the ecstasy user group (Thomasius et al. 2003). Another study found that 
ecstasy users only performed worse relative to controls on days 2 and 3 of a 
controlled study, although performance between the groups on days 4 and 5 was not 
reported (McCann et al. 1999). One study found ecstasy-related effects in male 
ecstasy users only on two tasks of switching, and male ecstasy users also gave more 
perseverative responses on the WCST (Alting von Geusau et al. 2004). To further 
support a deficit in task switching, Dafters et al. (1999) found that decreases in scores 
over a year of ecstasy self-administration were related to extent of ecstasy use. It is 
surprising that the studies which have found the deficits to be related to ecstasy 
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(Alting von Geusau et al. 2004; Dafters et al. 1999; McCann et al. 1999) have much 
smaller total lifetime doses than those studies not reporting ecstasy related deficits. So 
it appears that any observed ecstasy-related deficits in task switching may not be 
related to dosage. Moreover, the paradoxical evidence of the presence of deficits in 
light users, but not heavy users, casts doubt on the robustness of the positive findings. 
Nevertheless, as one aim of this thesis is to assess the impact of ecstasy (and 
polydrug) use on executive functions, measures of task switching will form one 
chapter combined with measures of response inhibition (see section 3.3.4). 
3.3.2 Word Fluency 
Word fluency recruits executive resources to access semantic memory and 
retrieve task-relevant information; thus the more correct words an individual can 
retrieve from a particular category, the more efficient the central executive is at this 
task (Ruff, Light, Parker & Levin, 1997). The most commonly used tasks in ecstasy 
users involve participants being given one minute to recall as many words as possible 
beginning with a certain letter (usually F, A, S), or from a particular category (e. g. 
animals). This appears to be one, task in which between groups effects are apparent in 
half of the studies (although most studies have used the same task so it may be 
something in the nature of the task). 
Using an unspecified word fluency task Klugman, Hardy, Baldeweg and 
Gruzelier (1999) compared 36 ecstasy users with 19 controls. Ecstasy users did not 
perform worse than controls. Also using an unspecified task, Wareing et al. (2000) 
found that current ecstasy users, former users and nonusers performed similarly. 
Using the Controlled Oral Word Association (COWA) task where participants have to 
generate as many words as possible beginning with the letter "F', "A" or "S" in 60 
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seconds, Semple et al, (1999) found that there were no significant differences in the 
performance of 10 regular ecstasy users and 10 polydrug controls. Fox et al. (2002) 
also used the COWA task with letter and semantic categories. In the letter category, 
participants had to generate as many words as possible beginning with a specified 
letter (F, A, S) in one minute. In the semantic category, participants were asked to 
produce as many different members of a semantic category (animals) as possible in 
one minute. Mean word generation was calculated for both conditions, and in the 
letter category, participants were also given scores for semantically linked words and 
phonemically linked words (e. g. flash, flake). Twenty ecstasy users were compared 
with 20 controls, matched for age (27.3: 27.5 years), and intelligence (estimated PMI 
100.3: 103). Ecstasy users generated significantly fewer words than the polydrug 
control in the letter condition, but not the semantic condition. In the letter category, 
regression analysis revealed that effective use of phonemic strategy accounted for the 
majority of the variance, while semantic strategy approached significance. Heffernan, 
Jarvis, Rodgers, Scholey et al. (2001 a) used a similar task in which participants had 
one minute for each of 3 categories: verbal fluency (words beginning with "C"), 
semantic fluency (animals) and a combined verbal/semantic category (household 
items beginning with "T"). The 30 ecstasy users performed significantly worse than 
the 37 non-ecstasy users on all three tasks. The results remained significant after 
control for alcohol, cannabis and tobacco. The age range for both groups was 
atypically high for samples in this area (upper limit 40 for ecstasy users and 50 for 
nonusers), so it is possible (although perhaps unlikely) that the results reflect some 
aspect of ecstasy use combined with cognitive ageing. 
Bhattachary and Powell (2001) used the COWA test comparing 20 nonusers, 
18 novice users, 26 regular users, and 16 currently abstinent users. Nonusers 
34 
performed significantly better than regular users and currently abstinent users on a 
total score for the 3 categories (F, A, S), although novice users did not differ from 
controls, and regular and currently abstinent users did not differ from each other. In 
the ecstasy user group (novice, regular, abstinent) there was a strong correlation with 
lifetime consumption of ecstasy, but not recency of use, which was replicated when 
the abstinent users were excluded (correlations with cannabis used in the last 30 days 
were also non-significant). In addition, word fluency scores of those reporting 31-50 
doses of ecstasy scored significantly lower than those reporting 1-30 doses (although 
differences between the 31-50 and 51+ groups were non-significant). Hanson and 
Luciana (2004) reported that 26 ecstasy users made more errors on the COWA task 
than 26 non drug-user controls, although they generated just as many words. When 
the ecstasy group was split into those diagnosed with a substance abuse disorder 
(N=14; lifetime consumption 95.4 tablets) and those without (N=12; lifetime 
consumption 29.3 tablets), those diagnosed with a disorder had a lower total word 
score than those without (although error scores, inappropriate words and 
perseverations were non-significant). The relationship between substance use and 
word fluency is unclear from the paper. Croft et al. (2001a) used the COWA and an 
"animal" category fluency test in a sample of 11 ecstasy/cannabis users (mean 
lifetime cannabis consumption of 10964 joints), 18 cannabis only users (mean lifetime 
cannabis consumption of 7762.4 joints), and 31 drug-naive controls. There were no 
significant differences between the ecstasy/cannabis and cannabis only groups. A 
combined drug-using group (ecstasy/cannabis and cannabis only) performed 
significantly worse than controls on the "animals" category, although test scores were 
correlated with frequency of cannabis use rather than frequency of ecstasy use, or 
total ecstasy use. Croft and co-workers concluded that the observed deficits in word 
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fluency were more related to cannabis than ecstasy. In another study Morgan et al. 
(2002) used the COWA test, and a category fluency task in which participants were 
given 90 seconds to name as many fruits as they could, then a further 90 seconds to 
name as many vegetables as they could. Eighteen current heavy recreational ecstasy 
users, who had used ecstasy on 20+ occasions and also used other drugs, 15 heavy 
ecstasy users who had been abstinent for at least 6 months but still used other drugs, 
16 poly-drug users and 15 drug-naive controls were recruited. No significant 
differences were observed between the groups, although there was a trend towards 
significance in the category fluency task, as ecstasy users tended to generate 
significantly fewer items for both categories. Back-Madruga et al. (2004) also used 
the COWA task, and found that 22 ecstasy users did not perform worse than 28 
nonusers on a total score for the "FAS" categories, and no indices of ecstasy use were 
correlated with task performance. 
Using a variation of the COWA task in which the three categories were letter, 
semantic and alternating criteria (phonological/phonological, semantic/semantic, 
phonological/semantic), Gouzoulis-Mayfrank et al. (2000) found no significant 
differences between 28 ecstasy users, cannabis users (matched for cannabis use with 
the ecstasy users) and nonuser controls in terms of number of words produced. 
Likewise, Halpern et al. (2004) found that ecstasy users did not differ from controls 
on this task, and there were no significant differences between dosage groups 
(moderate= fewer than 50 occasions, high= more than 50 occasions). Curran and 
Verheyden (2003) also failed to detect differences on category (letters "IT' and "12' 
for 90 seconds) and semantic (fruit/vegetables for 90 seconds) fluency tasks between 
32 current ecstasy users, 32 former users and 32 nonuser controls. In a clinical 
controlled study, Lamers, Ramaekers, Muntjewerff, Sikkema et al. (2003) 
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administered either 75 mg of MDMA or 0.5 g/kg of pure ethanol to 12 recreational 
ecstasy users (mean use 9 times a year; total average use 39 times). The word fluency 
task required participants to name as many four-letter words as possible beginning 
with a particular letter (B, H, R, L, P, or M) within one minute. Order of the six 
versions was balanced over test days, and number of correctly produced words was 
recorded. No significant differences were observed between baseline and treatment, 
although no control group was included, so it is possible that as the sample were 
already recreational ecstasy users, they were impaired at the start of testing. 
Four of the studies that assessed word fluency in ecstasy users found an 
ecstasy-related effect, with a further one study finding a trend towards an ecstasy- 
related effect (Morgan et al. 2002). Another study found that performance on a 
category fluency task (animals) was more related to cannabis use than ecstasy use 
(Croft et al. 2001 a). Of those studies finding an ecstasy-related effect, one found that 
this was due to the ineffective use of a phonemic strategy by ecstasy users (Fox et al. 
2002), while another study found that ecstasy users generated similar numbers of 
words to nonusers, but gave more incorrect words (Hanson & Luciana 2004). Only 
one study related performance on the word fluency task to lifetime dose of ecstasy 
use: in Bhattachary & Powell's (2001) study regular and currently abstinent users 
were worse than controls and novice users, with lifetime consumption of ecstasy use 
being strongly correlated with performance. In the other studies which did find 
ecstasy related effects, lifetime dose of ecstasy was not atypically high, so this is in 
need of further clarification. 
Most studies reviewed have used short versions of a word fluency task. It may 
be that in a task that only requires the generation of words for a minute, ecstasy users 
perform comparatively with nonusers as this is a relatively short amount of time. 
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Access to semantic memory has recently been elucidated as a separable executive 
function (Fisk & Sharp 2004; see also Chapter 2 on the structure of working 
memory). Chapter 8 of this thesis will therefore assess word fluency performance in 
ecstasy users using a longer version of a word fluency task, to give a complete 
assessment of the nature of executive function deficits. The Chicago Word Fluency 
Test also imposes constraints on words like Heffernan et al. (2001 a) who found 
ecstasy-related deficits. On another supposedly harder version, Gouzoulis-Mayfrank 
et al. required ppts to switch between phonological and semantic aspects without 
obtaining ecstasy-related deficits, so it is unclear whether ecstasy-related deficits will 
be observed on this task. The CWFT is also very useful at discriminating between 
brain damaged and non-brain damaged individuals (Cohen and Stanczak, 2000) and 
may thus provide further support for the supposition that ecstasy damages the brain. 
3.3.3 Reasoning/Decision Making 
Reasoning is an area that is under investigated in users of ecstasy. This section 
incorporates studies that have looked at planning ability (usually time taken to plan a 
specific action), logical reasoning, and analogical reasoning. 
A number of studies have investigated decision-making and planning in 
ecstasy users using the Tower of London (TOL) task. The task requires participants to 
move three different coloured balls across three different sized pegs in order to 
duplicate the goal configuration. The smallest peg can only hold one ball, the middle 
sized can hold two, and the largest peg can hold three. Only the highest ball on a peg 
can be moved, only one ball at a time, and a larger ball cannot be placed on a smaller 
one. The number of trials to be completed varies from two upwards. Trials are scored 
for planning and solution times. Fox et al. (2001) compared TOL performance 
38 
between polydrug controls and ecstasy users over 12 trials (two 2-move trials, two 3- 
move trials, four 4-move trials, and four 5-move trials). The ecstasy users who 
reported cognitive problems (average lifetime dose of 372.3) had significantly longer 
planning times than the non-problem users (average lifetime dose 356.9 tablets) and 
controls. Of the three dosage groups (low, medium, high), the high users also 
exhibited significantly longer planning times than the low and medium users. The 
groups did not differ in solution times, number of errors or number of trials 
completed. Schifano, Di Furia, Forza, Minicuci et al. (1998) compared the 
performance of 10 ecstasy users presenting for treatment at a clinic with 20 healthy 
controls. Ecstasy users performed significantly worse than controls on the TOL task 
(specific dimensions not specified), but as the sample is relatively small, and the users 
were presenting for treatment, it is possible that the results reflect some non-ecstasy 
related psychological deficit. Alting von Geusau et al. (2004) found that 17 male 
ecstasy users performed significantly worse than 12 non-ecstasy using men on two 
dimensions of the TOL (number of extra moves and hence total number of moves), 
but needed significantly less planning time, and completed the task is less time overall 
(although this was non significant). Female users were not significantly impaired on 
this task compared to female nonusers. 
Again using the TOL, Morgan (1998) compared 16 ecstasy users, 12 polydrug 
users, and 16 non-drug users. There were no group differences in number of excess 
moves, initial thinking time, proportion of perfect solutions or thinking time per 
move, meaning that all three groups performed similarly. In the second study of this 
paper, Morgan (1998) reported that ecstasy users, polydrug users (using tobacco, 
cannabis, cocaine, amphetamine, alcohol and "mushrooms"), and controls performed 
similarly on the TOL task; there was a trend towards longer initial thinking times for 
39 
the nonuser controls on the first trial (although not statistically significant), but no 
differences in the number of excess moves, proportion of perfect solutions, or 
thinking time per move for the ls` or 2 °d administrations. After analysing the pooled 
data for studies 1 and 2, there were no group differences in TOL performance. Lamers 
et al. (2003) also used the TOL task in a sample of 12 recreational ecstasy users. All 
participants were tested on 3 occasions at least 2 weeks apart. On each occasion, they 
were administered either 75mg MDMA, 0.5g/kg of pure ethanol, or placebo 
(participants were unaware of which condition they were in). There were no 
significant effects of MDMA on reaction time or number of errors made, although the 
alcohol condition did produce fewer errors than the placebo group. Fox et al. (2002) 
used a slight variation of this task in which participants were shown two arrangements 
of balls hanging in stockings, one at the top of the screen, and one at the bottom. They 
were asked to touch a numbered box at the bottom of the screen (numbered 1-6) 
which corresponded to the minimum number of moves it would take to match the 
bottom arrangement to the top arrangement, without actually moving the balls. Each 
participant was given 24 trials comprising of four of each kind of trial (1-move 
through to 6-move). Trials were, collapsed into 2 categories: easy (1-3 moves) and 
difficult (4-6 moves). Percentage correct, mean number of attempts taken to 
completion of trial, and mean latency to first response were recorded. The 
performance of twenty ecstasy users and 20 non-ecstasy user controls was compared. 
No between group differences were observed on the three test measures (percentage 
correct, mean attempts to completion, mean latency to first response), and although 
there was a within groups effect of difficulty of trial, there was no interaction between 
difficulty and group. 
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In the same sample, Fox et al. (2002) also assessed decision-making. An array 
of ten red and blue boxes was displayed at the top of the screen, and participants were 
informed that a yellow counter was hidden inside one of the boxes. The task was to 
decide whether it was more likely for the counter to be found in a red or blue box; 
ratios of red and blue boxes were changed from trial to trial. Participants started with 
100 points, and if incorrect, points were deducted, but added if their bet was correct. 
Participants had to select the appropriate response from a selection at the side of the 
screen. Mean percentage of total points bet, mean deliberation time, and mean 
probability of choosing the correct outcome were recorded. Both groups bet fewer 
points in the higher risk condition, although there was no group by ratio interaction. 
No significant group differences were observed regarding probability of choosing the 
most likely outcome, or deliberation time. 
Moving on to logical reasoning, Gouzoulis-Mayfrank et al. (2000) compared 
28 ecstasy users, 28 cannabis users (matched with the ecstasy group for cannabis use) 
and 28 non drug-users. Participants were assessed on the LPS-4 abstract logical 
thinking task (a problem solving task in which subjects have to find out the rule in a 
series of digits and letters and indicate the "wrong" element which is violating the 
rule) and the Mosaic test from the WAIS-R (which is a fluid intelligence test that also 
assesses visuomotor performance, planning and problem solving. Participants are 
required to reproduce complex visual patterns with cubes). Post-hoc analysis revealed 
that ecstasy users performed worse than both cannabis users and nonusers on these 
tasks. In Gouzoulis-Mayfrank et al. 's (2003) study, 60 ecstasy users and 30 nonuser 
controls (reporting only moderate cannabis use) were recruited. The ecstasy users 
were split into 2 groups, heavy users and moderate users. The Plan-a Day (PAD) task 
was used to assess planning ability; it requires participants to plan a working day and 
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try to solve as many tasks as possible within a given time period. In order to achieve 
this, they have to "go" to different locations, and consider the distances between 
locations, and prioritise their goals. A demanding version, with a large number of 
tasks was used. There were no performance differences on any of PAD measures 
(peak score, end score, single deletions of actions, sequences of deletions) or on the 
test overall. McCann et al. (1999) measured logical reasoning in 22 ecstasy users 
compared to 23 non-ecstasy user controls over a5 day study. The logical reasoning 
task, taken from the WRAIR-PAB is a self-paced task of semantic recognition and 
transformational grammar. The letter pair "AB" or "BA" is presented with an active, 
passive, positive or negative statement, that correctly or incorrectly describes the 
order of the letters within the pair (e. g. "A is not preceded by B"). The participant was 
required to press a key indicating whether the statement was correct or incorrect. 
There was a main effect of ecstasy use on logical reasoning, although no group by 
time taken interactions were observed, and indices of ecstasy use were not significant 
predictors of performance in the regression equation. In addition, performance was 
not significantly correlated with decreased metabolite levels in CSF. 
In a study of polydrug users, Verdejo-Garcia et al. (2005) used the 
"similarities" scale of the WAIS-R to assess analogical reasoning, which requires 
participants to state a word that is similar to a given word''. Although the difference 
between ecstasy users and nonusers was not directly assessed, in the regression 
equation the use of ecstasy among the polydrug users was a significant predictor of 
performance on the similarities task. Halpern et al. (2004) tested 23 ecstasy users and 
16 nonusers using the Revised Strategy Application Task (R-SAT), an unstructured 
pencil and paper task requiring participants to work towards an overall goal of 
2 The authors state that this is a test of analogical reasoning; It is possible that the test is a vocabulary 
measure. 
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achieving points by identifying targets with high payoff among readily available 
lesser-value targets. To maximise efficiency, participants must gradually shift strategy 
as the test progresses (i. e. become more selective in which items they choose to 
complete), thus inhibiting the response pattern reinforced at the beginning of the test. 
Ecstasy users did not perform significantly worse than nonusers, but when the ecstasy 
user group was split into moderate vs. heavy users, heavy users completed 
significantly fewer total items (counting both high and low payoff items) in the 10- 
minute period allowed, suggesting that they were less successful at developing 
efficient strategies for quickly identifying high payoff items. Zakzanis and Young 
(2001 b) assessed 24 ecstasy users and 24 nonusers on The Action Program Task 
(involving novel problem solving where participants have to devise a plan of action in 
order to solve the problem at hand. Number of steps completed on their own was 
recorded), The Key Search Task (designed to examine a participants ability to plan an 
effective and efficient course of action), The Zoo Map Test (participants have to plan 
in advance how they would visit a series of designated locations on a map of a zoo, 
without breaking a number of rules; correct locations, and number of rules broken 
were scored), and the Revised Six Elements Task (requiring participants to organise 
themselves according to certain rules and restrictions in order to complete at least 
some of the 6 subtasks at hand. Participants were scored on the number of tasks 
attempted, the number of rules broken, and time taken on any one subtask). 
Significant group differences were only observed on the overall score for the six 
elements task, and as no break down is given for the 3 separate scores on this task, it 
is difficult to ascertain the contribution of logical thinking to the decrement in overall 
performance. 
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Finally, in a clinical study, 21 MDMA experienced participants (aged between 
20 and 58) were allowed to self-administer doses of MDMA ranging from 0.8mg/lb to 
1.9mg/lb (mean of 1.14 mg/lb) and were then tested on a decision-making gambling 
task. Although no statistical analyses were performed, baseline and post-drug scores 
were compared with on-drug scores, and it was reported than 4/10 participants gave 
idiosyncratic responses during the task, which implies impaired judgement while on- 
drug. These effects were not however observed post-drug (Downing, 1986). 
It appears that one of the studies assessing planning ability using the TOL 
found that ecstasy users exhibited slower planning times than nonusers (Fox et al. 
2001), finding both a dose related effect (heavy users slower than moderate and 
nonusers) and that problem users were slower than those not reporting problems. One 
study also reported that ecstasy users performed worse on the overall measure of TOL 
performance (Schifano et al. 1999). However, one study found that although male 
ecstasy users made more moves, they actually required less planning time (Alting von 
Geusau et al. 2004). Logical reasoning and analogical reasoning seem to be 
susceptible to the effects of ecstasy, with three out of six studies finding that ecstasy 
users were impaired on tasks that assess this. One of these also found that ecstasy 
users performed worse than cannabis users and controls (Gouzoulis-Mayfrank et al. 
2000). Most studies report using tests that rely more on planning abilities (recorded in 
times), and it would be interesting to see if ecstasy users exhibit deficits "pure" 
reasoning tasks, which rely solely on one's reasoning ability. As syllogistic reasoning 
has been described as the basis for rational thought and impairments in this may be 
quite detrimental to the lives of users of ecstasy, Chapter 9 will focus on assessing 
syllogistic reasoning performance. It is also possible that performance on reasoning 
tasks may be related to deficits in executive functioning. Thus one aim of this thesis is 
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to ascertain the contribution that executive deficits may have on performance in 
reasoning tasks. 
3.3.4 Response Inhibition 
Inhibition is an executive process that refers to an individual's ability to inhibit 
automatic responses when they are no longer appropriate. A classic test used to assess 
inhibition is the Stroop test. In the test, colour words (e. g. blue, red) are printed in the 
ink of another colour, and participants are required to report the colour of the ink 
rather than the word. Thus they have to inhibit the normal response of reading the 
word. Gouzoulis-Mayfrank et al. (2000) used this task, and found no significant 
differences between ecstasy users, cannabis users and nonusers on the interference 
factor (it is not stated how this was calculated). In Morgan et al. 's (2002) study, the 
Stroop task was used, and dependent measures were the time taken to complete the 
task (longer time indicating impaired response inhibition), and number of errors 
made. Again, no statistically significant differences were observed between ex- 
ecstasy users, current users, polydrug users and nonusers. Back-Madruga et al. (2004) 
also found that ecstasy users and nonusers did not perform significantly different on 
this test, although ecstasy users did take slightly longer to complete the task (114 
seconds to 110.6 seconds). Again, Semple et al. (1999) failed to detect a significant 
difference between ecstasy users and polydrug users (N=10 in each group- which is 
perhaps too small for adequate statistical power) using the Stroop task. In a clinical 
within-participants study, Vollenweider et al. (1998) tested 13 MDMA naive 
participants on the Stroop task, at two different sessions: 1 placebo, and 1 receiving 
1.7 mg/kg of MDMA. Participants completed both the congruent (colour words 
printed in correct colour) and incongruent (colour words printed in different colour), 
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and dependent measures were "facilitation" (percentage of time reduction in 
congruent condition compared to control condition), "interference" (percentage of 
increase in time in incongruent condition compared with control word condition), 
time taken, and errors. In all cases, the main effect of MDMA was non-significant, 
and the MDMA by condition interaction was non-significant, suggesting that a single 
dose of recreational ecstasy does not affect response inhibition while on-drug. 
Alting von Geusau et al. (2004) used the Eriksen Flankers task and Stop 
Signal task to measure response inhibition. In the arrow version of the Eriksen 
Flankers task, participants are required to respond to a left vs. right pointing arrow in 
the centre of the screen by pressing a left or right response key. The central arrow is 
flanked by four arrows pointing in the same direction (congruent condition). 
Occasionally and unpredictably, the flanking arrows point in the opposite direction 
(incongruent condition), thereby activating the competing response. A rectangle 
appears on the screen, and the stimulus appears in the rectangle 500ms later. There 
were 50 practise trials and 100 experimental trials. In the Stop Signal task, 
participants have to respond as fast as possible to a left vs. right pointing arrow, by 
pressing a button on the right or left. On 25% of the trials, the colour of the arrow 
changes randomly from green to red indicating that the response should be inhibited. 
The time interval between arrow presentation and arrow colour change ranges from 
200 to 1250 ms: the longer it takes the arrow to change colour, the more difficult it is 
to inhibit the pre-potent response. There were 50 practise trials and two blocks of 100 
experimental trials. On the Eriksen Flankers task, although there was a within groups 
effect of interference on reaction time, there was no between groups difference; with 
reference to accuracy, male ecstasy users did not perform worse than male controls, 
but there was a main effect of ecstasy use in the female group, and the group by 
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interference interaction was significant for females, indicating that female ecstasy 
users performed worse on the incongruent condition. There were no group differences 
in either reaction time on the stop signal task, either in males or females. 
Using the Random Letter Generation task, Wareing et al. (2000) assessed 
response inhibition in current, previous and non-ecstasy users. In the version used, 
participants are required to generate random sequences of consonants only, and are 
asked to avoid repeating the same letter sequence, avoid alphabetical sequences, and 
try and speak each letter with the same overall frequency. Three sets of letters were 
generated, one at a rate of I letter every 4-seconds, one every 2-seconds and one 
every 1-second. Redundancy (the extent to which each letter is said with the same 
overall frequency), number of letters produced, and number of vowel intrusions were 
recorded. Both ecstasy user groups were impaired relative to controls on the task 
(mainly due to more vowel intrusions at all 3 rates, and also a higher degree of 
redundancy, and fewer letters at the 1-s rate), and the deficit remained significant after 
control for the use of other drugs. This suggests that the effects of ecstasy persist for 
at least 6 months after abstinence. However, the estimated average lifetime dose of 
ecstasy was atypically high (about 1000 tablets) and the sample sizes are relatively 
small. In a subsequent follow up study, where participants were allowed to generate 
consonants and vowels (not the consonants only version used in the first study), the 
results were not replicated (although the average lifetime dose was also somewhat 
smaller at 583 tablets- Wareing, Fisk and Murphy 2002). More recently, Fisk et al. 
(2004) also found that ecstasy users were unimpaired on the random letter generation 
task. There was no overall group effect and interactions between task difficulty and 
user group were non-significant. 
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None of the published studies that used the Stroop inhibition task found that 
ecstasy users were impaired to compared to nonusers. One study using the random 
letter generation task (Wareing et al. 2000) found that ecstasy users performed worse 
than nonusers, however this result has not been replicated by two subsequent follow 
up studies from the same laboratory (Fisk et al. 2004; Wareing, Fisk, Murphy and 
Montgomery 2003), and should be treated with caution, especially as the lifetime dose 
of ecstasy users in the original paper may be atypically high. In only one paper using 
a novel test of inhibition, female users performed worse than female nonusers (Alting 
von Geusau et al. 2004). Consequently it appears that recreational use of ecstasy does 
not appear to impair response inhibition. Nonetheless, one aim of this thesis is to 
provide a complete assessment of executive functions in ecstasy users, and as 
mentioned earlier one chapter will focus on deficits in task switching and response 
inhibition. 
3.3.5 Working Memory and Updating 
Updating the contents of working memory refers to an individual's ability to 
monitor incoming information and update the contents of working memory, deleting 
material that is no longer relevant. The updating executive component process also 
appears to be affected by ecstasy use. 
One popular task which uses the updating component of working memory is 
the backward digit span task. In this task participants are required to repeat sequences 
of digits presented orally by the experimenter, backwards. The length of the 
sequences increases with the participants' success, and points are gained for each 
sequence repeated in the correct order. Results on this task suggest that ecstasy users 
are unimpaired. Gouzoulis-Mayfrank et al. (2003) found no differences between 
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heavy ecstasy user, moderate users and nonusers on this task. Thomasius et al. (2003) 
also failed to detect a difference between current ecstasy users, former users, polydrug 
users and controls. It is also noteworthy that the male current ecstasy users had a 
mean maximum exposure per session of 12 tablets, and the male former users of 9 
tablets. It has been suggested that a single neurotoxic dose of ecstasy is all that is 
required for serotonergic neurotoxicity, which in turn would supposedly manifest 
itself in cognitive deficits. Assuming that self-reports of ecstasy use in this study are 
accurate, it is especially surprising that no between group differences were observed, 
and also that indices of ecstasy use were not significant predictors of performance. 
Similarly, McCardle et al. (2004) failed to find ecstasy-related differences on this 
task. Likewise, Bhattachary and Powell (2001) found no differences between 
nonusers, novice users, regular users and currently abstaining users on this task, 
neither did recency of ecstasy use, lifetime ecstasy consumption, or cannabis use in 
the last 30 days correlate with performance on the task. By way of contrast, 
Gouzoulis-Mayfrank et al. (2000) found that ecstasy users performed worse on the 
backward digit span task (with a score of 7 compared to 9 for nonusers), but 
differences between cannabis users and ecstasy users, and cannabis users and 
nonusers were non-significant. Finally, Croft et al. (2001x) found that while a 
combined ecstasy/cannabis group did not perform significantly worse than cannabis 
only users and controls on the task, a combined drug user group (incorporating 
ecstasy/cannabis and cannabis only users) did perform worse than non-drug users. 
This suggests the possible mediating effects of other drugs on memory, and highlights 
the possibility that cognitive deficits in ecstasy users may be in part related to 
cannabis use. 
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The Subtracting Serial Sevens (SSS) task has also been used to tap working 
memory updating in ecstasy users. The task requires participants to subtract 7 from a 
given 3-digit number and then continue to count backwards in 7s. The number of 
correct subtractions and errors made in 90-seconds are usually the dependent 
measures. Curran and Verheyden (2003) found that prior to a tryptophan drink, 
previous ecstasy users carried out fewer correct subtractions (22.8) than current users 
(28.5), or controls (27.7). After controlling for pre-tryptophan supplementation scores, 
there were no significant group or treatment effects on post supplementation scores. 
Frequency of ecstasy use was also correlated with baseline scores on the task. A 
previous study from the same laboratory (Curran & Travill 1997) also found that 
ecstasy users carried out significantly fewer subtractions than nonusers on days 1,2, 
and 5 after ecstasy use, although there as no difference in terms of errors committed. 
In a study comparing former and current ecstasy users with polydrug users and 
nonusers (Morgan et al. 2002), it was found that while there was no ecstasy-related 
deficits in terms of number of correct subtractions made in 90s (number not reported), 
both groups of ecstasy users produced significantly more errors than controls and 
polydrug users (again numbers not reported). 
Wareing et al. (2004b) used the computation and reading span tasks which 
both contain a serial recall component and the simultaneous processing of information 
(the former numerical, the latter verbal). Both current and former users of ecstasy 
performed worse on the computation span task. This remained significant after control 
for the use of other drugs. This was replicated by Fisk et al. (2004), where ecstasy 
users again performed worse than controls on the computation span task (which also 
remained significant after control for indices of other drug use). A similar task was 
used by Dafters et al. (1999), which required the recall of words following distraction 
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with a mathematical problem, in which participants were presented with a series of 
cards that contained either a word or a mathematical problem to solve. Recall of the 
words was tested at appropriate points throughout the task. As this was a correlational 
study (which did not incorporate a control group), statistical analysis for between 
group differences was not performed, although correlations between ecstasy use and 
performance on this task were non significant. 
The final task in this section which is used to tap working memory updating is 
the "N-back" task. This task consists of the sequential visual presentation of single 
digits or simple figures. Participants have to press a button when the presented digit or 
figure is the same as the one presented a specified number of trials earlier. Gouzoulis- 
Mayfrank et al. (2003) used the 2-back version (i. e. having to remember the stimulus 
that was presented 2 trials earlier). No significant differences were observed between 
the heavy users, moderate users and controls either for errors or correct responses for 
figures or digits. In Daumann et al. 's (2003) study, participants performed three N- 
back tests, consisting of the visual presentation of single letters (B, C, D, G, P, T, F, 
N, L), and had to press a button when the target stimulus appeared. For the 0-back 
condition, participants responded when a stimulus within a sequence matched a target 
stimulus specified at the beginning of the trial (specified letter was "D"). In the 1- 
back condition, targets were defined as stimuli within the sequence that were identical 
to the immediately preceding one, and in the 2-back, if the target was identical to one 
that was presented two trials before. Thus the 2-back is the hardest of the three, 
placing the most demand on updating resources. Although there was a within- 
participants effect of memory load, pure ecstasy users (using solely ecstasy), 
polyvalent ecstasy users (also using amphetamine/cannabis), and controls did not 
differ significantly in terms of reaction times or errors. Pure ecstasy users did however 
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present lower levels of activation during the 1-back task in the inferior temporal and 
angular region. Again in the 2-back condition, pure ecstasy users showed lower 
activations, mainly in the angular gyrus compared to polyvalent users and controls. 
Jacobsen et al. (2004) used this task, and although they did not perform statistical 
analysis for between group differences, ecstasy users did fail to activate certain brain 
areas relative to nonusers on the 1- and 2-back conditions. 
In attempting to separate the effects of ecstasy on various executive functions, 
Alting von Geusau et al. (2004) used the Tic-Tac-Toe and mental counters tasks. In 
the Tic-Tac-Toe task, participants are required to keep visual information active in 
working memory about the orientation of patterns and figures. In a 3x3 grid, Xs and 
Os are presented briefly during the memorising phase. In the recognition phase, Xs 
and Os are presented one after another in the grid. The task is to press a button as 
soon as soon as the pattern of Xs and Os matches the pre-specified pattern. Memory 
load is varied using patterns consisting of three or four stimuli. The number of trials 
per block was 15, and the series length of the stimulus presentation until the pre- 
specified pattern was reached varied from 4-9 presentations. The mental counters task 
requires participants to keep numerical information active in working memory, by 
keeping track of the values of two or three (blocked) independent "counters" which 
change rapidly and in random order. The counter consists of a horizontal line above or 
below which squares appear. Participants add one to the value of the counter if above 
the line, and subtract one if below the line. When any counter reaches a given criteria 
value, participants have to press a button. Length of the series of stimuli was 5 or 7. 
On the Tic-Tac-Toe task, there were no significant between groups differences in 
terms of accuracy, but in male ecstasy users, there was an interaction between 
working memory load and reaction time (as the male ecstasy users were slower in the 
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high load condition). Male ecstasy users were also slower than controls on the mental 
counters task, although females were not impaired. It is noteworthy that these tasks 
appear to be relatively simple compared to other tasks used to assess memory 
updating, and may thus not be true indices of performance ön this function. 
Only two of the six studies using backwards digit span to assess memory 
updating found group differences, one finding that ecstasy users were worse than 
controls but not cannabis users (Gouzoulis-Mayfrank et al. 2000), and one finding that 
a drug-using group (ecstasy/cannabis and cannabis only) performed worse than a non 
drug-using control group (Croft et al. 2001 a). It is therefore possible that deficits on 
the backwards digit span task may relate to cannabis use more than ecstasy use, or the 
concomitant use of cannabis and ecstasy. Three studies using the Subtracting Serial 
Sevens task found that current and former users of ecstasy performed worse than 
nonusers, one through making more errors on the task (Morgan et al. 2002) and two 
through fewer correct subtractions in the allotted time (Curran & Travill 1997; Curran 
& Verheyden 2003). The latter study also found that frequency of ecstasy use was 
correlated with baseline scores. Using the computation span task two studies have 
found that ecstasy users performed worse than nonusers (Fisk et al. 2005; Wareing et 
al. 2004b). Two studies that did not incorporate a control group (Daumann et al. 2003; 
Jacobsen et al. 2004) found that ecstasy users failed to activate certain brain areas 
while performing the 1- and 2-back conditions of the n-back task. So it appears that 
ecstasy users do not consistently show impairments on simple tasks of memory 
updating (e. g. digit span and SSS). It has been suggested that poor performance on the 
SSS task (through giving more errors) is related to heightened impulsivity so it is 
possible that ecstasy users exhibit heightened impulsivity leading to shorter response 
latencies and so more errors on this task, rather than being unable to perform the 
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subtractions correctly). Both studies that used a more complex memory updating task 
(Fisk et al. 2004; Wareing et al. 2004b) found that ecstasy users performed worse than 
nonusers supporting the view that memory updating is relatively preserved after 
ecstasy use under less demanding task conditions. The two studies finding that ecstasy 
users failed to activate certain brain areas during the 1- and 2- back test did not make 
between group comparisons in performance measures, so this should be treated with 
caution as another study using the task and comparing heavy users, moderate users 
and controls found that ecstasy users were did not perform worse (Gouzoulis- 
Mayfrank et al. 2003). 
Chapter 6 of this thesis will seek to investigate ecstasy-related differences in 
memory updating. The more complex tasks mentioned above that did find between 
group differences may also rely heavily on arithmetic ability (the SSS through being 
able to subtract, and the computation span task through being able to add). 
Accordingly a purer memory-updating task will be used to assess working memory 
updating. The task used will be a running memory task in which participants are 
presented with strings of letters (of varying length), and are required to remember the 
last six letters of each string (unaware of how long each will be). According to Morris 
and Jones (1990) and Kusak, Grune, Hagendorf and Metz (2000) updating from the 
fourth letter onwards is believed to require executive control processes. Consonant 
updating was chosen to tap this aspect of executive function as it is relatively 
complex. Whereas the n-back task is only generally used with a maximum memory 
load of three, the task used in this thesis will require participants to recall six letters 
from strings of varying length. It is therefore expected that under this higher memory 
load, ecstasy-related updating deficits may be elucidated. 
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3.4 Attention 
It is possible that while ecstasy users are exhibiting deficits in higher level 
cognitive processes, this may be due to lower level functions such as poorer 
attentional skills (i. e. ecstasy users find it harder to concentrate their attention for 
example on a memory updating task, but are not impaired on the task per se). Most 
studies in this area have assessed focused and divided attention, although some papers 
have reported findings on more complex tasks (e. g. Object Movement Estimation 
under Divided Attention). 
Parrott et al. (1998) used a number vigilance task to assess attention. A single 
target was displayed on the right of the screen and when it matched a pre-specified 
target (from a changing series), participants were required to press the yes response 
key. Dependent measures were number of target selections and response time. All 
three groups (nonusers, novice users, and regular users) had similar reaction times and 
a similar percentage correct indicating that they were not impaired compared to 
controls in this task. Gouzoulis-Mayfrank et al. (2000) used a number of subtests from 
the Test for Attentional Performance (TAP) test battery. Test 1, for tonic and phasic 
alertness required participants to respond to a simple visual target appearing on a 
computer screen, preceded or not preceded by a warning acoustic signal (reaction 
time measured). The selective visual attention Subtest required participants to identify 
two critical pre-specified targets (from five similar complex figures), and react by 
pressing a computer key (and ignoring non-critical targets). The divided attention 
subtest is a demanding dual RT task, requiring attention to simultaneously presented 
visual and acoustic cues. Participants have to respond to the appearance of a square 
composed of small crosses among other irregular shapes on the screen, and to any 
irregularity occurring in an alternate sequence of high and low tones. In the 
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intermodal integration subtest, participants view upward or downward directed arrows 
on the screen, and simultaneously listen to high or low tones. They have to react by 
pressing a computer key whenever a match is detected (e. g. simultaneous appearance 
of a high tone and upward arrow). Finally, the visual scanning task requires 
participants to scan a 5x5 matrix of similar graphic elements for a target, which is 
presented before the onset of the trial. In the test of selective visual attention, the 
ecstasy users had longer reaction times than the nonusers, and cannabis users. In the 
divided attention and intermodal integration tasks, ecstasy users had significantly 
longer reaction times than cannabis users. Longer reaction times in the ecstasy users 
in the divided attention task were also associated with a longer period of ecstasy use. 
In their 2003 study, Gouzoulis-Mayfrank et al. used the visual scanning sub-test of the 
TAP and found that there were no group differences between heavy, moderate and 
non-ecstasy users. To further support this Thomasius et al. (2003) also used the 
divided attention and selective visual attention subtests of the TAP test battery, but no 
significant differences were observed between previous ecstasy users, current users, 
polydrug users, and nonuser controls. 
Using the Test of Everyday Attention (TEA) battery Zakzanis et al. (2002) 
assessed attentional processes in ecstasy users and nonusers. The first subtest is a map 
search task, requiring participants to circle as many symbols (restaurants, garages, and 
petrol stations) as they can on a map of Philadelphia, USA. They are given one 
minute to circle as many symbols as they can in red pen (map search 1), then an 
additional minute to circle more symbols in blue pen (map search 2). In both cases, 
total number of symbols correctly circled in the time span is recorded, In the Elevator 
Counting subtest, participants have to count a series of single tones which each 
symbolise a floor on the elevator. The floor count obtained at the end of counting is 
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compared with the correct count. This task is used as a baseline for the elevator 
counting with distraction task, which is essentially the same, except participants are 
required to ignore a high pitched distracter tone. The visual elevator task requires 
participants to count a series of elevator icons and to change direction on the basis of 
the arrows within each series (either up or down). The floor count, and time taken to 
complete each series are recorded. The elevator counting with reversal task requires 
participants to listen to three different tones; the middle tone represents a floor, while 
high-pitched tones represent upward arrows, and low-pitched tones downwards 
arrows (thus participants change direction of counting when they hear a high or low 
tone). The telephone search test requires participants to search through a phone 
directory and circle services with double symbols (two squares, stars, circles, crosses) 
by the company name. Total number correctly circled and time taken to complete 
were recorded. The Telephone search while counting task was the last Subtest, and 
combined elevator counting with the telephone search. Dependent measures were the 
floor count for each series, the total number correctly circled, and time taken to 
complete the tasks. Although the only significant ecstasy-related effect was on the 
map search 2 task, correlations between ecstasy dosage and map search 1, visual 
elevator 2, and elevator counting with reversal were significant. A significant 
correlation was also observed between the number of ecstasy tablets used and the 
telephone search while counting. In the same test battery Dafters et al. (2004) used the 
visual elevator to assess attentional processes, although in this study differences 
between heavy ecstasy/cannabis users, light ecstasy/cannabis users, cannabis only and 
drug-naive participants were non-significant. 
In Curran and Verheyden's (2003) study participants were administered a 
tryptophan drink, and the digit cancellation task (cross out target digits in a random 
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sequence of 400 digits) was used to assess focussed attention, and the Rapid Visual 
Information Processing (RVIP) test was used to assess sustained attention. In the first 
part (10 minutes) of the RVIP, digits are presented on a computer at a rate of 100 
digits/minute, and participants have to press a key when either 3 consecutive odd, or 3 
consecutive even digits appear. In the second part (5 minutes), participants performed 
the task again while listening to high and low tone through headphones, and were 
required to count the number of low tones. On single digit cancellation, there were no 
group or treatment effects. On double-digit cancellation, groups did not differ pre 
treatment, but there was a group by time interaction: current ecstasy users were slower 
post than pre drink, and previous users were slower than other groups, but took about 
the same time pre and post drink. On the 10-minute RVIP task, previous users made 
fewer correct responses than current users or controls pre-drink. After covarying for 
pre-drink scores, these differences were non-significant post-drink. Ex-users also 
performed slower than current users and controls. In the 5-minute RVIP, there was a 
trend for pre-drink differences. After covarying for these, ex-users made fewer correct 
responses than the other two groups, although errors and reaction times were not 
significantly different. One possible implication of this study is consequently that 
discontinuing ecstasy use may adversely affect attentional processes more so than 
continuing use, as both user groups had similar average doses (although ex-users 
reported using the drug more frequently. See Table 3.1), and current users had used 
for a longer period of time overall and had a shorter abstinence period. 
Jacobsen et al. (2004) assessed sustained attention using Conners Continuous 
Performance Test (CPT), and selective and divided attention were assessed using a 
computerised word recognition task. Auditory selective attention was assessed by 
comparing an auditory simple attention condition (press one button if verbal stimulus 
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is a real word and another if not; simultaneously presented with 4 diagonal lines on 
the screen) with an auditory selective attention condition (same judgement, with 
visual word or non-word distractors on the screen). Visual selective attention was 
assessed by comparing a visual simple attention condition (participants viewed a letter 
string and pressed one button if the stimulus was a real word, and another button if 
not; with simultaneous presentation of a tone) with a visual selective attention 
condition (same judgements, but instead of tones auditory word or non-word 
distracters were played through the headphones) condition. In the divided attention 
condition, word or non-word stimuli were presented simultaneously in both auditory 
and visual modalities. A visual cue was then presented to indicate which word/non- 
word combination was correct, and participants then pressed the corresponding 
button. So, unlike selective attention, divided attention in this case required 
participants to fully process both auditory and visual stimuli before making a 
judgement. There were no significant between group differences in terms of accuracy, 
although there was an ecstasy-related trend towards less accuracy. Ecstasy users did 
have significantly longer reaction times across simple, select, and divided attention 
conditions (this remained significant after removal of those with THC metabolites in 
their urine). There was also an ecstasy-related trend towards longer reaction times on 
the CPT. Significant correlations were observed between the number of ecstasy 
episodes reported and accuracy on the visual simple and divided attention tasks. 
Gamma, Buck, Berthold and Vollenweider (2001) also used a computerised CPT in 
which participants have to click a mouse button with the right index finger whenever 
they view the target sequence of letters (A followed by X), but ecstasy users did not 
give more omission (missed targets) or commission (false alarms) errors on this task. 
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Similar results were obtained by Gamma, Buck, Berthold, Hell and Vollenweider 
(2000) in a clinical study after administration of 1.7mg/kg of MDMA. 
Lamers et al. (2003) used three tasks to assess attentional processes in 12 
regular ecstasy users, who were administered either 75mg MDMA, 0.5 g/kg of pure 
ethanol, or placebo. The Divided Attention Task (DAT) assesses a participant's 
ability to divide attention between tracking (trying to keep a cursor on a computer 
screen central using a joystick) and monitoring (participants have to monitor 24 
peripheral LED displays fixed to the four sides of the screen; these display the 
numbers 0-9, and change every 5-s; participants have to remove their foot from a 
pedal when they detect the target numeral-"2") tasks performed simultaneously. The 
Object Movement Estimation under Divided Attention (OMEDA) task requires 
participants to estimate the Time To Contact (TTC) of a moving object to a fixed 
point (in this case, the time taken for a red dot to travel to the centre of the screen, 
disappearing under a yellow circle before it gets there), while in the divided attention 
condition, participants also have to press a key if a geometric shape at the top of the 
screen, and the centre match. The Signal Detection Task (SDT) was also used, which 
is a visual search task requiring participants to press a key when a target configuration 
of squares is achieved on the screen (400 squares are presented altogether, with 56 
target configurations). There was a main effect of treatment on tracking performance 
in the DAT, and separate comparisons showed that MDMA administration actually 
improved performance by lowering errors, compared to placebo. In the OMEDA task, 
MDMA elevated TTC error (both over and under estimation), but no treatment effects 
were observed on the OMEDA divided attention condition. There were no group 
differences on the SDT task. There thus appears to be an unanticipated ecstasy-related 
improvement in some aspects of attention (tracking performance) although ecstasy 
60 
users were neither impaired nor improved by a dose of ecstasy on the SDT task or the 
divided attention aspect of the OMEDA (although there was an increased incidence of 
errors on this task. 
Semple et al. (1999) also assessed attention using the Wechsler Memory 
Scale-Revised (WMS-R) digit span task, but no differences were observed between 
the groups, and performance was not related to observed reduced serotonin binding in 
ecstasy users. Hanson and Luciana (2004) assessed attention using a letter 
cancellation task, and found that 26 ecstasy users made more errors (failing to cancel 
a letter) than 26 nonusers, although there were no differences in reaction time or 
commission errors. These participants had a relatively low lifetime dose, and those 
who were diagnosed with mental health problems performed worse than those 
without, lending further support to the importance of predisposing factors in drug use 
research. Using a visual search task requiring participants to pick a target letter ("L") 
out of a 2x2 or 4x4 array of distractor letters in different orientations, Parrott and 
Lasky (1998) found that there were few differences in scanning ability between the 
novice, regular, and non-ecstasy users off-drug, but the regular users were impaired 
compared to controls while on-drug, as were the novice users (to a lesser extent). 
To summarise, of the studies assessing selective visual attention two found 
that ecstasy users had longer reaction times than nonusers (Gouzoulis-Mayfrank et al. 
2000; Jacobsen et al. 2004), with two studies also finding significant correlations 
between performance and ecstasy dosage (Zakzanis et al. 2002) and ecstasy use and 
accuracy (Jacobsen et al. 2004). Of the studies assessing divided attention, one found 
that ecstasy use exhibited longer reaction times than nonusers (Jacobsen et al. 2004), 
and one found that previous ecstasy users gave fewer correct responses (Curran & 
Verheyden 2003). Three studies also found correlations between reaction times and 
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length of ecstasy use (Gouzoulis-Mayfrank et al. 2000), DAT performance and 
ecstasy dosage (Zakzanis et al. 2002), and accuracy and dosage (Jacobsen et al. 2004). 
Of the studies assessing simple attention, one found that ecstasy users were slower 
after tryptophan supplementation (Curran & Verheyden 2003); one found that ecstasy 
users made more errors than nonusers (Hanson & Luciana 2004); and one found that 
performance was associated with lifetime dose of ecstasy (Zakzanis et al. 2002). 
Assessing on-drug performance, one study found that a dose of ecstasy improved 
tracking performance (Lamers et al. 2003); conversely one study found that ecstasy 
users made more errors on a visual search task while on-drug (Parrott & Lasky 1998). 
Clearly there is much evidence for ecstasy-related deficits in attentional processes. 
Given that executive processes have been viewed from the perspective of an 
attentional control system (Norman and Shallice, 1986), while this thesis will not 
directly assess attention per se, a key focus will be on higher level executive 
functioning. Clearly it is possible that deficits in lower-level attentional processes 
might result in executive function deficits. A key purpose of this thesis is to establish 
whether ecstasy-related executive deficits do actually exist. 
3.5 Immediate and Delayed Recall 
Immediate and delayed recall are areas that most consistently appear to be 
susceptible to the effects of ecstasy use. Most studies in this area have used word 
recall tasks such as the Rey Auditory Verbal Learning Test, or prose recall tasks such 
as the Rivermead Behavioural Memory Test. Twenty out of the twenty-five reviewed 
studies found a relationship between ecstasy use and performance on recall tasks. 
Parrott et al. (1998) used immediate (15 words appear on a screen, then 
participant has to write down as many as they can remember) and delayed (required to 
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again recall the words from the original list after a number of other tasks) recall tasks. 
On both of these tasks, novice and regular ecstasy users performed worse than 
controls. The immediate word recall task (using 16 words) also revealed ecstasy- 
related differences in Parrott & Lasky's (1998) study, in which recreational ecstasy 
users (both novice and regular) recalled fewer words than controls at all testing 
sessions (at baseline when ecstasy free for 7 days, on-drug, 2-days post-drug, and 4- 
days post drug). 
Gouzoulis-Mayfrank et al. (2000) used a German version of the Rey Auditory 
Verbal Learning Task (RAVLT) which consists of the presentation 15 words, and a 
number of learning and recall trials, with trial 1 being the immediate recall condition. 
Ecstasy users recalled fewer words than nonusers, and furthermore poorer 
performance was associated with heavier ecstasy use (estimated cumulative lifetime 
dose). Thomasius et al. (2003) found that ex-ecstasy users recalled fewer words on 
trial one than drug naive participants (no significant differences between current users 
and controls or polydrug users), and performance was best predicted by the typical 
number of exposures to ecstasy. Again using word recall, Reneman, Lavalaye. 
Schmand, de Wolff et al. (2001a) found that both former and current ecstasy users 
recalled significantly fewer words than controls on both the immediate and delayed 
recall RAVLT tests, although extent of ecstasy use was only associated with 
immediate recall performance, and in addition, recall performance was not related to 
observed decreases in serotonin transporter density. In a further study from the same 
laboratory (Reneman, Majoie, Schmand, van den Brink et al. 2001b) ecstasy users 
(N=8) recalled significantly fewer words than 7 controls on the delayed condition 
only, and decrements in delayed recall were strongly associated with decreases in N- 
acetylaspartate creatine (a measure of neuronal function) in the prefrontal cortex. In 
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another study, monthly dose of ecstasy (not duration of use, number of exposures, or 
cumulative lifetime dose) was the only significant predictor of impaired immediate 
verbal memory, and the interaction between vocabulary score and dose on immediate 
verbal memory approached significance, with those with higher doses and lower 
vocabulary scores performing worst (Bolla et al. 1998). 
Ecstasy users also performed worse at baseline (day 1 of a 5-day inpatient 
study) on the delayed recall of digit and symbol pairs (McCann et al. 1998). Not all 
studies however report differences in immediate recall: on trial 1 of the Rey Auditory 
Verbal Learning Test (participants hear a list of words, and in trial 1 have to recall as 
many as possible after initial presentation) there were no significant differences in 
recall between ecstasy users and nonusers (McCardle et al. 2004). Using a similar test, 
Halpern et al. (2004) found that list learning performance of ecstasy users and 
polydrug-using controls was not significantly different, and no dosage effects were 
observed (moderate <50 occasions vs. heavy >50 occasions). A study employing the 
California Verbal Learning Test (participants are presented orally with "Monday's 
shopping list" containing 16 items in 4 groups e. g. fruit, herbs, and have to recall as 
many as possible on successive repetition trials, and after a delay) used sample sizes 
of limited statistical power (N=10), and although larger doses of ecstasy were 
associated with decreased overall verbal memory performance, this was reduced to 
below statistical significance after control für pre-morbid IQ (Semple et al. 1999). 
Moving onto prose recall, using a task adapted from the WMS participants 
were required to listen to a short story, and then recall as much of it as they could 
remember (immediate condition), and then recall it again after 90 minutes (delayed 
condition). One point was given for each correct idea (maximum of 40). Neither users 
reporting problems, nor those not reporting problems were impaired on the prose 
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recall task, and no dosage effects were observed (control vs. low, medium, and high 
users) between the groups on either condition (Fox et al. 2001). Using the same test, 
an early study found that compared to published norms, 5 out of 9 ecstasy users 
exhibited deficits on the immediate recall condition, with four also exhibiting deficits 
on the delayed recall condition (Krystal et al. 1992), although performance was not 
correlated with cumulative lifetime dose of ecstasy. Bhattachary and Powell (2001) 
also used a prose recall task containing 24 ideas, with immediate (immediately after 
oral presentation of story) and delayed (after 30 minutes) recall. There was a main 
effect of group, with non-users showing significantly better memory than novice, 
regular and abstaining ecstasy users (although regular and abstaining users did not 
differ). For delayed recall, there was also a main effect of group, with nonusers 
recalling more than regular and abstinent users (although differences between 
nonusers and novice users were non-significant). Immediate and delayed recall were 
both correlated with lifetime consumption of ecstasy (higher consumption predicting 
lower scores). In the novice and regular users, there was also a positive correlation 
between recall and days since last ecstasy use (although when the currently abstaining , 
users were included, this was reduced to below statistical significance. Bhattachary 
and Powell (2001) also controlled for cannabis and IQ in the regression equation, and 
both came out as non-significant predictors). 
Zakzanis and Young (2001 a) used the immediate and delayed prose recall 
subtests of the Rivermead Behavioural Memory Test (RBMT), again requiring 
participants to listen to a short news story and recall as many ideas as possible 
(maximum of 21) immediately, then after a delay. The 15 ecstasy-users were tested 
twice over a period of 12 months, and performance on both the immediate and 
delayed recall tests had declined. Morgan (1999) also used the immediate and delayed 
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recall subtests of the RBMT. Ecstasy users recalled significantly fewer ideas than 
polydrug users and controls in both the immediate and delayed recall conditions. 
Cannabis consumption was significantly correlated with immediate recall 
performance in the ecstasy group, and across the ecstasy and polydrug group, 
although cannabis consumption was not a significant covariate. There were also 
trends towards significant correlations between immediate recall and average dose of 
ecstasy and duration of use. Further analysis also revealed that those ecstasy users 
who had used ecstasy within the last 1-6 months recalled significantly fewer ideas 
than those who had not used ecstasy for over 6 months. A further study using the 
same test found that current and ex-ecstasy users performed significantly worse than 
controls on both the immediate and delayed recall tasks, and ex-users also performed 
worse than polydrug users (although current users and polydrug users were not 
significantly different). There were also significant negative correlations between the 
lifetime consumption of current ecstasy users and immediate and delayed recall 
performance, and lifetime ecstasy consumption was the only significant predictor of 
recall in the regression equation (Morgan et al. 2002). In another study, former 
ecstasy users performed worse than drug-naive controls on both immediate and 
delayed recall subtests of the RBMT, although amount of cannabis smoked in the last 
year was found to be the most significant predictor of performance (Thomasius et al. 
2003). Curran and Verheyden (2003) found that only former users of ecstasy were 
impaired on the delayed recall condition, with current users showing no impairment, 
although duration of use was associated with lower scores in both groups. 
By way of contrast, in Dafters et al's (2004) study, there were no immediate or 
delayed recall differences between heavy ecstasy/cannabis users, light 
ecstasy/cannabis users, cannabis only users and controls. When the drug-users were 
66 
collapsed into one group, there was a main effect of drug use, with the combined drug 
user group performing significantly worse than the drug-naive. The combined drug 
using group also performed significantly worse than the controls on a free recall task, 
where participants were presented orally with 30 words, and immediately required to 
recall them. In a correlational study, performance on the RBMT news story was not 
significantly correlated with indices of drug use (Dafters et al. 1999). In a sample of 
ecstasy users reporting for treatment (Schifano et al. 1998), 150 ecstasy users were 
significantly impaired compared to 20 nonuser controls on the overall RBMT battery 
measure (separate subtest scores not reported). Ecstasy users were also found to have 
lower age-corrected percentile scores in a study assessing immediate and delayed 
prose recall, although no control group was incorporated. Those ecstasy users who 
also reported substance use disorders (N=14) scored lower on both tests than those not 
diagnosed with substance use disorders (N=12) (Hanson & Luciana 2004). There was 
a trend for poorer performance in former, not current users of ecstasy in Curran and 
Verheyden's (2003) study, and Halpern et al. (2004) noted that 23 ecstasy users 
performed worse than polydrug controls on a similar prose recall task; when the group 
was split into 2 dosage groups: <50 occasions, >50 occasions, no such deficits were 
seen (although once again, small sample sizes may have given limited statistical 
power). Gouzoulis-Mayfrank et al. (2003) used the "construction of a library" subtest 
of a German test battery (LGT-3), in which participants are given a text consisting of 
10 sentences about the construction of a library (e. g. name of the architect, address 
etc. ), and in the retrieval phase they have to answer a list of 21 questions on these 
items. There was a main effect of group, and post-hoc analyses revealed that this was 
due to the heavy users performing worse than the moderate users, but not controls. 
This was reduced to below statistical significance following control for general 
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knowledge scores. Frequency of ecstasy use was also significantly associated with 
immediate recall. 
To recapitulate, eight studies found that ecstasy users were impaired in some 
aspect of word recall with seven (Bolla et al. 1998; Gouzoulis-Mayfrank et al. 2000; 
McCann et al. 1999; Parrott et al. 1998; Parrott & Lasky 1998; Reneman et al. 2001 a; 
Thomasius et al. 2003) finding deficits in both immediate and delayed recall, and a 
further one (Reneman et al. 2001b) in delayed word recall only. Of these, three 
studies found that indices of ecstasy use were related to performance: in one study 
recall was correlated with estimated lifetime dose of ecstasy (Gouzoulis-Mayfrank et 
al. 2000); in one performance was predicted by typical number of ecstasy exposures; 
and in another monthly dose predicted immediate recall score (Bolla et al. 1998). 
Referring to Prose recall, six studies found that ecstasy users performed worse than 
nonusers (Bhattachary & Powell, 2001; Halpern et al. 2004; Krystal et al. 1992; 
Morgan 1999; Morgan et al. 2002; Schifano et al. 1998), with a further two finding 
deficits in former users only (Curran & Verheyden 2003; Thomasius et al. 2003). One 
study found deficits on a novel prose recall task to be dose related with heavy users 
recalling fewer items than moderate users (Gouzoulis-Mayfrank et al. 2003). Finally, 
one study found that deficits in prose recall were more related to polydrug use than 
solely to ecstasy use (Dafters et al. 2004). Consequently this seems to be an area of 
ecstasy research that yields significant results in the majority of studies, and it is 
therefore likely that the use of ecstasy does impair word and prose recall; thus 
immediate and delayed recall will not be researched further in this thesis. 
3.6 Recognition 
Tasks used to assess recognition in ecstasy users used either visual (e. g. face 
or figure recognition) or verbal (e. g. word recognition) tasks. Tasks took the format of 
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matching-to-sample requiring participants to recognise a pre-specified target from a 
number of choices. Recognition tasks in ecstasy users did not generally yield 
significant differences, perhaps due to the relative simplicity of the tasks. 
An auditory recognition task was used by Fox et al. (2001) in which 
participants were required to recognise 24 pre-specified target words from a list of 40 
unrelated words. No significant differences were observed in the number of words 
recognised with respect to those reporting problems/not reporting problems or dosage. 
Using a verbal and face recognition task (The Warrington Recognition Task, requiring 
participants to identify the face/word that was previously presented from a pair of 
faces/words) Croft et al. (2001 a) found that a combined drug using group performed 
worse (recognised fewer correct items) than a drug-naive group on the face 
recognition task only, although there were no group differences between cannabis 
only users and cannabis/ecstasy users; it was concluded that deficits were more 
related to cannabis use than ecstasy use. Using a similar task, Klugman et al. (1999) 
also found that ecstasy users exhibited poorer facial recognition than nonusers. Verkes 
et al. (2001) used word and figure recognition tasks (requiring the recognition of a 
previously presented word/figure from 6 items; 24 trials in total), and found that 
performance was related to dosage and difficulty: serially presented words were 
recognised less well by heavy users than nonusers, but simultaneously presented 
words were recognised less well by both heavy and moderate users. In the serial and 
simultaneous presentation of figures, heavy users recognised fewer items than 
moderate users, who recognised fewer items than nonusers. Using the delayed figure 
and face recognition tasks from the RBMT, Zakzanis and Young (2001a) found that 
over a one-year period, performance remained static. Using the Sternberg task 
(participants are required to identify a target digit from lists of presented digits), 
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Parrott et al. (1998) found no dosage effects (comparing nonusers, novice users and 
regular users). No group differences were observed between ecstasy users and 
nonusers on a matching to sample task requiring the identification of a target 
configuration of red and yellow squares on a6x6 matrix, from two possible stimuli 
(McCann et al. 1999). On a delayed matching to sample task (CANTAB) ecstasy 
users and nonusers performed similarly, and performance on the task was not related 
to indices of ecstasy use (Semple et al. 1999). Rodgers (2000) also used the matching 
to sample Subtest of the Wechsler Memory scale, and found no significant differences 
between ecstasy users, cannabis users and nonusers. 
To sum up, one study found that ecstasy users performed worse than nonusers 
on face recognition (Kiugman et al. 1999) and a further one study finding a dose 
related effect with heavy users exhibiting worse figure and word recognition than 
nonusers (Verkes et al. 2001). One study also found that word and figure recall was 
impaired in a combined drug-using group (ecstasy/cannabis and cannabis only) 
compared to drug-naive controls (Croft et al. 2001a). It appears that recognition of 
visual and verbal material is relatively preserved after ecstasy use, with only 2 out of 
the nine studies that assessed it finding a relationship with ecstasy use, and one of 
these (Verkes et al. 2001) having an especially high estimated lifetime dose compared 
to the other studies (see Table 3.1). As not many studies assessing recognition in 
ecstasy users found group differences, this will not be investigated further in this 
thesis. 
3.7 Everyday Memory 
A number of laboratory studies have assessed self-reports of cognitive failures 
and prospective memory in ecstasy users. 
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3.7.1 Prospective Memory 
Prospective memory refers to one's efficiency at remembering to do 
something in the future (for example keeping an appointment, remembering 
someone's birthday). Five studies have reported findings of prospective memory 
deficits in drug users, with different subscales being related to the use of different 
drugs. Heffernan et al. (2001 a) assessed prospective memory in recreational drug 
users. Ecstasy users reported more prospective memory errors on the subscales of 
short-term habitual prospective memory (e. g. "I forgot to turn my alarm clock off 
when I got up this morning"), long-term episodic prospective memory (e. g. "I forgot 
to pass a message on to someone") and internally cued prospective memory (e. g. "I 
forgot what I wanted to say in the middle of a sentence") than non-users in study one, 
although there were no group differences in strategies used to aid remembering. This 
was replicated for short-term habitual and long-term episodic prospective memory in 
study two, where ecstasy users also performed worse on an executive function task 
(word fluency- see earlier). It was concluded that prospective memory and executive 
function are linked, although the possible link was not investigated. The findings of 
study one were replicated by Heffernan et al. (2001b), where ecstasy users reported 
more errors in short-term habitual, long-term episodic, and internally cued prospective 
memory (although the mean occasions of ecstasy use for this study was at least 10 
times per month, which is atypically high). There were no group differences in 
strategies used to remember. Using the belonging (a possession belonging to the 
participant is borrowed, hidden, and participants have to ask for it and remember 
where it is at the end of the testing) and appointment (an alarm is set for 20 minutes, 
and participants have to ask a particular question when it sounds) subtests of the 
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RBMT, no ecstasy-related decline was observed after a one-year follow up, during 
which ecstasy users had been self-administering ecstasy (Zakzanis & Young 2001a). 
In a study on the World Wide Web, Rodgers et al. (2001) assessed everyday 
memory and prospective memory in drug users. It was found that while cannabis use 
was associated with recent memory deficits in short-term habitual and internally-cued 
prospective memory, ecstasy use was associated with long-term memory problems, 
that were more related to storage and retrieval problems. In a second World Wide 
Web study, Rodgers et al. (2003) found that long-term prospective memory deficits 
were associated with ecstasy use. Thus it is possible that different recreational drugs 
affect human memory in distinct ways. 
Although the World Wide Web is an effective way of collecting large amounts 
of data, and Rodgers et al (2001,2003) have managed to attribute specific deficits in 
everyday memory to specific drugs, it is possible that individuals visiting drug 
websites may already believe that they have a memory problem, and thus are not 
representative of the drug-using population as a whole. 
3.7.2 Cognitive Failures 
Cognitive failures refer to everyday memory slips, and three studies have 
collected data on self-reports of cognitive failures in ecstasy users. This is an area that 
is under investigated in ecstasy users, and research in this area is relatively new. 
Although in one study, ecstasy users reported a higher incidence of cognitive 
slips (e. g. failing to notice signposts on the road) than nonusers (Fox et al, 2001), this 
was not replicated by Rodgers (2000). Furthermore. Heffernan et al. (2001 a) reported 
no differences on the cognitive failures questionnaire between ecstasy users, cannabis 
users, and nonusers. 
3.7.3 Everyday Memory 
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Only one study has assessed everyday memory via a separate questionnaire 
(Rodgers et al. 2003), but increases in self-reported everyday memory slips were more 
related to cannabis than ecstasy use. 
3.7.4 Objective Measures of Prospective Memory 
The lack of evidence on self-reported cognitive failures and the inconsistent 
results with reference to the three subscales of the prospective memory questionnaire 
could reflect a metacognitive deficit in ecstasy users, whereby they do not realise their 
cognitive slips. Heffernan, Jardine and Betney (2005) attempted to control for this by 
using a self-report and objective measure (video-based) prospective memory task. 
Ecstasy users reported significantly more forgetting on the long-term prospective 
memory scale, and also recalled significantly fewer items on the video-based 
prospective memory task. 
To summarise, ecstasy users report more prospective memory slips on Long- 
Term PM, although self-reports of slips in other areas of PM may be related to the use 
of cannabis. Everyday memory slips also appear to be related to cannabis use, while 
only one of three studies assessing cognitive failures has found that ecstasy users 
report more failures. In addition, it is possible that ecstasy users do realise their 
prospective memory slips as one study found that objective and subjective measures 
of PM were similar. 
This area of research is relatively new, and is in need of further clarification. 
The reliance on the World Wide Web to collect data may perhaps lessen the extent to 
which the findings of such research can be generalised. A link has also been 
suggested between prospective memory slips and executive function deficits 
(Heffernan et al. 2001a) although the existence of such a link has not been 
investigated. Therefore Chapter 11 of this thesis will systematically investigate 
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aspects of everyday memory, and investigate a possible link with executive 
functioning, and the knowledge of one's own slips will be assessed using an objective 
measure. As it is clear from the literature that the use of other drugs, cannabis in 
particular, is related to self-reports of slips, the potential effects of cannabis as a 
mediator or sole contributor will also be investigated. 
3.8 Simple Span 
A number of studies (Back-Madruga et al. 2004; Dafters et al. 2004; 
Gouzoulis-Mayfrank, et al. 2000; Klug man et at. 1999; Rodgers 2000; Semple et at. 
1999; Wareing et al. 2004b) have assessed simple span via the digit span task, which 
requires participants to recall strings of digits increasing in length. However, only two 
studies have found drug related differences: McCardle et al. (2004) found that ecstasy 
users performed worse than controls, while Croft et al. (2001a) found that a drug- 
using group performed worse than controls. 
3.9 Verbal Learning 
Most studies with ecstasy users have used associative learning tasks (learning 
links between previously unrelated concepts) or word list learning (where a list of 
words is read out over a number trials and recall measured at each trial) tasks to assess 
verbal learning. A number of studies have used the RAVLT to measure verbal 
learning: a list of 15 words is read out loud, after which a participant has to recall as 
many of the words as possible. The same list is then read out 4 more times after which 
a new list is read out and recall again requested. The new list serves as an interference 
task, and following it, the original list is read out and recall again requested. Thus list 
1 measures immediate recall and trial 6 (after 30 minutes delay) delayed recall 
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(reported earlier in section 2.6), while trials in between provide an index of list 
learning. Gouzoulis-Mayfrank et al. (2000) used a German version of this task, and 
found that ecstasy users exhibited poorer learning performance over 5 trials than 
nonusers, and required more trials to learn the associations than cannabis users and 
nonusers. The ecstasy users also forgot more words than controls after presentation of 
the second word list. Poor performance in the test overall was associated with heavier 
ecstasy use; interference of the second word list with frequency of ecstasy use, and 
number of repetitions required with average nightly ecstasy dose and frequency of 
cannabis use. Croft et al. (2001 a) found that ecstasy/cannabis users did not perform 
worse than cannabis only users or controls, although a combined drug-user group 
performed worse than controls on a composite measure of lists 1-5. Using a slightly 
longer version of the test in which trial 7 is recall after interference and trial 8 is 
delayed recall, former ecstasy users performed worse than drug-naive controls on a 
composite score of trials 1-5, and on the interference list (trial 6), although within the 
whole sample the latter was associated with the amount of cannabis smoked in the 
year prior to testing (Thomasius et al. 2003). In another study, controls recalled more 
words than ecstasy users on trials 4 and 5 of the RAVLT (McCardle et al. 2004) 
although performance was not significantly correlated with indices of drug use. 
Some studies have also used paired associates learning tasks requiring 
participants to learn associations between previously unrelated concepts (usually 
words or spatial locations). Croft et al. (2001a) used a task requiring participants to 
learn associations between 6 colour pairs, primarily through guessing, then through 
feedback with the experimenter ("yes" or "no"). The task finishes when the 
participant correctly reports 18 consecutive associations, and the number of guesses it 
takes to get to this point is the score. Again, only after the ecstasy/cannabis and 
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cannabis only groups were merged to form a drug-user group were there any group 
differences, with the drug users performing worse than controls. Rodgers (2000) used 
the verbal paired associates sub-test of the Wechsler Memory Scale-Revised (WMS- 
R), requiring participants to learn eight word pairs, four reflecting common 
associations and four reflecting non-common associations, however, the performance 
of ecstasy users, cannabis users and controls did not differ significantly. There were 
also no significant performance differences between heavy ecstasy users, moderate 
users and nonusers on a task requiring the learning of associations between German- 
Turkish word pairs (Gouzoulis-Mayfrank et al. 2003). 
By way of summary, of the studies measuring verbal learning through word 
list learning, all four found some group differences, although in one of these the 
combined drug-using group performed worse than the nonuser control group (Croft et 
al. 2001a). One of these found that ecstasy users learned fewer words by trials 4&5 
(McCardle et al. 2004) and one that former ecstasy users performed worse than a 
drug-naive control group (Thomasius et al. 2003). The fourth found that ecstasy users 
performed worse over the five trials than nonusers, required more trials to learn all 
words than cannabis users and nonusers, forgot more after the second list 
presentation, and there was also a significant correlation between performance and 
heavier ecstasy use (Gouzoulis-Mayfrank et al 2000). Consequently, there is a degree 
of consensus that deficits in verbal learning appear to be related to the use of ecstasy 
and are thus not the focus of this thesis. Research on associative learning is not as 
well documented, with one study using a word-pair learning task finding that ecstasy 
users, cannabis users and nonusers did not differ (Rodgers 2000), and another 
(Gouzoulis-Mayfrank et al. 2003) also finding that ecstasy users were not impaired on 
a word-pair learning task. One study that used a colour-pair learning task found that a 
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combined drug user group performed worse than non-users (Croft et al. 2001a). To 
summarise, in ecstasy users only two studies have assessed word pair learning as an 
index of associative learning, and one of these required the learning of a Turkish word 
(non-native) paired with a German word (native). As it was not stated that all 
participants were bilingual, it is possible that the task was too difficult for everyone, 
and so masked the ecstasy-related deficits. In light of the evidence set out above, there 
seems a dearth of evidence on associative learning deficits so Chapter 10 of this thesis 
will focus on associative learning deficits in ecstasy users, assessed using a word-pair 
learning task. In addition to the measures assessed in previous studies (trials taken to 
learn all associations, total number learned), new measures will be introduced so as to 
better understand the processes underlying any potential ecstasy-related deficits: 
number of pairs recalled correctly at each trial, number of pairs forgotten at each level 
(with level one forgetting being forgetting after one correct recall of the pair), trials to 
completion (the number of trials it takes participants to learn all associations) and the 
number of perseverative errors (i. e. giving the same incorrect response on successive 
trials). 
3.10 Visual Processing 
A number of visual attention task results have been reported in section 3.4, 
and are not repeated here, so this section focuses on spatial span, spatial working 
memory and spatial learning. 
3.10.1 Spatial Span 
Studies that assess spatial span usually use it as a simple span measure, to 
covary for if deficits in higher level visuospatial processing are apparent. Like the 
reports on digit span performance (section 3.8), group differences are not usually 
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significant in this task. Verkes et at. (2001) used a computerised version of the Corsi 
Block Tapping Test consisting of nine grey buttons on the screen. It starts with three 
buttons flashing in serial order. The task of the participant is to tap out the same order. 
If all responses are correct, the number of flashing buttons is increased in increments 
of 1 until the participant fails on two consecutive trials- the maximum is defined as 
span, and subsequently, superspan is defined as span-plus-one for 24 trials. Corsi 
Block span and Span plus one was significantly less in both moderate and heavy 
ecstasy users than in nonusers. Using the original wooden block version of the Corsi 
Block task, ecstasy users, cannabis users and nonusers did not differ significantly 
(Gouzoulis-Mayfrank et al. 2000). In a study utilising a similar task from the 
CANTAB battery (requiring participants to replicate the sequence of highlighted 
squares from a computer screen, starting with 2 locations to a maximum of 9), 
nonusers, polydrug users and ecstasy users did not differ significantly (Morgan, 
1998). Using a similar task, Wareing et al. (2004a) found that former and current 
ecstasy users performed similarly to nonusers. Again using a similar task from the 
Wechsler Memory Scale-Revised (WMS-R) Rodgers (2000) found that cannabis 
users, ecstasy users and nonusers performed similarly. It is noteworthy that the only 
study that found a deficit in spatial span had a noticeably larger lifetime dose than all 
of the other studies where no differences were evident (see Table 3.1). Although 
unlikely, the possibility that very high lifetime doses of ecstasy impair spatial span 
performance cannot be ruled out. 
3.10.2 Visual Memory 
The visual recognition tests used in the studies reviewed require participants to 
reproduce or recognise complex visual figures. 
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Rodgers (2000) used the WMS-R Figural Memory (participants have to 
identify pre-specified abstract design from array of designs), and visual reproduction 
(participants have to draw from memory simple geometric shapes that they are 
exposed to for 10-seconds) Subtests, but again, ecstasy users, cannabis users and 
nonusers performed similarly. Back-Madruga et al. (2004) also found that ecstasy 
users and controls performed similarly on this task, and no dosage effects were 
observed. Bhattachary and Powell (2001) used the Rey-Osterrieth task in which 
participants are requested, without warning, to reproduce a complex geometric figure 
that they had previously copied, but there were no performance differences between 
nonusers, novice users, regular users and currently abstaining users. Another study 
using the Rey-Osterrieth test found that after ecstasy users were divided into 11 light 
users and 11 heavy users, those reporting higher lifetime ecstasy consumption had 
lower visual recall scores on the Rey-Osterrieth, and also an increased rate of false- 
alarm errors on the Continuous Visual Memory Test (CVMT), although no between 
group differences were observed between ecstasy users and nonusers in the initial 
analysis. Lifetime ecstasy consumption was however associated with lower scores on . 
the CVMT, for both false alarms and recognition (Back-Madruga et al. 2004). In 
another study, Rey-Osterrieth scores were not significantly different between ecstasy 
users and light polydrug using controls (Halpern et al. 2004). Gouzoulis-Mayfrank et 
al. (2003) used the LGT-3 Logos (participants have to remember and identify 20 logo- 
like figures) and city-map (participants have to memorise and reproduce a line drawn 
through a map-like display of geometric shapes) subtests. Recall on both tasks was 
significantly impaired in heavy users compared to controls and moderate users, 
although moderate users did not differ significantly from controls. Recall in this study 
was correlated with frequency of ecstasy use. Finally, Thomasius et al. (2003) used 
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the "company signs" test of visual memory, requiring the retention of learned 
information over a period of 30 minutes, but no group differences were observed 
between current ecstasy users, former ecstasy users, polydrug users and drug-naive 
controls. 
For visual memory, it appears that ecstasy users are not generally impaired on 
the tasks that have been administered. Only one of the reviewed studies reports 
differences between ecstasy users and nonusers (Gouzoulis-Mayfrank et al. 2003), 
and this was only the case for heavy users of the drug (503 tablets average lifetime 
dose). One other study also found that heavy ecstasy users performed worse than light 
users but not controls, and also had increased errors on a visual memory test (Back- 
Madruga et al. 2004). While it remains a possibility that visual memory is 
comparatively preserved until a certain threshold of ecstasy use is reached (most of 
the studies finding no ecstasy related deficits have lower lifetime doses than 
Gouzoulis-Mayfrank et al. 2003). this is unlikely as the study reporting the highest 
estimated lifetime doses in abstinent and current ecstasy users (Thomasius et al. 2003) 
found that there were no differences in performance. Hence it is possible that the test 
used (LGT-3 Logos) by Gouzoulis-Mayfrank and colleagues is supersensitive to 
cognitive deficits in ecstasy users, or does not actually measure the target function. As 
the majority of studies have not found ecstasy-related deficits in visual memory, this 
aspect of cognitive functioning will not be investigated further in this thesis. 
3.10.3 Spatial Working Memory 
Some tasks of visual working memory have been reported previously in this 
chapter as they belong to another cognitive domain also (Alting von Geusau et al. 
2004, section 3.3.5). The studies reviewed in this section refer specifically to spatial 
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working memory tasks and include visuospatial rotation tasks, backwards spatial span 
tasks, and "dual-task" span measures. 
In a study performed by Hanson and Luciana (2004) ecstasy users were more 
accurate overall on a visual working memory task but had lower scores than controls 
when they had to delay their responses. Using a visual version of the two-back task in 
which participants had to press a key when the figure presented is the same as that 
presented two trials earlier, heavy ecstasy users, moderate users and controls 
performed similarly (Gouzoulis-Mayfrank et al. 2003). McCann et al. (1999) used the 
Manikin test, a visuospatial rotation task testing the ability to mentally manipulate 
objects and determine the orientation of a stimulus (an object in the hand of a model). 
There were no differences between ecstasy users and controls on days one, two or 
three of testing in this inpatient study. Using the spatial span backwards test from the 
WMS-III battery no group differences were observed between ecstasy users and 
controls, and when the groups were further divided into heavy and moderate users, the 
differences failed to achieve statistical significance (Halpern et al. 2004). Semple et 
al. (1999) used the CANTAB spatial working memory task (similar to that used by 
Fox et al. 2002) but again, no group differences were observed between ecstasy users 
and nonusers, although in the ecstasy user group larger lifetime doses of ecstasy were 
associated with lower scores indicating that higher ecstasy use is associated with 
deficits in spatial working memory. As the study also found decreased serotonin 
transporter binding in certain brain areas, but not dopamine, this was interpreted to be 
directly related to reduced serotonin binding as a result of ecstasy use. 
Fox et al. (2002) used a task requiring participants to search through a display 
of boxes in order to find a certain number of hidden blue tokens. Only one box was 
filled at a time and only once over the task, so participants were scored for errors in 
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going back to an empty box, or one that had previously held a token. Ecstasy users 
performed significantly more of both types of error than nonusers, and in both cases 
there was also a significant group by trial size interaction indicating that ecstasy users 
performed more errors on the most difficult trials. No differences were observed in 
terms of search strategy. Lastly, Wareing et al. (2004a) used a spatial working 
memory task in which participants have to remember a spatial sequence on a 4x4 
matrix while at the same time performing a concurrent visual judgement. Both current 
and former ecstasy users performed worse than nonusers, and this remained 
significant after control for the use of other drugs in the last three months, and was not 
related to decreased visual memory capacity (spatial span). 
Two studies assessing spatial working memory found that ecstasy users 
performed worse than nonusers, one that current and former users were worse than 
nonusers (Wareing et al. 2004a) and one than ecstasy users committed more errors, 
especially on the more difficult trials (Fox et al. 2002). Ecstasy users also performed 
worse in the delayed recall of material on one task, but were actually more accurate 
overall (Hanson & Luciana 2004), and in one task increased lifetime doses were 
associated with lower scores on. a spatial working memory test. Thus there is a broad 
consensus that spatial working memory is impaired in ecstasy users and this aspect of 
cognitive functioning will not be explored further in this thesis. In addition, since the 
role of executive processes in maintenance and maintenance plus visuo-spatial 
processing tasks remains unclear, spatial working memory will not be assessed. The 
focus will instead be on executive measures that are well defined in the existing 
research literature (e. g. Miyake et al. 2000). 
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3.10.4 Spatial (Associative) Learning 
Spatial learning appears to be an element of cognitive function that is 
particularly neglected in ecstasy use research, with only the design learning task 
(similar to the AVLT) yielding drug-related deficits. In this task, participants have to 
redraw 15 designs that they were shown previously instead of a list of 15 words (with 
a reminder being given after each trial- 5 trials in total). Thus the task also yields 
scores for each trial. Cannabis users performed worse (recalled fewer figures) than 
ecstasy users, although when the drug using groups were combined, the drug users did 
not perform significantly worse than controls (Croft et al. 2001a). Using a similar task 
(VIG) Gouzoulis-Mayfrank et al. (2000) found that found that ecstasy users 
performed worse than both cannabis users and nonusers on the immediate recall 
component, although there were no between group differences in terms of number of 
trials required for learning and learning score over 5 trials. 
Fox et al. (2002) used a paired associates learning task in which participants 
are presented with a set of six white boxes around the screen, and are required to 
remember the location of a number of abstract patterns that appear inside these boxes. 
The task increased in difficulty as participants were required to remember more 
patterns in each subsequent trial. No group differences were observed with respect to 
number of presentations required, number of errors, or memory score, although the 
group by difficulty interaction for errors approached significance indicating that 
ecstasy users made more errors on the 8-box trials. In Croft's (2001a) study, 
participants were required to learn the associations between six spatial (unspecified as 
to the nature of these) pairs, beginning by guessing, then being prompted by feedback 
from the experimenter. No differences were observed between ecstasy users, cannabis 
users and nonusers, and when the ecstasy users and cannabis users were combined 
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into a drug-user group, the results remained non-significant. Using the WMS-R visual 
paired associates task, requiring participants to learn the colours associated with six 
abstract line drawings, ecstasy users, cannabis users, and nonusers performed 
similarly on a composite measure of the first three trials of the first presentation, 
however, when the task was repeated (measuring delayed recall of the material), the 
ecstasy users were found to be performing at a significantly lower level than the 
cannabis users and controls (Rodgers 2000). 
Therefore both studies that have assessed spatial learning by AVLT-type tasks have 
found that ecstasy users performed worse than nonusers. The results with respect to 
spatial associative learning do not appear to be as clear. Only one study found that 
ecstasy users performed worse than nonusers, and this was only on the delayed recall 
of the material, so may reflect some deficit in delayed recall, and not learning 
performance in itself (Rodgers 2000). This area is perhaps in need of more research to 
clarify the precise nature of deficits in spatial associative learning (recall or learning 
deficits) but is outside the aims and scope of this thesis. 
Summary 
This thesis utilises recent theoretical models of executive functioning (see 
Chapter 2). The present chapter has presented a rationale for studying the four specific 
executive functions updating, switching, inhibition and access in ecstasy users, to 
establish whether these deficits exist. The first three empirical Chapters (6,7,8) will 
examine the nature of ecstasy-related deficits in executive processes. More 
specifically, Chapter 6 will assess memory updating (via a running memory test), 
Chapter 7 will assess Switching (via the plus-minus and number-letter tasks) and 
Inhibition (via random letter generation), and Chapter 8 will assess access to long- 
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term memory (via the Chicago Word Fluency Test). The pattern of results obtained in 
these Chapters will form the basis for the next three empirical Chapters (9,10,11). If 
executive deficits are observed, then Chapter 9 will assess their contribution to 
reasoning performance (via a syllogistic reasoning task), Chapter 10 their contribution 
to associative learning (via a verbal paired associates task) and Chapter 11 their 
contribution to lapses in everyday memory (via prospective memory, cognitive 
failures, everyday memory and cognitive-failures-for-others questionnaires). The 
executive functions under investigation in this thesis are of vital importance in 
everyday life, and thus the results of thesis could have very serious implications for 
individuals concerning using the drug. 
Before investigating whether or not executive deficits might be found in 
ecstasy users, brief reference will be made to serotonergic neurotoxicity and its role in 
ecstasy-related deficits. There is still much debate about whether ecstasy is actually a 
neurotoxin in humans, and the amount required for a neurotoxic dose in humans. The 
next Chapter will briefly review studies that have assessed alterations in brain 
function in ecstasy users and possible corollaries of these alterations in terms of 
function. 
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Table 3.1. 
Summary of Participants' ecstasy use in reviewed studies 
Authors Groups 
(N) 
Total 
Lifetime 
Use (tablets 
unless 
specified) 
Frequency 
(days/month 
unless 
specified) 
Average 
Dose 
(Tablets) 
Duration of 
use 
Time since 
last use 
(weeks) 
Alting von 26 E M 53.82 1.96; 1.44 2.28; 2.24 -2 
Geusau et 33 NU F 38.78 tabs/mth Years 
al. (2004) 
Back- 22 E 74.6 times 6.3 years 25.56 
Madruga et 28 NU 
al. (2003) 
Bhattachary 26 E 16+ times 1.06 * 
& Powell 18 EN 1-5 times 1.22 * 
(2001) 16 Abs 16+ times 6.61 * 
20 NU 
Curran & 32 E 3.48 2.58 4.33 years 5.57 * 
Verheyden 32 Abs 6.95 2.43 3.49 years 120.19 
(2003) 32 PD 
Dafters et 23 E 14.04 in -1 
at. (1999) previous 
year 
Dafters et 16 EH+C 363.8 
al. (2004) 19 EL+C 20.21 
15C 
19 NU 
Daumann et 8E 74.5 
al. (2003) 8E PD 56.25 
Fox et al, 
(2001) 
Fox et al. 
(2002) 
Fisk et al. 
(2005) 
1.44 
3.65 
20 E Pr 372.3 
20 E NPr 356.9 
20 NU 
20 E 172 
20 NU 
44 E 343 0.44 
59 NU 
-1 * 
1.66 34.29 3.29 * 
1.44 18.43 8.91 * 
months 
1.9 62.6 33.8 * 
2.9 65.2 10.83 * 
51.9 months -2 
2.14 183 weeks 10.90 
Gamma et 16 E 270 
al. (1999) 17 NU 
Gouzoulis- 28 E 93.4 2.4 1.4 27 months 5.86 
Mayfrank et 28 C 
al. (2000) 28 NU 
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Authors Groups Total Frequency Average Length of Time Since 
(N) Lifetime (days/month Dose Use Last Use 
Use unless (tablets) (Weeks) 
specified) 
Gouzoulis- 30 EH 503.2 4.5 2.6 40.9 27.83 * 
Mayfrank et 30 EM 39.5 1.8 1.4 16.0 months 36.61 
al. (2003) 30 NU 
Hanson & 
Luciana 
(2004) 
Halpern et 20 E 60 
al. (2004) 20 NU occasions 
Heffernan et 46 E 10 1.0 0.14 
al. (2001 a) 46 NU 
Study 1 
Heffernan et 30 E 5.6 tablets/ 0.14 
al. (2001 a) 37 NU month 
Study 2 
Heffernan et 15 E 20 times/ 1.0 8.66 
al. (2001a) 15 C year 
Study 3 15 D-Na 
Heffernan et 30 E 13.1 Not under 
al. (2001b) 31 NU influence at 
time of study 
Jacobsen et 6E 10 times 
al. (2004) 6 NU 
Lamers et 14 E 39 times 9 times/year Urine screen 
al. (2003) performed. 
Time 
unspecified 
McCann et 22 E 215 times 5.72 2.72* 4.52 years 13.91 
al. (1999) 23 NU 
McCardle et 17 E 4-9 times 1.65 2.2 years 18.57 * 
al. (2004) 15 NU (median) 
Morgan 16 E 35.6 2.94 1.12 2.12 years 2.91 
(1998) 12 PD 
Study 1 16 D-Na 
Morgan 25 E 49.6 4.36 1.47 4.12 years 9.3 
(1998) 20 PD 
Study 2 19 D-Na 
Morgan 25 E 50 -9.3 * (1999) 22 PD 
19 D-NA 
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Authors Groups Total Frequency Average Length of Time Since 
(N) Lifetime (days/month Dose Use Last Use 
Use unless (tablets) (weeks) 
specified) 
Morgan et 18 EH 513; 93 2.6; 1.8 6.4; 2.4 years 5.1; 3.0 
al. (2002) 15 Abs 336; 577 1.6; 1.8 3.5; 4.3 years 110; 113 
16 PD M: F 
15 D-Na 
Parrott & 15 E 10+ times 1.8 Pre-, on-, and 
Lasky 15 EN 1-9 times 1.45 post- drug 
(1998) 15 NU 
Parrott et al. 10 E 10+ times Not taken 
(1998) 10 Nov 1-9 times "recently" 
10 NU 
Parrott et al. 12 EH 371 times Drug-free on 
(2000) 16 EL 6.8 times day of testing 
22 NU 
Parrott et al. 109 EN 1-9 times 1-2 
(2002) 136 EM 10-99 times (mode) 
37 EH 100+ times 
Reneman et 5E 218 19.93 
al. (2000) 9 NU 
altered 5- 
HT trans 
Rodgers 15 E 20 times 8.67 
(2000) 15 C over 5 years 
15 D-Na 
Rodgers et 69 EN 1-9 times 
al. (2001) 66 EM 10-99 times 
20 EH 100+ times 
333 NU 
Rodgers et EN 38: 51% 1-2 
al. (2003) EM 50: 35% (mode) 
EH 12: 14% 
Schifano et 79 Prob 47 1/week 52 
al. (1998) 71 N-Prob 3 0.4/week 14 
tablets 
Semple et 10 E 672 tablets 2.57 
al. (1999) 10 NU 
Simon & 47 E 258 2.4 45.9 months 2.63 
Mattick 37 C 
(2002) 
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Authors Groups Total Frequency Average Length of Time Since 
(N) Lifetime (days/month Dose Use Last Use 
Use unless (tablets) (weeks) 
specified) 
Thomasius 30 E 1033: 600 5: 3 46: 61 3.14: 3.57 
et al. (2003) 30 Abs 987: 534 6: 2 56: 52 69.377.86 
29 PD M: F months 
30 D-Na 
Verkes et al. 21 EM 169 2 4.4 years 2.24 
(2001) 21 EH 741 3.1 4.5 years 1.29 * 
20 NU 
Wareing et IOE 101 3.25 4.1 years 1.17 * 
al. (2000) 10 Abs 100 days/ 3.40 3.9 years 46.14 
10 NU year 
Wareing et 36 E 591 221 weeks 3.3 weeks 
al. (2004a) 12 Abs 433 177 weeks 93 weeks 
31 NU 
Wareing et 42 E 552 212 weeks 3 weeks 
al. (2004b) 17 Abs 385 197 weeks 112 weeks 
31 NU 
Zakzanis & 15 E 19 times 2.4 1.17* 18.4 months 6 weeks 
Young Baseline 
(2001a) Follow-up 55 times 2.4 1.75* 30.4 months 4 weeks 
Zakzanis & 24 E 31 times 1.91 1.21 1.99 years 17 weeks 
Young 24 NU 
(2001b) 
Zakzanis et 24 E 22.3 times 1.7 1.3 14.7 years 26 weeks 
al. (2002) 30 NU 
* Denotes number converted (if dose then from milligrams assuming 100 mg per tablet; if abstinence 
period then from months or days to weeks) 
NU = Nonuser of ecstasy 
E= Regular Ecstasy User 
Abs = Currently abstinent ecstasy user 
EH = Heavy ecstasy user 
EM = Moderate user of ecstasy 
EN = Novice user of ecstasy 
EL = Light user of ecstasy 
PD = Polydrug user 
C= Cannabis user 
D-Na = Drug-Naive 
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Chapter 4: Review of Literature on ecstasy Neurotoxicity 
Chapter 3 reviewed evidence for cognitive deficits in users of ecstasy. The use 
of ecstasy may cause such deficits by degrading/damaging the serotonin system. This 
chapter will focus on evidence in humans for the neurotoxicity of ecstasy. It is 
believed that ecstasy is neurotoxic to the serotonin system, and the most likely cause 
of this is oxidative stress from serotonin or dopamine metabolites, or a down- 
regulation of serotonin neurons (see Sprague, Everman & Nichols 1998). Due to 
ethical constraints most studies are retrospective. There are a number of indices that 
can be used to assess the integrity of the serotonin system, and each is discussed at the 
beginning of the sub-section. It is possible that any in deficits in human memory and 
cognition observed in this thesis, might be related to deficiencies in serotonergic 
functioning. Thus possible memory deficits resulting from deficiencies in certain 
areas are discussed. 
4.1 Single Photon Emission Computer Tomography (SPELT) 
A number of studies have assessed the densities of serotonin receptors (SERT) 
in different brain areas via means of SPECT. This involves labelling receptors with 
radioactive markers that can then be "tracked" in the brain enabling researchers to 
assess the densities of the receptors. While high density of serotonin receptors may 
reflect a functional serotonin system, lower density may reflect some ecstasy-related 
damage to serotonergic functioning. Indeed the serotonin transporter is a structural 
element of the serotonin neuron and is believed to reflect the integrity of serotonin 
neurons (see e. g. Scheffel & Ricaurte 1990; Zhou et al. 1998). 
Reneman, Booij, Schmand, van den Brink et al. (2000) sought to investigate 
neurotoxic damage in post-synaptic receptors. Post-synaptic 5HT-2a receptors are 
associated with cognitive abilities such as learning (See Buhot, Martin & Segu 2000 
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for review), so if deficits in learning are observed in this thesis, it is possible that they 
may be due to serotonergic neurotoxicity. Reneman et al. used Single Photon 
Emission Computed Tomography (SPECT) in which a radio-ligand (a radioactive 
marker), in this case [123 I]-5-I-R91150, with a high and selective affinity for 5HT-2a 
receptors is used to label the neurons. This makes it possible to assess the density of 
these neurons. Five participants comprised the MDMA group (having used MDMA 
on at least 50 occasions, but with an average lifetime dose of 218 tablets, and average 
abstinence period of 4.6 months), and 9 people were in the non-MDMA group. In 
most brain areas the [123 I]-5-I-R91150 binding ratios were higher in ecstasy users 
than in nonusers, but this was only significant for the occipital cortex, and indicated 
an up-regulation of the post-synaptic 5HT-2a receptors. In addition, as mentioned in 
Chapter 3, section 3.6 the binding was significantly correlated with recall in the 
ecstasy group (but not the nonuser group). It is likely in this case that the up- 
regulation of the receptors is related to ecstasy neurotoxicity, as it is consistent with 
animal and human studies finding neurotoxicity in the occipital cortex only (Scheffel, 
Szabo, Mathews, Finley et al. 1998; Semple, Ebmeier, Glabus, O'Carroll et al. 1999). 
In another study from the same laboratory, Reneman et al. (2001 a) used a 
different radio-ligand: iodine 123-labeled 2p-carbomethoxy-3ß-(4-iodophenyl) 
tropane (hereafter referred to as [123 I]ß-CIT) to assess cortical 5-HT neuron density. 
In a sample of 22 recent ecstasy users (2.4 months mean abstinence period; average 
lifetime dose of 485 tablets), 16 previous users (29 months mean abstinence period; 
average lifetime dose of 268 tablets) and 13 non ecstasy-using controls, mean cortical 
[123 I] 3-CIT binding was significantly lower in recent ecstasy users indicating 
decreased SERT density. Previous users performed similarly to controls, and although 
both groups of ecstasy users performed worse on the RAVLT, this wasn't 
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significantly correlated with cortical binding. In another study from the same 
laboratory, 29 ecstasy users (average lifetime dose of 324 tablets), 9 ecstasy and 
amphetamine users (average lifetime ecstasy dose of 358 tablets), and 15 nonuser 
controls were compared. [123 I](3-CIT was used to assess dopamine binding ratios in 
the striatum, as it is possible that ecstasy may also affect the dopaminergic system. 
[123 I]ß-CIT binding ratios were significantly higher for ecstasy users than for 
controls. The binding ratios of the ecstasy + amphetamine group were significantly 
lower than the ecstasy only group, but did not differ from controls. Correlations 
between extent of amphetamine and ecstasy use and binding ratios were not 
significant. While the binding ratios suggest that amphetamine or combined ecstasy 
and amphetamine use may affect the dopaminergic system, this should be treated with 
some caution as correlations with drug use were non significant. (Reneman, Booij, 
Lavalaye, de Bruin et al. 2002). 
Using the same radio ligand, Semple et al. (1999) assessed SERT densities in 
10 long-term male ecstasy users (18 days abstinence period, lifetime dose of 672 
tablets) and 10 ecstasy-naive controls who used a range of other drugs. Using 
Regions-of-Interest (ROI) analysis, a reduction of [123 I]ß-CIT binding was found in 
posterior cortical regions, and uptake in many regions was correlated with time since 
last dose of ecstasy, which remained significant after control for estimated lifetime 
dose. Performing further analysis of the data using a voxel-based method, the largest 
reductions were seen in the primary sensori-motor cortex, and significant correlations 
were also observed between the abstinence period from ecstasy and binding in the 
mid-line limbic areas. 
Chang, Grob, Ernst, Itti et a!. (2000) used SPECT to assess cerebral blood 
flow (CBF) in 21 ecstasy users (211 lifetime occasions of use) and 21 drug-naive 
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controls. At baseline scans, the MDMA users only exhibited slightly lower CBF than 
the nonusers, and reductions in individual regions were also non-significant. Eight 
participants were administered MDMA and scanned 2 and 3 weeks later. At these 
scans, MDMA users exhibited decreased regional and global CBF compared to their 
baseline scans and the non-ecstasy group. The largest significant reductions were 
observed in the caudate, superior parietal cortices, and the right DLPFC. Furthermore, 
these decreases in CBF were more pronounced in the participants who had received 
larger doses of MDMA, and in those with more recent MDMA administration. 
To summarise, those studies using SPECT have generally found ecstasy- 
related changes in SERT binding ratios (Reneman et al. 2000; Reneman et al. 2001a; 
Semple et al. 1999). One study also found that increases in post-synaptic binding 
(which the authors state reflects lower synaptic 5HT levels) were significantly 
correlated with recall in ecstasy users (Reneman et al. 2000), although this was not 
supported by a later study (Reneman et al. 2001a). In the two studies that used the 
radioligand [123 I]ß-CIT, recency of ecstasy use appeared to be an important factor in 
the extent of 5HT reductions- in one study recent ecstasy users had lower binding 
ratios than former users and nonusers (Reneman et al. 2001a), and in another binding 
was significantly correlated with abstinence period (Semple et al. 1999). Recency of 
use was also significantly correlated with decreased CBF in ecstasy users (Chang et 
al. 2000). However, it appears that amphetamine use is a more important contributor 
to decrements in dopaminergic function than ecstasy use (Reneman et al. 2002). To 
summarise, SPECT studies in ecstasy users have reported decrements in serotonin 
function which if present among the ecstasy users to be investigated in the chapters 
that follow, might be responsible for any possible decrements in cognitive function 
observed in this thesis. 
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4.2 Electroencephalogram (EEG) measures 
EEG has also been used to assess brain function in ecstasy users, by using 
electrodes placed on the scalp to measure patterns of electrical activity in the brain. 
Croft, Klugman, Baldeweg and Gruzelier (2001b) examined the relationship 
between an index of 5HT function (the intensity of evoked auditory potentials) and 
frequency of MDMA use and cumulative lifetime dose. In the primary auditory 
cortex, 5HT is thought to protect against loud auditory stimuli by attenuating cortical 
response. If 5HT is intact in the primary auditory cortex, it would be expected that the 
attenuation to loud stimuli would be greater than if the 5HT was not intact (and thus it 
may be expected that ecstasy users do not show such great attenuations). Twenty-two 
MDMA users (total lifetime dose of 226 tablets), 19 cannabis users, and 20 drug- 
naive participants were compared. The MDMA users had significantly larger evoked 
potentials than the cannabis users and nonusers (although the latter two groups did not 
differ significantly. Total ecstasy use was found to be a significant predictor of the 
evoked potential, although frequency of use was not. 
Using the same rationale Tuchtenhagen, Daumann, Norra, Gobbele et al. 
(2000) performed an auditory evoked potentials study in 28 ecstasy (lifetime dose of 
93.4 tablets; abstinent for 41 days) users, 28 cannabis users (abstinent for 4 days), and 
28 nonusers. Ecstasy users and cannabis users were comparable for cannabis use. As 
with Croft et al's study, the ecstasy users exhibited significant increases in evoked 
auditory potentials. Although the main effect of group was marginally non-significant, 
the interaction between stimulus intensity and group was significant. Post-hoc tests 
revealed that while group differences were not apparent at the lower intensities, at 
80dB the ecstasy users differed significantly from the cannabis users (but not the 
nonusers), and at 90 dB the ecstasy users differed significantly from both the control 
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groups. However there were no significant correlations between indices of ecstasy and 
cannabis use, and evoked auditory potentials. Both of these studies therefore support 
the notion that ecstasy users present degraded serotonergic functioning. 
In another study (Gijsman, van Gerven, Verkes, Schoemaker et al. 2002) 
alpha, delta and theta EEG waves were assessed following administration of 
dexfenfluramine (a serotonin releaser) every hour for 6 hours. Nonusers, moderate 
users and heavy users were assessed. Dexfenfluramine produced a concentration 
dependent decrease in slow wave EEG activity (this effect was greater in heavy 
users). Dexfenfluramine was also associated with decreased alpha activity in 
frontal/central areas in heavy ecstasy users compared with moderate users and 
controls. So it appears that ecstasy is associated with changes in electrical brain 
activity. 
EEG power in different brain areas has also been shown to correlate with 
extent of ecstasy use. In a correlational study, Dafters, Duffy, O'Donnell and Bouquet 
(1999) evaluated different EEG frequencies in 23 ecstasy users (having used an 
average of 14 tablets in the previous year). There was a positive correlation between 
ecstasy use in the last 12 months and EEG power in the alpha frequency band (all 
brain areas with the exception of the right anterior quadrant of the brain), and also a 
positive correlation with the beta frequency band in the left-posterior quadrant only. 
There was also a significant negative correlation with low frequency delta EEG waves 
across the brain. 
EEG studies have revealed that serotonin function may be degraded in the 
frontal cortex, with one study finding that total lifetime ecstasy dose was a significant 
predictor of evoked potentials (Croft et al. 2001b) and another study finding a non- 
significant trend towards higher evoked auditory potentials (Tuchtenhagen et al. 
95 
2000). The non-significant result in the latter study may reflect the lower lifetime dose 
than the former study. EEG power in different brain areas was also correlated with 
ecstasy use in the last 12 months. 
4.3 Magnetic Resonance Imaging (MRI) & Magnetic Resonance Spectroscopy (MRS) 
4.3.1 Magnetic Resonance Imaging (MRI 
In an MRI scan a large cylindrical magnet creates a magnetic field around the 
participant's head, and radio waves are sent through the magnetic field. Sensors then 
read the signals and an image of the brain is constructed using a computer. Functional 
MRI (fMRI) is used to assess brain function while performing an action, and relies on 
the magnetic properties of blood (thus enabling researchers to image blood flow in the 
brain while participants are performing tasks). 
Cowan, Lyoo, Sung, Ahn et al. (2003) performed structural MRI scans on 31 
ecstasy-polydrug users (having used ecstasy at least 5 times; abstinent for 3 weeks) 
and 29 nonusers and compared scans using voxel-based metamorphy (VBM), to 
assess regional brain grey and white matter concentration 3. It was hypothesised that 
only grey matter would reveal ecstasy-related differences as it is believed that ecstasy 
primarily affects unmyelinated axons from the dorsal raphe nucleus (e. g. Ricaurte et 
al. 1988). Ecstasy users had decreased grey matter in several brain regions, which 
were localised to the neocortex in bilateral Brodmann's area (BA) 18, left BA 21, left 
BA 45 in addition to bilateral cerebellum and midline brainstem. It is suggested that 
these decrements may be responsible for the neuropsychiatric impairments observed 
in ecstasy users. More specifically both left BA 45 and left BA 21 play important 
VBM employs gray/white matter segmentation and statistical parametric mapping analysis to 
calculate a voxel-wise comparison of matter concentration. 
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roles in the retrieval from semantic memory (e. g. Booth et al. 2002; Lee et al. 2002). 
This may be particularly relevant to this thesis as access to semantic memory is one of 
the key areas under investigation. 
To try and elucidate any structural differences apparent during 
different aspects of information processing, Jacobsen et al. (2003) used fMRI to scan 
6 ecstasy users (average lifetime exposure of 10 occasions) and 6 nonusers, while 
performing a verbal working memory task (the N-back task at 1- 2- and 3-back 
conditions). The main finding was that ecstasy users had abnormal function in the left 
hippocampus during the task (they failed to deactivate the left hippocampus normally 
during high verbal working memory load). Correlational analysis also revealed that 
there were strong negative relationships between left hippocampal activity and 
MDMA abstinence period, with the strongest correlation occurring under the highest 
memory load. However, total lifetime episodes of MDMA use and age of onset were 
not significantly correlated with hippocampal activity, suggesting that changes are 
related to recency of use and may be reversed with prolonged abstinence. The 
observation of abnormal hippocampal activity in the left hippocampus is consistent 
with previous studies in ecstasy users in which specific memory deficits have been 
observed (e. g. Parrott & Lasky, 1998; Gouzoulis-Mayfrank et al. 2000; Fox et al. 
2001), although as the n-back task supposedly loads on prefrontal resources, this is 
somewhat surprising. 
Reneman, Majoie, Habraken and den Heeten (2001c) used MRI to assess 
cerebral volume ratios in 8 ecstasy users (lifetime dose of 154 tablets; average 
abstinence period of 14.6 weeks) and 6 nonusers. Diffusion and perfusion MRI were 
used, allowing apparent diffusion coefficient and cerebral volume maps to be 
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constructed. Apparent Diffusion Coefficient values and relative cerebral volume ratios 
were significantly higher in the globus pallidus of ecstasy users compared to 
nonusers, and the increases in cerebral volume in this area were significantly 
positively correlated with extent of previous ecstasy use, suggesting that this was an 
ecstasy-related effect and not a premorbid difference. Reneman et al. (2001 c) suggest 
that this is a distinct possibility considering that serotonin is believed to have a 
vasoconstrictory role in the brain (Cohen, Bonvento, Lacombe & Hamel 1996), and if 
ecstasy does decrease serotonergic function, then it would be expected that 
vasodilation would occur, thus increasing CBV ratios. In terms of the possible 
functional correlates of such CBV changes in this thesis, the globus pallidus is part of 
the basal ganglia and is involved in word fluency (access) tasks and syllogistic 
reasoning (e. g. Fisk & Sharp, 2002). 
Overall, MRI has revealed some abnormalities in the brain structure of ecstasy 
users. Participants (who were only required to have used ecstasy 5 times) showed 
significant decreases in grey matter in the globus pallidus (Cowan et al. 2003) while 
ecstasy use also appears to increase cerebral blood volume (Reneman et al. Ole). As 
with studies mentioned in the previous sections, it appears that recency of use may be 
an important factor in abnormal brain structure. Jacobsen et al. (2003) found that 
ecstasy users failed to deactivate the left hippocampus during a high load working 
memory condition, although there was a significant negative correlation between 
abstinence and activity suggesting some recovery of function over time. 
4.3.2 Magnetic Resonance Spectroscopy (MRS) 
Proton magnetic resonance spectroscopy ('H MRS) is a non-invasive 
technique that can measure concentrations of N-acetylaspartate (NAA- a neuronal 
marker) or myo-inositol (MI- a tentative filial marker). Chang, Ernst, Grob and Poland 
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(1999) used this method to evaluate 21 ecstasy users (average lifetime dose of 131 
tablets; abstinent for 4 months) and 37 nonusers in mid-frontal, mid-occipital and mid 
parietal brain regions. The NAA ratios were normal in all brain regions in both 
groups. However, the MI ratio and the MI to creatine ratio were increased in the 
parietal white matter of ecstasy users. Cumulative lifetime dose of ecstasy had 
significant effects on MI concentration in the parietal white matter and the occipital 
cortex in ecstasy users. While the lack of a difference in NAA ratios in brain areas 
may reflect the lack of ecstasy-related neuronal damage, the increases in MI suggests 
an ecstasy-related increase in glial content. 
Using the same method, Obergriesser, Ende, Braus and Henn (2001) assessed 
hippocampal function in 5 ecstasy users (having used an average of 100 doses; 
abstinent for at least 3 weeks) and 5 non-ecstasy users. Like Chang et al. (1999), no 
significant differences were observed between the two groups in terms of NAA and 
creatine metabolism in the hippocampus. Thus taken together, the findings of these 
two studies suggest that either ecstasy users do not exhibit decreases in neuronal 
function resulting from their use of the drug, or that NAA concentration assessed 
using MRS is not the most sensitive measure of evaluating neuronal damage (however 
this method has been shown to be sensitive in other populations). 
4.4 Positron Emission Tomography 
PET scanners measure emissions from radioactive chemicals (radioligands) 
that are usually injected in to the bloodstream of participants. Like MRI, this data can 
then be fed in to a computer which produces 2- and 3-D images of the brain. 
Some studies use PET scanning to assess serotonin transporter (SERT) density 
in brain regions (as with SPECT). Thomasius et al. (2003) used this method in 30 
regular ecstasy users (used for at least 20 weeks prior to participation), 29 polydrug 
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using controls (similar drug use to the ecstasy users with the exception of ecstasy), 31 
former ecstasy users (lifetime exposure of at least 250 tablets; abstinent for 20+ 
weeks), and 30 drug-naive controls. PET was performed with the 5HT transporter 
ligand ["C] (+) McN5652, a tracer which has been demonstrated to provide a highly 
specific binding to 5HT transporters of the human brain in vivo (Szasbo, Kao & 
Scheffel, 1995), in the mesencephalon, putamen, caudate and thalamus. The 
Distribution Volume Ratios (DVRs) did not differ significantly between the groups in 
the control region (white matter) or the putamen. There were however significant 
group differences in the mesencephalon, caudate nucleus and thalamus: current 
ecstasy users exhibited significantly lower DVRs in the mesencephalon relative to all 
other groups, and in the caudate nucleus relative to polydrug users. Typical number of 
exposures to ecstasy was a significant covariate for DVRs of SERT in the caudate 
nucleus, and together with gender and LSD taken in the last year, was also a 
significant covariate for the thalamus. In the regression equation, DVRs of SERT 
were best predicted by parameters of ecstasy use, with typical exposures being the 
best predictor in the thalamus and caudate nucleus, and tablets taken in the previous 
year with the mesencephalon 
McCann, Szabo, Scheffel, Dannals et al. (1998) used the same radio ligand as 
Thomasius et al. (2003) in 14 former heavy ecstasy users (having used 228 times over 
4.6 years; 386 mg average dose; 6 times per month, but abstinent for 19 weeks) and 
15 control participants. Ecstasy users were found to have significant global and 
regional (hypothalamus, midbrain, caudate, putamen, pons, cerebellum and the 
cingulate, frontal, occipital and parietal cortices) decreases in DVRs for specific 
binding of [11C] (+) McN5652. This suggests that the ecstasy users had a lower brain 
density of 5HT transporter sites than participants in the control group. The cerebellum 
100 
in particular has been shown to play an important role in visuo-spatial judgement (e. g. 
Fink et al. 2000), which may be an important contributory factor to performance in 
syllogistic reasoning tasks (e. g Goel, Buchel, Frith & Dolan). In addition, decreases in 
5HT transporter binding were significantly correlated with extent of previous ecstasy 
use, and there was no correlation between duration of abstinence and extent of 
binding. 
Vollenweider, Gucker, Schonbachler, Kamber et al. (2000) measured 5HT 
uptake binding in healthy volunteers via PET with [11C] (+) McN5652. Participants 
were scanned at baseline, after administration of 1.5 mg/kg MDMA, and at one month 
following administration. No differences in binding could be detected at one month 
following treatment, although on scan 2 (after administration) significantly decreased 
binding was observed in the ecstasy group in the caudate, putamen, thalamus, 
midbrain, and occipital, temporal, frontal and parietal cortices. 
Using the same radioligand, Buchert, Thomasius, Nebeling, Petersen et al. 
(2003) compared 30 current ecstasy users (827 tablets lifetime dose over 54 months; 
abstinent for 24 days), 29 former users (793 tablets lifetime dose over 55 months; 
abstinent for 514 days), 29 drug-naive participants, and 29 polydrug controls. In all 
SERT rich areas, the mean DVR was lowest in the group of current ecstasy users. In 
the mesencephalon, the DVR for current users was significantly lower than for all 
other groups, while in the caudate the DVR was significantly lower for current ecstasy 
users than for polydrug users. In the thalamus, the DVR was significantly smaller for 
the current ecstasy users than for drug-naive participants and polydrug users. The 
mean standardised uptake volumes (SUV- the ratio of tracer uptake to injected dose 
per bodyweight) although non-significant were highest for drug-naive participants in 
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all regions. The mean SUVs were similar for the current users and polydrug users, 
although former users had the lowest of all groups. 
Gamma, Buck, Berthold, Hell et al. (2000) administered 1.7 mg/kg of MDMA 
to MDMA-naive participants in a cross-over design. It was found (via statistical 
parametric mapping) that although there were main effects of drug and Continuous 
Performance Task (CPT) on regional cerebral blood flow (ICBF indexed by H2150), 
the interaction was non-significant indicating that task had no significant effect on 
how ecstasy affected rCBF compared to placebo. MDMA produced significant 
bilateral increases in ICBF in the ventromedial prefrontal cortex (VMPFC), and the 
ventral anterior cingulate, inferior temporal lobe, medial occipital lobe, and 
widespread activation of the entire cerebellum. It also caused decreases in ICBF 
bilaterally in the pre- and para-central lobule, dorsal anterior and posterior cingulate, 
superior temporal gyrus, insula and thalamus. One-sided decreases were also found in 
the left amygdala and right parahippocampal formation and uncus. 
Again trying to assess the relationship between brain activation and task, 
Gamma, Buck, Berthold and Vollenweider (2001) used [H2150]-PET to compare 
blood flow in 16 regular ecstasy users (270 tablets lifetime dose) and 17 non-ecstasy 
using controls. Participants were scanned at baseline and twice while performing a 
continuous performance task (CPT). While in both groups the CPT produced 
alterations in rCBF, no ecstasy-related differences were observed, and there were no 
significant correlations between extent of ecstasy use and rCBF. 
Obrocki, Schmoldt, Buchert, Andresen et al. (2002) used PET labelled with 2- 
[18F]-fluoro-2-deoxy-D-glucose (FDG) in 94 ecstasy users (438 tablets cumulative 
lifetime dose; 6.4 months abstinence) and 27 controls. Glucose metabolism as indexed 
by uptake of FDG was reduced in ecstasy users compared to controls in the cingulate, 
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BA 11, putamen, caudate, amygdala and the hippocampus bilaterally. These 
differences were only significant for the putamen and caudate bilaterally and the left 
amygdala. Although no significant relationship was detected between cumulative 
lifetime dose and FDG uptake, there was a statistically significant relationship 
between FDG uptake and abstinence period in the left cingulate and right amygdala. 
In a pilot study from the same laboratory, 7 ecstasy users were found to have reduced 
glucose metabolism rates in the hippocampus and striatum compared to controls 
(Obrocki, Buchert, Vaterlein, Thomasius et al. 1999). 
In terms of significant findings most studies using PET scanning in ecstasy 
users find abnormal functioning. Three studies found significant decreases in SERT 
binding in ecstasy users with two of these finding that the decreases were significantly 
related to extent of previous ecstasy use (McCann et al. 1998; Thomasius et al. 2003). 
The other study showing decreases in SERT binding found that former ecstasy users 
had the lowest binding ratios of all groups (Buchert et al. 2003), supported by the 
non-significant correlation with abstinence in McCann et al's study. In contrast with 
this Vollenweider et al. (2000) found that there were differences in SERT binding 
immediately after administration of MDMA but no such differences were apparent 
after one month. Contrasting findings were also shown in relation to cerebral blood 
flow with one study finding ecstasy-related increases and decreases in certain brain 
areas (Gamma et al. 2000) and one finding no differences in blood flow (Gamma et 
al. 2001). One study also found decreases in glucose metabolism in ecstasy users 
(Obrocki et al. 2002). The final section of this chapter focuses on decrements in 
serotonin metabolites. 
4.5 Cerebrospinal Fluid (CSF) metabolites 
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One way in which serotonergic function can be assessed is by measuring the 
metabolites of serotonin in cerebrospinal fluid. The rationale behind this being that if 
there are lower levels of serotonin due to ecstasy use, then there will also be lower 
levels of serotonin metabolite. In an early study Ricaurte, Finnegan, Irwin and 
Langston (1990) measured CSF levels of 5-hydroxyindoleacetic acid (5-HIAA- a 
serotonin metabolite) in 33 ecstasy users (lifetime dose of 64 tablets; abstinent for at 
least 2 weeks) and 24 nonusers. Ecstasy users showed a significant 26% decrease in 
CSF-5HIAA compared to nonusers, although correlations between CSF-5HIAA 
concentration and number of ecstasy exposures, duration of use and abstinence period 
were not significant. Such results are consistent with damage to the central 
serotonergic system in ecstasy users. 
Another study found that memory impairments in abstinent ecstasy users were 
correlated with lower levels of CSF 5-HIAA. Specifically, amounts of 5-HIAA were 
assessed in 28 ecstasy users (lifetime use of 60 occasions; abstinent for 4 weeks) and 
28 nonusers. Participants also completed a number of memory measures. The mean 
concentration of 5-HIAA was significantly lower for ecstasy users than for controls; 
the concentration of 5-HIAA was also significantly negatively correlated with ecstasy 
dose (mg/month). In addition CSF levels of 5-HIAA were significantly associated 
with delayed visual memory (the lower the concentration, the lower the memory 
score). Significant associations were also observed between 5-HIAA concentration 
and immediate figural memory and delayed visual reproduction (Rolla, McCann and 
Ricaurte 1998). 
McCann, Eligulashvili, Mertyl, Murphy et al. (1999) also assessed CSF- 
5HIAA levels in 22 ecstasy users (lifetime usage of 215 occasions; abstinent for 13.91 
weeks) and 23 nonusers. Ecstasy users were found to have lower CSF levels of 5- 
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HIAA than nonusers, although concentrations of 5-HIAA were not significantly 
correlated with cognitive performance. An earlier study from the same laboratory 
(McCann, Ridenour, Shaham & Ricaurte, 1994) also found that ecstasy users had 
significant decreases in CSF 5-HIAA. While the 30 ecstasy users (lifetime exposure 
of 94.4 occasions; abstinent for 17.9 weeks) had lower metabolite concentrations than 
the 28 controls, there was also a significant group by gender interaction reflecting that 
in the ecstasy group females had a larger reduction in 5-HIAA than males (46% 
compared to 20%), and in the controls, males had lower levels than females. Levels of 
5-HIAA were not significantly correlated with any indices of ecstasy use. 
An early study of 5-HIAA concentration contradicts the preceding studies. 
Peroutka, Pascoe and Faull (1987) measured levels of the metabolite in 5 ecstasy 
users (with lifetime doses of 1,17,18,22, and 33 tablets; abstinent for at least 6 
weeks). When compared to the mean levels of metabolite for a control group, there 
were no significant differences, and there was no significant correlation between 
extent of ecstasy use and concentration of CSF-5HIAA. 
By way of summary, the earliest study assessing levels of 5-HIAA (Peroutka 
et al. 1987) found no differences in levels of the metabolite, although the sample size 
and ecstasy doses were rather small in this study. Subsequent studies did find that 
ecstasy users had lower levels of 5-HIAA in their cerebrospinal fluid (Bolla et al. 
1998; McCann et al. 1994; McCann et al. 1999; Ricaurte et al. 1990) with one finding 
that the decrease was greater in females than in males (McCann et al. 1994). Two of 
these studies also investigated the possible link between decreases serotonin 
metabolite levels and performance, with one finding that decrements were 
significantly related to poor performance (Bolla et al, 1998) and one finding that they 
were not related (McCann et al. 1999). 
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Chapter Summary 
It appears that in some way the use of ecstasy degrades the serotonin system. 
Serotonin is known to be involved in memory and learning processes, whether 
directly or indirectly (through modulation of another neurotransmitter system e. g. 
dopamine) (see e. g. Buhot et al. 2000). Abstinence from ecstasy seems to be a 
particularly important confound in such studies with some finding that any observed 
decrements in the serotonin system may be reversible after prolonged abstinence, 
although a number of studies also found that former users (in some cases having not 
used for as long as 514 days- Buchert et al. 2003) had lower uptake ratios than current 
users. Some studies mentioned in Chapter 3 (e. g. Wareing et al. 2000) also find that 
the cognitive deficits observed in ecstasy users persist after prolonged abstinence. 
Therefore all participants in this thesis will be required to abstain from the use of 
ecstasy for at least 7 days prior to testing (in line with other studies in this area e. g. 
Wareing et al. 2000) although in most chapters, the average abstinence period was 
actually longer than this. 
In Chapter 3 the use of other recreational drugs, especially cannabis, appear to 
be important contributors/mediators of the ecstasy-related deficits. For example, 
moderate cannabis use may offer some protection against the neurotoxic effects of 
ecstasy, while the use of drugs such as cocaine may exacerbate the neurotoxic effects 
of ecstasy. In turn both the use of cannabis and cocaine have been implicated in 
deficits in their respective users over a range of tasks. The following chapter (Chapter 
5) reviews evidence for cognitive deficits in cannabis and cocaine users, and discusses 
how might be the best way to statistically control for the use of these drugs. 
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Chapter 5: The effects of Cannabis and Cocaine on cognitive processes. 
As previously reviewed in Chapter 3, the use of ecstasy has been associated 
with cognitive decline. Some studies reviewed in Chapter 3 (e. g. Croft et al. 2001a) 
highlighted the significance of using other recreational drugs at the same time as 
ecstasy (in Croft et al's study this was cannabis, which was found to be more 
responsible for the cognitive deficits than ecstasy use in their sample). There may 
therefore be interaction effects between ecstasy and cannabis (see Parrott, Gouzoulis- 
Mayfrank, Rodgers & Solowij, 2004 for review). In their own right, cannabis and 
cocaine have been implicated in cognitive deficits in their respective users, although 
in the case of the former it is unclear in some studies if deficits persist after 30 days of 
abstinence, and in the latter most studies assess individuals presenting for dependence 
at clinics (as opposed to recreational use). Chapter 5 presents evidence for cognitive 
deficits in cannabis and cocaine users, which provides a rationale for quantifying the 
use of these drugs as well as ecstasy in this thesis. As most of the participants in this 
thesis were infrequent users of other recreational drugs (e. g. psilocybin mushrooms, 
amphetamine, GHB, Ketamine), the focus of this review is cannabis and cocaine. 
5.1 Cannabis 
Marijuana comes from the plant Cannabis Sativa. The psychoactive properties 
of cannabis are mainly4 due to its active ingredient 09 tetrahydrocannabinol, hereafter 
referred to as THC. Just as with ecstasy use in Chapter 3, the use of cannabis has also 
been associated with cognitive deficits. A review of some of the literature is provided 
below. 
5.1.1 Intelligence 
4 Marijuana does contain other cannabinoids e. g. cannabinol, cannabidiol, but these are not thought to 
contribute to its psychoactive properties. 
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Three studies pre-matched their group on IQ tests in an attempt to normalise 
performance. Whitlow, Liguori, Livengood, Hart et al. (2004) matched groups (long- 
term heavy cannabis users reporting daily use on 25 out of 30 days a month for at 
least 5 years, with an average abstinence period of 14.6 hours and controls reporting 
using cannabis 1-50 times, with none reported in the last year) on the WASI; 
Schwartz et al. (1991) matched groups (10 daily cannabis users, 8 light users 
reporting using less than 35 times in total and 9 nonusers) for IQ on an unspecified 
full-scale IQ test (all participants between 90 and 120 IQ); and Ehrenreich, Rinn, 
Kunert, Moeller et al. (1999) matched early onset cannabis users (26 hour abstinence 
period; 3.9 days/week frequency of use in the last six months; 4.6 years of use; 
estimated lifetime use of 1087.5 days), late onset users (33.4 hour abstinence period; 
3.2 days/week frequency of use in the last six months; 3.9 years of use; estimated 
lifetime use of 709.8 days) and controls on a PMI test. 
Other research suggests that cannabis users are not intellectually impaired 
relative to non-cannabis users. Millsaps, Arzin and Mittenberg (1994) used the 
WAIS-R to estimate full-scale and premorbid intelligence in a group of cannabis 
users. Fifteen cannabis dependent adolescents (length of use 29.13 months; 8.93 
grams/week used; 27.2 days of abstinence) participated in the study. There were no 
significant differences between values obtained for each scale and both were within 
the normal range. Again using the WAIS-R, Pope et al. (1997) found no differences 
between light (N=30; smoking a median of 1 day in the last 30) and heavy cannabis 
users (N=25; smoking a median average of 29 days in the last 30). To further support 
this Varma et at. (1998) used the WAIS-R verbal IQ scale (incorporating the 
information, digit span, arithmetic and comprehension subtests) and found that the 26 
long-term heavy cannabis users (regularly consuming cannabis for 5 years, 20+ times 
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a month, with a daily intake equivalent to 150mg 0-9-THC) did not perform worse 
than 26 non-cannabis-using controls). Finally, in another study only the cannabis user 
group were tested on the WAIS verbal intelligence scale, so comparisons were not 
made with controls. Nevertheless, Intelligence scores in the cannabis-using group 
(N=12; 19,200 occasions of use in lifetime; current use of at least 7 times/week) were 
not significantly correlated with any other measures (Kanayama, Rogowska, Pope, 
Gruber et al. 2004). Using the culture fair IQ test (scale three) and the Intelligence 
Structure Test (IST- measuring verbal memory and assessing learning efficiency) 
Kurzthaler, Hummer, Miller, Sperner-Untwenger et at. (1999) found no significant 
differences between controls and cannabis users at baseline, after cannabis 
administration, or on day three of the study. However, whereas controls showed an 
increase in performance from day one to day two, and day two to day three, the 
cannabis group only improved from day two to three indicating that they have not 
learned from their performance while on cannabis. Solowij, Stephens, Roffman, 
Babor et al. (2002) used a measure of full-scale IQ (Wide Range Achievement Test- 
Revised, Reading subtest), and premorbid IQ (North American Adult Reading Test- 
NAART) in fifty-one short-term cannabis users (10.2 years of use; smoking on an 
average of 28.3 days a month), 51 long-term users (23.9 years of use; smoking on an 
average of 27.4 days a month) and 33 of control participants; comparisons were also 
made between a combined group of the cannabis users (17.1 years of use; smoking on 
an average of 27.9 days a month; and an average of I/4 ounce per week in two large 
joints) and 33 nonuser controls. Neither intelligence measure was significantly 
different between the cannabis users and nonusers. One study also using a measure of 
fluid intelligence (Raven's Progressive Matrices) found that cannabis users and 
nonusers did not differ significantly (Varma, Malhotra, Dang, Das et al. 1998). 
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As with studies in ecstasy users, there appear to be few differences between 
cannabis users and nonusers in terms of intellectual functioning, indeed no studies 
reviewed above found that cannabis users and nonusers performed differentially, and 
none found dosage effects. 
5.1.2 Attention/Concentration 
Although there is evidence that cannabis use may be associated with deficits in 
attention/concentration, the studies outlined below reveal that this may be related to 
recent cannabis use, rather than being a long-term consequence of using the drug. 
Pope, Jacobs, Mialet, Yurgelun-Todd et al. (1997) used a divided attention 
letter detection task requiring participants to monitor a9x9 matrix and when one 
letter changed to an asterisk for 250 ms, they had to indicate which one it was (the 
target was either at the centre or the periphery of the display). The 25 heavy users 
(smoking a median average of 29 days in the last 30) and 30 light users (smoking a 
median of 1 day in the last 30) did not differ significantly on this task. Nicholson, 
Turner, Stone and Robson (2004) used a letter vigilance task to assess the differential 
effects of placebo, THC, or a mixture of THC and cannabidiol (another cannabinoid 
contained in marijuana that is not believed to contribute to its psychoactive 
properties). Eight participants took part in this cross-over design completing 3 
separate sessions of testing after being administered 15mg THC, a combination of 
THC/cannabidiol, or placebo. Participants had to press a key when two letters in a 
random sequence on the screen matched the critical stimulus at the top. No 
performance differences were observed between the three groups. Using a test battery 
incorporating tests of visual scanning (participants have to indicate the presence or 
absence of a "0" shaped stimulus in a 100 x 100 matrix), tonic alertness (responding 
to a tone), phasic alertness (enhancing attention by expecting a tone) and divided 
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attention (dual-task in which participants have to divide their attention between visual 
stimuli and tones), one study found that cannabis users performed worse than 
nonusers on the phasic alertness, visual scanning and divided attention tasks. In 
addition, on the visual scanning task cannabis users with an early age of onset 
performed significantly worse than late onset users. Early age of onset was also the 
only significant predictor of performance, not THC urinary metabolites or cannabis 
use variables (Ehrenreich et al. 1999). 
Kurzthaler et al. (1999) used a digit cancellation task requiring participants to 
go through a list of numbers and cancel every eighth zero, then every eighth one, etc. 
While performance at baseline and on day three of the study was comparable, those 
given 200 gg/kg of body weight of THC in a cigarette performed significantly worse 
than those who were not given it on day two, suggesting an on-drug impairment. In 
another study utilising a crossover design and using single (participants are presented 
with 400 numbers on a piece of paper and have to cross out all the "4"s as quickly as 
possible) and double (same as before, but with numbers "2" and "6") digit 
cancellation, participants were administered placebo, 7.5mg THC or 15mg THC on 
separate occasions. On single digit cancellation, there were no differences in time 
taken to complete the task, but errors showed a main effect of drug administration and 
time of testing (in days), although the interaction was non-significant. On the double 
digit cancellation task, the time taken to complete the task approached significance, 
with the drug group (i. e. on occasions participants were administered 7.5 or 15mg of 
THC) performing worse, and there was a main effect of drug administration on errors, 
as errors were increased by both doses of THC (Curran, Brignell, Fletcher, Middleton 
et al. 2002). D'Souza, Perry, MacDougall, Ammerman et al. (2004) used a 
Continuous Performance Task (CPT) requiring participants to attend to sequentially 
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presented numbers and push a key if a number one was preceded by a number nine, 
and a "distractibility" task, which was the same as the CPT except that the numbers 
were in three columns and participants were told to attend to the middle column only. 
All 22 participants (modal cannabis use of less than 5 times and 1-6 months of 
abstinence) performed 3 separate trials under placebo, 2.5 mg or 5 mg of THC. THC 
had no effect on omission or commission errors in the CPT task although there was a 
trend towards significance on response latencies. On the distractibility task, there 
were dose effects of THC on omission errors and latencies with larger doses giving 
rise to more errors. Finally, Curran et al. (2002) used the Rapid Visual Information 
Processing Task (RVIP- previously described in Chapter 3, section 3.4), and although 
differences between the THC trial and placebo trial were non-significant, there was a 
trend towards a main effect of drug administration. 
A further study (Solowij et al. 2002) used the Paced Auditory Serial Addition 
Task (PASAT) to assess sustained attention. In this task, 61 random digits are 
presented sequentially on an audiotape, and participants have to add the last presented 
digit to the preceding number and say the answer aloud before moving on to the next 
digit. Long-term cannabis users were significantly slower than short-term users on 
trial one, and there were trends towards a significant effect on trial 2 and the sum of 
all trials. This was however reduced to below statistical significance following the 
removal of those with THC metabolites in their urine indicating that perhaps recency 
of cannabis use is a more important contributor to cognitive deficits than having ever 
used cannabis. 
While it appears from some of the studies above that cannabis impairs 
cognitive functioning, this may due to the residual post-intoxication 
neuropsychological effects of the drug. Only one retrospective study (Ehrenreich et al. 
112 
1999) found a clear cannabis related effect with cannabis users performing worse than 
nonusers, while all those involving administration of THC found a significant effect 
of drug administration, or a trend towards a significant effect. To further support this, 
another study found that significant drug effects were reduced to below statistical 
significance following the removal of those with THC metabolites in their urine 
(Solowij et al. 2002). 
5.1.3 Recall 
As with ecstasy use, recall seems to be one area of cognition that does reveal 
cannabis-related deficits. Solowij et al. (2002) used the RAVLT immediate and 
delayed recall components (previously described in Chapter 3, section 3.6) and found 
that long-term heavy cannabis users, short-term users and controls did not differ 
significantly on immediate recall. The nonusers and short-term users did however 
perform significantly better than the long-term users on the delayed recall of words. 
The effects on delayed recall were reduced to below statistical significance following 
the removal of those participants with THC metabolites in their urine, although the 
heavy cannabis user group still performed significantly worse on the RAVLT total 
score. Nicholson et al. (2004) used immediate and delayed word recall tasks in which 
participants were required to recall a list of 16 words after 45 seconds, and after 76 
minutes. On immediate recall, 15mg of THC impaired performance (recalling fewer 
words) compared to placebo. On delayed recall, 15mg of THC impaired performance 
compared to placebo and a 5mg dose of THC and cannabidiol, suggesting an on-drug 
dose related effect. D'Souza et al. (2004) used a similar word learning test with three 
trials (the first immediate recall, the 2 "d and 3rd learning trials) of recall of a 12-item 
semantically categorised list, and 30 minutes later a delayed and cued recall trial. 
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THC administration significantly impaired immediate recall in a dose dependent 
manner across the three trials. THC also impaired delayed recall and cued recall in a 
dose related fashion. Another study also used a word recall test (the Buschke 
Selective Reminding Test) with similar trials to that of D'Souza et al. Immediate 
recall showed that there was a drug x trial interaction which reflected a lack of 
learning over trials under the higher dose of THC. In delayed recall, there were main 
effects of drug and time, although the interaction between the two only approached 
significance. There were dose dependent impairments by THC which were most 
marked at 2 hours (Curran et al. 2002). 
Two studies also assessed Prose Recall in cannabis users. Schwartz (1991) 
used the prose recall test of the WMS in daily cannabis users, light users and 
nonusers. At the initial testing session immediate recall of the material was impaired 
in daily cannabis users relative to controls, and although slightly attenuated at 6-week 
retest, this remained significant. Curran et al. (2002) used a prose recall news story 
which participants had to recall immediately and after a 45-minute delay. On 
immediate recall there was a significant drug x time interaction, with the higher dose 
trial performing worse than the lower dose trial and placebo trial. For delayed recall 
the interaction between dose and time only approached significance, again with 
participants performing worse after administration of the higher doses than the lower 
doses and placebo. 
One study (Varma et al. 1988) assessed visual recall using the Bender Visual- 
Motor Gestalt Test (BVMG) in which each participant is required to reproduce 9 
designs on a piece of paper, and the Nahor-Benson Test (NBT) which again requires 
the reproduction of designs. No significant differences were observed between 
cannabis users and nonusers on the BVMG, but the cannabis users did give 
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significantly more errors on the NBT. Finally, Millsap et al. (1994) used the WMS 
delayed recall component (specific tests unspecified) to test 15 cannabis-dependent 
adolescents (using a mean average of 9 grams/week for and average of 29 months). 
The scores for full-scale IQ and delayed recall were standardised and the full-scale IQ 
score was significantly higher than the delayed recall score, although no between 
group comparisons were made. 
To summarise, like research in ecstasy use, this seems to be one area in which 
cannabis users are impaired. Moreover deficits appear to be dose-related in all clinical 
studies (Curran et al. 2002; D'Souza et al. 2004; Nicholson et al. 2004), although may 
dissipate somewhat after prolonged abstinence (Schwartz et al. 1991; Solowij et al. 
2002). 
5.1.4 Executive functions 
5.1.4.1 Access to Semantic Memory 
One particular focus of this thesis is access to semantic memory. It is therefore 
particularly interesting to see if cannabis users exhibit impairments in this area. Two 
studies have assessed the effects of THC administration on access to semantic 
memory. D'Souza et al. (2004) used a category fluency task similar to the COWA 
(Chapter 3, section 3.3.2) requiring participants to generate as many words as possible 
in one minute, beginning with a specific letter. Administration of THC had no 
significant dose related effects on the number of words generated in a minute. There 
was however a trend towards significance for the number of perseverative errors 
given, which has been linked to deficits in mental set switching (e. g. Miyake et al. 
2000). In another study, Curran et al. (2002) used a crossover design in which 15 
males with some cannabis experience (although not regular users) took part in 3 
sessions, one week apart on which they were administered either placebo, 7.5mg of 
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THC, or 15mg of THC. The test required participants to give as many words as 
possible beginning with a certain letter in one minute. There was a significant drug x 
time interaction and a main effect of time indicating that THC actually enhanced 
performance, especially at 6 hours after administration when the higher dose THC 
group gave significantly more words than the low dose group. 
To sum up, results in this area are equivocal with one study finding no effect 
of THC administration, and another finding that THC administration actually 
enhanced performance. Thus it is possible that in this thesis, cannabis use in the 
sample as a whole may have some mediating effect of performance on access tasks, 
and this will therefore be investigated statistically. 
5.1.4.2 Inhibition 
Skosnik, Spatz-Glenn and Park (2001) used a negative priming task to assess 
attentional inhibition in current cannabis users (average use of 1.3 times/week, at least 
48 hours abstinence), previous users (having used at least once in their lifetime, but 
not in the last 45 days) and controls. In this visuospatial task, pairs of prime and probe 
displays were presented on a computer screen. First a prime is presented in which the 
target stimulus ("0") must be located, and a distractor ("+") ignored. After this, the 
target is presented at the previously ignored position, and an increase in reaction time 
while participants ignore the previously relevant position is expected. Accuracy was 
non-significantly different between the groups, with all groups getting nearly 100% 
correct. Current cannabis users did however get a more positive negative-priming 
score, indicating disinhibition or absence of negative priming, while previous users 
and controls showed normal negative priming. Correlations between negative priming 
and the amount of cannabis consumed in a week was non-significant. Current 
cannabis users were also faster than controls and previous users on the task, but again 
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correlations with the amount of cannabis consumed in a week were non-significant. 
The other two studies that assessed inhibition in cannabis users used the Stroop task. 
Solowij et al. (2002) used the Stroop interference task (requiring participants to read a 
colour word, rather than say the colour of that word- colour read) and a more 
cognitively demanding modification of this task in which naming of the items 
depends on a special visual cue given with each item (colour word). There were 
significant within group differences with the short-term and long-term cannabis users 
performing more poorly on the colour-read than colour-word condition (perhaps due 
to increased inhibition resources), although there were no differences between users 
and nonusers. Duration of cannabis use was also negatively related to the number of 
items completed on the CR and CW conditions. All of the significant results on the 
Stroop test in this study were however reduced to below statistical significance 
following the removal of those with urinary THC metabolites, suggesting that 
performance may be more related to recency of cannabis use, rather than cumulative 
use or duration of use. Finally, Pope et al. (1997) used the Stroop different colour 
(analogous to the colour read condition) and opposite colour (where participants are 
instructed to say a certain response for each colour e. g. say "red" for "green) 
conditions. Differences between the groups were non-significant, although heavy 
users were slightly slower than light users. 
While in general response inhibition does not appear to be affected by 
cannabis use, it is possible that deficits are related to recent cannabis use (Solowij et 
al. 2002). Inhibition is also a particular focus of this thesis so it may be that if 
cognitive deficits are observed in ecstasy users, that these are genuinely an ecstasy- 
related effect and not related to cannabis. 
5.1.4.3 Reasoning/Decision Making 
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Like inhibition and access, reasoning is a particular focus of this thesis. 
Whitlow et al. (2004) used a computerised card gambling task where decks A and B 
have higher monetary gains but also higher losses, while decks C and D have smaller 
monetary gains but also smaller losses, and are therefore the more advantageous pack. 
Participants were instructed to win as much money as possible, and told that the 
person who won the most money would receive a $50 reward. The net score was 
significantly lower for long-term heavy cannabis users than controls. There was also a 
significant interaction between group and block that indicated that while nonusers had 
started to choose more cards from the advantageous pack on successive blocks, the 
cannabis users continued with the disadvantageous pack. Thus cannabis users sought 
greater monetary gains while ignoring the losses. Curran et al. (2002) used the 
Baddeley reasoning task in which participants have to verify a series of statements on 
a computer, for example "A does not precede B... BA" by pressing true or false. There 
was a trend towards a THC effect on response times with both 7.5mg and 15mg doses 
increasing response times compared to placebo at lhr after administration, although 
the effects on errors were non-significant. Taken together, the results of these studies 
suggest that the use of cannabis may impair rational thinking. In one study the results 
were found one hour after THC administration (and were non-significant) so this 
should be treated with some caution (Curran et al. 2002). Whitlow et al. did find that 
long-term heavy cannabis users exhibited impaired reasoning. Consequently, as with 
access and inhibition it is necessary to control for the use of cannabis. 
5.1.4.4 Updating 
Again, updating is a particular focus of this thesis so it is important to review 
evidence of cannabis-related decrements in memory updating. Ehrenreich et al. (1999) 
used a task similar to the 1-back task (Chapter 3, section 3.3.5) in which a participant 
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has to press a key when the previous digit is the same as the one presented. There 
were no significant differences between early and late onset cannabis users and 
controls. In addition, performance on this task was not predicted by THC metabolites 
in the urine indicating that recency of cannabis use is not an important factor in 
memory updating deficits. Using a similar task (the digit memory recall task) 
requiring participants to state if a presented digit was the same or different from the 
preceding digit, there were no performance differences between those administered 
THC, placebo or a combination of THC/cannabidiol in terms of errors. The group that 
was administered THC/cannabidiol were however significantly slower than the 
placebo group on the day after administration (Nicholson et al. 2004). Solowij et al. 
(2002) used the Auditory Consonant Trigrams test, in which 3 consonants are 
presented and participants have to recall these after intervals of 0- 9- 18- and 36- 
seconds. During the 9- 18- and 36-second gaps participants were required to count 
aloud backwards in "3"s from a specified number, as a distraction task. Long-term 
users recalled significantly fewer consonants than short-term users, controls and 
published norms on this task, although performance was not significantly correlated 
with length of cannabis use. After removal of those participants with THC metabolites 
in their urine, this was only significant for the 9-second delay. Curran et al. (2002) 
used the Subtracting Serial Sevens (Chapter 3, section 3.3.5), however neither 
reaction time nor errors committed showed an effect of THC administration. 
The lack of cannabis-related deficits in tests that assess memory updating may 
indicate that if ecstasy-related decrements are observed in memory updating in this 
thesis, then they reflect the use of ecstasy, rather than the use of cannabis (although an 
interaction effect cannot be ruled out). 
5.1.4.5 Switching 
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Switching has also been assessed in cannabis users via methods similar to 
those used in this thesis. Using a task similar to that used in this thesis (the 
number/letter task) that required participants to switch between attending to two 
opposing stimuli (numbers/letters) on the left and right hand side of the screen, there 
were no observed group differences between early onset users, late onset users and 
controls. In addition, performance was not correlated with the presence of urinary 
THC metabolites suggesting that although the abstinence period was relatively short, 
recent cannabis use was not a predictor of performance (Ehrenreich et al. 1999). 
Kurzthaler et al. (1999) used the Trail Making Test-B (previously described in 
Chapter 3, section 3.3.1) and found that THC administration did not impair 
performance. However, the THC group did not improve from day 1-2 of the study 
(immediately after THC administration) while the controls did. The THC group only 
improved from day 2-3 suggesting that while under the immediate influence of THC, 
they were not capable of learning from their experience. 
Solowij et al. (2002) used the Wisconsin Card Sort Task (WCST- previously 
described in Chapter 3, section 3.3.1) and the alphabet task (the nature of the switch 
part of this task is unspecified in the paper) to assess switching in long-term cannabis 
users, short-term users and controls. On the WCST, no significant differences were 
observed on any of the dimensions, but there was a trend towards significance in 
maintaining mental set: with long-term users failing to maintain set more often than 
short-term users and controls. Correlations between length of use and performance 
were however non-significant so this should be treated with caution. On the alphabet 
task, the time taken to complete the alternating condition of the task increased with 
increasing duration of use, as did the times taken on alternating and difference trials 
(which the authors state is an indication of interference and a lack of cognitive 
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flexibility). This was however reduced to below statistical significance following 
removal of those with THC metabolites in their urine, suggesting that it may be more 
related to recent cannabis use. Whitlow et al. (2004) used the CANTAB intra- and 
extra-dimensional shift task (previously described in Chapter 3, section 3.3.1), and 
found a trend towards a cannabis effect with users giving more errors than nonusers. 
Again, it appears that cannabis use does not impair performance on switching 
tasks, with most studies finding non-significant effects, or a trend towards a cannabis 
effect. The only study that did find that cannabis users were impaired in switching 
was reduced to below statistical significance following control for those with THC 
metabolites in their urine, indicating that recency of cannabis use is an important 
factor. 
5.1.5 Psychomotor Speed 
To assess psychomotor speed, Varma et al. (1988) used the pencil-tapping test 
(a participant has to tap a pencil on a piece of paper as quickly as possible for 30- 
seconds). The mean number of taps was significantly lower for cannabis users than 
for nonusers indicating decreased psychomotor speed. Using the Gibson Spiral Maze 
Task (place a pencil on the arrow in the centre of a maze and then find the way out 
without touching the sides or circles around the maze) another study found that there 
was a main effect of time after administration of THC, and a significant drug x time 
interaction indicating that those who were administered 7.5mg and 15mg of THC 
were faster than nonusers. This was however at the cost of accuracy: a significant 
main effect of drug was observed with more errors being given under THC 
administration than placebo (Curran et al. 2002). 
5.1.6 Reaction Time 
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Some studies used tests to assess simple and choice reaction time. Varma et al. 
(1988) used a task which required participants to listen to 20 words read out by the 
experimenter, repeat them as quickly as possible (one by one) and say what ideas 
came to mind. On this task, cannabis users were significantly slower than nonusers 
although it was not clear if this was due to the cannabis users being slower at the 
repeating of the word, or if they were perhaps slower at thinking of the related word. 
Whitlow et al. (2004) also found no differences between the groups on the CANTAB 
reaction time task. In Curran et al's (2002) study, a simple RT task requiring 
participants to press a key as soon as a target symbol appeared on the screen was 
used. There were trends towards significant effects of drug, time of administration and 
significant drug x time interactions with the higher dosage sessions reaction times, 
compared to placebo administration. 
Three studies also used choice reaction time tasks. In one study, the task used 
required participants to press a key in response to one of three letters (A, Z, E) on a 
screen. "A" and "Z" appeared alternately on the left and right sides of the screen, and 
occasionally they were replaced by "E" (which participants were required to respond 
to). Differences between heavy (N = 25; smoked a median of 29 days in the last 30) 
and light (N = 30; smoked a median of 1 day in the last 30) users were non-significant 
although the mean scores showed that heavy users were faster than light users, but 
also made more errors (Pope et al. 1997). In Nicholson et al's (2004) study, 
participants had to press keys corresponding to the positions of asterisks on the 
screen. The performance of the eight participants in this crossover design did not 
differ under administration of 15mg THC, a combination of THC/cannabidiol, or 
placebo. Finally, Curran et al. (2002) used a task requiring participants to respond to 4 
targets (ABCD) presented at different response-stimulus intervals, by pressing the 
122 
corresponding key as quickly as possible. There were no effects of drug 
administration on reaction time. There was however a significant main effect of drug 
on errors due to 15mg of THC increasing errors (at 1 hour after administration), and 
7.5mg increasing errors (at 2 and 8 hours after administration). 
Only one retrospective study found that cannabis users were slower than 
nonusers (Varma et al. 1998) although it is not clear if the task used is solely a simple 
RT task. Most studies found that THC administration had no effect on reaction time, 
although it may increase the number of errors given (e. g. Curran et al. 2002). One 
study suggests that while under the influence of cannabis, users may sacrifice 
accuracy in favour of speed (Pope et al. 1997). 
5.1.7 Visuo-Spatial Workin Mg emory 
Pope et al. (1997) used the Checkerboard test in which a6x6 matrix with 
randomly distributed shaded squares is presented on a computer screen, after which 
participants have to indicate which squares were shaded (ranges from 2-11 squares). 
The differences between light and heavy cannabis users approached significance for 
the total number correct, span length and number of errors. When the groups were 
further split by gender a highly significant effect emerged with heavy female users 
performing significantly worse than light female users, although light and heavy using 
men performed comparably. Schwartz (1991) used the Benton Visual Retention Test 
(Chapter 3, section 3.10.3), in which daily cannabis users performed significantly 
worse than light users and controls at the initial testing session, and following six 
weeks abstinence, providing some support that the cognitive deficits do persist. In 
another unspecified spatial working memory task, the same study found that daily 
cannabis users did not perform worse than nonusers. 
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Skosnik et al. (2001) used a task requiring participants to remember the 
location of a black dot on the circumference of an imaginary circle, and after 
presentation, they had to perform a verbal distractor task then touch the point where 
they believed the original target had been. There were no significant differences 
between current cannabis users, previous users and controls. 
One study used fMRI during a task in which participants focused on a cross at 
the centre of a screen that was surrounded by three dots. The dots disappeared then 
after a 3-second delay a circle appeared and participants had to press a key once or 
twice to indicate if it marked the place where a dot had previously been. The 12 
cannabis users and controls both demonstrated activation in certain brain areas 
(bilateral middle frontal gyrus, bilateral inferior frontal gyrus, right anterior 
cingulate). The activation in cannabis users was stronger than in nonusers, and 
cannabis users also activated other areas of the brain (3 areas of the lentiform nucleus, 
and 1 of the superior frontal gyrus), although correlations between activation and 
THC metabolites and lifetime cannabis were non-significant. Performance was not 
significantly different between the groups, which the authors suggest may represent a 
ceiling effect due to task simplicity, while they suggest that increases in activation in 
cannabis users may reflect attentional dysfunction (Kanayama et al. 2004). 
In a study using a crossover design, with all 22 participants performing 3 
separate trials under placebo, 2.5 mg or 5 mg of THC, the delayed match-to-sample 
task required participants to select 5 previously presented shapes from an array of 20 
(easy and difficult trials were implemented depending on stimulus complexity). 
Administration of both doses of THC significantly decreased the number of correct 
responses in the easy subtest without affecting reaction time. In the hard Subtest, there 
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was no effect of THC administration on errors, but there was a trend towards a THC 
effect on reaction times (D'Souza et al. 2004). 
While it appears that cannabis use does not impair performance on some easier 
visuo-spatial memory tasks (Kanayama et al. 2004; Skosnik et al. 2001) the severity 
of use may be important. Two studies found that heavy use of cannabis causes deficits 
in visuo-spatial working memory (Pope et al. 1997; Schwartz et al. 1991), with the 
former finding that this effect was particularly evident in female heavy users but not 
male users. 
5.1.8 Verbal Learning 
As with studies in ecstasy users, recall seems to show cannabis-related effects. 
One study using the RAVLT found that long-term cannabis users performed worse 
overall than short-term users and nonusers. In addition, the percentage of participants 
with very poor learning ability (less than 3 words acquisition over 5 trials) was 
significantly greater among long-term users (13.7 %) than controls (0 %), but not 
short-term users (5.9 %). The long-term users also recalled less than 10 words on trial 
5 compared to 8.5% of short-term users, and 3% of controls. The differences in 
RAVLT total remained significant after removal of those with urinary THC 
metabolites (Solowij et al. 2002). In another study using a test similar to the RAVLT, 
THC administration had no effects on learning over three trials (D'Souza et al. 2004). 
5.1.9 Information Processing Speed 
In Varma et al's (1988) study, cannabis users committed significantly more 
errors on the TMT-A (Chapter 3, section 3.2), although two other studies using the 
Stroop-A task found no differences in reaction times between users and nonusers 
(Pope et al. 1997; Solowij et al. 2002). Solowij et al. (2002) used the Speed of 
Comprehension Test (Chapter 3, section 3.2) and found that cannabis users did not 
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differ significantly from controls in the number of items completed, but both short- 
term and long-term users did make more errors than controls (although they did not 
differ from each other). Nicholson et al. (2004) used the Digit Symbol Substitution 
Test (DSST, Chapter 3, section 3.2) and the Multiattribute Task (MAT) Battery, 
which contains four tasks that airline crew would be expected to perform (system 
monitoring, tracking, communications, fuel management). It was not reported in the 
paper if there were differences between administration of THC, THC/Cannabidiol or 
placebo on the MAT battery, and there were no significant differences in the number 
of substitutions made on the DSST. 
5.1.10 Recognition 
Kurzthaler et al. (1999) used the Benton Multiple Choice Form G in which 
participants have to recognise a previously presented stimulus from a choice of 15. 
There were no significant differences between the groups at baseline, after THC 
administration (day 2 of the study), or on day three of the study. Another study using 
the CANTAB pattern recognition task found that there were no performance 
differences between heavy long-term cannabis users and controls (Whitlow et al. 
2004). Another study found no significant effects of administration of THC, placebo 
or THC/cannabidiol on a letter recognition task requiring participants to pick out 
previously presented letters from a random string (Nicholson et al. 2004). Similarly, 
D'Souza et al. (2004) found only a trend towards an effect of THC administration on 
the number of words recognised, false positive responses, and intrusions on a word 
recognition test (from the Hopkins Verbal Learning Battery). Using another word 
recognition task (the recognition of lists A and B from the RAVLT), Solowij et al. 
(2002) found that overall long-term cannabis users recognised fewer words from list 
A (the original list) and list B (the interference list), although long-term and short- 
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term users did not differ. Significantly more long-term users had recognised less than 
12 words for list A, and also mis-assigned more words than short-term users and 
controls. All significant results in this case remained significant after the removal of 
those with THC metabolites in their urine. The same study also used the omitted 
numbers task in which participants have to recognise numbers omitted from a 
previously presented list. No significant differences were observed between short- 
term cannabis users, long-term users or controls in terms of recognition, and 
performance was not significantly correlated with cannabis use variables (this also 
remained non-significant after the removal of those with urinary THC metabolites). 
To summarise, cannabis has been associated with mild decrements in a 
number of areas of cognition. However, unlike the studies in ecstasy users reported in 
Chapter 3, it appears that in cannabis users these decrements are more related to 
recent use. The next section reviews a number of studies examining aspects of 
cognition in cocaine users, as it is also possible that the use of cocaine may contribute 
to deficits observed in the ecstasy-users in this thesis. 
5.2 Cocaine 
Also a naturally occurring substance, cocaine has been used culturally for centuries. 
The use of cocaine among recreational drug users in the UK has risen in recent years 
(British Crime Survey 04-05) and like ecstasy, cocaine use has been associated with 
deficits in some areas of cognition. 
5.2.1 Intelligence 
Two studies in cocaine users have used the WAIS-R scale to assess 
intelligence. Gillen, Kranzier, Bauer, Burleson et al. (1998) used the verbal 
intellectual scale, performance IQ scale and full-scale IQ scale of this battery. On the 
verbal intellectual scale controls had significantly higher scores overall than the 
127 
cocaine users, due to them having significantly higher scores on the "information" 
and "vocabulary" subtests. In the same study, the controls also scored significantly 
higher on a visual intellectual measure, incorporating scores from a number of tests. 
Goldstein, Leskovjan, Hoff, Hitzemann at al. (2004) used the WAIS-R information 
and vocabulary subscales, Raven's Progressive Matrices, the Wide Range 
Achievement Test-Revised (WRAT-R), and the Woodcock-Johnson word attack test 
to assess IQ. Between group comparisons were not made for the separate tests 
although on an overall measure of verbal knowledge, the cocaine users were worse 
than the nonusers (on standardised scores). Other studies used different tests including 
the Shipley IQ scale (where the 12 cocaine abusers had significantly lower IQ scores 
than the 14 controls, although IQ was not a significant predictor of performance on a 
gambling task (see below), Stout, Busemeyer, Lin, Grant et al. 2004), and the New 
Adult Reading Test-Revised (where cocaine dependent participants who had been 
using for a minimum of six months did not differ significantly from controls, Berry, 
van Gorp, Herzberg, Hinkin et al. 1993). Finally, one study used the Barona IQ scale 
and the Shipley Institute for Living Scale (SILS) vocabulary and estimated IQ scales. 
The cocaine dependent participants had lower IQs than the alcoholic group and 
control group (Beatty, Katzung, Moreland and Nixon, 1995). 
Unlike ecstasy and cannabis use, it appears that cocaine users perform worse 
on tests assessing IQ. It is unclear whether this reflects a difference in the sample that 
may pre-date drug use or a cocaine-related decrement. It is noteworthy that most 
studies in this area assess those presenting at clinics for treatment rather than 
recreational users (as with ecstasy and cannabis studies), thus those using cocaine in 
the studies reported in this section are likely to be chronic heavy users. 
5.2.2 Attention/Concentration 
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To assess concentration, Berry et al. (1993) used the Paced Auditory Serial 
Addition Task (PASAT, previously described in section 4.1.2). Cocaine users were 
significantly worse at session one, but not session two, after a longer period of 
abstinence, although the group by trial interaction approached significance suggesting 
that the cocaine users did not improve to the same extent as the nonusers. On a 
combined deficit score for the PASAT and the WMS-III number-letter sequencing 
task (requiring the re-ordering of a sequence of numbers/letters to alphabetical and 
numerical order), cocaine users who did not use cannabis performed similarly to those 
who did and controls (Gonzalez, Rippeth, Carey, Heaton et al. 2004). 
Two studies used the WAIS-R digit span and arithmetic subtests to assess 
attention. On one there was no difference between cocaine users and controls (Gillen 
et al. 1998). In the other study, the 42 cocaine and/or crack dependent participants 
(who had been dependent for at least two years, with 2 months of abstinence) 
performed significantly worse than controls on both tasks. Performance on the 
arithmetic subtest was predicted by the "drug problems" scale of the Personality 
Assessment Inventory (Rosselli et al. 2001). Beatty et al. (1995) found no significant 
performance differences between cocaine users and controls on the Distractibility Test 
from the Gordon Diagnostic Battery (requiring the detection of 2 target numbers in a 
sequence, presented against a background of other numbers). Similarly, cocaine users 
did not perform significantly worse on an "attention/executive" scale incorporating 
the WMS digit span task, and a letter cancellation task (Goldstein et al. 2004). 
Cocaine use does therefore not appear to be degrading to the attentional 
system in the studies reviewed above (although this may be because some of these 
tasks are not reliant on attentional processes only). 
5.2.3 Recall 
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A number of studies used the CVLT (see Chapter 3, section 3.6). In one study, 
cocaine users performed significantly worse than controls on the immediate and 
delayed recall scales, and performance on immediate recall was predicted by the 
"drug problems" scale of the Personality Assessment Inventory (Roselli, Ardila, 
Lubomski, Murray et al. 2001). Butler & Frank (2000) also found that on a combined 
measure of verbal recall, cocaine users performed worse than nonusers at an initial 
testing session, although this had improved significantly after one month of 
abstinence. However, Gillen et al. (1998) did not find any significant differences 
between cocaine users and nonusers on immediate and delayed recall. On a total score 
for the Arizona Battery for Communicative Disorders of Dementia (ABCD) 
incorporating a prose recall task, cocaine users were significantly worse than norms at 
one weeks abstinence, but after one month performance had significantly improved, 
although between group comparisons were not performed on separate subtests (Butler 
& Frank, 2000). Another study assessing prose recall found that cocaine users and 
alcoholics performed worse on immediate and delayed recall, and the cocaine users 
were also worse than the alcoholics on the delayed component. Performance also 
appeared to be related to amount of cocaine used: the Quantity of Cocaine Index was 
significantly negatively correlated with immediate recall of stories (Beatty et al. 
1995). 
Two studies specifically tested nonverbal recall: one found a trend towards a 
cocaine effect on the Rey-Osterrieth delayed recall at session 1, but the cocaine users 
were significantly worse at session 2, although the group by trial interaction was non- 
significant (Berry et at 1993). Beatty et al. (1995) used the WMS-Figures subscale, 
but no differences were observed between controls, alcoholics and cocaine users on 
immediate and delayed recall. Two studies also used a range of recall tests and 
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analysed results as a whole. Goldstein et al. (2004) used the CVLT, WMS immediate 
and delayed recall, and the WMS visual reproduction immediate and delayed recall 
tasks. No separate analyses were performed for these tasks, but the cocaine users did 
not perform significantly worse on the "verbal memory" scale incorporating these 
measures. Gonzalez et al. (2004) used the HVLT"R delayed recall component (a word 
learning test similar to the CVLT and RAVLT), the BVMT-R delayed recall test, the 
story memory test, and the figure memory test. Those cocaine users who did not 
smoke cannabis performed significantly worse than controls on a total score for these 
measures (while those who did use cannabis did not differ significantly from 
controls). 
Again, studies assessing recall in cocaine users yield mixed results. It may be 
that recent use of cocaine, like cannabis is an important contributor to deficits in recall 
as some studies found that performance improved after abstinence (e. g. Butler & 
Frank, 2000). It may also be that severity of cocaine use is important as heavy cocaine 
use produced worse deficits in some studies (e. g. Beatty et al. 1995). 
5.2.4 Executive functions 
5.2.4.1 Access to Semantic Memory 
As with cannabis and ecstasy use most studies use the COWA task to assess 
access to semantic memory. Only one of the reviewed studies found that cocaine users 
performed worse than nonusers on this task (Gillen et al. 1998). In this study, the 19 
cocaine dependent participants (using an average of 10.6 days and 15.8g in the last 30 
days; an average of 6.3 years of use; 68.4% using freebase; average abstinence period 
of 181.7 hours) gave significantly fewer words than the 16 non-cocaine using 
controls. However, Butler & Frank (2000) and Berry et al. (1993) did not report 
significant differences on this task, and another study reported that cocaine users did 
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not perform worse on a "language" scale incorporating this task (Goldstein et al. 
2004). Two studies used the COWA and a category fluency task (having to say as 
many types of animals as you can in one minute), with one finding no significant 
differences between cocaine users and nonusers (Rosselli et al. 2001). The other 
aimed to assess the possible neuroprotective properties of cannabis in chronic cocaine 
use. The 26 cocaine users who were only light cannabis users (median 2784g of 
cocaine in lifetime, 608 joints in lifetime) did not perform worse than the 27 heavier 
cannabis users (median 3462g of cocaine in lifetime, 3614 joints in lifetime) or the 
41-nonuser controls (Gonzalez et al. 2004). 
Three studies used the Boston Naming Test (BNT), or similar tasks requiring 
participants to match words to their pictorial representations. Gillen et al. (2001) 
found that there were no significant differences between the groups on this task, and 
Butler and Frank (2000) found that the cocaine only users did not perform worse than 
norms following one week or one month of abstinence on the Peabody Picture 
Vocabulary Test. Goldstein et al. (2004) did however find that cocaine users 
performed worse than nonusers on a "verbal knowledge" scale incorporating the 
BNT. Lastly, one study used the ABCD subtests for linguistic expression (comprising 
of tests of object description, generative naming, confrontational naming, and concept 
definition). The cocaine only users performed significantly worse than norms at one 
week of abstinence, although this improved significantly after one month of 
abstinence. 
Access to semantic memory is a particular focus of this thesis. From the 
studies above, it is likely that neither cannabis or cocaine cause deficits in access. 
Indeed the only cocaine study that found cocaine users recalled fewer words on the 
COWA used a sample consisting of 68.4% free-base (crack cocaine) using 
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participants. As with recall it may be that heavier use is associated with greater 
functional deficits. 
5.2.4.2 Inhibition 
Three studies used the Stroop task, One found no differences between cocaine 
users and nonusers following one week and one month of abstinence (Berry et at. 
1993), while another found that cocaine users did not perform worse on an 
"Attention/executive" scale incorporating this task (Goldstein et al. 2004). Rosselli et 
al. (2001) did however find that cocaine users were worse than nonusers on the colour 
word score of this task. Performance on the Stroop task in this study was predicted by 
the "drug problems" and "antisocial features" scales of the Personality Assessment 
Inventory (PAI). 
5.2.4.3 Reasoning/Decision Making 
Stout et al. (2004) used the Iowa gambling task described previously in the 
section on cannabis use (Chapter 5, section 5.1.7) to assess decision-making 
performance among cocaine users. While the control group gradually learned to 
choose from the advantageous deck, the cocaine group (reporting regular cocaine 
abuse and the use of other drugs- no values given) chose nearly equally from both 
packs and selected significantly fewer advantageous cards. This remained significant 
after control for age and IQ. Using Cognitive Modelling Analysis it was found that 
decision-making in cocaine users was less responsive to losses (as participants were 
offered a monetary reward, this may suggest that motivation processes are a possible 
source of decision-making differences in cocaine users). Cocaine users also responded 
more randomly with choices less likely to lead to payouts suggesting that the response 
process was also a source of differences. Learning and memory processes did not 
however distinguish the groups. Gillen et at. (1998) used the Porteus Maze Task, a 
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motor task that assesses foresight and planning ability, although no differences were 
observed between controls and cocaine users. Another study using the Conceptual 
Levels Analogy Task found that both cocaine users and alcoholics performed worse 
than controls (Beatty et al. 1993). One study assessed performance in 6 cocaine-only 
users (mean duration of usage 5.83 years) on the RIPA problem solving and abstract 
reasoning task and organisation and general knowledge task. On the problem solving 
and abstract reasoning task, the cocaine users did not perform worse than published 
norms after one week or one month of abstinence, nor did their scores at one week 
and one month differ significantly from each other. On the organisation and general 
knowledge test, the cocaine users were significantly worse than published norms 
following one week of abstinence; this had significantly improved after one month of 
abstinence, suggesting that differences at one week may be related to residual cocaine 
intoxication (Butler & Frank, 2000). Finally one study used the WAIS-R similarities 
subscale, which has been used in other papers as a measure of analogical reasoning 
(e. g. Verdejo-Garcia et al. 2005). No separate analysis was performed on this 
subscale, although the cocaine group did perform significantly worse on an overall 
scale for verbal knowledge which incorporated this measure (Goldstein et al. 2004). 
5.2.4.4 Switching 
Most tests in this area have used the TMT-B and the WCST (both described in 
Chapter 3, section 3.3.1), although one used the Halstead Category test (a test with 
similar principles to sorting tests such as the WCST). Beatty et al. (1995) found that 
cocaine users performed worse on the TMT-B than controls, and another study found 
that a cocaine-using group took significantly longer than controls, and performance 
was not predicted by PAI scores (Rosselli et al. 2001). Berry et al. (1993) used the 
TMT-B and found a significant main effect of group with the cocaine users 
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performing worse than the nonusers at the second session of testing (after 2 weeks 
abstinence), although the group by time interaction was non-significant indicating that 
abstinence was not an important factor in cocaine-related switching deficits. Another 
study using this test and the Halstead Category Test found that the cocaine-dependent 
group (without concomitant use of cannabis) did not perform worse on a "deficit 
score" for executive function incorporating these tests, (although the cocaine users 
were worse on a total measure of all tasks; Gonzalez et al. 2004). Similarly, again 
using this test both Gillen et al. (1998) and Goldstein et al. (2004) found no 
significant differences between cocaine users and controls. Cocaine users performed 
worse than controls on the WCST in both Rosselli et al's study (by giving more errors 
and correctly classifying fewer categories) and Beatty et al's study (where both 
alcoholics and cocaine users gave more perseverative responses and errors than 
controls). By way of contrast, Gillen et al. (1998) and Goldstein et al. (2004) did not 
observe cocaine-related deficits on these tasks. 
5.2.5 Visuo-Spatial Working Memory 
Three studies used the WAIS-R block design subtest. One finding a 
significant main effect of cocaine use at an initial testing session and after a month of 
abstinence, although the group by time interaction was non-significant indicating that 
although the cocaine users had improved over the month, they were still impaired 
relative to controls (Berry et al. 1993). Another study also observed deficits on this 
task, with the 23 cocaine users (average dose of 3 g/week, and using for an average of 
7.1 years) performing worse than controls (Beatty et al. 1995). However, the third 
study found no differences between cocaine users and controls on this task (Gillen et 
al. 1998). Using a different visuospatial construction task requiring generative 
drawing and figure copying (from the ABCD), Butler and Frank (2000) found that the 
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6 cocaine only users did not perform worse than norms at one week, or after one 
month of abstinence. In two studies using spatial orientation tasks, one a line 
orientation task (Gillen et al. 1998) and the other a temporal orientation, spatial 
orientation and orientation to environment test, no significant differences were 
observed between cocaine users and controls/published norms in either study (in the 
latter deficits were not apparent at 1 week or 1 month following abstinence). 
Two studies used the Rey Osterrieth Complex Figure copy test with both 
finding that cocaine users performed worse than nonusers (Berry et al. 1993; Rosselli 
et al. 2001). Two studies also used the Benton Visual Retention Test. Roselli et al. 
(2001) found that cocaine users performed worse than nonusers on this task and 
performance was predicted by the "drug problems scale of the Personality Assessment 
Inventory; but on a "visual memory" scale incorporating this task Goldstein et al. 
(2004) did not find any cocaine-related differences in the number correct and number 
of errors. Another study used the Brief Visuospatial Memory Test-Revised and the 
Figure Memory Test. Separate analyses of these two tests was not performed, but the 
methamphetamine dependent participants who did not use cannabis performed 
significantly worse on this measure (Gonzalez et al. 2004). Finally Roselli et al. 
(2001) found that cocaine users did not perform worse on the Hooper Visual 
Organisation Task. 
5.2.6 Verbal Learning 
As in Chapter 3, a number of studies used list-learning tasks such as the CVLT 
and RAVLT to assess learning. Berry et al. (1993) found that cocaine users performed 
worse than controls at an initial testing session and also following 1S days abstinence 
on the RAVLT trials 1-5 total. There was a significant group by trial interaction 
indicating that learning processes in cocaine users differed from the patterns evident 
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in controls. Three studies used the CVLT and found no differences between cocaine 
users and nonusers (Gillen et al, 1998; Rosselli et al. 2001). Similarly no differences 
were observed following one month of abstinence (Butler & Frank, 2000). 
One study used a combined verbal and visual paired associates task in which 
12 black and white photos of faces with highly concrete names were presented to 
participants for 10 seconds each. Then each face was shown in turn and participants 
had to recall the name that went with that face, Both cocaine users and alcoholics 
were worse than controls, getting fewer correct at trials 1 and 6. The quantity of 
cocaine index was also significantly positively correlated with performance on trial 1 
(Beatty et al. 1995). Two studies also used a combination of tests. Using the Hopkins 
Verbal Learning Test-Revised total recall score and the story memory test learning 
score, those who used cocaine but not cannabis performed significantly worse than 
controls, although the cocaine users who did use cannabis did not differ significantly 
from either group (Gonzalez et al. 2004). In another study, cocaine users did not 
perform worse on a "verbal memory" scale incorporating the WMS paired associates 
task and the CVLT (Goldstein et al. 2004). 
5.2.7 Information Processing Speed 
All reviewed studies assessing processing speed used the TMT-A and/or the 
DSST (both previously described in Chapter 3, section 3.2). Berry et al. (1993) found 
a trend towards significance at the initial testing session on the DSST, and in Beatty et 
al's (1995) study, the cocaine users and alcoholics performed significantly worse than 
controls, while Gillen et al. (2004) found no significant differences between cocaine 
users and controls, and in Goldstein et al's (2004) study the cocaine users did not 
perform worse on an overall measure of attention/executive functioning (although 
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separate between group comparisons were not made for each test comprising the 
scale). 
For the TMT-A, one study found that cocaine users did not differ significantly 
from controls at the initial testing session, although there was a significant group by 
time interaction indicating that the cocaine group did not improve as much as the 
controls (Berry et al. 1993). One study found that cocaine users performed worse than 
controls on this task (Beatty et al. 1995), while another found that the performance of 
42 cocaine users did not differ from that of controls (Roselli et al. 2001). In another 
study, cocaine users were actually faster on the TMT-B than nonusers (Gillen et al. 
1998). Finally, one study found that cocaine users did not perform significantly worse 
on an "attention/executive" scale incorporating this measure, although separate 
comparisons were not made for the individual components (Goldstein et at. 2004). 
Chapter Summary 
It is therefore apparent that the use of cannabis or cocaine may result in 
cognitive deficits in users of these drugs. Given the fact that most ecstasy users are 
not solely users of ecstasy, using a range of other drugs at different stages of their 
night out, it is possible that other drugs might be responsible for any apparent ecstasy- 
related deficits. This chapter therefore provides a rationale for assessing the impact 
that cannabis and cocaine use might have on cognitive deficits relative to ecstasy use. 
As with a number of studies in this area, it is likely that while the ecstasy users will 
use a range of other drugs, the use of drugs in the non-ecstasy group will be mainly 
limited to the use of cannabis. This raises a problem when using ANCOVA to control 
for indices of illicit drug use. Thus correlations (and where appropriate, part 
correlations) are used to assess the impact of ecstasy, cannabis and cocaine on the 
cognitive deficits in ecstasy users. In addition all participants were required to be drug 
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free for at least 24 hours, although actual abstinence periods in each Chapter were 
longer than this. 
To summarise thus far the aim of this thesis is to study the separability of 
executive function deficits in recreational ecstasy users. If any such deficits are 
observed then it is possible that these reflect the drug's neurotoxic potential. In 
addition, it is possible that cocaine and cannabis use may contribute to any executive 
function deficits observed in ecstasy users. The next chapter is the first of the 
empirical chapters. Chapter 6 assesses performance of ecstasy users and nonusers on a 
letter-updating task. 
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Chapter 6: Working Memory Updating 
6.1 Chapter Overview: 
Chapter 3 reviewed evidence for cognitive deficits in ecstasy users. A key aim 
of this thesis is to assess ecstasy-related cognitive deficits within Miyake et al's 
conceptualisation of executive processes, and this Chapter will explore memory- 
updating deficits in ecstasy users. Twenty-nine ecstasy users and 35 nonusers were 
assessed using a running memory task requiring them to remember the final six 
presented letters in lists varying in length (either 6,8,10, or 12 letters). On each trial, 
participants were unaware of the number of letters that would be presented. The 
interaction between ecstasy use and list length was non-significant although there was 
a main effect of ecstasy use on the task. Separate ANOVAs revealed that this was due 
to ecstasy users performing worse on the intermediate list lengths (8 and 10 letters). 
While indices of ecstasy use were significantly correlated with performance on chain 
lengths of 10 letters, cannabis was significantly correlated with chain lengths of 8 
letters, and cocaine with 6 letters. The results of this chapter suggest that 
ecstasy/polydrug users are impaired on a running memory-updating task, with 
different drugs impacting on different aspects of the task. 
6.2 Introduction 
The updating component of the central executive requires monitoring and 
coding incoming information, assessing its relevance, and reviewing the contents of 
working memory. This involves deleting information that is no longer relevant, and 
replacing it with more recent salient information. The fundamental nature of memory 
updating is that it requires active manipulation of relevant information, rather than 
acting as a short-term store (Lehto, 1996; Miyake et al. 2000; Morris & Jones, 1990). 
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Indeed to support this dissociation, neuroimaging studies show differences in 
activation between tasks requiring passive storage of information (parietal lobes) and 
those requiring the active manipulation of information (Dorsolateral Prefrontal 
Cortex- DLPFC) (Jonides & Smith, 1997). Moreover, as the usefulness of working 
memory as a whole is related to the efficiency with which we maintain, monitor, and 
edit the online contents, the updating component is one of the most often used 
functions in cognition (Carretti, Cornoldi, De Beni, & Romano, 2005). Within the 
context of Miyake et al's conceptual framework, this aspect of executive functioning 
is under investigated in ecstasy users, with only two studies using tasks that are key 
indicators of the framework (Fisk et al. 2004; Wareing et al. 2004b). 
How may this updating of information be achieved? Ruiz, Elosua and Lechuga 
(2005) suggest that a recency strategy is used (remembering those items that one saw 
most recently via phonological rehearsal). Ruiz et al. found a clear recency effect on 
letter and word memory-updating tasks, which increased with increasing list length 
(i. e. the recency strategy was more likely to be used for longer list lengths). However, 
Morris and Jones (1990) found that memory updating on a running memory task was 
not affected by articulatory suppression, and consequently concluded that updating 
was not performed by the articulatory loop but rather by the central executive. 
Furthermore, Baddeley and Hitch (1993) maintain that recency is a short-term 
memory phenomenon and is not related to Working memory. Nevertheless, it is 
possible that remembering items at the minimum task requirement (6 letters) may 
require a different strategy to remembering items at list length +2 items (8 letters), list 
length +4 items (10 letters), and list length +6 items (12 letters), with the former 
requiring a passive storage mechanism, and the longer list lengths requiring the 
updating of items. Therefore as it is likely that an updating strategy will be recruited 
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on the longer list lengths, it is expected that executive deficits, should they exist, will 
be found on these, relative to the shorter lengths. 
A complicating factor emerges in recent research that suggests that in 
cognitive ageing, updating the contents of working memory is mediated by 
information processing speed. Indeed Fisk and Sharp (2004) found that all of the age- 
related variance in updating was reduced to below statistical significance following 
control for processing speed. This appears to be a consistent finding in the cognitive 
ageing literature (e. g. Fisk & Warr, 1996; Salthouse & Babcock, 1991). However the 
same may not be true for users of ecstasy. Wareing et al. (2005) found that differences 
in computation span remained significant after control for differences in processing 
speed. To summarise the preceding paragraphs it is likely that if ecstasy users are 
impaired on the letter updating task then this will reflect a genuine updating deficit, 
although it remains a possibility that it is due to ineffective use of a phonological 
recency strategy. 
As discussed in Chapter 3, cognitive deficits in ecstasy users are reported 
frequently over a wide range of tasks. The focus of this chapter is the updating of 
working memory. A number of studies have found that ecstasy users and nonusers 
perform comparably on tests believed to tap the updating executive component 
process (see Chapter 3, Section 3.3.5 for full review). Using backward digit span, 
which requires participants to listen to a string of digits and recite them to the 
experimenter in reverse order thus recruiting executive updating resources, no 
performance differences were observed in most studies (Bhattachary & Powell 2001; 
Gouzoulis-Mayfrank et al. 2003; McCardle et al. 2004; Thomasius et al. 2003). One 
study did find that ecstasy/cannabis users were impaired on the backward digit span 
task. Gouzoulis-Mayfrank et al. (2000) found that ecstasy/cannabis users performed 
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worse than nonuser controls. They were not impaired relative to cannabis only users 
(matched for cannabis use), and cannabis only users did not differ significantly from 
controls. Cumulative lifetime ecstasy dose and age of onset of cannabis use were 
significantly correlated with performance on this task. Thus it appears that some 
aspect of cannabis use may also affect performance on this task. This was supported 
by Croft et al's (2001 a) study in which no performance differences were observed 
between 11 ecstasy/cannabis users (with a cumulative lifetime ecstasy dose of 42 
tablets, and cannabis of 10965 joints), 18 cannabis only users (with a cumulative 
lifetime cannabis dose of 7762 joints), and 31 drug-naive controls on the backward 
digit span task. After forming a single drug-using group (by combining the 
ecstasy/cannabis and cannabis only users), this group performed worse than controls, 
which the authors propose was more related to the use of cannabis rather than ecstasy. 
Although this proposition may seem quite plausible considering the estimated lifetime 
doses of each drug in the study, as there were no significant differences between the 
cannabis only users and nonusers before the groups were combined, it may be that the 
new significant difference between the groups reflects a decrease in the error variance 
due to the integration of the user groups and/or an increase in the main effect mean 
square due to the reduced degrees of freedom. 
In the same way as backward digit span, Subtracting Serial Sevens (SSS) also 
recruits updating resources. Curran and co-workers have found ecstasy users make 
significantly fewer subtractions than nonusers on this task (Curran & Travill 1997; 
Curran & Verheyden 2003), while Morgan et al. (2002) found that ecstasy users made 
significantly more errors on the task. The possibility that these differences in terms of 
errors indicate an updating function deficit should be treated with some caution as the 
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authors suggest that the increased number of errors in ecstasy users reflects 
heightened impulsivity, not a specific memory updating impairment. 
Some studies have also used established indicators of memory updating, similar 
to the operation span task used by Miyake et al. (2000). Wareing et al. (2004b) used 
computation and reading span tasks, analogous to Miyake et al's operation span task. 
Although no group differences were observed on the reading span measure, ecstasy 
users were significantly impaired on the computation span. From the same laboratory, 
Fisk et al. (2004) also used the computation span task and found that current ecstasy 
users attained a lower level than the nonusers. This remained significant after control 
for the use of other drugs indicating that memory updating performance is related to 
the use of ecstasy in this study. Dafters et al. (1999) used a similar working memory 
span task requiring the recall of words following distraction with a mathematical 
problem. Although no control group was employed, in the ecstasy user group (N=23), 
performance on this task was not significantly correlated with ecstasy use in the 
previous 12 months. 
Another task that recruits executive updating resources is the N-back task. 
Gouzoulis-Mayfrank et al. (2003) used the 2-back version of the task, with both digit 
and figure versions. There were no significant differences between the heavy ecstasy 
users, moderate users and nonusers (indices of ecstasy use presented earlier in this 
thesis) in terms of reaction time or number of correct responses. Daumann et al. 
(2003) used a 0-back (having to press a key in response to a pre-specified target), 1- 
back and 2-back condition. Again, there were no significant differences in terms of 
correct responses and reaction times between the pure ecstasy users and polyvalent 
ecstasy users. In terms of fMRI activation during the 1-back task, polyvalent ecstasy 
users did not differ significantly from controls, however pure ecstasy users presented 
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lower activations than controls in the inferior temporal and angular region; 
additionally, pure users had lower signal changes in the striate cortex, and a higher 
BOLD response in the premotor cortex compared to polyvalent users. During the 2- 
back condition, again pure users showed lower activation relative to both controls and 
polyvalent users, mainly in the angular gyrus. A further study also found evidence for 
decreased activation in the left hippocampus of 6 ecstasy users relative to 6 nonusers, 
which significantly negatively correlated with length of abstinence from ecstasy 
(Jacobsen et al. 2004). Using a similar task (the Tic-Tac-Toe task), Alting von Geusau 
et al. (2004) found that users were unimpaired (although in male users there was a 
significant interaction indicating that they performed worse under high demand 
conditions). 
Alting von Geusau et al. (2004) also used an arithmetic based memory 
updating task (mental counters) in which male ecstasy users were significantly slower 
than male nonusers, although there was no interaction between working memory load 
and ecstasy use. 
Finally, Verdejo-Garcia et al. (2005) used a combined measure of updating 
(incorporating the backward digit span task, the arithmetic subtest from the WAIS-Ill, 
and the letter-number sequencing from the WAIS III) and found that ecstasy use was 
an important contributory factor in deficits in working memory updating among a 
clinical sample of poly-substance abusers. Indeed, severity of ecstasy use was the best 
predictor of performance on this dimension. 
From the research set out above, it remains unclear whether or not ecstasy 
users are impaired in memory updating tasks. Many of the studies employed tasks 
with a strong arithmetic/numerical component. It has been suggested by Wareing et 
al. (2004b) that ecstasy-related deficits were evident in computation but not reading 
145 
span in their study, because ecstasy use impacts number processing and not verbal 
working memory updating. Thus one aim of the present study was to use a purer 
measure of memory updating, supposedly reliant on executive prefrontal resources 
(Van der Linden, Collette, Salmon, Delfiore et al. 1999) while being free of numerical 
abilities. The task used has featured in the evaluation of adult age differences in 
working memory capacity (e. g., Fisk & Sharp, 2004; Van der Linden et al. 1994), and 
also in evaluation of executive functioning in dyslexia (Smith-Spark, Fisk, Fawcett & 
Nicholson, 2003). In the context of executive functioning, Miyake and co-workers 
also used this measure to investigate the idea that executive processes are in fact 
separable rather then unitary in nature (Miyake et al. 2000). This test which is a key 
indicator of the updating executive construct within Miyake et al's conceptual 
framework has not been used before in a sample of ecstasy users. Furthermore, 
deficits in updating may support an MDMA related deficit in the dorsolateral 
prefrontal cortex (Goldman-Rakic, 1996; Postle, Berger, Goldstein, Curtis et al. 2001) 
or the left fronto-polar cortex (Van-der-Linden et al, 1999). It is now widely 
supported that ecstasy use has adverse effects on the serotonin system in animals (e. g. 
Hatzidimitriou et al. 1999), and also in humans (e. g. Ricaurte et al. 1990). In turn, 
research in other clinical populations has shown that those with similar 5HT 
dysfunctions (e. g. depression) are also impaired in memory updating tasks (e. g. 
Porter, Gallagher, Thompson & Young 2003). Thus it seems reasonable to expect that 
ecstasy users will be impaired on a "pure" measure of memory updating. 
Given the nature of ecstasy poly-drug use, it is possible that any observed 
deficits in cognitive functioning may be in part attributable to the concomitant use of 
"other" drugs (e. g. Croft et al. 2001 a). Indices of the frequency and intensity of other 
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drug use will be collected and where possible, we shall attempt to evaluate the impact 
of these on the executive measures included in the present study. 
To summarise, this chapter investigated the updating executive component 
process. It was predicted that ecstasy users would perform worse than non-users on a 
memory-updating task (a running memory task). The letter-updating task is widely 
accepted as an established pure measure of the memory updating function (Miyake et 
al. 2000; Morris & Jones 1990). The task is a key indicator of Miyake et al's 
conceptual framework, and has not been used in research with ecstasy users before. It 
was expected that ecstasy users would perform worse on the longer list lengths as 
these recruit greater executive resources. 
6.3 Method 
6.3.1 Design. 
With regard to the updating, mixed ANOVA was used, with ecstasy user 
group (2 levels) as the between groups variable, and list length (number of letters 
correctly recalled at 6,8,10, and 12 letter lengths) as the within participants variables. 
Subsequent ANOVAs were used to analyse performance on separate list lengths. 
Letter span was also measured and incorporated into ANCOVA, to remove the 
potentially mediating effects of differences in simple span. 
6.3.2 Participantss 
Twenty-nine ecstasy users (mean age 21.62; 16 male) and 35 non-user 
controls (mean age 21.69; 10 male) completed the updating task. Participants were 
recruited via direct approach to university students, and the snowball technique 
(Solowij et al, 1992). With 29 ecstasy users, the present sample is sufficient to detect 
a difference of 0.75a for a =. 05 and 0 =. 20 (Hinkle, Wiersma & Jurs, 1994). 
S Due to the nature of the studies, there is some overlap in terms of the participants in each Chapter. 
See Appendix 1 for specific numbers in each study. 
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Participants were requested to refrain from ecstasy use for at least 7 days and ideally 
10 days prior to testing (the mean period of abstinence was actually 5 weeks, median 
abstinence period 2 weeks). Participants were also requested not to use any other 
illicit drugs for at least 24 hours and ideally for 7 days prior to testing. 
6.3.3 Materials 
Patterns of drug use and other relevant lifestyle variables were investigated via 
means of a background questionnaire 6. The questionnaire gauged the use of ecstasy 
and other drugs, as well as current age, years of education, general health and other 
relevant lifestyle variables. In relation to other drugs, participants were asked a range 
of questions including frequency and duration of use and the last time that they had 
used each drug. Participants were also questioned concerning their history of drug 
use, and using a technique employed by Montgomery, Fisk, Wareing, Newcombe et 
al. (2005), these data were used to estimate total lifetime use for each drug. Average 
weekly dose and the amount of each drug consumed within the previous 30 days were 
also calculated. 
Sleep Quality: Research has shown that ecstasy users exhibit altered sleep 
patterns, with less total sleep time and qualitative changes in the characteristics of 
Stage 2 sleep (Allen, McCann & Ricaurte, 1993). As it has been suggested that 
ecstasy-related cognitive deficits may be in part due to differences in other lifestyle 
variables such as sleep quality (Cole, Sumnttll & Grob, 2002) a screening 
questionnaire and the Epworth Sleepiness Scale (ESS, Johns, 1991) were used to 
investigate any group differences in sleep quality. The ESS is a measure of subjective 
daytime sleepiness and contains eight items, which a participant has to score on a 
scale of 0 (would never doze off in this situation) to 3 (high chance of dozing off in 
6 See Appendix 2 for a copy of the questionnaire. 
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this situation). A total score of all eight items was used in the analysis, and a high 
score was indicative of increased subjective daytime sleepiness. The screening 
questionnaire contained a number of questions on sleep quality, e. g. hours per night. 
Letter Span: Consonants were presented sequentially on a computer screen for 
1.25 seconds. Participants were then required to recall the letters in the order in which 
they were presented. The task commences with three sets of two letters, and is then 
increased to three sets of three, four, five etc., until the individual fails on at least two 
out of three trials. 
Consonant Updating: This task was based on the running memory task (Morris 
and Jones, 1990). In this computer-based task, the participant was presented with a 
random sequence of between 6 and 12 consonants on a computer screen. Twenty-four 
such lists were presented, and in each case, the participant was unaware of the number 
of consonants to be presented. The task was always to recall the most recent six 
consonants in the order in which they were presented. An answer book was provided 
for this purpose. The participant experienced six trials at each of the four list lengths: 
6,8,10, and 12 items, and the order in which the lists were presented was 
randomised. 
Raven's Progressive Matrices (Raven, Raven & Court, 1998): Each of the 
problems in Raven's Standard Progressive Matrices (SPM) was presented in the form 
of a sequence of symbolic figures. Participants were required to understand the nature 
of the relationships within each sequence and select one figure that completes each 
sequence. The Standard (SPM) consists of 60 problems divided into five sets of 12. In 
each set the first problem is self evident, the others becoming progressively more 
difficult. The test yields a total score out of 60 with a high score being indicative of 
good performance, and has been used extensively as an indicator of fluid intelligence. 
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The National Adult Reading Test (NART) (Nelsons 1982): The NART is an 
oral word reading test assessing premorbid intelligence. The test consists if 50 words 
of atypical phonology, whose pronunciations cannot be derived from standard 
grammatical rules (e. g. ache; gaoled). The total number correct was calculated for 
each participant, with a high score being indicative of high premorbid intelligence. 
6.3.4 Procedure 
Participants were informed of the general purpose of the experiment, and 
written informed consent was obtained. The tests were administered under laboratory 
conditions, and a computer running MS-DOS was used for the computer based tasks. 
The tests were administered in the following order: background questionnaire, sleep 
questionnaires, NART, letter span, consonant updating, and Raven's progressive 
matrices. Participants were fully debriefed, paid £15 in store vouchers, and given 
drugs education leaflets. The study was approved by the Ethics Committee of 
Liverpool John Moores University, and was administered in accordance with the 
ethical guidelines of the British Psychological Society. 
6.4 Results 
Scores for background variables are set out in Table 6.1. The t test revealed 
that the ecstasy users did not differ significantly from the nonusers in terms of age, 
self-rated health, number of years of education, intelligence (Raven's and NART 
scores), number of hours sleep per night, and letter span. The ecstasy users did 
however report significantly higher average weekly alcohol consumption than 
nonusers, t(38.58) = 3.86, p<. 001, and also a significantly higher score on the 
Epworth Sleepiness Scale, t(61) = 2.23, p<. 05, indicating increased daytime 
sleepiness (for alcohol consumption Levene's test was significant so degrees of 
freedom have been adjusted accordingly). Gender distribution was also significantly 
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different between the groups, with the ecstasy users being predominantly male and the 
nonusers predominantly female, x2 (df. 1, N=64) = 4.65, p<. 05. 
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Table 6 1: Age, Years of Education, Intelligence and Sleep Quality for Ecstasy Users 
and Nonusers. 
Ecstasy 
users 
Mean 
Nonusers 
S. D. Mean S. D. 
Age (years) 21.62 1.63 21.69 1.94 
Years of Education 16.00 1.41 15.69 2.08 
Raven's Progressive Matrices (Max. 60) 49.76 4.45 48.26 5.11 
NART (Max. 50) 29.66 6.11 30.49 6.23 
Units of Alcohol (per week) 23.60 16.63 10.58 7.79 
Hours of Sleep per night 8.14 1.64 7.90 1.45 
Epworth Sleep Scale (Max. 24) 6.89 3.31 5.26 2.51 
Self Report Health* 3.72 0.80 3.97 0.89 
Letter Span Score 5.21 0.56 5.26 0.74 
Weeks Since Last Used Ecstasy 5.28 7.31 - - 
* The self report health measure scores range from 1 (very poor) to 5 (very good) 
Table 6.2 shows that the ecstasy users scored lower than nonusers on all four 
list lengths. The data were entered into repeated measures ANOVA. Mauchly's test of 
Sphericity was non-significant for list length, p>. 05, so the sphericity assumed values 
were used. There was a significant main effect of length indicating that all participants 
had performed worse on the longer list lengths, F(3,186) 11.95, p<. 001. It was 
predicted that ecstasy users would perform worse at the longer list lengths, but 
analysis revealed that the list length by user group interaction was non-significant 
indicating that ecstasy users did not perform worse at the longer list lengths as 
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originally predicted, F(3,186) = 0.96, p>. 05. However, the main effect of ecstasy use 
on letter updating was statistically significant, F(1,62) = 5.44, p<. 05 with an effect 
size (partial Eta squared) of 0.081. To ascertain which aspects of letter updating were 
affected by ecstasy use, ANOVAs were performed with each list length. This revealed 
that ecstasy users and nonusers performed comparably on the 6-letter lists F(1,62) 
0.98, p>. 05, and 12-letter lists, F(1,62) = 1.05, p>. 05. Ecstasy users did perform worse 
than nonusers on the 8-letter lists, F(1,62) = 4.16, p<. 05, and 10-letter lists, F(1,62) = 
9.52, p<. 01. The lack of an updating deficit across all list lengths was not associated 
with a significant interaction. It was predicted that ecstasy users would perform worse 
at the longer list lengths, while no deficit would be evident at list length 6. The lack of 
a significant interaction argues against this proposition. 
Covariate Analyses 
As ecstasy users scored significantly higher than non-ecstasy users on the 
ESS, reported drinking significantly more units of alcohol per week, and were 
predominantly male, it was possible that some or all of these factors may have 
contributed to the observed group differences on the letter-updating task. Thus these 
variables were incorporated into mixed ANCOVA. 
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Table 6.2: Mean Numbers of Letters Recalled and Significance Levels (F values) For 
Main Effects. 
Chain Length 6 
Chain Length 8 
Chain Length 10 
Chain Length 12 
Ecstasy Users Non Ecstasy Users F 
Mean S. D. Mean S. D. 
2.56 0.79 2.76 0.73 0.98 
2.06 0.59 2.41 0.76 4.16* 
1.93 0.56 2.40 0.64 9.52** 
2.07 0.82 2.26 0.68 1.05 
* p<. 05, two-tailed 
** p<. 01, two-tailed 
After control for all three covariates, the main effect of ecstasy use on letter 
updating was slightly intensified, F(1,56) = 8.47, p<. O1 (with a partial Eta squared of 
0.131) and the length by user group interaction remained non-significant, F<1. While 
the univariate analyses revealed that the group differences on the chain length 6 trials 
were still non-significant, differences on the chain length 12 items were now 
significant, F(1,56) = 2.80, p<. 05 (one-tailed).? The ecstasy-related differences on 
chain length 8 remained significant after control for these covariates, F(1,56) = 5.71, 
p<. 05, as did the differences on chain length 10, F(1,56) = 10.15, p<. 01. 
Although there were no significant group differences in letter span, it was 
possible that the effect of ecstasy use on the letter-updating task could in part be 
mediated by letter span. To address this possibility letter span was entered as a 
covariate. The main effect of ecstasy use on letter updating remained significant 
F(1,61) = 5.31, p<. 05, although the interaction between chain length and user group 
' See Appendix 3 for adjusted means following ANCOVA. 
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was still non-significant. The differences in chain length 8 and chain length 10 proved 
more robust and remained significant after control for differences in letter span, 
F(1,61) = 4.00; 9.29, p<. 05 and p<. 01 respectively. Homogeneity of regression was 
achieved with respect to all covariates, p>. 05 for the group by covariate interaction. 
Table 6.3: Indicators of Drug Use Among Ecstasy Users and Non Ecstasy Users 
Ecstasy Non Ecstasy 
Users Users 
Mean S. D. NI Mean S. D. N 
Total Use 
Ecstasy (Tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Frequency of Use (times 
per week) 
Ecstasy 
Amphetamine 
Cannabis 
Cocaine 
Amount Used During 
Previous 30 Days 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Average Weekly Dose 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Number Ever Used 
Amphetamine 
Cannabis 
Cocaine 
329.83 358.22 29 
4.08 4.22 6 
2503.48 2503.70 20 
19.59 23.64 12 
0.42 0.36 29 
0.03 0.03 3 
2.57 2.58 20 
0.32 0.23 12 
3.25 3.32 28 
2.00 3.46 3 
22.66 36.04 19 
1.68 1.83 10 
1.79 1.41 29 
0.20 0.25 5 
9.69 ' 9.24 19 
0.17 0.26 12 
12 -- 
26 -- 
22 -- 
4.00 -1 
1291.98 1494.15 15 
0.93 0.92 15 
8.89 11.49 14 
0.09 01 
6.13 10.74 15 
2-- 
20 -- 
5-- 
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Indices of Drug use 
It is clear from Table 6.3 that while the ecstasy users were also regular users of 
other drugs, in the nonuser group this was restricted mainly to the use of cannabis. 
The ecstasy users smoked cannabis significantly more often than nonusers (2.57 times 
a week compared to 0.93), t(24.95) = 2.63, p<05. Other indices of cannabis use were 
comparable between the groups: differences in total use were non-significant, t(31.65) 
= 1.78, p>. 05; as were differences in amount used 
in the last 30 days, t(31) = 1.37, 
p>. 05; and differences in average weekly dose, t(32) = 1.04, p>. 058. The non-ecstasy 
users had actually used cannabis more recently than the ecstasy users (average 
abstinence period of 5.16 weeks for nonusers, and 10.54 weeks for ecstasy users), 
although not significantly so, t(41) = 0.70, p>. 05. 
Correlations with Indices of Drug Use. 
Aside from cannabis, due to the small number of illicit drug users among the 
non ecstasy user group it was not possible to control statistically for the effects of 
other drugs through the use of ANCOVA. Therefore it is possible that some or all of 
the ecstasy-related effects might have been attributable to the effects of other drugs. 
To address this possibility, non-parametric correlations were performed with different 
measures of ecstasy, amphetamine, cannabis and cocaine use. Measures of lifetime 
use of each drug, the number of times each drug was consumed each week, the 
amount of each drug consumed within the last 30 days, and the average weekly dose 
(i. e. total amount consumed divided by the length of use in weeks) were all included9. 
For each of these a value of zero was entered for nonusers of the drug in question. In 
8 Although in this and subsequent chapters some of the differences between ecstasy users and nonusers 
regarding drug use were non-significant, it is noteworthy that in most cases the ecstasy users had 
substantially larger means. However the large standard deviations inflated the error variance and 
rendered these differences non-significant. 
9Those in the nonuser group who reported that they had ever used amphetamine or cocaine (N= 2 and 5 
respectively) felt that they were unable to estimate their pattern of use accurately. 
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addition, for each illicit drug, a categorical variable in which users and nonusers of 
each drug were coded as 0 or 1 respectively was included. 
A full Bonferroni correction is not appropriate in this case, as the performance 
measures are intercorrelated (Sankoh, Huque & Dubey, 1997). However multiple 
comparisons remain potentially problematic, therefore an intermediate level of 
correction has been used, with correlations being evaluated at p<. 01. The results, set 
out in Table 4, show that ecstasy use was significantly correlated with a number of the 
performance measures. The correlations revealed an interesting dissociation of the 
effects of different drugs on letter updating. While total lifetime dose of ecstasy, 
frequency of ecstasy use, average dose, and having ever used ecstasy were all 
significantly correlated with chain length of 10 letters, total use of cannabis, 
frequency of cannabis use, average dose and having ever used cannabis were all 
significantly correlated with chain length of 8 letters. In addition, total lifetime dose 
of cocaine and amount used in the last 30 day were significantly correlated with chain 
length of 6 letters. Indices of amphetamine use were not significantly correlated with 
any of the letter updating measures. 
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Table 6.4: Correlations between Measures and Indices of Drug Use. 
Ecstasy Cannabis Cocaine Amphetamine 
Total use N 64 53 49 53 
Chain Length 6 -0.106 -0.257 -0.349** 0.009 
Chain Length 8 -0.170 -0.371** -0.130 0.002 
Chain Length 10 -0.306** -0.070 -0.132 0.013 
Chain Length 12 0.005 -0.064 -0.165 0.073 
Frequency of Use N 64 53 49 53 
Chain Length 6 0.135 -0.178 -0.298 -0.117 
Chain Length 8 -0.226 -0.321** -0.180 -0.071 
Chain Length 10 -0.309** -0.073 -0.149 0.008 
Chain Length 12 -0.040 -0.062 -0.185 0.012 
Average dose N 64 52 49 56 
Chain Length 6 -0.110 -0.232 -0.331 -0.044 
Chain length 8 -0.199 -0.338** -0.125 -0.037 
Chain Length 10 -0.310** -0.056 -0.130 -0.027 
Chain Length 12 -0.040 -0.028 -0.168 0.025 
Current Use N 64 64 64 64 
Chain Length 6 -0.078 -0.092 -0.297** -0.086 
Chain Length 8 -0.148 -0.199 -0.012 -0.055 
Chain Length 10 -0.208 0.045 -0.037 -0.041 
Chain Length 12 0.001 0.035 -0.119 0.175 
Ever Used N 64 64 64 64 
Chain Length 6 0.136 0.245 0.155 0.072 
Chain Length 8 0.257 0.374** 0.116 -0.018 
Chain Length 10 0.374** 0.092 0.107 0.054 
Chain Length 12 0.110 -0.020 -0.037 -0.065 
** Correlation significant at p<. O1 
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Implications of Chapter 6 
The results of Chapter 6 support an ecstasy-related deficit in memory updating 
that is not related to gender, alcohol use, subjective daytime sleepiness, or 
amphetamine use. The interaction between list length and ecstasy use was non- 
significant indicating that ecstasy users did not perform worse at the longer list 
lengths under increased working memory load. Interestingly, there was a dissociation 
between the effect of ecstasy, cannabis, and cocaine on the letter updating task, with 
indices of ecstasy use being correlated with chain length 10, cannabis with chain 
length 8, and cocaine use with 6. It is possible that this reflects the different strategies 
(e. g. a recency strategy or an updating strategy) used by ecstasy users, cannabis users, 
and cocaine users, this proposal will be discussed at length in Chapter 12. Chapter 6 
has shown that ecstasy users are impaired in a letter-updating task, a key indicator of 
Miyake et al's conceptual framework. As discussed in Chapters 2 and 3 there are four 
postulated executive functions under investigation in this thesis. The next Chapter will 
investigate possible ecstasy-related differences in the switching and inhibition 
components of Miyake et al's model. 
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Chapter 7: Mental set switching and response inhibition 
7.1 Chapter overview 
Chapter 6 showed that ecstasy users were impaired in a memory-updating 
task; the present chapter assessed the postulated executive functions of switching and 
inhibition. Fifty-one ecstasy users and 42 nonusers completed tasks that assess mental 
set switching (number/letter task and plus/minus task) and response inhibition 
(random letter generation). Unexpectedly, ecstasy users performed significantly better 
on the inhibition task producing more letters than nonusers. No group differences 
were observed on the switching tasks. Correlations between indices of ecstasy use and 
number of letters produced were significant. The surplus evident on the inhibition task 
should be treated with some caution as this was limited to a single measure and has 
not been supported by previous research (e. g. Fisk et al. 2004; Wareing et al. 2000). 
7.2 Introduction 
As discussed in Chapter 3, "switching" or "shifting" refers to a participant's 
ability to shift the focus of their attention between different tasks or different elements 
of the same task. Neural substrates have been identified with reference to both 
switching and inhibition, and any observed deficits in either could indicate a possible 
structural change in the brains of ecstasy users. For example, while poorer 
performance of ecstasy users on switching tasks may be linked to the anterior 
cingulate cortex (Posner and Raichle, 1994), the left frontal lobe (Rogers, Sahakian, 
Hodges, Polkey et al, 1998) and the bioccipital and parietal lobes (Moulden, Picton, 
Merran, Stuss et al, 1998), performance on a response inhibition task may be linked to 
the pre-frontal cortex (Casey, Trainor, Orendi, Schubert et al, 1997; Kiefer, 
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Marzinzik, Weisbrod, Scherg et al, 1998), and damage to the inferior frontal gyrus 
(Aron, Sahakian & Robbins 2003). 
Some studies have shown that ecstasy users exhibit impairments in task 
switching by longer response latencies in a switching condition as opposed to a non- 
switch condition, while some have revealed an ecstasy-related inability to switch set 
when a certain rule changes (i. e. a perseverative error). Nonetheless it appears that 
ecstasy users are not generally impaired in task switching. Though as mentioned in 
Chapter 3 (See section 3.3.1 for full review), this may reflect the nature of the tasks 
used. The Trail Making Test-B (TMT-B) requires participants to alternately connect 
numbers and letters in numerical/alphabetical order (e. g. 1-A-2-B-3-C). The letters 
and numbers are randomly distributed on a piece of paper; hence the task requires 
switching attention between attending to number/letter stimuli. Ecstasy users were not 
generally impaired on this task (Krystal et al. 1992; McCardle et al. 2004; Semple et 
al. 1999; Thomasius et al. 2003). One study utilising this task did however find 
ecstasy-related effects. Morgan et al. (2002) found that ecstasy users made more 
errors on this task, although this was found to be more related to the use of 
mushrooms and LSD than ecstasy. The lack of group differences on the TMT-B may 
reflect the relative simplicity of the. Effects on this task are not dose related either, 
and it is not a key indicator within Miyake et al's conceptual framework. 
McCann et al. (1999) used the Serial Add and Subtract Task from the Walter 
Reed Army Institute of Research Performance Assessment Battery (WRAIR-PAB). 
As described in Chapter 3 this computer based mental arithmetic task requires 
participants to perform an addition/subtraction for two numbers on the screen, enter 
the least significant number (while adding 10 if this is a negative number). Ecstasy 
users performed worse than nonusers on days 2 and 3 of the study. While part of this 
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task (the serial addition/subtraction) is similar to the one used in the present study (the 
plus/minus task), the task is made more complex by additionally requiring participants 
to identify the lower of the numbers and identify if that is a positive/negative response 
(i. e. a+ or -). If the number is negative the participant then has to add 10 to it. Thus it 
is unlikely that this task solely measures task switching as it requires the coordination 
of a number of other aspects. 
Alting von Geusau et al. (2004) used two tasks that are indicative of Miyake et 
al's conceptual framework. Both tasks are described in detail in Chapter 3, Section 
3.3.1, but in short the dots-triangles task requires participants to switch between 
making judgements about the quantity of dots or triangles on a computer screen, while 
the local-global task requires participants to switch between attending to the 
local/global components of shapes. An interesting pattern of results were observed 
with male ecstasy users being significantly slower than male nonusers, and also 
having significantly higher switch costs than the male nonusers on both tasks, 
although this was not true of the female ecstasy users. However, in the dots-triangles 
task, the male ecstasy users were actually more accurate than the controls indicating 
that they had sacrificed speed in favour of accuracy (although the same was not true 
for the local-global task). 
As mentioned in Chapter 2, another task that Miyake et al. (2000) found 
loaded on switching resources was the Wisconsin Card Sort Task (WCST). Ecstasy 
users were not generally impaired on this task (Alting von Geusau et al. 2004; Back- 
Madruga et al. 2004; Dafters et al. 1999; Dafters et al. 2004; Fox et al. 2001; Halpern 
et al. 2004; Thomasius et al. 2003; Verkes et al. 2001; Zakzanis and Young 2001b) 
although two studies (Alting von Geusau et al. 2004; Thorasius et al. 2003) did find 
that ecstasy users gave more perseverative errors than nonusers. However, as 
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literature suggests (e. g. Reitan and Wolfson, 1994) the WCST sa complex cognitive 
task which may require other resources in addition to the ability to switch sets, e. g. the 
ability to inhibit a previous rule (e. g. Ozonoff & Strayer, 1997). 
To summarise the literature on task switching in ecstasy users, most studies do 
not find ecstasy-related deficits. Those that have found between group differences 
appear to have used harder tasks (Alting von Geusau et al. 2004; Fox et al. 2002; 
McCann et al. 1999). In Miyake et al's conceptual framework, the tasks used to assess 
switching were the number/letter task, the plus/minus task, the local-global task and 
the dots/triangles task. Thus it is possible that ecstasy users are impaired in task 
switching, but most tasks used in ecstasy users (with the exception of Alting von 
Geusau et al. 2004; Fox et al. 2002; McCann et al. 1999) do not solely tap this target 
function. 
Switching the focus to inhibition, the Stroop task has been used to assess this 
aspect of executive functioning in ecstasy users. As reviewed in Chapter 3 (section 
3.3.4), none of the studies using the Stroop task (Back-Madruga et al. 2004; 
Gouzoulis-Mayfrank et al. 2000; Morgan et al. 2002; Semple et al. 1999; 
Vollenweider et al. 1998) found ecstasy-related deficits, and as this task is not the 
focus of the present chapter the research will not be discussed again here. Alting von 
Geusau et al. (2004) also used the Stop Signal Reaction Time Task and the Eriksen 
Flankers Task, but as these are not key indicators of Miyake et al's framework, they 
are not discussed further here. 
A number of studies in ecstasy users have used Random Letter Generation 
(RLG) to assess response inhibition in ecstasy users. Miyake et al. (2000) proposed 
that Random Number Generation loads on the inhibition and updating components of 
the central executive, whereas Fisk and Sharp (2004) propose that Random Letter 
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Generation loads solely on the inhibition component. Random generation is a 
relatively demanding cognitive process and is known for placing a continuous strain 
on executive resources (see Baddeley 1996). Participants are asked to produce letters 
in a random sequence avoiding alphabetical or well-known sequences (e. g., CIA, 
BBC, or FBI). They are also asked to try to produce each letter with the same overall 
frequency. The task is repeated three times with letters produced at one every four 
seconds, one every two seconds, and one per second (with 100 letters each time). 
Wareing et al. (2000) found that current ecstasy users and previous users were 
impaired relative to drug-naive controls at the 1-second rate of production. One 
stipulation of the task was that participants were only allowed to produce consonants 
(i. e. no vowels), and Wareing et al. found that both user groups gave more vowel 
intrusions at all 3 rates. One problem with this study is that sample sizes were very 
small (N=10), and estimated lifetime dose of ecstasy was atypically high compared to 
other studies (see e. g. Halpern et al. 2004; Verkes et al. 2001). Another study from the 
same laboratory (Fisk et al. 2004) did not use the consonants only version of the RLG 
task. In this study, the ecstasy users (with a total lifetime ecstasy dose of 343 tablets- 
somewhat more modest than their first study) did not perform worse than the controls. 
Thus it may be that response inhibition under more difficult conditions (i. e. inhibiting 
alphabetical sequences and vowels) may require greater inhibitory control, and thus 
place greater demand on the central executive. As with the task switching data, this is 
an executive process that does not appear to be susceptible to the effects of ecstasy 
use. Nonetheless, one aim of this thesis was to use tasks that assess Miyake et al's 
conceptual framework, and thus inhibition, along with task switching formed the basis 
for this Chapter. 
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Tasks loading on the switching and inhibition component executive processes 
were administered. These included random letter generation. In this task participants 
were asked to produce letters in a random sequence avoiding alphabetical and well- 
known sequences (e. g., ABC, CIA, BBC, or FBI). They were also asked to try to 
produce each letter with the same overall frequency. The task was repeated three 
times with participants respectively generating a letter every four seconds, or every 
two seconds or one per second. Random generation yields a number of performance 
measures, (i) redundancy, which measures the extent to which each letter is produced 
with equal frequency, (ii) alphabetical, and (iii) repeat sequences (alphabetically 
ordered pairs or pairs of letters that are repeated). For all of these, a high score is 
indicative of poor performance. The fourth measure generated by the random 
generation task is the total number of letters generated. For this variable a high score 
is indicative of good performance. There is general agreement that alphabetic and 
repeat sequences load on the inhibition component executive process (Fisk & Sharp, 
2004; Miyake et al, 2000). Consensus is lacking as to whether or not the redundancy 
measure loads on any of the component processes. While Miyake et al found that with 
random number generation, redundancy appears to load on the updating component 
process, Fisk and Sharp (2004) found that this was not the case with random letter 
generation. As we are using Random Letter Generation in the present study, it was 
deemed that as Fisk and Sharp found, this would load solely on the inhibition 
component 
The two tasks chosen to tap shifting were the plus-minus task and 
number/letter task. Both require switching between mental sets, the plus-minus task 
by alternately adding and subtracting, and the number/letter task by switching 
attention between attending to numbers and letters. Previous research has shown that 
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the ability to switch sets involves temporal cost (indexed by increased response 
latencies on switch conditions as opposed to non-switch) (e. g. Rogers & Monsell, 
1995). There is also growing evidence that this involves the frontal lobes (see 
beginning of Chapter). 
It has already been shown in Chapter 6 that ecstasy users are impaired in the 
updating executive component process on a pure measure of updating. In light of the 
evidence set out above, it was unclear whether or not ecstasy users would perform 
worse than nonusers on measures of task switching and inhibition. Research suggests 
that both processes are executive prefrontal tasks. In turn, research (e. g. Renema et al. 
2001a) has shown that the prefrontal cortex may be subject to the neurotoxic effects 
of ecstasy use. However, previous research has revealed mixed results on other tasks 
thought to assess both target functions. Thus using the measures outlined by Miyake 
et al. (2000) we assessed task switching and inhibition. It was not expected that 
ecstasy users would perform worse than nonusers, more specifically, both groups 
would have similar switch cost latencies, and similar numbers of alphabetical 
sequences, repeat sequences, similar redundancy, and would produce a similar 
number of letters. 
7.3 Method 
7.3.1 Design 
A multivariate design was used for the switching measures with ecstasy user 
group (2 levels) as the between participants independent variable, and the shift cost 
latencies (seconds) as the dependent measures. For the random generation task, 
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MANOVA was used with ecstasy user group as the between participants variable, and 
the four random letter generation scores as the dependent measures. 
7.3.2 Participants 
Fifty-one ecstasy users (mean age 21.96,27 male) and 42 nonuser controls 
(mean age 20.83,9 male) were recruited via direct approach to university students, 
and the snowball technique (Solowij et al, 1992). With 42 nonuser controls, the 
present sample is sufficient to detect a difference of between 0.5 and 0.75 a for a= 
. 05 and 
ß =. 20 (Hinkle et al, 1994). Participants were requested to refrain from 
ecstasy use for at least 7 days and ideally 10 days prior to testing (the mean period of 
abstinence was actually 22 weeks, median abstinence period 4 weeks). Participants 
were also requested not to use any other illicit drugs for at least 24 hours and ideally 
for 7 days prior to testing. 
7.3.3 Materials 
Background questionnaires, intelligence tests and sleep quality tests were used 
as in Chapter 6. 
Plus-minus task. The plus-minus task, adapted from Miyake et al (2000) 
consists of three lists of 30 two-digit numbers (the numbers 10-99, randomised). On 
the first list, participants were instructed to add three to each number, and write their 
answer in the box next to it. On the second list, participants were instructed to subtract 
three from each number. On the third list, participants were required to alternately add 
and subtract three from the list (i. e. add three to the first number, subtract from the 
second, and so on). List completion times were measured with a stopwatch. The cost 
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of shifting between adding and subtracting was calculated as the difference between 
the time for list three and the average of the times for lists one and two. 
Number-Letter task. In the number-letter task, adapted from Rogers and 
Monsell (1995) and Miyake et al (2000), a number letter pair (e. g. D4) is presented in 
one of four quadrants on a computer screen. If the target is in the top half of the 
screen, the task is to indicate if the letter is a vowel (A. E, I, 0 or U) or a consonant. If 
the target is in the bottom half of the screen, the task is to indicate if the number is 
odd or even. Responses are made via pressing the key `°Z" for odd and consonant and 
they key "P' for even and vowel. The practise version of the task comprises three sets. 
The target is presented in the top half of the screen for 12 trials, then the bottom half 
for 12 trials, and then in a clockwise rotation around all 4 quadrants for a further 12 
trials. The main task follows the same structure, except there are 64 targets in each 
block. Therefore, the trials in the first two blocks required no switching, while the 
third set did. The shift-cost was the difference between the average decision times of 
the third block and the averages of the first two blocks. 
Random letter generation. A computer display and concurrent auditory signal 
was used to pace responses. Participants were asked to speak aloud a letter every time 
the signal was presented. They were told to avoid repeating the same sequence of 
letters, to avoid producing alphabetical sequences, and to try to speak each letter with 
the same overall frequency. Individuals attempted to produce three sets of 100 letters; 
one set at a rate of one letter every 4 s, a second set at one letter every 2 s, and a third 
at one letter every 1 s. The order in which the sets were generated was randomised. 
The experimenter recorded the responses on an answer sheet. The test yields four 
scores, First, the number of alphabetically ordered pairs; second, a repeat sequences 
score corresponding to the number of times that the same letter pair is repeated; third, 
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a "redundancy" score, which measures the extent to which all 26 letters of the 
alphabet are produced equally often (0% being truly random); and fourth, the number 
of letters produced. In the first three cases, higher scores indicate poor performance; 
in the fourth the opposite is the case. The scores for each separate variable, at each of 
the three generation rates, were standardised. A single score was calculated for each 
variable by summing the score for each rate and dividing by three. 
7.3.4 Procedure 
Participants were informed of the general purpose of the experiment, and 
written informed consent was obtained. The tasks were administered under laboratory 
conditions, and a computer running MS-DOS was used for the computer based tasks. 
The tests were administered in the following order: background questionnaire, sleep 
quality questionnaires, NART, random letter generation, plus-minus task, number- 
letter task, and Raven's progressive matrices. Participants were fully debriefed, paid 
£15 in store vouchers, and given drugs education leaflets, The study was approved by 
the Ethics Committee of Liverpool John Moores University, and was administered in 
accordance with the ethical guidelines of the British Psychological Society. 
7.4 Results 
The scores for background variables are set out in Table 7.1. An initial t-test 
revealed that there were no significant differences between the groups in age, pre- 
morbid intelligence, Raven's Progressive Matrices, the Epworth Sleepiness Scale, 
sleep (hours per night), years of education, or self-rated health, so these are not 
discussed any further. 
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Table 7 1: Age, Years of Education, Intelli gence and Sleep Quality for Ecstasy Users 
and Nonusers 
Ecstasy Nonusers 
users 
Mean S. D. Mean S. D. 
Age (years) 21.96 2.11 20.83 1.45 
Years of Education 15.62 1.94 15.07 1.92 
Raven's Progressive Matrices (max. 60) 46.66 6.53 47.83 5.47 
NART (max. 50) 28.67 6.53 28.71 4.90 
Hours Sleep per night 7.92 1.45 8.09 1.13 
Epworth Sleep Scale (max. 24) 6.48 3.54 7.63 3.22 
Self Report Health* 3.54 0.88 3.83 0.70 
Weeks Since Last Used Ecstasy 22.15 40.71 - - 
* The self report health measure scores range from 1 (very poor) to 5 (very good) 
Scores for the switching and inhibition tasks are set out in Table 7.2. Contrary 
to expectations, the main effect of ecstasy on inhibition was statistically significant, 
F(4,88) = 2.63, p<. 05 for Pillai's Trace, Separate univariate analyses revealed that this 
was due to ecstasy users producing more letters than non-users, F(1,91)= 8.29, 
p<. 005. There were no differences between the groups on the other random letter 
generation scores of alphabetic sequences, repeat sequences and redundancy, F<1 in 
all cases. The main effect of ecstasy use on switching was also non-significant, F<I 
for Pillai's Trace. Separate univariate analyses revealed that there were no significant 
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between group differences in performance on the plus/minus task or the number letter 
task, F<1 in both cases. 
Table 7.2: Mean Random Letter Generation and Switching scores and Significance 
Levels for Measures 
Ecstasy 
Users 
Non 
Ecstasy 
Users 
F 
Mean S. D. Mean S. D. 
Random Letter Generation 
(standardised scores) 
Alphabetic Sequences 0.0568 0.7719 -0.0720 0.7821 0.63 
Repeat Sequences 0.0005 0.6453 -0.0007 0.6955 0.00 
Redundancy -0.0490 0.6341 0.0622 0.9591 0.45 
Number of Letters 0.1967 0.4203 -0.2495 1.0137 8.29*** 
Switching Tasks 
Plus/Minus Switch Cost 28.63 19.46 29.58 18.18 0.06 
(seconds) 
Number/Letter Switch Cost 39.27 18.14 38.52 18.98 0.04 
(seconds) 
*** p<. 01, two-tailed 
Indices of Drug Use 
Inspection of Table 7.3 shows that the use of other drugs among the non- 
ecstasy group was limited mainly to the use of cannabis, alcohol, and tobacco. The 
ecstasy users had a lifetime dose of cannabis many times that of the non-users (3544 
joints to 368 joints), in addition to using it more frequently (2.78 times a week, 
compared to 0.94 times a week), having smoked more in the last 30 days (41.14 joints 
compared to 17.29 joints), and having a larger average weekly dose (9.10 joints 
compared to 1.91 joints). A t-test revealed that all these differences between the 
groups except amount used in the last 30 days were statistically significant: t(43.40; 
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40.80; 50.79) = 4.42; 3.27; 3.65, p<. 005, for total, frequency and average dose 
respectively. (As Levene's test was significant, degrees of freedom have been 
adjusted accordingly). 
Table 7.3: Indicators of Drug Use Among Ecstasy Users and Non Ecstasy Users 
Ecstasy 
Users 
Total Use 
Ecstasy (Tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Frequency of Use (times 
per week) 
Ecstasy 
Amphetamine 
Cannabis 
Cocaine 
Amount Used During 
Previous 30 Days 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Average Weekly Dose 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Number Ever Used 
Amphetamine 
Cannabis 
Cocaine 
Mean S. D. n 
373.87 542.91 52 
90.85 127.19 16 
3544.16 4410.04 40 
57.12 92.39 21 
0.27 
0.04 
2.78 
0.71 
2.18 
0.04 
41.14 
0.83 
1.46 
0.26 
9.10 
0.30 
0.29 52 
0.13 14 
2.65 40 
1.57 21 
3.17 52 
0.13 14 
59.45 40 
0.87 21 
1.40 52 
0.37 14 
11.58 40 
0.38 21 
Non Ecstasy 
Users 
Mean S. D. N 
367.54 622.96 13 
0.94 
17.29 
1.91 
1.36 13 
42.97 12 
3.37 13 
19 -- 0-- 
46 -- 23 -- 41 -- 4-- 
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Correlations with Indices of Drug Use. 
There was no evidence of any ecstasy-related deficit on the inhibition and 
switching measures, although it is possible that other illicit drugs might exert an 
influence. To address this possibility, correlations were performed with different 
measures of ecstasy, amphetamine, cannabis and cocaine use. Measures of lifetime 
use of each drug, the number of times each drug was consumed each week, the 
amount of each drug consumed within the last 30 days, and the average weekly dose 
(i. e. total amount consumed divided by the length of use in weeks) were all included'o 
For each of these a value of zero was entered for nonusers of the drug in question. In 
addition, for each illicit drug, a categorical variable in which users and nonusers of 
each drug were coded as 0 or 1 respectively was included. 
As in Chapter 6, a full Bonferroni correction is not appropriate in this case, as 
the performance measures are intercorrelated (Sankoh et al. 1997). However multiple 
comparisons remain potentially problematic, therefore an intermediate level of 
correction has been used, with correlations being evaluated at p<. Ol. The results are 
set out in Table 7.4. Frequency of ecstasy use, average dose of ecstasy, and amount 
used in the last 30 days were significantly correlated with the number of letters 
produced (p<. 0l) . In all cases, 
increased ecstasy use was associated with more letters 
produced. No correlations with indices of other drug use were significant at p<. 01. 
10 Those in the nonuser group who reported that they had ever used amphetamine or cocaine (N= 1 and 
4 respectively) felt that they were unable to estimate their pattern of use accurately. 
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Table 7.4: Correlations with Indices of Drug Use 
Ecstasy Cannabis Cocaine Amphetamine 
Total use N 93 76 67 85 
P/M switch cost -. 015 -. 136 . 196 . 106 
N/L switch cost . 124 . 143 . 212 . 077 
Redundancy . 028 -. 032 . 051 . 042 
Repeat sequence . 084 . 004 . 131 . 139 
Alpha sequence . 080 . 
010 . 113 -. 137 
Number of Letters . 228 . 
174 . 018 . 032 
Frequency of Use N 93 76 67 85 
P/M switch cost -. 043 -. 125 . 108 . 220 
N/L switch cost . 071 . 050 . 144 . 139 
Redundancy -. 079 -. 145 . 041 . 034 
Repeat sequence -. 062 -. 169 . 100 . 044 
Alpha sequence . 106 -. 110 . 025 -. 105 
Number of Letters . 335* . 186 . 078 -. 051 
Average dose N 93 76 67 83 
P/M switch cost -. 025 -. 167 . 186 . 115 
NIL switch cost . 060 . 
122 . 210 . 025 
Redundancy . 035 -. 056 . 048 -. 029 
Repeat sequence . 053 -. 017 . 129 . 097 
Alpha sequence . 071 . 033 . 120 -. 159 
Number of Letters . 283* . 199 . 018 . 034 
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Ecstasy Cannabis Cocaine Amphetamine 
Current Use N 93 93 93 93 
P/M switch cost -. 106 -. 045 . 133 . 197 
N/L switch cost . 041 . 062 . 068 -. 025 
Redundancy -. 109 -. 100 -. 057 . 013 
Repeat sequence -. 155 -. 033 . 075 . 055 
Alpha sequence -. 021 -. 048 . 062 -. 071 
Number of Letters . 344* . 116 . 000 . 102 
Ever Used N 93 92 92 92 
P/M switch cost . 
051 . 118 -. 007 -. 073 
N/L switch cost -. 063 -. 062 -. 176 -. 052 
Redundancy . 028 . 050 -. 142 . 077 
Repeat sequence -. 022 . 055 -. 118 -. 056 
Alpha sequence -. 134 . 069 -. 029 . 129 
Number of Letters -. 258 -. 037 -. 018 -. 023 
* correlation significant at p<. 01. 
Implications of Chapter 7 
To summarize, the results of Chapter 7 suggest that ecstasy-related group 
differences are not apparent in task switching. Ecstasy users did however produce 
significantly more letters on the inhibition task, although there were no group 
differences on the three other inhibition measures. This finding is not supported by 
previous research and should thus be treated with caution. Thus far, the pattern of 
results suggests that ecstasy users are impaired in Miyake et al's updating component, 
but not the switching and inhibition components. This may in part reflect the different 
neural substrates activated during performance on each task. The next chapter will 
assess performance on the fourth postulated executive function: access to long-term 
memory. 
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Chapter 8: Access to Long-term Memory 
8.1 Chapter Overview 
Thus far, it appears that while ecstasy users are impaired in memory updating 
(Chapter 6), the same is not true for shifting and inhibition (Chapter 7). This chapter 
assess the fourth executive function postulated in Chapter 2, access to long-term 
memory. Twenty-Seven ecstasy users and 34 nonusers were assessed on tasks to tap 
access to long-term memory (a semantic fluency test and the Chicago Word Fluency 
Test). MANOVA revealed that ecstasy users performed worse on the Chicago Word 
Fluency Task (C- and S-letter fluency), but not on the semantic fluency task. 
However, notwithstanding the significant ecstasy-group related effects, indices of 
cocaine and cannabis use were also significantly correlated with performance on the 
"C" and "S" letter tasks. Further analyses revealed that effect sizes for ecstasy use 
were marginally larger than for cocaine use for "S" and "C" letter fluency. This 
chapter provides further support for ecstasy/polydrug related deficits in access to 
long-term memory. Of the four executive functions assessed, it appears that updating 
and access are affected by ecstasy use. 
8.2 Introduction 
The focus of this chapter is access to semantic memory (hereafter referred to 
as "access"). Although access is not a key component of Miyake et al's conceptual 
framework, Baddeley (1996) has noted that one of the key functions of the executive 
is the temporary activation of long-term memory. In a study of cognitive ageing, Fisk 
and Sharp (2004) provided further support for the three components of Miyake et al's 
model. Factor analysis revealed that certain tasks loaded on each of the three 
components identified by Miyake et al., but there was also a distinct executive 
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function loading on another factor which Fisk and Sharp termed access to long-term 
memory (although age was not a significant predictor of performance on "access" 
tasks). It is not surprising that word fluency requires the activation of long-term 
memory as it requires participants to retrieve as many words as possible from long- 
term memory; this has been supported in previous research where performance on a 
word fluency task was significantly correlated with long-term recall (Ruff et al. 1997). 
Word fluency has been used extensively as an indicator of prefrontal/executive 
function, and is believed to be particularly sensitive to lesions in the prefrontal lobes 
(especially the left prefrontal lobe) (Benton, 1968; Milner, 1964; Perret, 1974). There 
is also a dissociation between the neural correlates of semantic and letter fluency 
tasks, with semantic fluency being related to temporal lobe lesions (e. g. Monsch et al. 
1994) and letter fluency being related to lesions in the frontal lobes (Monsch et al. 
1994; Stuss, Alexander, hamer & Palumbo 1998). As reviewed in Chapter 4, it is 
likely that humans, like animals, are subject to lesions in the prefrontal cortices 
following ecstasy administration, and accordingly it is expected that ecstasy users will 
perform worse than nonusers, especially on the letter fluency tasks. 
Some studies have shown that ecstasy users exhibit deficits in word fluency 
(see Chapter 3, Section 3.3.2 for full review). In investigating the effects of ecstasy 
use nearly all researchers have used the Controlled Oral Word Association test 
(COWA), or similar tests, to assess access to long-term memory, The task requires 
participants to generate as many words as possible in 60-seconds beginning with a 
certain letter (usually F, A, S- although some studies alternated between a variety of 
consonants (e. g. Curran & Verheyden, 2003). Only three of the 12 studies assessing 
word fluency (Bhattachary & Powell, 2001; Fox et al. 2002; Heffernan et al. 2001 a) 
found that ecstasy users retrieved fewer words than nonusers. Some studies also use a 
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semantic fluency task, requiring the retrieval of as many words as possible from a 
certain category (e. g. animals, fruit). On the semantic fluency task, one study found 
that group differences were only apparent in a combined drug-using group (Croft et 
al. 2001a), which the authors concluded was more related to cannabis use rather than 
ecstasy use. One found a trend towards an ecstasy effect (Morgan et al. 2002), while 
another found that ecstasy users performed worse than nonusers (Heffernan et al. 
2001 a). The present chapter will assess access via the Chicago Word Fluency Task. 
Although this area is already well researched in ecstasy users, most studies have used 
the same task. It is possible that a one-minute task of word retrieval does not recruit 
executive resources in such a way that ecstasy users would be impaired. Indeed 
testing other areas of cognition, it becomes apparent that ecstasy users are only 
impaired in the more difficult aspects of some tasks while easier tasks seem to be 
unaffected (e. g. Fox et al. 2002,3D-IDED). The present chapter aimed to assess this 
proposal by using a longer version of a word fluency task, and a semantic fluency 
task. It was expected that ecstasy users will perform worse on both the semantic 
fluency task (as many animals as possible in 4 minutes) and also the first part of the 
CFWT (as many words as possible beginning with "S" in 5 minutes), as greater 
executive resources will be recruited (see below). The second part of the CFWT 
imposes further restrictions on participants' retrieval by asking them to generate as 
many four-letter words as possible beginning with the letter "C". Only one study in 
ecstasy users has imposed further restrictions such as this. In Heffernan et al's (2001 a) 
study participants were asked to recall as many household items as they could 
beginning with the letter "T" in one minute. On this task the ecstasy users performed 
worse than nonusers, so we have reason to believe that the deficit will be even more 
pronounced in the longer version of the task used in the present study. With reference 
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to which part of the task will be most affected by ecstasy use, research suggests that 
"animals" is one of the best-retrieved semantic categories, and in one study number of 
words retrieved on the animals category was higher than for "S" letter (for a one 
minute recall) in normal participants (Baldo & Shimamura, 1998). It is therefore 
expected that retrieval will be highest on the semantic task (with between group 
differences being less evident), while larger performance deficits will be observed on 
the "S" letter task, and most pronounced on the "C" letter task. 
One aim of the present chapter was to establish the separability of a specific 
deficit in access, as opposed to access being mediated by working memory capacity. 
Previous research has shown that individual capacities of working memory are 
reflected in performance on a word fluency task. For example, Engle and Rosen 
(1994) found that those with high working memory span were impaired by 
performing a concurrent task with semantic fluency (animal names) whereas those 
with low span were not. It also seems reasonable to expect that those with a high 
working memory span would have higher activation of access to long-term memory 
and thus be more efficient at this process. This may be reflected in the present study 
(and indeed previous studies) by ecstasy users performing worse on an access task, 
due to reduced working memory capacity. Consequently we will control for working 
memory capacity in the present chapter. With reference to which aspect of Miyake et 
al's model of executive functioning may be related to performance on the CWFI', 
Shimamura (2001) suggests that retrieval from long-term memory requires an ability 
to monitor previously retrieved items after each response, and consequently keep 
these in mind for future selections so that mistakes will not be made. From this it is 
possible that different aspects of Miyake et al's model may impact on performance in 
different ways. While inhibition may be related to errors on the task (writing down 
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words that do not meet the specific criteria), shifting may be related to the occurrence 
of perseverative errors (in the case of the word fluency task, making the same 
response more than once, whether it complies with the criteria or not). The updating 
component however may be more generally involved in the process of retrieval, 
through monitoring past choices and thus facilitating the retrieval of future ones. It 
was deduced that the updating component of Miyake et al's model was most likely to 
relate to word fluency performance in the present chapter. In keeping with this, 
Chapter 6 of this thesis found that ecstasy users performed worse on a memory 
updating task, but not on tasks that assess switching and inhibition (Chapter 7). 
It was predicted that ecstasy users would perform worse than non-users on 
measures of access to long-term memory (a semantic and category fluency task) 
Although word fluency has been assessed in samples of ecstasy users (e. g. 
Bhattachary and Powell, 2001; Fox et al, 2002), the task used in the present study is 
more likely to recruit executive prefrontal resources as it is a longer version than 
previously used and places further constraints on the categories thus making it harder 
for participants. Cohen and Stanczak (2000) found that the Chicago Word Fluency 
Test (CWFT- also known as the Thurstone Word Fluency Test) has high test-retest 
reliability over 6 weeks, high inter-rater reliability, and good construct validity. In 
addition, performance on this task was also significantly correlated with performance 
on the COWA and FAS tasks previously used with ecstasy users. The CWFT differs 
in that longer time limits are imposed on participants (5 minutes for "S" letter words, 
and 4 minutes for 4-letter "C" words). Consequently, it seems reasonable to expect 
that with the constrained categories and longer time limits the task imposes greater 
demands on access to semantic memory. Indeed, Cohen and Stanczak (2000) found 
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that attention and memory contribute to performance on this task. In the present 
chapter, we have controlled for differences in memory updating (computation span) 
and attention (digit span). To our knowledge, this task has not been used in research 
with ecstasy users before. It seems reasonable to expect that semantic knowledge, 
more specifically available word knowledge is necessary for optimum performance on 
a word fluency task (this is evidenced by correlations between WAIS-R vocabulary 
scores and COWA scores, Ruff et al. 1997). Consequently verbal IQ and level of 
education will be controlled for. 
8.3 Method 
8.3.1 Design. 
A multivariate design was used for the word fluency tasks, with ecstasy user 
group as the between participants independent variable, and the three word fluency 
scores (semantic, "S" letter, and C" letter) as the dependent variables. " To ascertain 
the extent to which memory and attention may play a role in the word fluency deficits 
observed in the present study, ANCOVA was used with computation span and digit 
span as covariates. Where group differences were observed in terms of background 
variables, these were also incorporated into ANCOVA. 
8.3.2 Participants 
Thirty-six ecstasy users (mean age 21.72; 19 male) and 62 non-user controls 
(mean age 21.32; 18 male) completed the word fluency tasks. Participants were 
recruited as in Chapter 6. With 36 ecstasy users, the present sample is sufficient to 
detect a difference of between 0.5 and 0.75a for a= . 05 and ß =. 20 (Ilinkle et al, 
1994). Participants were requested to refrain from ecstasy use for at least 7 days and 
11 Data in this Chapter are analysed in a multivariate design. Appendix 4 contains supplementary 
analyses for a mixed design incorporating the same variables. 
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ideally 10 days prior to testing (the mean period of abstinence was actually 5 weeks, 
median abstinence period 2 weeks). Participants were also requested not to use any 
other illicit drugs for at least 24 hours and ideally for 7 days prior to testing. 
8.3.3 Materials 
Patterns of drug use, sleep quality, fluid intelligence, premorbid intelligence, 
and other relevant lifestyle variables were investigated as described in Chapter 6 
(section 6.3.3). 
Semantic Fluency: In the semantic fluency task, participants were required to 
produce as many animal names as they could think of. This could be different species, 
or breeds within species. Participants were given four minutes for this task. 
Chicago Word Fluency Test (CWFT). Participants were instructed not to write 
any place names, peoples name or plurals in this test. Firstly participants were given 
five minutes to write down as many words as they could, beginning with the letter 
"S". Secondly, they were given four minutes to write down as many four-letter words 
beginning with "C" as they could. As plurals were not allowed words such as " cats", 
and repetitions of words were excluded. Scores for all three fluency tasks were the 
number of appropriate words in each case. For both semantic fluency and the CWFT 
participants wrote their responses in an answer booklet provided for this purpose. 
Digit Span: Digits were presented sequentially on a computer screen for 1.25 
seconds. Participants were then required to recall the digits in the order in which they 
were presented. The task commences with three sets of two digits, and is then 
increased to three sets of three, four, five etc., until the individual fails on at least two 
out of three trials. 
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Working memory updating. The computation span measure was used to 
assess these aspects of cognitive functioning. Computation span has been used as an 
indicator of working memory functioning in the cognitive ageing literature (Fisk & 
Warr, 1996; Salthouse & Babcock, 1991) and it is similar to the operation span 
measure used by Miyake et al. (2000) in their investigation of executive processes. In 
addition, it has been shown to be sensitive to the effects of ecstasy use (Fisk et al. 
2004). Participants were required to solve a number of arithmetic problems (e. g., 4+7 
?) by circling one of three multiple-choice answers as each problem was presented. 
They were also required to simultaneously remember the second digit of each 
presented problem. At the end of each set of problems the second digits had to be 
recalled in the order in which they were presented. The number of arithmetic 
problems that the participant had to solve, while at the same time remembering each 
second digit, gradually increased as the test proceeded. For each of the first three trials 
only a single problem was presented. For the next three trials, two problems were 
presented. Subsequently, the number of problems presented per trial increased by one 
every third trial. In order to proceed, the participant was required to be correct in at 
least two of the three trials at the current level. Computation span was defined as the 
maximum number of end digits recalled in serial order, with the added requirement 
that the corresponding arithmetic problems had been solved correctly. 
8.3.4 Procedure 
Participants were informed of the general purpose of the experiment, and 
written informed consent was obtained. Completed under laboratory conditions, the 
tests were administered in the following order: background questionnaire, sleep 
questionnaires, NART, semantic fluency, computation span, word fluency, and 
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Raven's progressive matrices. Participants were fully debriefed, paid £15 in store 
vouchers, and given drugs education leaflets. The study was approved by the Ethics 
Committee of Liverpool John Moores University, and was administered in accordance 
with the ethical guidelines of the British Psychological Society. 
8.4 Results 
The scores for background measures are set out in Table 8.1. The t-test 
revealed that there were no significant differences between the groups in age, pre- 
morbid intelligence, sleep (hours per night), subjective daytime sleepiness, years of 
education, self-rated health, digit span, or computation span 
12. Group differences on 
Raven's Progressive Matrices approached significance, t(95) = 1.92, p=0.058. 
Ecstasy users also reported significantly higher average weekly alcohol consumption 
(21.65 units compared to 11.82 units), t(48.21) = -3.27, p<. 01, than nonusers (as 
Levene's test was significant, degrees of freedom have been adjusted accordingly). 
Gender distribution was also significantly different between the groups, with the 
ecstasy users being predominantly male, and the nonusers predominantly female, x2 
(df. 1, N= 98) = 5.47, p<. 05. 
12 Although the lack of a significant difference on computation span in this chapter suggests that 
ecstasy users may not be impaired in updating, this is not consistent with the majority of chapters and 
should therefore be treated with caution. 
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Table 8.1: Age, Years of Education, Intelligence and Sleep Quality for Ecstasy Users 
and Nonusers. 
Ecstasy 
users 
Nonusers 
Mean S. D. Mean S. D. 
Age (years) 21.72 1.63 21.32 1.80 
Years of Education 15.77 1.85 15.34 2.13 
Raven's Progressive Matrices (max. 60) 50.00 4.76 47.97 5.16 
NART (max. 50) 28.94 6.03 29.89 5.77 
Hours of Sleep per night 8.08 1.55 8.00 1.27 
Epworth Sleep Scale (max. 24) 6.46 3.42 5.82 2.83 
Self Report Health* 3.67 0.79 3.85 0.81 
Units of Alcohol Consumed in a Week 21.65 16.57 11.82 9.14 
Digit Span 6.5 1.03 6.5 1.05 
Computation Span 3.89 1.60 4.24 1.29 
Weeks Since Last Used Ecstasy 15.79 39.24 - - 
* The self report health measure scores range from 1(very poor) to 5 (very good) 
Table 8.2 shows that ecstasy users retrieved fewer words on all three access 
tasks although the deficit was not as evident on the semantic fluency task. The main 
effect of ecstasy use on word fluency was significant, F(3,94) = 4.55, p<. O1 (all 
multivariate effects reported in the results section relate to Pillai's Trace). This was 
due to ecstasy users' poorer performance on the "S" letter, F(1,96) = 6.44, p<. 05, and 
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the "C" letter categories, F(1,96) = 13.70, p< . 001. There were no significant 
differences between the groups on the semantic fluency task, F(1,96) = 1.65, p>. 05 
Table 8.2: Word Fluency Scores and Significance Levels (F values) For Main Effects. 
Ecstasy Users Non Ecstasy Users F 
Mean S. D. Mean S. D. 
Semantic Fluency 40.64 8.87 43.19 9.83 1.65 
"S" Letter 40.94 10.30 46.58 10.76 6.44* 
"C" Letter 11.64 5.29 15.98 5.77 13.70*** 
* p<. 05, two-tailed 
*** p<. 001, two-tailed 
Covariate Analyses. 
As there was a gender imbalance between the groups, and ecstasy users also 
reported consuming significantly more alcohol than nonusers, while group differences 
on Raven's Progressive Matrices approached significance (indicating that ecstasy 
users had a higher IQ), it was possible that some or all of these factors may have 
influenced ecstasy-related group differences in access to long-term memory. 
ANCOVA was conducted to investigate the possible mediating effects of alcohol 
consumption, intelligence, and gender on word fluency. The main effect of ecstasy 
use was intensified after control for these three covariates, F(3,87) = 5.70, p<. 001. In 
addition, after ANCOVA to control for alcohol, gender and fluid intelligence, group 
differences in all three word fluency scores were significant: F(I, 89) = 4.00, p<. 05 for 
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semantic fluency; F(1,89) = 6.18, p<. 05, for "S" letter fluency; and F(1,89) = 15.97, 
p<. 001 for "C" letter fluency. 
Although there were no significant group differences in NART scores, it was 
possible that the effect of ecstasy use on access to long-term memory could in part be 
mediated by verbal IQ, and hence NART scores. Using Pearson's correlations it was 
found that NART scores were significantly correlated with semantic fluency (r = 
0.231, p<. 05), "S" letter fluency (r = 0.240, p<. 05), and "C" letter fluency (r = 0.326, 
p<. 01). To address this possibility NART scores were entered as a covariate. The 
main effect of ecstasy use on word fluency remained significant after control for 
NART scores, F(3,92) = 4.41, p<. 01. Group differences in semantic fluency remained 
non-significant (p>. 05), but differences in "S" and "C" letter fluency remained 
significant, F(1,94) = 5.92; 13.22, p<. 05 and p<. 001 respectively. Homogeneity of 
regression was achieved with respect to all covariates, p>. 05 for the group covariate 
interaction. Correlations between years of education and semantic fluency, "S" letter 
fluency, and "C" letter fluency were non significant (r = 0.070; 0.154; 0.097 
respectively, p>. 05). Nonetheless, it was possible that ecstasy group differences in 
word fluency may be mediated by available word knowledge, and thus be related to 
education. The main effect of ecstasy use on access remained significant after control 
for years of education, F(3.93) = 4.99, p<. 01, although differences in semantic 
fluency were still non-significant, F(1,95) = 1.86, p>. 05. Ecstasy-related differences 
in "S" and "C" letter fluency were actually intensified after control for number of 
years spent in education, F(1,95) = 7.57, p<. O1 and F(1,95) = 14.81, p<. 001 
respectively. 
As mentioned in the introduction, it is possible that access to semantic 
memory may be mediated by differences in working memory capacity and attention. 
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To evaluate the impact of working memory capacity on access, computation span was 
entered as a covariate. The main effect of ecstasy use remained significant after 
control for computation span, F(3.93) = 4.01, p<. 01. Differences in semantic fluency 
remained non-significant, F(1,95) = 1.22, p>. 05. Although very slightly attenuated, 
differences in "S" letter fluency remained significant, F(1,95) = 5.03, p<. 05, as did 
differences in "C" letter fluency, F(1,95) = 12.01, p<. 001. After entering digit span as 
a covariate, the main effect of ecstasy use was slightly intensified, F(3,93) = 4.80, 
p<. 01, as were group differences in "C" letter fluency, F(1,95) = 14.48, p<. 001. 
Differences in Semantic fluency remained non-significant, F(1,95) = 1.66, p>. 05. 
There was also no change in differences in "S" letter fluency following control for 
digit span, F(1,95) = 6.48, p<. 05. Homogeneity of regression was achieved for all 
covariates, p>. 05 for the group by covariate interaction. 
To summarise, ecstasy-related differences in access do not appear to be 
mediated by differences in intelligence, lifestyle factors, working memory capacity or 
attention. 
Indices of Drug Use 
Inspection of Table 8.3 shows that the use of other drugs was limited mainly 
to the use of cannabis among the non-ecstasy group. The ecstasy users had a lifetime 
dose of cannabis twice that of the non-users (2620 joints to 1083 joints), in addition to 
using it more frequently (2.69 times a week, compared to 0.77 times a week), having 
smoked more in the last 30 days (25.31 joints compared to 7.91 joints), and having a 
larger average weekly dose (8.77 joints compared to 5.14 joints). In relation to the 
cannabis measures, t-test revealed that the group difference was statistically 
significant for total lifetime dose, frequency of use, and amount used in the last 30 
days: t(40.40) = -2.36, p<. 05; t(35.98) = -3.56, p<. 001; and t(33.62) = -2.36, p<. 05 
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respectively (As Levene's test was significant, degrees of freedom have been adjusted 
accordingly). 
Table 8.3: Indicators of Drug Use Among Ecstasy Users and Non Ecstasy Users. 
Ecstasy 
Users 
Total Use 
Ecstasy (Tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Frequency of Use (times per 
week) 
Ecstasy 
Amphetamine 
Cannabis 
Cocaine 
Amount Used During 
Previous 30 Days 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Average Weekly Dose 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Number Ever Used 
Amphetamine 
Cannabis 
Cocaine 
Mean S. D. 
Nonusers 
n Mean S. D. N 
314.93 326.23 36 --- 
47.11 129.38 94-1 
2620.46 2888.46 27 1082.54 1439.33 18 
18.10 21.57 16 --- 
0.39 0.34 35 
0.04 0.04 5 
2.69 2.61 28 
0.25 0.23 16 
3.14 3.39 35 
1.20 2.68 5 
25.31 35.51 27 
1.20 1.71 14 
1.94 1.67 36 
0.32 0.52 8 
8.77 8.81 26 
0.15 0.23 16 
17 -- 
33 -- 
29 -- 
0.77 
7.91 
0.09 
5.14 
3 
30 
7 
0.90 18 
11.04 16 
10.01 18 
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Correlations with Indices of Drug Use. 
Due to the small number of illicit drug users among the non ecstasy user group 
it was not possible to control statistically for the effects of other drugs through the use 
of ANCOVA. Therefore it is possible that some or all of the ecstasy-related effects 
might have been attributable to the effects of other drugs. To address this possibility, 
correlations were performed with different measures of ecstasy, amphetamine, 
cannabis and cocaine use. Measures of lifetime use of each drug, the number of times 
each drug was consumed each week, the amount of each drug consumed within the 
last 30 days, and the average weekly dose (i. e. total amount consumed divided by the 
length of use in weeks) were all included 13. For each of these a value of zero was 
entered for nonusers of the drug in question. In addition, for each illicit drug, a 
categorical variable in which users and nonusers of each drug were coded as 0 or 1 
respectively was included. 
A partial Bonferroni correction was applied as in Chapter 6. Specifically a 
value for alpha of 0.01 was selected. The results, set out in Table 8.4, show that 
ecstasy use was significantly correlated with a number of the performance measures. 
1' Those in the nonuser group who reported that they had ever used amphetamine or cocaine (N= 3 and 
7 respectively) felt that they were unable to estimate their pattern of use accurately. 
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Table 8.4: Correlations between Word Fluency Measures and Indices of Drug Use 
Ecstasy Cannabis Cocaine Amphetamine 
Total use N 98 80 78 88 
Semantic Fluency 
"S" letter 
"C" letter 
-0.114 -0.113 
-0.274** -0.119 
-0.369** -0.272** 
Frequency of Use N 97 
Semantic Fluency -0.044 
"S" letter -0.176 
"C" letter -0.304** 
Average dose N 98 
Semantic Fluency -0.068 
"S" letter -0.262** 
"C" letter -0.381 ** 
Current Use N 98 
Semantic Fluency -0.046 
"S" letter -0.164 
"C" letter -0.329** 
Ever Used N 98 
81 
-0.106 
-0.084 
-0.259** 
79 
-0.092 
-0.100 
-0.236 
98 
-0.163 
-0.104 
-0.253** 
98 
-0.156 0.041 
-0.307** 0.075 
-0.420** -0.028 
78 83 
-0.201** 0.145 
-0.279** 0.054 
-0.426** -0.065 
78 87 
-0.151 0.004 
-0.300** 0.035 
-0.420** -0.046 
98 98 
-0.205 0.022 
-0.224 -0.048 
-0.249** -0,094 
98 98 
Semantic Fluency 0.095 0.033 0.154 -0.021 
"S" letter 0.248** 0.096 0.226** -0.046 
"C" letter 0.370** 0.231 0.357** 0.072 
** Correlation significant at p<01 
Total ecstasy use, average dose of ecstasy, and having ever used ecstasy were 
all significantly correlated with "S" letter fluency (at p<. 01), while total lifetime dose, 
frequency of use, average dose, amount used in the last 30 days, and having ever used 
ecstasy were all significantly correlated with "C" letter fluency. 
In relation to other drugs, total lifetime cannabis dose, frequency of use, and 
amount used in the last 30 days were all significantly correlated with "C" letter 
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fluency. Total lifetime cocaine dose, frequency of cocaine use, average weekly 
cocaine dose, and having ever used cocaine were all significantly correlated with "S" 
letter fluency, while like ecstasy, total lifetime dose, frequency of use, average weekly 
dose, amount used in the last 30 days, and having ever used cocaine were all 
significantly correlated with "C" letter fluency. 
While correlations with ecstasy were all stronger than those for cannabis use, 
this was not the case for correlations with cocaine use (with the exception of having 
ever used and amount used in the last 30 days on "C" letter fluency, where ecstasy 
was higher), and it is clear from the correlations that aspects of cocaine use may have 
contributed or possibly caused the observed ecstasy-related deficits in word fluency. 
To evaluate the potentially confounding effects of cocaine we performed several 
analyses with a categorical cocaine user/nonuser independent variable, with those 
reporting that they had ever tried cocaine, N=36 versus those who reported that they 
had never tried cocaine, N=62, which would enable us to compare effect sizes for 
ecstasy versus cocaine analyses. There was a main effect of cocaine use on access to 
long-term memory, F(3,94) = 4.62, p<. Ol, and separate univariate analyses revealed 
that cocaine users performed significantly worse on the "S" and "C" letter fluency 
tasks, F(1,96) = 5.82; 13.38, p<. 05 and p<. 001 respectively, while cocaine-related 
differences on semantic fluency approached significance, F(1,96) = 3.52, p=0.064. 
To try and compare cocaine and ecstasy group-related effects on word fluency, we 
compared the effect sizes for the two sets of analyses. The multivariate effect size was 
marginally larger for cocaine user than for ecstasy user (partial Eta squared of 0.129 
and 0.127 respectively), as was the semantic fluency effect size (partial Eta squared of 
0.035 and 0.017 respectively). Effect sizes on the other indices of access to semantic 
memory were however marginally smaller for cocaine that for ecstasy: partial Eta 
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squared of 0.057 compared to 0.063 for "S" letter fluency, and partial Eta squared of 
0.122 compared to 0.125 for "C" letter fluency. This is consistent with either an 
ecstasy-related word fluency deficit, or an exacerbated cocaine/ecstasy deficit in 
access to long-term memory. 
Supplementary to the effect size analyses, part correlations were performed 
between ecstasy use and word fluency after control for indices of cocaine use. The 
results are summarised in Table 8.5. Although slightly attenuated following control 
for cocaine use, most of the significant correlations with ecstasy use remained 
significant. 
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Table 8.5 Part correlations after control for cocaine use indices 
Semantic "S" Letter "C" Letter 
fluency Fluency Fluency 
Control for Total Cocaine 
Total ecstasy Use -0.167a -0.128 -0.158 a 
Frequency of ecstasy Use -0.104 -0.072 -0.172 ° 
Current Ecstasy Use -0.072 -0.076 -0.157 
Average Ecstasy Dose 0.046 -0.116 -0.258** 
Ever used Ecstasy 0.051 0.118 0.301** 
Control for Cocaine Frequency 
Total ecstasy Use -0.137 -0.095 -0.038 
Frequency of ecstasy Use -0.037 0.051 0.042 
Current Ecstasy Use 0.005 0.037 0.026 
Average Ecstasy Dose 0.054 -0.126 -0.180 
Ever used Ecstasy 0.044 0.099 0.212* 
Control for Current Cocaine 
Total ecstasy Use -0.065 -0.174* -0.198* 
Frequency of ecstasy Use 0.008 -0.093 -0.195* 
Current Ecstasy Use 0.007 0.005 -0.189* 
Average Ecstasy Dose 0.061 -0.163 a -0.261** 
Ever used Ecstasy 0.020 -0.176* 0.303** 
Control for Average Cocaine 
Total ecstasy Use -0.228* -0.208* -0.213* 
Frequency of ecstasy Use -0.145 -0.121 -0.204* 
Current Ecstasy Use -0.127 -0.138 -0.197* 
Average Ecstasy Dose -0,012 -0.169 a -0.288** 
Ever used Ecstasy 0.104 0.173 a 0.330** 
Control for Ever Used Cocaine 
Total ecstasy Use -0.138 -0.194* -0.115 
Frequency of ecstasy Use -0.052 -0.104 -0.115 
Current Ecstasy Use -0.087 -0.044 -0.137 
Average Ecstasy Dose 0.063 -0.135 -0.171* 
Ever used Ecstasy -0.011 0.119 0,160 ° 
* denotes correlation significant at p<. 05 
** denotes correlation significant at p<. 01 
denotes correlation approached significance. 
Implications of Chapter 8 
This chapter supports an ecstasy-related deficit in access to long-term 
memory that is not related to gender, intelligence, alcohol use, cannabis use or 
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amphetamine use. However, it is possible that access to long-term memory (as 
indexed by the word fluency scores) is also sensitive to aspects of cocaine use. Indeed 
Table 4 reveals that among ecstasy users, in the majority of cases outcome measures 
were more related to aspects of cocaine use than they were to the equivalent indices of 
ecstasy use. Working memory updating and attention do not appear to be important 
mediating factors of word fluency deficits in ecstasy users, suggesting the presence of 
a specific access deficit in users, rather than a lower level attentional deficit. To 
summarise the results of this thesis so far, ecstasy users exhibit impairments in tasks 
that tap memory updating and access, but not switching and inhibition. It is possible 
that these differences in updating and access may mediate a range of other cognitive 
abilities. Reasoning is one area that is under-investigated in research in ecstasy users. 
The next Chapter will assess reasoning competence in ecstasy users via a syllogistic 
reasoning task. The impact of differences in memory updating and access on 
syllogistic reasoning will also be investigated. 
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Chapter 9: Syllogistic Reasoning 
9.1 Chapter Overview 
The aim of this chapter was to assess reasoning deficits in ecstasy users and 
the contribution of access and updating to performance on reasoning tasks. Previous 
research has demonstrated working memory and executive deficits in recreational 
users of ecstasy. In turn, both of these constructs have been implicated in syllogistic 
reasoning performance. Thirty ecstasy users and 30 non-ecstasy user controls were 
tested on syllogisms of varying difficulty, and on measures of updating (computation 
span) and access (word fluency). Ecstasy users were significantly impaired in aspects 
of syllogistic reasoning. However, the ecstasy-related variance was reduced to below 
statistical significance following control for group differences in working memory 
span. The results are consistent with the possibility that ecstasy-related deficits in 
aspects of executive functioning result in impaired reasoning performance among 
ecstasy users. 
9.2 Introduction 
Syllogistic reasoning performance in normal populations has been shown to 
rely on working memory and executive resources (Fisk & Sharp, 2002; Gilinsky and 
Judd, 1994). The purpose of this chapter was to establish whether ecstasy-related 
deficits in working memory might give rise to reasoning deficits. Since syllogistic 
reasoning is generally regarded as an indicator of the capacity for rational thought, 
ecstasy-related deficits on this measure raise the possibility that extensive use of 
ecstasy might be associated with impaired rational thinking. However, the possibility 
that ecstasy users might be impaired in reasoning, and more specifically in syllogistic 
reasoning, has not yet been investigated. 
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Johnson-Laird (1983) has proposed that rather than using some logical 
propositional calculus to solve reasoning problems, we generally construct mental 
models of the problem. Johnson-Laird (1983) suggests that individuals generally go 
through three stages when attempting to solve a syllogism. The first stage involves 
forming a mental model of the first premise of the problem, then incorporating the 
second premise into this model. The second stage involves using their mental model 
to propose a conclusion to the problem. In the third stage, individuals supposedly test 
their conclusion by searching for possible alternative models, and if none are 
available the conclusion is accepted as valid. If the conclusion is not valid, then 
another conclusion is deduced, and again tested against the models. Some syllogisms 
however have no valid conclusions. Syllogistic reasoning requires a participant to 
draw valid inferences from a set of premises. For Example the pair of premises: 
Some A are B, 
and 
All Bare C 
can be accommodated within a single model, from which it follows that: 
Some of A are C 
as there is no alternative model of the premises that violates the conclusion. 
On the other hand, the pair: 
All of B are A 
and 
None of B are C 
initially gives rise to a model that is consistent with the proposition that 
No Aare C 
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This in turn then requires the construction of a second model, which remaining 
consistent with the premises, falsifies this conclusion. The second model however 
leaves open the propositions that: 
Some of the C are not A 
and 
Some of the A are not C 
which in turn requires the construction of a third model, leaving only the second of 
these conclusions as valid (see Johnson-Laird, 1983, pp. 98-100). 
Johnson-Laird (1983) maintains that reasoning involves constructing mental 
models of the premises and testing conclusions against these models. As described 
above, constructing a single model may solve some problems, while others may 
require up to three models. The more complex the problem, the greater number of 
models required and the greater the load on working memory and executive resources. 
Among the different measures of reasoning competence, syllogistic reasoning 
is perhaps one of the best known. It was central in the development of Johnson- 
Laird's mental models theory (Evans, Handley, Harper & Johnson-Laird, 1999; 
Johnson-Laird, 1983). Within a developmental context, it has been used as a key 
indicator of reasoning competence in early childhood (Lourenco & Machado, 1996) 
and over the adult lifespan (Gilinski & Judd, 1994; Fisk & Sharp, 2002). Syllogisms 
have also featured prominently in the debate on human rationality (e. g., Stanovich & 
West, 2000). Syllogistic reasoning is also believed to utilise resources outside of 
working memory, for example relations between linguistic concepts such as `all', 
'some' and the logical operator `not', as well as spatial representations of class 
inclusion relationships (see, for example, Ford, 1995). 
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Some studies in ecstasy users have assessed decision making/reasoning (see 
Chapter 3, Section 3.3.3 for full review). While one study (McCann et al. 1999) found 
that ecstasy users were impaired in logical reasoning, another found that ecstasy use 
was a significant predictor of poor performance on an analogical reasoning task 
(Verdejo-Garcia et al. 2005). Of the other studies that assessed logical reasoning, 
most used tasks that also supposedly tap other functions (e. g. the Revised Strategy 
Application Task used by Halpern et al. 2004 may be reliant on shifting and 
inhibition, as well as planning and reasoning). The majority of studies in ecstasy users 
have utilised planning tasks (e. g. the Tower of London Task: Alting von Geusau et at. 
2004; Fox et al. 2001; Lamers et al. 2003; Morgan 1998; Schifano et al. 1998) to 
assess planning/reasoning skills. There were mixed results on tasks of planning 
ability, with some studies finding that ecstasy users exhibited longer planning times 
(Fox et al. 2001), and some that they exhibited shorter planning times (Alting von 
Geusau et al. 2004). However, the constructs underlying of the Tower of London 
(TOL) task are not well established. While the TOL is used to assess 
planning/decision making, Miyake et al. (2000) found that performance on the TOH 
(which is similar to the TOL) was related to the inhibition component of executive 
functioning. Indeed it was suggested that participants did not generally use a 
"planning strategy", but a "perceptual strategy" to solve the TOL task. This entailed 
making a move that would bring the present state of the task closer to the goal state, 
rather than a move which may temporarily take them away from the goal state, but 
result in arriving at their goal sooner (e. g. moving a disk away from the final peg). In 
this scenario, it is the inhibition of a prepotent response to move closer to, and not 
away from, the goal that may be impaired rather than a planning strategy itself (Goel 
& Grafman, 1995). Miyake et al. also postulate that if a planning strategy is 
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implemented as opposed to a perceptual strategy, then task performance may be more. 
related to the updating component, which is involved in the management of goal 
information. 
With reference to which aspects of executive functioning might be related to 
syllogistic reasoning in the present study, Gilhooly and co-workers (Gilhooly et al. 
1993; Gilhooly et al. 1999) have found that concurrent random number generation 
(which Miyake et al. postulate is related to inhibition and updating) impaired 
performance on a syllogistic reasoning task, indicating that the two tasks may share 
the same modality. In addition, a number of studies have found that syllogistic 
reasoning performance is related to working memory capacity. One study 
investigating the extent to which performance on a syllogistic reasoning task can be 
predicted by working memory capacity in normal populations used the operation span 
task, a key indicator of Miyake et al's conceptual framework. It was found that those 
with larger working memory capacities performed better, which the authors conclude 
indicates a greater ability to effectively utilise mental models (Copeland & 
Radvansky, 2004), and thus performed better on the task. It is also possible that due to 
the linguistic nature of the task, requiring the understanding of relationships such as 
"some" "all" and "none" that linguistic abilities may be related to syllogistic 
reasoning performance (Ford, 1995). To summarise, inhibition, updating and access 
components of central executive functioning have been implicated in syllogistic 
reasoning deficits in normal populations. As Chapters 6 and 8 revealed that ecstasy 
users exhibit deficits in updating and access respectively, it was possible that these 
components may underpin syllogistic reasoning performance in the present study. In 
contrast, no deficits were observed on the inhibition task. Consequently, the present 
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chapter will ascertain if deficits in access and updating (indexed by word fluency and 
computation span) are responsible for ecstasy-related deficits in syllogistic reasoning. 
While the preceding paragraphs suggest that reasoning in general, and 
syllogistic reasoning in particular are well researched outside the area of 
Psychopharmacology, an important area of cognitive functioning that has not been 
directly addressed with regard to ecstasy users is reasoning. Of the broad range of 
intellectual abilities that has been investigated, reasoning is perhaps the most 
cognitively demanding. There is cause to believe that among the many illicit drugs 
commonly in use, ecstasy in particular has the potential to disrupt reasoning 
processes. The drug is believed to have long-term adverse effects on the serotonin 
system (Morgan, 2000). In turn, the serotonin system is believed to underpin the 
operation of working memory processes through its modulation of the dopaminergic 
systems that support prefrontal executive processes (Luciana, Collins, & Depue, 
1998; Robbins 2000). Indeed in his review of the literature, Morgan (2000, page234) 
has noted that `it has been proposed that it [serotonin] may play an orchestrating role 
in cognition'. Given that ecstasy use has been associated with impaired working 
memory and executive functioning (As in Chapter 6 of this thesis; Wareing et al. 
2000; Wareing et al. 2004b), and that these cognitive constructs are believed to 
underpin syllogistic reasoning performance (e. g., see Fisk & Sharp, 2002; Gilhooly, 
Logie and Wynn, 1999), it seems reasonable to expect that ecstasy users might be 
impaired on this measure of reasoning ability. 
To sum up, it is expected that ecstasy users will perform worse compared to 
controls in a syllogistic reasoning task and that consistent with Johnson-Laird's 
mental models theory, the ecstasy related deficit will be most pronounced on the two 
and three-model syllogisms, as these load most heavily on working memory and 
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executive resources. ANCOVA will be used to investigate the extent to which 
ecstasy-related differences in syllogistic reasoning are related to group differences in 
working memory capacity and executive functioning. Updating and access will be 
assessed through a computation span task and through word fluency. It is also 
possible that the use of other drugs may play a part in the observed syllogistic 
reasoning deficits, accordingly correlations will be performed between indices of drug 
use and syllogistic reasoning. 
9.3 Method 
9.3.1 Design. 
A mixed design was used with ecstasy user group (with two levels, user/non- 
user) as the between participants variable, and level of difficulty of the syllogism 
(again with two levels, low and high) as the within participants variable. Level of 
difficulty was based on the number of models required to derive a solution. Thus one- 
model syllogisms were low in difficulty. Since the NVC and three-model syllogisms 
require a similar number of models to produce a solution, responses for these types 
were combined to form the high difficulty level. The dependent variable was the 
number of correct solutions for the low and high difficulty syllogisms (maximum 
score was eight in both cases). We also sought to determine whether the main effect 
of user group was qualified by a user-by-difficulty interaction. ANCOVA was used to 
statistically control for group differences in updating and access as indexed by 
computation span and word fluency. 
9.3.2 Participants 
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Thirty ecstasy users (mean age 21.37,16 male) and 30 non-ecstasy user 
controls (mean age 21.3,10 male) were recruited14. With 30 participants in each 
group, the present sample is sufficient to detect a difference of 0.75a for a= . 05 and 
ß 
=. 20 (Hinkle et al, 1994). As in Chapter 6 participants were initially recruited through 
direct approach to Liverpool John Moores University undergraduate students. 
Participants were requested to refrain from ecstasy use for at least 7 days and ideally 
10 days prior to testing (the mean period of abstinence was actually 12.70 weeks, 
median 2 weeks). Participants were also requested not to use any other illicit drugs for 
at least 24 hours and ideally for 7 days prior to testing. Participants were paid 15 UK 
pounds in store vouchers for their participation. 
9.3.3 Materials. 
Background data on drug use, fluid intelligence, premorbid intelligence, sleep 
patterns and other relevant lifestyle variables was collected as described in Chapter 6 
(section 6.3.3). 
Syllogistic reasoning. The syllogisms were presented in abstract form as in the 
example set out above. Participants attempted to generate solutions for four one- 
model syllogisms, four three-model syllogisms, and four syllogisms for which there 
was no valid conclusion (NVC). The syllogisms were the same as those used by Fisk 
and Sharp (2002). Scores were based on the number of correct solutions, or in the 
case of the NVC syllogisms, a response was deemed correct when the participant 
indicated that no valid conclusions were possible. According to Johnson-Laird (1983), 
NVC syllogisms require either two or three mental models in order to derive the 
correct solution. In the present study, two of the NVC syllogisms were two-model and 
14 Due to an oversight, only 15 ecstasy users and 18 nonusers completed the access tasks. 
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two were three-model. Therefore, in terms of the number of models required, three- 
model and NVC syllogisms were the hardest, and one-model the easiest. The 
syllogisms used in the study were presented in random order. The test was 
administered following the procedure outlined by Fisk and Sharp (2002). 
Working Memory Updating: Computation span was used as described in 
Chapter 8. Since computation span is reliant on both phonological and executive 
processing resources, a simple digit span task (Fisk & Warr, 1996) was also 
administered so that it could be ascertained that any observed ecstasy related deficits 
were not simply a result of lower level non executive impairments (i. e., the 
phonological loop). 
The Chicago Word Fluency Test and a Semantic Fluency Test (Animals) were 
used to assess access as in Chapter 8. 
9.3.4 Procedure. 
Informed consent was obtained. The tests were administered under controlled 
laboratory conditions. A computer, using MS-DOS was used for the computation span 
test. Tasks were administered in the following order: Health/education questionnaire, 
drug use background questionnaire and sleep questionnaires, word fluency tests, 
computation span test, syllogistic reasoning test, NART, and finally Ravens 
progressive matrices. The order of the access, computation span and syllogistic 
reasoning tests was rotated, to eliminate order effects. The study was approved by the 
Ethics Committee of Liverpool John Moores University, and was administered in 
accordance with the ethical guidelines of the British Psychological Society. 
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9.5 Results 
Background Variables. 
Average age, years of education, fluid intelligence, premorbid intelligence, 
and other background variables for the two groups are set out in Table 9.1. A t-test 
revealed that there were some significant group differences among the background 
variables. Ecstasy users performed worse than non-users on the computation span test, 
t(56) _ -3.50, p<. 001, and also reported consuming more alcohol than nonusers in an 
average week, t(58) = 2.24, p<. 05. Unlike group differences evident in chapter 8, 
ecstasy users did not perform significantly worse than nonusers on the access tasks, 
although the difference approached significance for "C letter fluency, t(31) = -1.99, p 
0.055. In this study, the gender distribution of the groups was comparable, x2 (d. f. 1, 
N=60) = 2.44, p>. 05. 
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Table 9.1: Performance of ecstasy users and nonusers on Background Variables 
Ecstasy Users Nonusers 
Mean S. D. Mean S. D. 
Age (Years) 21.37 1.65 21.30 1.62 
Years of Education 15.10 2.77 15.80 1.85 
Raven's Progressive Matrices (max. 60) 48.40 6.13 48.31 5.81 
NART (max. 50) 28.07 6.72 29.67 5.86 
Units of Alcohol consumed in a week 22.40 12.21 14.71 13.90 
Hours of Sleep per Night 8.30 1.45 8.25 1.01 
Epworth Sleepiness Scale (max. 24) 5.76 3.14 6.50 2.45 
Self-report Health' 3.50 0.78 3.83 0.83 
Computation Span 3.33 1.56 4.77 1.61 
Semantic Fluency2 43.13 6.93 41.50 9.73 
"S" Letter Fluency2 39.80 9.48 46.00 10.88 
"C" Letter Fluency2 11.07 4.74 14.78 5.78 
Weeks since last used Ecstasy 12.70 33.79 - - 
1 On a scale of 1= poor to 5= good health 
2 Mean numbers of words 
Main Analysis 
Table 9.2 reveals that ecstasy users performed worse than non-users both on 
the one-model and on the three-model/NVC syllogisms although in the latter case the 
group difference was much less pronounced. Mixed ANOVA yielded a significant 
models by user interaction, F(1,58)=5.56, p<. 05, and a main effect of ecstasy use, 
F(1,58) = 5.76, p<. 05. Subsequent analyses revealed that ecstasy users performed 
significantly worse on the one-model syllogisms, F(1,58) = 8.02, <. 01, but there was 
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little difference between the groups on the NVC/three-model problems, F(1,58) = 
0.97, p>. 05. 
Correlations also revealed that although there were only group differences on 
the one-model syllogisms, not the three-model/NVC syllogisms, performance on the 
two in the sample as a whole was significantly correlated (r = 0.355, p<. 01 one- 
tailed). 
Table 9.2: Average number of correct responses for syllogistic reasoning task 
Ecstasy Users Nonusers 
Mean S. D. Mean S. D. 
One-Model Syllogisms 
Three-model/NVC Syllogisms 
3.73 
1.33 
2.01 
1.88 
5.10 
1.77 
1.71 
1.50 
Total Percentage Correct 31.63 42.94 
Note: for the four one-model problems (for which there were two valid conclusions 
per syllogism), and the eight three-model/NVC syllogisms (for which there was one 
valid conclusion per syllogism), the maximum possible score was eight. A one- 
sample t-test was conducted to see if performance of ecstasy users and nonusers was 
above chance on the syllogisms, with chance level of performance being one out of 
eight correct. For the one-model syllogisms, the ecstasy users and nonusers both 
performed well above chance, t(29) = 2.80, p<. O1 and 13.14, p<. 001 respectively. 
However, only the nonusers performed significantly better than chance on the three- 
model/NVC syllogisms, t(29) = 7.43, p<. 001. 
Covariate Analyses. 
Working memory and executive functioning. It is possible that the observed 
ecstasy-related deficit in syllogistic reasoning might be mediated by executive 
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components. One aim of this thesis was to ascertain the extent to which ecstasy- 
related deficits in syllogistic reasoning are mediated by updating and access. Ecstasy 
users performed significantly worse than nonusers on the computation span measure, 
although no group differences were observed on the access tasks (Table 9.1). 
Nevertheless, as access may still have contributed to syllogistic reasoning deficits in 
the present sample, this was incorporated into ANCOVA. ANCOVA generated a non- 
significant result with respect to computation span F(1,57) = 2.00, p>. 05. However, 
the ecstasy user group by models interaction was reduced to below statistical 
significance following control for computation span, F(1,57) = 1.00, p>. 05. The main 
effect of user group was also reduced to below statistical significance, F<1. By way of 
contrast, ANCOVA with word fluency as a covariate generated a non-significant 
result with respect to all three word fluency measures, p>. 05 in all cases. The 
interaction effect between group and models on syllogistic reasoning was however 
reduced to below statistical significance following control for access, F(1,28) = 0.10, 
p>. 05. The ecstasy-related differences in syllogistic reasoning remained significant 
after control for access, F(1,28) = 5.72, p<. 05. In both analyses the group by covariate 
interactions were non-significant, F< 1, indicating that homogeneity of regression was 
obtained (with the exception of semantic fluency). 
To ascertain the extent to which computation span, word fluency, and having 
ever used ecstasy might be responsible for differences observed in reasoning, linear 
regression analysis was performed. Computation span emerged as the only significant 
predictor of performance on 1-model syllogistic reasoning problems t(32) = 2.60, 
p<. 05. 
As ecstasy users reported drinking significantly more alcohol in an average 
week than nonusers, this was also incorporated into ANCOVA. The models by 
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ecstasy user group interaction was reduced to below statistical significance, F(1,55) _ 
1.65, p>. 05. On the contrary, the main effect of ecstasy use on syllogistic reasoning 
was actually slightly intensified after control alcohol use, F(1,55) = 7.01, p<. 05. 
Indices of Drug 
As in Chapters 6,7, and 8 inspection of Table 9.3 reveals that the use of 
"other" drugs was commonplace among ecstasy users, while among non-ecstasy 
users, drug use was mainly limited to alcohol. Ecstasy users reported a larger total 
lifetime dose of cannabis (3790 joints compared to 1141 for nonusers), using cannabis 
more frequently (2.62 times per week compared to 0.70), having smoked more in the 
30 days prior to testing (55 joints compared to 6), and reporting a larger average 
weekly dose (12 joints compared to 4 joints for nonusers). Differences in total lifetime 
dose, and average weekly dose were non-significant, t(29) = 1.12, and t(25.04) = 1.91, 
p>. 05 respectively. Group differences in terms of frequency of use were significant, 
t(25.17) = 3.15, p<. 01, as were differences in amount of cannabis used in the last 30 
days, t(20.49) = 2.49, p<. 05 (for average dose, frequency of use and amount used in 
the last 30 days, Levene's test was significant so degrees of freedom have been 
adjusted accordingly). 
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Table 9.3: Indices of Drug Use 
Ecstasy 
Users 
Nonusers 
Mean S. D. Nl Mean S. D. N 
Total Use 
Ecstasy (tablets) 277.45 328.63 30 - -- 
Amphetamine (grams) 74.07 186.06 7 - -- 
Cannabis (joints) 3789.77 6198.92 22 1141.44 1723.69 9 
Cocaine (grams) 45.62 70.02 15 - -- 
Frequency of Use (times per 
week) 
Ecstasy 0.40 0.37 22 - -- 
Amphetamine 0.11 0.13 3 - -- 
Cannabis 2.62 2.71 22 0.70 0.58 9 
Cocaine 0.59 0.55 15 - -- 
Use in last 30 Days 
Ecstasy (tablets) 5.86 7.38 29 - -- 
Amphetamine (grams) - - - - -- 
Cannabis (joints) 54.83 88.86 21 6.28 6.46 9 
Cocaine (grams) 2.35 2.42 15 - -- 
Average Dose 
Ecstasy (tablets) 2.56 3.65 30 - -- 
Amphetamine (grams) 0.24 0.47 6 - -- 
Cannabis (joints) 12.33 18.46 21 4.08 4.68 9 
Cocaine (grams) 0.42 0.47 15 - -- 
Number Ever Used 
Amphetamine 15 0 
Cannabis 29 15 
Cocaine 22 2 
It was necessary to establish whether the prevalence of polydrug use, 
especially among the ecstasy user group (see Table 9.3), contributed to the ecstasy- 
related differences in reasoning. As once again there were relatively small numbers of 
users of cannabis, amphetamine and cocaine in the non-ecstasy group, correlations 
were performed between indices of the use of ecstasy, cannabis, cocaine and 
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amphetamine to ascertain the extent to which each drug may contribute to reasoning 
performance. 
Table 9.4: Correlations with Indices of Drug Use 
Ecstasy Cannabis Cocaine Amphetamine 
Total Use N 60 47 51 52 
One-model -0.342** -0.210 -0.258 -0.314 
Three-model/NVC -0.126 -0.078 0.050 -0.106 
Frequency of Use N 59 47 51 48 
One-model -0.257 -0.330 -0.294 -0.186 
Three-model/NVC -0.023 -0.061 0.083 -0.134 
Use in last 30 Days N 60 60 60 - 
One-model -0.201 -0.155 -0.240 - 
Three-model/NVC 0.051 -0.030 0.141 - 
Average Dose N 60 46 51 51 
One-model -0.352** -0.229 -0.262 -0.274 
Three-model/NVC -0.128 -0.072 -0.068 -0.161 
Ever Used N 60 60 60 60 
One-model 0.343** 0.134 0.187 0.311** 
Three-model/NVC 0.217 0.101 0.026 0.067 
** Correlation significant at p<. 01 one-tailed 
A partial correction was used as in Chapter 6 to adjust for inflated error rates 
following multiple comparisons". No indices of drug use were significantly 
correlated with performance on the three-model syllogisms at p<. 01. With reference 
to 1-model syllogisms, total lifetime dose of ecstasy, average weekly dose, and having 
ever used ecstasy were all significantly correlated with performance. This was also 
" Again, those in the nonuser group who had used cocaine (n=2) felt hat they were unable to accurately 
estimate their pattern of use. 
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true of having ever used amphetamine, although the correlation was higher for having 
ever used ecstasy than having ever used amphetamine, and as all participants on 
whom this analysis was based were also ecstasy users, the significant correlation may 
reflect some aspect of ecstasy use. 
Implications of Chapter 9 
The present chapter demonstrates an ecstasy related deficit in syllogistic 
reasoning. Ecstasy users performed worse on the one-model syllogisms, although 
there was little difference on the three-modelINVC syllogisms. The absence of 
differences on the three-model/NVC syllogisms provides further support for Evans et 
al's proposition that individuals only generally construct one mental model of 
premises (see general discussion). One aim of this chapter was to ascertain the role 
that the executive deficits observed in Chapters 6 and 8 might play in ecstasy-related 
differences in syllogistic reasoning. Following control for computation span, ecstasy- 
related differences in syllogistic reasoning were reduced to below statistical 
significance, although the same was not true for access to long-term memory (though 
this may reflect the reduced sample size in this analysis). This highlights the role of 
Miyake et al's updating component in contributing to syllogistic reasoning deficits in 
ecstasy users. 
Syllogistic reasoning as assessed in this Chapter is a higher level cognitive 
process which is reliant on executive prefrontal resources (e. g. Goel, Buchel, Frith & 
Dolan 2000). Another aspect of cognition that utilises executive prefrontal resources 
is associative learning. While research suggests that the hippocampal formation may 
be important in associative learning performance (e. g. Collie et al. 2002), there is also 
clear evidence that the prefrontal cortex is involved in human associative learning 
(e. g. Moscovitch and Winocur 2002). This involvement may be especially evident 
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during the initial phases of learning or when pre-existing associations break down (i. e. 
forgetting) (Fletcher, Anderson, Shanks, Honey et al. 2001). Thus like syllogistic 
reasoning, associative learning is a higher-level cognitive process that may also rely 
on executive resources. The next chapter assesses possible ecstasy-related differences 
in associative learning and the contribution of updating and access to performance on 
these tasks. 
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Chapter 10: The Nature of Associative Learning Deficits 
10.1 Chapter Overview 
In view of the results of the preceding chapters, it was possible that ecstasy- 
related differences in associative learning may be mediated by differences in updating 
and access - this was explored in the present chapter. Research has revealed 
associative learning deficits among users of ecstasy, the present chapter explored the 
component processes underlying these deficits. Thirty-five ecstasy users and 62 non- 
ecstasy users completed a computer-based, verbal paired-associates learning task, 
requiring the learning of eight sequentially presented word pairs. After all eight had 
been presented, the first member of each pair was displayed and participants 
attempted to recall the second. Correct responses on each trial, forgetting at various 
levels of learning, perseveration errors and the rate at which the associations were 
learned (trials to completion) were all recorded. There was a main effect of ecstasy 
use indicating that ecstasy users performed worse overall and subsequent ANOVAs 
showed that users performed significantly worse on virtually all measures. Regression 
analysis revealed that over half of the ecstasy-group related variance in trials to 
completion was attributable to group differences in initial learning and forgetting. In 
relation to forgetting, it appears that cannabis use may be the primary determinant. In 
relation to rate of learning (trials to completion) and initial learning, both ecstasy and 
cannabis may be implicated. Unlike syllogistic reasoning, it appears that ecstasy- 
related differences in associative learning are not underpinned by group differences in 
updating and access. There appears to be abundant evidence of associative learning 
deficits among ecstasy users. However, it appears that a range of illicit drugs 
including cannabis and ecstasy may contribute to these deficits. 
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10.2 Introduction 
Developing an understanding of relationships between concepts is a 
fundamental aspect of human learning. One key aspect of this is associative learning, 
which involves forming appropriate links between previously unrelated phenomena. 
The working memory system in general, and the executive in particular are essential 
components in learning new skills before they become automatic, so that learning and 
the acquisition of knowledge is dependent on working memory (Tanji & Hoshi, 
2001). The term associative learning describes the process by which an organism 
develops or reinforces connections between stimulus representations (Rose et al, 
2001). Ecstasy users have been shown to exhibit deficits in aspects of working 
memory functioning (e. g., Fisk et al, 2004; Wareing et al. 2004b) and in view of the 
role of working memory and executive processes in supporting associative learning 
(Collie et al. 2002) it is possible that users might also experience impairments in 
learning processes. 
Much of the research in this domain has focussed on animal learning and to 
date the results have been equivocal. While some studies have found MDMA-related 
deficits in aspects of learning (Broening, Morford, Inman-Wood, Fukumura et al. 
2001; Frederick, Ali, Slicker, Gillam et al. 1995; Taylor & Jentsch, 2001; Williams, 
Morford, Wood, Rock et al. 2003) others have not (Frederick & Paule 1997; Ricaurte 
et al. 1993; Romano & Harvey 1994; Winsaeur, McCann, Yuan, Delatte et al. 2002). 
In a study examining learning in rats, Robinson, Castaneda and Whishaw (1993) 
found that the extent of 5HT denervation (72.6%) was not sufficient to produce 
marked deficits (this may be a sign of neurocompensatory changes). More generally, 
it is possible that the apparent lack of MDMA-related deficits in some animal studies 
is because the tasks are too simple, and they do not mirror learning in humans. 
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Although some studies in human ecstasy users have investigated associative 
learning, this is an area that is still under investigated as a number of tasks used relate 
more to immediate and delayed recall, rather than the learning of associations (see 
Chapter 3, Section 3.10 for full review). Gouzoulis-Mayfrank et al. (2003) used the 
word-pair learning test of the LGT-3 test battery, which requires participants to 
memorise 20 word pairs consisting of a Turkish word and it's German translation. In 
the retrieval phase, participants had to identify the correct Turkish word 
corresponding to each German word (out of 5 possible answers). Heavy ecstasy users 
performed worse than non-users in the delayed recall of the word pairs, but not the 
immediate recall component. However, the effect was reduced to below statistical 
significance after control for general knowledge scores. 
Croft et al (2001a) studied the relative contributions of ecstasy and cannabis to 
spatial and non-spatial Paired Associates Learning (PAL). Participants were required 
to learn associations between six spatial pairs (spatial) and six colour pairs (non- 
spatial), but no significant differences were observed between the ecstasy/cannabis 
group and the cannabis only group. A combined drug-user group performed 
significantly worse than controls on the non-spatial PAL. ANCOVA revealed that this 
effect was more due to cannabis than ecstasy. However, the average cannabis 
abstinence period was only 17 hours so it was possible that participants were still 
intoxicated. Also, Croft et al's participants only had a modest lifetime dose of ecstasy. 
A further study (Fox et al. 2002) also used a spatial PAL task in which 
participants were required to learn the spatial locations of abstract patterns. No 
significant group differences were observed in the number of errors, the number of 
presentations required per trial, or the memory score (total number of patterns 
successfully located on initial presentation). The group by trial interaction approached 
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significance, and post hoc tests revealed that the ecstasy group made a greater number 
of errors on the 8 pair trials. Rodgers (2000) found that ecstasy users were unimpaired 
during the initial learning phase of the verbal and visual paired associates sub-tasks of 
the Wechsler Memory Scale. However, subsequent deficits in the delayed recall of the 
verbal and visual paired associates were apparent among ecstasy users but not among 
cannabis-only users. 
In addition to deficits in associative learning, basic verbal learning deficits 
have also been observed using the Rey Auditory Verbal Learning Test (RAVLT) (see 
Chapter 3, Section 3.6 for full review). During trials 1-5, a list of 15 words is read to 
participants, and they are then required to recall as many words as possible in any 
order; in trial 6 this is repeated with a new list of words (interference). Trial 7 requires 
participants to again recall the original list. Finally, participants are given a list of 
words containing those from the first list with phonemic and semantic distractors, and 
required to circle words that appeared in the first list. McCardle et at. (2004) found 
that ecstasy users performed significantly worse than non-users trials 4 and 5, and 
Reneman et al. (2000) found that ecstasy users recalled significantly fewer words than 
non-users. In another study (Gouzoulis-Mayfrank et al. 2000) ecstasy users exhibited 
poorer learning performance over 5 trials than nonusers, and required more trials to 
learn all words than cannabis users and nonusers. However, two studies found that 
differences in list learning were more related to cannabis/polydrug use (Croft et al. 
2001 a; Thomasius et al. 2003). 
Thus the aim of this Chapter is to determine if users of ecstasy exhibit deficits 
in associative learning. Only two studies (Gouzoulis-Mayfrank et at. 2003; Rodgers 
2000) have assessed the learning of word pairs in ecstasy users, with both finding no 
significant differences between ecstasy users and nonusers. In addition to the 
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measures used by in previous research with ecstasy users, the test used in the present 
study assesses various measures of forgetting, perseverative errors, and the speed with 
which all associations are learned (trials to completion) which have not yet been 
systematically investigated in ecstasy research. The number of pairs repeated 
correctly on trial one gives a measure of initial learning, and the number of trials 
required for a participant to learn all associations ("trials to completion") gives an 
overall indication of speed of learning. Forgetting at each level will also be recorded, 
whereby forgetting a response that had previously been recalled correctly once would 
indicate forgetting at level one, forgetting a response that had previously been recalled 
two times would be forgetting at level two, and so on. In addition, the number of 
perseverative errors will be recorded (i. e. giving the same incorrect response on two 
or more consecutive trials). It was expected that ecstasy users would perform worse 
than controls in paired associate learning, more specifically, they will correctly recall 
fewer pairs on trial 1, forget more items, make more perseverative errors, and take 
more trials to learn all associations. An overall deficit in associative learning may 
provide further support for impaired executive function since optimal learning 
requires the effective use of strategies and self-monitoring meta processes. 
Furthermore, an increased number of perseverative responses might be associated 
with a failure to inhibit previously incorrect responses or with an inability to shift 
mental set, and may thus provide further support for specific executive deficits in 
ecstasy users (with reference to Miyake et al's model). Recalling fewer pairs on trial 
one may in part reflect hippocampal/medial temporal lobe impairment, while 
forgetting well-learned material would suggest a retrieval deficit (perhaps reflecting a 
deficit in access as in Chapter 8). As with Chapter 9, it was possible that the updating 
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and access deficits observed in Chapters 6 and 8 may have mediated deficits in 
associative learning. This relationship was explored in the current chapter. 
10.3 Method 
10.3.1 Design 
Dependent variables were various measures of associative learning including 
trials to completion, initial learning (number of correct responses in trial 1), 
perseverative responses, and forgetting at various levels of learning. The independent 
variable was ecstasy user group (users versus non-users), MANOVA was used 
supplemented by separate univariate analyses for each dependent variable, ANCOVA 
was used to ascertain the extent to which working memory capacity, access and 
differences in background variables may mediate ecstasy-related deficits in 
associative learning. In addition to these analyses, the relationship between aspects of 
illicit drug use and associative learning performance was assessed through bivariate 
correlation. 
In order to establish which of the learning processes shared variance with the 
ecstasy-user group variable, hierarchical regression analysis was used. In all cases, 
trials to completion was the dependent variable. The ecstasy user group related 
variance was estimated first by entering this measure as the sole independent variable. 
Next, measures of initial learning, perseverative responses and forgetting at various 
levels were entered as independent variables in separate regressions. In each case the 
measure of learning performance was entered first followed by ecstasy user group to 
establish how much of the ecstasy user-group related variance was accounted for by 
each learning sub-process. 
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10.3.2 Participants 
As in previous Chapters, participants were initially recruited through direct 
contact with under-graduates from Liverpool John Moores University, and through 
the snowball technique. Sixty-two non-ecstasy users (18 male, mean age 21.32) and 
35 ecstasy users (20 male, mean age 21.66) were recruited16. With 35 ecstasy users, 
the present sample is sufficient to detect a difference of between 0.5 and 0.75a for a= 
. 05 and 
ß =. 20 (Hinkle et al, 1994)Participants reported that they had abstained from 
ecstasy use for at least 7 days (mean = 12.16 weeks, median =2 weeks), and other 
psychoactive drugs for at least 24 hours prior to testing. Participants were paid 15 UK 
pounds in store vouchers for their participation. 
10.3.3 Materials 
Patterns of drug use and other relevant lifestyle variables were investigated by means 
of a background questionnaire, and fluid intelligence, premorbid intelligence and 
sleep patterns were assessed as in Chapter 6 (section 6.3.3). The computation span 
and word fluency measures were administered as indicated in Chapter 8. 
Associative Learning 
This was assessed via a verbal paired associates task. Participants were 
presented sequentially with the same eight word pairs (taken from Fisk, 2003) on a 
computer screen. For example, 
DOOR CASE 
YEAR PAGE 
16 Participants completed all tasks with the exception of the access task, which was completed by 33 
ecstasy users and 61 nonusers. 
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After each presentation, the participant was prompted with the first member of 
each pair and required to recall the second member. Eight such trials were 
administered. The order of presentation was randomised and changed for each trial. 
Measures included the number of correct responses in trial 1 (a measure of initial 
learning), forgetting at various levels, the number of trials required to learn all 
associations, and the number of perseverative errors (giving the same incorrect answer 
consecutively). 
10.3.4 Procedure 
The tests were administered under controlled laboratory conditions. A 
computer running on MS-DOS was used for the associative learning task. Tasks were 
administered in the following order: Health/education questionnaire, ecstasy and drug 
use background questionnaire, sleep questionnaires, associative learning, computation 
span, word fluency, NART and finally Raven's progressive matrices. Overall, testing 
took two to three hours per person. The study was approved by the Ethics Committee 
of Liverpool John Moores University, and was administered in accordance with the 
ethical guidelines of the British Psychological Society. 
10.4 Results 
Average age, years of education, fluid intelligence, premorbid intelligence and 
other background variables for the two groups are set out in Table 10.1. Statistical 
tests (ANOVA, t-test) revealed that there were no significant differences between the 
groups regarding these variables, so they are not discussed further in this chapter. The 
ecstasy users did however perform worse than the nonusers on the "S" fluency task, 
t(93) = -2.35, p<. 05, and the "C" letter fluency task, t(93) = 3.48, p<. 001. 
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Table 10.1: Age Years of Education, Intelligence, and Sleep Quality. 
Ecstasy Users Nonusers 
Mean S. D. Mean S. D. 
Age (Years) 21.66 1.64 21.32 1.80 
Years of Education 15.77 1.88 15.34 2.13 
Ravens Progressive Matrices (max. 60) 49.94 4.55 47.97 5.16 
NART (max. 50) 28.91 5.98 29.89 5.77 
Hours of Sleep per Night 8.11 1.56 8.01 1.28 
Epworth Sleep Scale (max. 24) 6.38 3.38 5.82 2.83 
Self Report Health * 3.74 0.74 3.85 0.81 
Units of Alcohol consumed in a week 22.81 16.46 11.82 9.14 
Computation span 3.77 1.66 4.24 1.29 
Semantic Fluency 41.36 8.38 43.19 9.83 
"S" Letter Fluency 41.15 10.71 46.58 10.76 
"C" Letter Fluency 11.76 5.36 15.98 5.77 
* The self report health measure scores range from 1 (very poor) to 5 (very good) 
Ecstasy users performed worse on all measures of associative learning. Users 
required more trials to learn the pairings; they scored lower on the measure of initial 
learning (the number of correct responses on Trial 1); and they made more 
perseverative responses. However, Table 10.2 reveals that the group differences were 
less pronounced for the measures of forgetting. Indeed, the means reported in the 
Table indicate that once the material had been learned to a moderate degree, 
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forgetting was a rare event among both users and nonusers. Thus, for example, once a 
response had been successfully learned for four or more consecutive trials, there was 
no occurrence of forgetting in the nonuser group and only seven of the 35 users forgot 
a previously learned response. MANOVA revealed that the ecstasy-related group 
difference on the measures of associative learning was statistically significant, F(7,88) 
= 4.60, p<. 001. Furthermore, subsequent univariate analyses revealed significant 
group differences on each of the measures with the exception of forgetting at levels 2 
and 4, although the latter approached significance (p = 0.06) (see Table 10.2). 
Table 10.2: Performance on Associative Learning Measures 
Ecstasy Users Nonusers F (1,95) 
Mean S. D. Mean S. D. 
Trials to Completion 6.11 
Number Correct on Trial 1 2.97 
1.94 
2.01 
4.33 
4.36 
1.47 26.96*** 
2.00 10.70** 
Number of Perseverative 0.69 1.16 0.15 0.65 8.50** 
responses 
Number Forgotten at: 
Level 1 0.86 1.03 0.40 0.76 6.35* 
Level 2 0.26 0.66 0.10 0.35 2.39 
Level 3 0.14 0.36 0,00 0.00 9.96** 
Level 4 0.06 0.24 Q. 00 0.00 3.62 
*** p<. 001; ** p<. 01; * p<. 05 
Covariate analyses 
As gender and alcohol use were significantly different between the groups, 
and group differences on Raven's Progressive Matrices approached significance, 
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these were incorporated into ANCOVA. The main effect of ecstasy use on associative 
learning remained significant after control for these covariates F(7,8 1) = 4.96, p<. 001. 
Table 10.3 shows the Univariate F values for each separate measure of associative 
learning following control for these covariates. In all cases, significant effects 
remained significant. Of particular note is the marked increase in the perseveration F 
value. 
Table 10.3: F values after Control for Group Differences in 10, Alcohol and Gender 
Alcohol, Gender & IQ Working Memory Access 
Updating 
Trials to Completion 26.67*** 23.13*** 16.56*** 
No Correct on Trial 1 10.44** 9.69** 6.86** 
Perseverations 12.36** 8.45** 7.16** 
Number forgotten at: 
Level 1 6.60* 5.76* 4.46* 
Level 2 2.23 2.01 0.21 
Level 3 10.31** 7.94** 6.50* 
Level 4 2.76 4.33* 3.68 
* p<. 05 
** p<. 01 
*** p<. 001 
Although no significant differences were observed between the groups in 
terms of updating and access, one aim of this chapter was to assess the contribution of 
updating and access to ecstasy-related differences in associative learning. After 
control for updating the main effect of ecstasy use remained significant F(7,87) _ 
4.18, p<. 001. Table 10.3 shows that although slightly attenuated, group differences in 
measures of associative learning remained significant. Contrary to expectations, 
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control for updating actually intensified group differences in forgetting at level 4. The 
main effect of ecstasy use on associative learning also remained significant after 
control for access, F(7,83) = 3.76, p<. 001. 
Indices of Drug Use 
Inspection of Table 10.4 reveals that the use of other drugs was commonplace 
among the ecstasy group, but was restricted mainly to the use of cannabis among the 
control group. The ecstasy users had a lifetime dose of cannabis nearly twice that of 
the controls (2128 joints compared to 1082 joints), in addition to using it more 
frequently (2.45 times per week, compared to 0.77 times), and having smoked more in 
the last 30 days (17.52 joints compared to 7.91 joints). There were significant group 
differences in the amount smoked in the last 30 days t(37.74) = 2.07, and the 
frequency of use t(32.56) = 3.20, p<. 05 in both cases. However the difference in 
lifetime use was not statistically significant: t(41.31)=1.80, p>. 05. (As Levene's test 
was significant, degrees of freedom have been adjusted accordingly. ) The ecstasy 
group reported an average total lifetime dose of ecstasy of 315 tablets; of 
amphetamine, 4 grams (n=8); and of cocaine, 18.96 grams (n=15). The average 
frequency of use for ecstasy was 0.4 times per week, and for cocaine, 0.26 times per 
week (n=15). 
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Table 10.4: Indicators of Drug Use. 
Ecstasy Users I Non Ecstasy Users 
Mean S. D. n 
Total Use 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine(grams) 
Frequency of Use (times 
per week) 
Ecstasy 
Amphetamine 
Cannabis 
Cocaine 
Amount Used During 
Previous 30 Days 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine(grams) 
Average Weekly Dose 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine(grams) 
315.30 330.10 35 
4.00 3.86 8 
2128.71 2401.96 26 
18.96 22.03 15 
0.40 0.34 35 
0.04 0.04 5 
2.45 2.40 25 
0.26 0.23 15 
3.38 3.58 34 
1.20 2.68 5 
17.52 18.26 24 
1.23 1.77 13 
1.67 1.31 35 
0.10 0.20 8 
7.75 8.73 25 
0.14 0.24 15 
Mean S. D. n 
4.00 -1 
1082.54 1439.33 18 
0.77 0.90 
7.91 11.03 
0.01 - 5.11 9.94 
18 
16 
1 
1$ 
It is possible that some or all of the ecstasy-related differences in associative 
learning might have been attributable to the effects of other drugs. Since the number 
of cocaine and amphetamine users among the non-ecstasy user group was small it was 
not possible to properly test for homogeneity of regression in relation to these 
measures via ANCOVA. Accordingly, bivariate correlations were performed to 
ascertain relationships between indices of drug use and performance measures. 
Evaluating the correlations at p<. OI, Table 10.5 reveals that there were a number of 
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significant correlations between measures of ecstasy, cannabis and cocaine use and 
the measures of associative learning. Correlations were higher for ecstasy than for 
cannabis and cocaine (with the exception of frequency of cocaine use and 
perseverative errors) for trials to completion and perseverative responses, so it appears 
that these aspects of associative learning may be related more to ecstasy use. 
However, it appears that aspects of cannabis use are related to the number of correct 
responses on trial one (initial learning), and contrary to expectations indices of 
cocaine use were most related to forgetting at level one. 
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Table 10.5: Correlations Between Various Measures of Learning Performance and 
Measures of Illicit Drug Use. 
Ecstasy Cannabis Cocaine Amphetamine 
Total Use 
Trials to Completion 0.410** 0.270** 0.380** 0.116 
Correct on Trial 1 -0.327** -0.334** -0.308** -0.083 Perseverations 0.380** 0.073 0.367** 0.213(*) 
Forgot at Level 1 0.280** 0.169 0.337** 0.058 
Frequency of Use 
Trials to Completion 0.350** 0.257 0.337** 0.140 
Correct on Trial 1 -0.233 -0.347** -0.341** 0.077 Perseverations -0.209 0.005 0.278** 0.244* 
Forgot at Level 1 0.240** 0.100 0.275** 0.199 
Use in last 30 Days 
Trials to Completion 0.292** 0.267** 0.163 -0.054 Correct on Trial 1 -0.156 -0.330** -0.236** 0.120 
Perseverations 0.182 0.087 0.167 -0.049 Forgot at Level 1 0.196* 0.138 0.175* 0.105 
Avers eý Dose 
Trials to Completion 0.405** 0.265** 0.381** 0.072 
Correct on Trial 1 -0.319** -0.338** -0.313** 0.005 
Perseverations 0.382** 0.077 0.364** 0.175 
Forgot at Level 1 0.246** 0.168 0.339** 0.103 
Ever Used 
Trials to Completion -0.434** -0.134 -0.291 ** -0.118 Correct on Trial 1 0.317** 0.163 -0.345** -0.182 Perseverations -0.404** -0.020 -0,209 -0.103 Forgot at Level 1 -0.280** -0.033 -0.151 -0.046 
N=97 
** p<. 001; ** p< . 01; one tailed 
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One aim of this Chapter was to ascertain the component processes underlying 
ecstasy-related deficits in associative learning. ANCOVA revealed that differences in 
updating were not related to performance on this task. Regarding the ecstasy-group 
related variance in trials to completion, it is important to emphasise that the ecstasy- 
group related variance potentially arises from a range of sources. In addition to using 
ecstasy, a range of other drugs was also used and there may also be premorbid 
differences between the two groups, as well as differences in psychological affect. 
Thus the ecstasy-group related variance might have arisen from any one of these 
sources. The focus here is to establish which sub-processes were responsible for the 
difference in overall learning performance among this group of poly-substance 
abusers. 
Table 10.6 reveals that the ecstasy-group related variance amounted to 21.8% 
of the total variance in trials to completion (as indicated by the R squared increment 
of . 218). In subsequent analyses, ecstasy use was entered in the regression equation 
following the inclusion of each specific learning sub-process. This makes it possible 
to establish how much of the ecstasy-group related variance was accounted for by 
each of the learning sub-processes. Inspection of Table 10.6 reveals that following 
statistical control for group differences in initial learning (as measured by the number 
of correct responses in Trial 1), the residual ecstasy-group related variance amounts to 
8.0%. Thus over half of the ecstasy-group related variance is accounted for by 
individual differences in the level of initial learning. Three other regression models 
were evaluated. Prior control for group differences in perseverative responses reduced 
the ecstasy-related variance from 21.8% to 13.0%. Inclusion of forgetting at level one 
and at higher levels in the first stage of the hierarchy removed at least half of the 
ecstasy-group related variance in both cases. 
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Table 10.6: Variance in Associative Learning. Uniquely Associated with Ecstasy User 
Group Following Statistical Controls for the Effects of Other Independent Variables 
Regression Independent Variables in the Model Total RR squared 
Model Prior to the inclusion of Ecstasy User squared increment 
Group associated with 
Ecstasy User 
Group 
0 None . 215 . 215*** 
1 Number of Correct Responses in Trial 1 . 458 . 080*** 
2 Number of Perseverative responses . 304 . 130*** 
3 Number Forgotten at level 1 . 440 . 107*** 
4 Number Forgotten at levels 2,3 and 4 . 401 . 089*** 
*** p<. 001; ** p<. 01; * p<05 
Implications of Chapter 10 
This chapter provides evidence for associative learning deficits in ecstasy 
users. Individual differences in initial learning, perseverative responses and forgetting 
all appear to be important determinants of verbal associative learning deficits in these 
individuals. However, while some of these impairments appear to be related to ecstasy 
use, others may be attributable to other drugs such as cannabis and cocaine. It appears 
that unlike deficits in syllogistic reasoning, associative learning deficits in ecstasy 
users are not related to memory updating or access to long-term memory. The final 
chapter of this thesis assesses aspects of everyday memory in ecstasy users via self- 
reports. While ecstasy-related differences in syllogistic reasoning were related to 
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group differences in memory updating and to a lesser extent, access, the same was not 
true for associative learning. In the context of ecstasy-related differences Chapter 11 
assessed the contribution of executive processes to everyday memory functioning. 
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Chapter 11: Everyday Memory 
11.1 Chapter Overview 
The aim of the present chapter was to assess the contribution that the deficits 
in access and updating observed in Chapters 8 and 6 have on ecstasy-related 
differences in everyday memory functioning. While research suggests that 
recreational drug use impacts aspects of "everyday" memory (e. g. remembering to do 
something in the future) the possible mediating effects of working memory capacity 
on such deficits has not been systematically investigated. Forty-three ecstasy- 
polydrug users and 51 non-ecstasy users completed the Cognitive Failures 
Questionnaire (CFQ) and Everyday Memory Questionnaire (EMQ). Of these, 28 
ecstasy-polydrug users and 35 non-ecstasy users completed the Prospective Memory 
Questionnaire (PMQ). In addition, an objective measure of cognitive failures (the 
CFQ-for-others) was completed by friends of participants. There was a main effect of 
ecstasy-polydrug use on CFQ, EMQ, CFQ-for-others, LT-PM and internally cued PM 
scores. Some of these effects were attenuated or reduced to below statistical 
significance following control for access and updating. Correlations were found 
between the different indicators of everyday memory and various measures of illicit 
drug use. Cannabis featured prominently in this respect. In addition, all ecstasy- 
related deficits were reduced to below statistical significance following control for 
cannabis use. This Chapter provides further support for cannabis related deficits in 
aspects of everyday memory functioning. Ecstasy may also be associated with 
cognitive slips, but not to the same extent as cannabis. Reduced working memory 
capacity emerged as a mediator of everyday memory deficits in ecstasy-polydrug 
users, and future research should investigate the relationship between the two in drug 
users. 
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11.2 Introduction 
This chapter assessed the relationship between slips in everyday memory and 
the updating and access executive functions in a sample of ecstasy users. Research 
suggests that ecstasy has adverse effects on human memory, but while there is 
substantial evidence of working memory impairments in users of ecstasy (See Chapter 
3), the investigation of the effects of ecstasy on more everyday aspects of memory is 
relatively neglected. Crucial aspects of everyday memory include prospective 
remembering (i. e. remembering to do a certain thing at a certain time in the future) 
and the occurrence of "cognitive slips" (e. g. slips of memory, language and attention). 
The link between reduced working memory capacity as a mediator of such deficits 
has not been investigated in ecstasy users. 
A number of laboratory studies have assessed self-reports of cognitive failures 
and prospective memory in ecstasy users. Heffernan et al (2001 a) assessed 
Prospective memory in recreational drug users. In study one, ecstasy users reported 
more prospective memory errors on the subscales of short-term habitual prospective 
memory, long-term episodic prospective memory and internally cued memory than 
non-users, although there were no group differences in strategies used to aid 
remembering. This was replicated for short-term habitual and long-term episodic 
prospective memory in study two, where ecstasy users also performed worse on an 
executive function task. It was concluded that prospective memory and executive 
function are linked, although the possible link was not directly investigated. The 
findings of study one were replicated by Heffernan et at (2001b), where ecstasy users 
reported more errors in short-term habitual, long-term episodic, and internally cued 
prospective memory (although the mean occasions of ecstasy use for this study was at 
least 10 times per month, which is atypically high). There were no group differences 
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in strategies used to remember. In a study on the World Wide Web, Rodgers et at 
(2001) assessed everyday memory and prospective memory in drug users. It was 
found that while cannabis use was associated with "here and now" memory deficits in 
short-term habitual and internally-cued prospective memory, ecstasy use was 
associated with long-term memory problems, that were more related to storage and 
retrieval problems. In a second World Wide Web study, Rodgers et al (2003) found 
that long-term prospective memory deficits were associated with ecstasy use, while 
deficits in everyday memory were associated with frequency of cannabis use. Thus it 
is possible that different recreational drugs affect human memory in distinct ways. 
Ecstasy users also reported a higher incidence of cognitive slips than nonusers (Fox et 
al, 2001), although this was not replicated by Rodgers (2000), and no differences 
between ecstasy users, cannabis users and nonusers were reported on the cognitive 
failures questionnaire by Heffernan et al (2001a). 
Although the World Wide Web is an effective way of collecting large amounts 
of data, and Rodgers et al (2001,2003) have managed to attribute specific deficits in 
everyday memory to specific drugs, it is possible that individuals visiting drug 
websites may already believe that they have a memory problem, and thus are not 
representative of the drug-using population as a whole. Therefore one aim of this 
Chapter was to assess prospective memory, everyday memory and cognitive failures 
in recreational ecstasy users in a controlled laboratory setting. 
The lack of evidence on self-reported cognitive failures and the inconsistent 
results with reference to the three subscales of the prospective memory questionnaire 
could reflect a metacognitive deficit in ecstasy users, whereby they do not realise their 
cognitive slips. Heffernan et al (2005) attempted to control for this by using a self- 
report and objective measure (video-based) prospective memory task. Ecstasy users 
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reported significantly more forgetting on the long-term prospective memory scale, 
and also recalled significantly fewer items on the video-based prospective memory 
task. However, Cohen (1996) argues that self-report questionnaires are assessed better 
by gaining an independent measure of everyday performance such as that provided by 
ratings by a third party. In the present study, this concern is addressed by the 
Cognitive Failures Questionnaire-for-others (CFQ-others), a questionnaire to be 
completed by individuals who have a significant relationship with the Cognitive 
Failure Questionnaire (CFQ) respondent. The CFQ-others provides a means of 
determining whether the self-reports of CFQ respondents are subjective, or whether 
their beliefs about their own cognitive failures are generally accurate. Broadbent et al. 
(1982) found that there was a good correlation between the judgements of CFQ 
respondents and CFQ-others respondents. The correlation suggests that individuals 
who report more cognitive slips do in fact produce more such errors. Thus the 
possibility of a metacognitive deficit in ecstasy users is investigated in this Chapter. 
The suggested relationship between central executive and prospective memory 
functioning would be in line with the finding that performance of a concurrent central 
executive task impaired performance in a laboratory-based prospective memory task 
in non drug using participants (Marsh & Hicks, 1998). As noted above, ecstasy users 
exhibit deficits on a number of executive tasks, and consequently the deficits in 
prospective memory noted above could be due to reduced executive resources, rather 
than a specific prospective memory deficit. Conversely, this may not be the case: van 
den Berg et al. (2004) found that although executive resources are involved in the 
processing of cues for remembering items, manipulating memory load had no effects 
on prospective remembering. 
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To summarise, the aim of this chapter was to assess everyday memory via 
self-reports of cognitive failures, prospective memory and everyday memory in a 
laboratory setting. In addition, a more objective measure of cognitive failures was 
included (the CFQ-others). The differential effects of recreational drugs on aspects of 
everyday memory was also investigated. As it has been suggested that there is a link 
between everyday memory and executive function, the possible mediating effects of 
executive processes on everyday memory functioning were also investigated. 
11.3 Method 
11.3.1 Design 
A multivariate design was used for the Everyday Memory Questionnaire 
(EMQ) and CFQ, with scores as the dependent variables. A univariate design was 
used for the CFQ-for-others and for the PM-strategies. A multivariate design was 
used for the PMQ, with the three subscales as the dependent measures (long-term 
episodic, short-term habitual, internally cued). In all analyses, ecstasy user/nonuser 
was the between participants variable. ANCOVA was used to assess the possible 
mediating effects of executive function (computation span, word fluency), gender, 
and strategies used to aid remembering on everyday memory. Correlations were used 
to assess the relationship between drug use variables and dependent variables. 
4.3.2 Participants 
Forty-three ecstasy-polydrug users (mean age 21.56; 24 male) and 51 nonusers 
(mean age 21.51; 17 male) completed the CFQ and EMQ. With 43 ecstasy users, the 
present sample is sufficient to detect a difference of between 0.5 and 0.75 a for a 
. 05 and ß =. 20 (Hinkle et at, 1994), As the PMQ only became available to use after 
the start of data collection, only 28 ecstasy-polydrug users and 35 nonusers completed 
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the PMQ. Data collected on the CFQ-others relied on the partners/families of 
participants returning the questionnaire; the partners/families of 26 ecstasy-polydrug 
users and 31 nonusers returned the questionnaires. With 26 or 28 ecstasy users, the 
present sample is sufficient to detect a difference of almost 0.75a for a= . 05 and ß 
=. 20 (Hinkle et al, 1994). Participants were recruited via direct approach to university 
students and the snowball technique (Solowij et al, 1992). Participants were requested 
to refrain from ecstasy use for at least 7 days and ideally 10 days prior to testing 
(mean abstinence period 8.82 weeks, median abstinence period 2 weeks). Participants 
were also requested not to use any other illicit drugs for at least 24 hours and ideally 
for 7 days prior to testing. 
4.3.3 Materials 
Patterns of drug use, sleep quality, fluid intelligence, premorbid intelligence, 
and other relevant lifestyle variables were investigated as in Chapter 6 (section 6.3.3). 
Cognitive Failures: The Cognitive Failures Questionnaire and the Cognitive 
Failures Questionnaire-for-others (Broadbent et al. 1982) were administered. The 25- 
item CFQ is argued to measure the relationship between attentional performance and 
general cognitive functioning. The questions relate to different aspects of cognitive 
functioning and failure, such as perceptual failures (e. g. do you fail to notice signposts 
on the road? ), misdirected actions (e. g. do you bump into people? ) and memory 
failures (e. g. do you forget what you came to the shops to buy? ) within the last 6 
months. The term "cognitive failure" is an umbrella term to cover all three types of 
slip. Each questionnaire item required a number (0-4 inclusive) to be circled. Four 
corresponded to "very often" and 0 to "never" (25 items in total). The direction of 
scoring for the CFQ was unidirectional, since pilot studies by Broadbent et al. (1982) 
found that reversed wording on some items only confused the participants and there 
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were no differences in a small sample using reversed wording. In the case of the CFQ- 
for-others half of the items began with "very often" and half with "never" (8 items in 
total). In the original study, Broadbent et at. use family or partners of the participant, 
but due to the nature of student populations, "housemate" has been added to the list of 
significant others in the present study. Total scores and percentage of slips reported 
were calculated to enable comparison between the two measures. 
Everyday memory: The Everyday Memory Questionnaire (EMQ, Sunderland 
et al. 1983) is a self-report measure of memory lapses in everyday activities. It 
consists of 27 statements, and in each case, participants respond on a 9-point scale 
ranging from "not at all in the last 6 months" to "more than once a day". Statements 
include: "forgetting where you put something"; "finding a television story difficult to 
follow"; a total score for everyday memory is calculated by summing the responses to 
all items. 
Prospective memory This was assessed using the Prospective Memory 
Questionnaire (PMQ), which is a reliable and valid self-report measure (Hannon et 
al., 1995). The PMQ provides measures of three aspects of PM on a scale of 1-9 for 
each scale. Fourteen questions measure short-term habitual PM, e. g. "I forgot to turn 
my alarm clock off when I got up this morning". Fourteen items measure long-term 
episodic PM, e. g. "I forgot to pass on a message to someone". Ten questions measure 
internally cued PM, e. g. "I forgot what I wanted to say in the middle of a sentence". 
In addition, 14 questions make up the "techniques to remember" scale, which 
provides a measure of the number of strategies used to aid remembering. Responses 
on the three PM scales range from 1 (little forgetting) to 9 (great deal of forgetting), 
and for the strategies scale from 1 (few strategies) to 9 (many strategies). For each of 
the 4 scales, a total score is calculated by summing the responses in each section, and 
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dividing by the number of items in that section (14 for ST-habitual, LT-episodic and 
strategies, 10 for internally cued). Thus scores on all 4 scales ranged from 1-9 with 
high scores being indicative of much forgetting, and many strategies used to aid 
remembering. 
Computation Span was the same as was used in Chapter 8. 
Word Fluency was the same as used in Chapter 817. 
11.3.4 Procedure 
Participants were informed of the general purpose of the experiment, and 
written informed consent was obtained. The tasks were administered under laboratory 
conditions, and a computer running MS-DOS was used for the computation span task. 
The tests were administered in the following order: background questionnaire, sleep 
quality questionnaires, NART, CFQ, EMQ, PMQ, word fluency, computation span, 
and Raven's progressive matrices. Participants were given the CFQ-for-others and 
asked to get someone that had a day-to-day experience with them to fill it in. The 
CFQ respondents were requested not to discuss the responses that they had made prior 
to completion of the CFQ-for-others. The CFQ-for-others was returned via post in a 
pre-paid envelope. Participants were fully debriefed, paid £15 in store vouchers, and 
given drugs education leaflets. The study was approved by the Ethics Committee of 
Liverpool John Moores University, and was administered in accordance with the 
ethical guidelines of the British Psychological Society. 
11.5 Results 
The scores for background measures are set out in Table 11.1. t"test revealed 
that there were no significant differences between the groups in age, self-rated health, 
" Completed by 28 ecstasy users and 38 nonusers 
239 
random letter generation, fluid intelligence, pre-morbid intelligence, years of 
education, subjective daytime sleepiness, or average hours of sleep per night. Ecstasy- 
polydrug users did however report consuming significantly more units of alcohol per 
week, t(76.99) = 3.60, p<. 001 (as Levene's test was significant, degrees of freedom 
have been adjusted accordingly). Ecstasy-polydrug users also attained a lower level 
on the computation span task, indicating reduced working memory capacity, t(92) =- 
3.45, p<. 001, and also a lower level on the Chicago Word Fluency Task, t(65) = 2.69; 
3.42, p<. O1 and p<. 001 for "S" and "C" letter fluency respectively. 
Table 11.1: Mean age, intelligence scores and other background variables 
Ecstasy 
Users 
Mean S. D. 
Nonusers 
Mean S. D. 
Age 21.56 1.68 21.51 1.79 
Units of Alcohol/week 23.62 15.69 13.11 11.71 
Self-Rated Health 3.60 0.76 3.84 0.92 
Sleep (Hours/night) 8.02 1.47 7.99 1.32 
Epworth Sleepiness Scale 6.26 3.25 5.57 2.59 
Years of Education 15.95 1.57 15.94 1.76 
Raven's Matrices (Max. 60) 48.84 5.93 48.22 5.30 
NART (max. 50) 28.95 6.91 30.27 5.74 
Computation Span 3.60 1.61 4.71 1.49 
Semantic Fluency 39.96 9.46 42.49 10.18 
"S" Letter Fluency 40.00 10.70 46.79 9.85 
"C" letter Fluency 11.32 5.34 16.31 6.24 
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The scores for everyday memory measures are set out in Table 11.2. 
CFO and EMO: Table 11.2 shows that ecstasy-polydrug users scored higher than 
nonusers on the CFQ and EMQ, indicating a higher incidence of self-reported 
everyday memory and cognitive failure slips. There was a main effect of ecstasy- 
polydrug use on these measures, F(2,88) = 4.61, p<. 05 for Pillai's Trace. Separate 
univariate analyses revealed that ecstasy-polydrug users scored significantly higher on 
both the EMQ and CFQ, F(1,89) = 9.02; 6.05, p<. O1 and p<. 05 respectively. 
Table 2: Mean Scores on Everyday Memory Measures 
Ecstasy 
Users 
Nonusers 
Mean S. D. Mean S. D. 
Everyday Memory Questionnaire 97.24 35.34 77.28 28.07 
Cognitive Failures Questionnaire 46.95 15.28 39.68 12.93 
Cognitive Failures-Others 14.65 6.44 10.71 3.63 
PM- Long-Term Episodic 3.06 1.52 2.52 0.76 
PM- Short-Term Habitual 1.26 0.32 1.19 0.32 
PM- Internally cued 2.92 1.25 2.30 0.76 
PM- Strategies 3.29 1.65 2.84 1.41 
CFQ-Percentage of Slips Reported 45.42 16.66 38.58 10.29 
CFQ-others: Percentage of Slips Reported 45.79 20.14 33.47 11.36 
CFO-for-others: The relatives/significant others reported more cognitive slips among 
ecstasy-polydrug users than nonusers (means of 14.65 and 10.71 respectively). 
Univariate ANOVA revealed that this difference was significant, F(1,55) = 8.44, 
p<. 01. 
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PM O: Table 11.2 shows that ecstasy-polydrug users scored slightly higher than 
nonusers on the four subscales of the PMQ. The three memory measures (long-term 
episodic, short-term habitual and internally cued prospective memory) were 
incorporated into MANOVA. The main effect of ecstasy-polydrug use was non- 
significant, F(3,59) = 2.00, p>. 05, as was the univariate ecstasy-related difference in 
short-term habitual PM, F(1,61) = 0.61, p>. 05. Ecstasy-polydrug related deficits in 
long-term and internally cued PM were significant, F(1,61) = 3.32, p<. 05 one-tailed, 
and F(1,61) = 5.82, p<. 05 respectively. Univariate ANOVA revealed that ecstasy 
users did not use significantly more strategies to remember than nonusers, F(1,61) _ 
1.35, p>. 05. 
Interaction between CFQ and CFQ-for-others: To assess whether users' own 
perceptions of cognitive failures were similar in magnitude to the equivalent 
judgements produced by others, the CFQ and CFQ-for-others responses were 
compared for users and non users. The percentage of slips reported for each scale was 
calculated and analysed using a mixed design, with one within participants factor for 
"cognitive failures", (with two levels, self-report versus others), and ecstasy-polydrug 
user group between participants. Mean percentages of self-reported slips and other- 
reported slips were similar for each group (indicating that ecstasy users were self- 
aware of their cognitive failures). This was supported by a main effect of ecstasy use, 
F(1,55) = 9.20, p<. 01. The interaction between cognitive failures and having used 
ecstasy was however non-significant indicating that ecstasy users were aware of their 
cognitive slips F(1,55) = 1.36, p>. 05. 
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Covariate Analyses 
Units of alcohol consumed in a week and gender composition were 
significantly different between the groups, thus these were incorporated into 
ANCOVA to control for the contribution of these factors to memory deficits. 
EMO and CFO: After controlling for gender, the main effect of ecstasy use remained 
significant, F(2,87) = 5.07, p<. 01, as did the univariate analyses, F(1,88) = 9.18; 8.05, 
p<. 005 and p<. O1 for EMQ and CFQ respectively. Following control for units of 
alcohol used in a week, the main effect of ecstasy use remained significant, F(2,85) = 
5.00, p<. 01. Ecstasy-related differences in EMQ and CFQ scores were intensified 
after controlling for alcohol use, F(1,86) = 9.65; 6.95, p<. 01 in both cases. 
CFO-for-others: After controlling for gender, the main effect of ecstasy use remained 
significant, F(1,54) = 8.23, p<. 01, and also after control for units of alcohol consumed 
in a week, F(1,52) = 9.02, p<. 01. 
PMQ: After controlling for gender, the main effect of ecstasy remained non- 
significant, F(3,58) = 2.15, p>. 05, as did differences in short-term PM (RI). The 
ecstasy-related differences in long-term PM and Internally cued PM remained 
significant after control for gender, F(1,60) = 3.26, p<. 05 one tailed and F(1,60) 
6.37, p<. 05 respectively. After controlling for average units of alcohol consumed in a 
week, the main effect of ecstasy use remained non-significant, F(3,37) = 1.12, p>. 05, 
as did differences in short-term PM (F<1). Ecstasy-related differences in long-term 
PM were reduced to below statistical significance after control for alcohol use. Again, 
although slightly attenuated the ecstasy-related differences in internally cued PM 
remained significant after control for alcohol use, F(1,59) = 3.31, p<. 0S one-tailed. 
As it was also possible that strategies used to remember may have mediated 
the nurpber of prospective memory slips (more strategies used may decrease the 
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number of slips), this was incorporated into ANCOVA. The main effect of ecstasy use 
remained non-significant, F(3,58) = 1.71, p>. 05, as did short-term PM (F<1). Ecstasy- 
related differences in long-term PM were reduced to below statistical significance 
following control for strategies used to remember. After control for strategies used to 
remember, ecstasy-related differences in internally cued PM remained significant, 
F(1,60) = 5.08, p<. 05. 
Homogeneity of regression was obtained with respect to all covariates in this 
block, p>. 05 for the group by covariate interaction. 
Everyday Memory and Executive Function 
One aim of this Chapter was to assess the possible mediating role of updating 
and access on deficits in prospective and everyday memory. Therefore, computation 
span and word fluency were also controlled for. 
EMO and CFO: After controlling for updating the main effect of ecstasy use 
remained significant, F(2,87) = 3.20, p<. 05. Although slightly attenuated, the ecstasy- 
related deficits in EMQ remained significant, F(1,88) = 6.45, p<. 05, although group 
differences in CFQ scores now only approached significance F(1,88) = 3.35, p= 
0.071. After control for access, the main effect of ecstasy use remained significant 
F(2,60) = 3.52, p<. 05. For the univariate analyses, the opposite pattern of results 
emerged compared to control for updating: ecstasy-related differences in EMQ scores 
were reduced to below statistical significance F(1,61) = 3.26, p=0.076, while 
differences in CFQ scores were intensified F(1,61) = 7.16, p<. 01. Homogeneity of 
regression was obtained, p>. 05 for the group by covariate interaction. 
CFO-for-others: The main effect of ecstasy use also remained significant after control 
for updating, F(1,54) = 5.42, p<. 05 and access F(1,34) = 4.89, p<. 05. Homogeneity of 
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regression was achieved with respect to access (F<1), but not computation span, so 
this result should be treated with some caution. 
Prospective Memory: After controlling for updating the main effect of ecstasy 
remained non-significant, F(3,58) = 1.62, p>. 05, as did differences in short-term PM 
(F<1). The ecstasy-related differences in long-term PM were reduced to below 
statistical significance after control for updating F(1,60) = 2.25. p>. 05, although 
ecstasy-related differences in internally cued PM proved more robust and remained 
significant after control for updating, F(1,60) = 4.74, p<. 05. A similar pattern of 
results emerged after control for access; the main effect of ecstasy use on PM 
remained non-significant F(3,55) = 2.26, p>. 05, as did differences in short-term PM 
(F<1). Group differences in long-term PM were reduced to below statistical 
significance following control for access F(1,57) = 2.12, p>. 05; differences in 
internally-cued PM remained significant, F(1,57) = 5.39, p<. 05. Homogeneity of 
regression was obtained with respect to these covariates, p>. 05 for the group by 
covariate interaction. 
Results of the preceding analyses are summarised in Table 11.3. 
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Indices of Drug Use 
Inspection of Table 11.4 reveals that while the use of other drugs among the 
ecstasy-polydrug users was commonplace, among the nonusers, it was limited mainly 
to the use of cannabis. The ecstasy-polydrug users had a lifetime dose of cannabis 
more than three times that of the non-users (4088 joints to 1228 joints), in addition to 
using it more frequently (2.90 times a week, compared to 0.84 times a week), having 
smoked more in the last 30 days (48.25 joints compared to 8.26 joints), and having a 
larger average weekly dose (13.91 joints compared to 5.84 joints). In relation to the 
cannabis measures, t-test revealed that all of the group difference were statistically 
significant t(36.75) = 2.74, p<. 01 for total lifetime dose; t(39.21) = 3.93, p<. 01 for 
frequency of use; t(30.93) = 2.80, p<. 01 for amount used in the last 30 days; and 
t(45.89) = 2.14, p<. 05 for average dose (As Levene's test was significant, degrees of 
freedom have been adjusted accordingly). 
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Table 11.4: Indicators of Drug Use Among Ecstasy Users and Non Ecstasy Users 
Ecstasy Non Ecstasy 
Users Users 
Total Use 
Ecstasy (Tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Frequency of Use (times 
per week) 
Ecstasy 
Amphetamine 
Cannabis 
Cocaine 
Amount Used During 
Previous 30 Days 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Average Weekly Dose 
Ecstasy (tablets) 
Amphetamine (grams) 
Cannabis (joints) 
Cocaine (grams) 
Number Ever Used 
Amphetamine 
Cannabis 
Cocaine 
Mean S. D. n Mean S. D. N 
346.50 379.32 43 
77.29 172.74 12 
4087.89 5484.74 31 
37.83 61.96 20 
0.45 0.38 41 
0.09 0.11 4 
2.90 2.70 31 
0.54 0.48 20 
4.67 6.45 42 
1.20 2.68 5 
48.25 77.02 30 
2.54 2.38 18 
2.31 3.04 43 
0.39 0.54 10 
13.91 16.08 30 
0.34 0.43 20 
21 -- 
40 -- 
34 -- 
4 
1277.76 
1 
1453.19 18 
0.84 0.85 18 
8.26 10.65 17 
1 0.09 1 
5.84 10.03 18 
2-- 
26 -- 
5-- 
Correlations with Indices of Drug Use. 
Due to the small number of illicit drug users among the non ecstasy-polydrug 
user group it was not possible to control statistically for the effects of other drugs 
through the use of ANCOVA. Therefore it is possible that some or all of the ecstasy- 
related effects might have been attributable to the effects of other drugs. To address 
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this possibility, correlations were performed with different measures of ecstasy, 
amphetamine, cannabis and cocaine use. Measures of drug use were included as in 
Chapter 618. 
A partial Bonferroni correction was applied as in Chapter 6. The results, set 
out in Table 11.5, show that ecstasy use was significantly correlated with a number of 
the performance measures. Having ever used ecstasy was significantly correlated with 
EMQ, CFQ, and CFQ-for-others scores, while total lifetime dose of ecstasy was 
significantly correlated with CFQ-for-others scores. Average weekly ecstasy dose was 
also significantly correlated with EMQ, CFQ and PM-internally cued scores. 
In relation to other drugs, cannabis appears to be an especially important 
predictor of everyday memory deficits. Indeed, being a cannabis user, total lifetime 
dose of cannabis, and average weekly dose of cannabis were significantly correlated 
with all measures of everyday memory (at p<. 0l). Frequency of cannabis use was 
significantly correlated with EMQ, CFQ, CFQ-for-others, PM-internally cued and 
PM-strategies scores, while amount used in the last 30 days was significantly 
correlated with PM-internally cued. Ever having used cocaine was significantly 
correlated with CFQ-for others and PM-internally cued scores. Indices of 
amphetamine use were also significantly correlated with memory scores; Ever having 
used amphetamine with CFQ, CFQ-for-others and PM-internally cued, total lifetime 
dose with CFQ and CFQ-for-others scores and average dose with CFQ scores. 
The focus of this Chapter was intended to be ecstasy use, but given the 
strength of correlations with cannabis use rather than ecstasy, main analyses were 
repeated with having ever used cannabis as the sole independent variable. This 
enabled us to compare effect sizes for the ecstasy and cannabis analyses. 
18 Those in the nonuser group who had used amphetamine and cocaine (n=2 and 5) felt unable to 
accurately estimate patterns of use. 
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Cannabis, EMO and CFQ (63 cannabis users, 28 nonusers): There was a main effect 
of cannabis use, F(2,88) = 8.47, p<. 001 on EMQ and CFQ (with a partial Eta squared 
of 0.161 compared to 0.095 for ecstasy use). This was owing to cannabis users 
scoring higher on both the EMQ, F(1,89) = 10.19, p<. O1 and the CFQ, F(1,89) _ 
16.75, p<. 001. With respect to effects sizes, those for cannabis were larger for both 
the EMQ (partial Eta squared of 0.103 compared to 0.092) and CFQ (partial Eta 
squared of 0.158 compared to 0.064) scores. 
Cannabis and CFQ-for-others (40 cannabis user, 17 nonusers): Again, there was a 
significant main effect of cannabis use, F(1,55) = 7.15, p<. 01, although in this case 
effect sizes were larger for ecstasy than for cannabis use (partial Eta squared of 0.115 
for cannabis and 0.133 for ecstasy). 
Cannabis and Prospective Memory (44 cannabis users, 19 nonusers): There was a 
significant main effect of cannabis use, F(3,59) = 5.89, p<. 001, and once again the 
effect size was larger for cannabis use than for ecstasy use (partial Eta squared of 
0.230 compared to 0.092). Cannabis users also scored significantly higher on the three 
memory scales of the PMQ: F(1,161) = 7.98, p<. 01 for LT episodic; 8.63, p<. O1 for 
ST habitual; and 12.30, p<. 001 for internally cued PM. Effect sizes for the three 
scales were larger for cannabis than for ecstasy in all cases (partial Eta squared of 
0.116,0.124,0.168 compared to 0.052,0.010,0.087). Contrary to expectations, the 
cannabis users also used significantly more strategies to aid remembering, F(1,61) = 
14.46, p<. 001 with a larger effect size for cannabis than for ecstasy (partial Eta 
squared of 0.192 compared to 0.022). ANCOVA to control for differences in the 
strategies scale slightly attenuated the main effect, F(3,58) = 3.87, p<. 05. Although 
somewhat attenuated, the differences in PMQ subscales remained significant, F(1,60) 
250 
= 3.42, p<. 05 (one-tailed) for LT episodic; 3.26, p<. 05 (one-tailed) for ST habitual; 
and 10.60, p<. O1 for internally cued PM. 
Cannabis and CFO/CFO-for-others interaction (40 cannabis users and 17 nonusers): 
As with ecstasy use, the interaction between the CFQ and CFQ-for-others was non- 
significant, F(1,55) = 0.56, p>. 05. 
Cannabis Everyday Memory and Executive Function: As with ecstasy use, all main 
effects for cannabis were attenuated after control for updating. However, most 
cannabis-related group differences remained statistically significant with the 
exception of the CFQ-for-others which was reduced to below statistical significance, 
p>. 05. The multivariate main effect on PM scales was reduced to F(3,58) = 4.77, 
p<. 01; with the univariate effect in the LT episodic, ST habitual and internally cued 
subscales being reduced to F(1,60) = 6.08; 6.29; 10.78, p<05,. 05 and . 01 
respectively. Strategies used to remember was reduced to F(1,60) = 11.31, p<. 001. 
The multivariate main effect on EMQ and CFQ was reduced to F(2,87) = 5.79, p<. 01; 
with EMQ and CFQ being reduced to F(1,88) = 7.00; 11.43, p<. 01 and . 001 
respectively. With reference to access, the multivariate main effect on PM scales was 
reduced to F(3,55) = 4.68, p<. 01; with LT episodic, ST habitual and internally cued 
subscales being reduced to F(1,57) = 5.39; 6.02; 11.27, p<. 05, . 
05 and . 001 
respectively. Strategies used to remember was reduced to F(1,57) = 13.15, p<. 001. 
The main effect on EMQ and CFQ was reduced to F(2,60) = 6.87, p<. 01; with EMQ 
and CFQ being reduced to F(1,61) = 6.29; 13.97, p<. 05 and . 001 respectively. 
So to summarise, cannabis appears to be a more important predictor of 
everyday memory deficits than ecstasy use, although on one scale (the CFQ-for- 
others) ecstasy emerged as a more significant predictor. 
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Table 11.4: Correlations With Indices of Drug Use 
Ecstasy Cannabis Cocaine Amphetamine 
Ever Used 
EMQ -. 283* -. 328* -. 165 -. 159 
CFQ -. 272* -. 380* -. 170 -. 225* 
CFQ-others -. 333* -. 329' -. 441* -. 515* 
PM-LT episodic -. 159 -. 368* -. 142 -. 158 
PM-ST habitual -. 111 -. 394* -. 190 -. 186 
PM-internally cued -. 276 -. 465* -. 307* -. 323* 
PM-strategies -. 130 -. 479* -. 013 -. 076 
Total Lifetime Use 
EMQ . 242 . 
305* . 202 . 214 
CFQ . 215 . 
361* . 158 . 267* 
CFQ-others . 312* . 
440* . 329 . 389* 
PM-LT episodic . 116 . 
416* . 122 . 201 
PM-ST habitual . 065 . 
366* . 304 . 097 
PM-internally cued . 224 . 
515* . 258 . 330 
PM-strategies . 053 . 
452* -. 017 . 072 
Frequency of Use 
EMQ . 213 . 
291* . 213 . 026 
CFQ . 194 . 
335* . 182 . 197 
CFQ-others . 224 . 
467* . 298 . 001 
PM-LT episodic . 093 . 
301 . 047 . 295 
PM-ST habitual . 034 . 161 . 182 -. 112 
PM-internally cued . 251 . 424* . 243 . 199 
PM-strategies . 071 . 346* . 027 -. 011 
Use in Last 30 days 
EMQ . 139 . 197 . 061 . 120 
CFQ . 034 . 165 . 015 . 064 
CFQ-others . 105 . 301 . 044 - 
PM-LT episodic . 045 . 213 -. 051 . 161 PM-ST habitual . 004 . 
068 . 034 -. 116 
PM-internally cued . 153 . 
380* 
. 095 . 077 PM-strategies -. 008 . 208 -. 169 -. 154 
Average Dose 
EMQ . 279* . 314* . 222 . 195 CFQ . 277* . 358* . 185 . 264* CFQ-others . 252 . 441 * . 348 . 326 
PM-LT episodic . 166 . 418* . 127 . 145 PM-ST habitual . 095 . 329* . 312 . 151 PM-internally cued . 297* . 486* . 261 . 280 PM-strategies . 111 . 452* . 009 . 111 
* Correlation significant at p<. 01, one-tailed 
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The results also suggest that aspects of executive functioning (access and 
updating) are important factors in everyday memory slips in both ecstasy and 
cannabis users. 
Implications of Chapter 11 
In this chapter ecstasy-polydrug users performed significantly worse than 
nonusers on a number of everyday memory measures, and on measures of updating 
and access to long-term memory: the CFQ, EMQ, two subscales of the PMQ (long- 
term episodic and internally cued PM), computation span and the Chicago Word 
Fluency Test. Compared to non-ecstasy users, ecstasy-polydrug users were also rated 
significantly worse by friends on the CFQ-for-others scale. The interaction between 
CFQ and CFQ-for-others scores and ecstasy-polydrug use was non-significant, 
indicating that ecstasy users are as aware of their cognitive slips as non-ecstasy users. 
However, cannabis emerged as a more significant predictor than ecstasy use on all 
everyday memory measures used, and effect sizes for all analyses incorporating 
having ever used cannabis as the sole IV were larger for cannabis use than for ecstasy 
use (except for the CFQ-for-others). Taken as a whole, the results of this chapter 
suggest that slips in everyday memory are more related to cannabis use than ecstasy 
use. In all analyses, the updating and access deficits observed in Chapter 6 were 
important predictors of performance, attenuating all significant results. The results 
and implications of Chapters 6-11 are discussed in detail in the following Chapter. 
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Chapter 12 General Discussion 
The aim of this thesis was to examine the separability of four executive functions 
(with reference recent theoretical models of executive functioning, Fisk & Sharp 2004; 
Miyake et al. 2000) in recreational ecstasy users, and to ascertain the contributions of 
these executive processes to performance of other cognitive functions (namely reasoning, 
associative learning and lapses in everyday memory). To summarise the results briefly 
ecstasy users exhibited impairments in tasks that tap the updating executive component 
process (letter updating - Chapter 6; Computation span - Chapters 8,9,11) and also 
access to long-term memory (Chicago Word Fluency Test - Chapter 8). No between 
group differences were observed in task switching (plus-minus task and number-letter 
task - Chapter 7), and the ecstasy users actually performed better than nonusers on a task 
of response inhibition by giving more letters (random letter generation - Chapter 7). 
Three chapters also assessed the contribution of executive processes to reasoning, 
associative learning, and everyday memory deficits in ecstasy users. While associative 
learning (verbal paired associates task - Chapter 10) deficits in ecstasy users were not 
mediated by reduced working memory capacity, the same was not true for syllogistic 
reasoning and everyday memory. Ecstasy-related group differences in syllogistic 
reasoning performance were reduced to below statistical significance following control 
for working memory updating, but not access. The occurrence of everyday memory slips 
was related to the use of cannabis rather than ecstasy use, and once again, deficits were 
attenuated following control for working memory updating and not access, This thesis is 
the first, to the author's knowledge, to study the separability of four executive processes 
in a sample of recreational ecstasy users. 
The first section of the discussion will focus on the results of Chapters 6,7, and 8 
i. e. the four specific executive functions. It was expected that ecstasy users would exhibit 
deficits on the letter updating task and the access tasks, but given previous research we 
were unsure if the same would be true for the switching and inhibition tasks. Chapter 6 
showed that ecstasy users were impaired on a pure measure of memory updating. The 
mean scores showed that ecstasy users recalled fewer correct letters at all four list 
lengths, although contrary to expectations the list length by user group interaction was 
non significant indicating that ecstasy users did not perform worse at the longer list 
lengths as originally predicted. There was however a main effect of ecstasy use on chain 
length 8 and 10 letters. Focusing initially on the list length analysis, bivariate correlations 
revealed a clear dissociation between the effects of ecstasy, cannabis and cocaine on 
aspects of letter updating with indices of ecstasy use being related to performance on list 
length 10, cannabis with list length 8, and cocaine with list length 6. Indeed all ecstasy 
use variables (with the exception of amount used in the last 30 days) were significantly 
correlated with updating at list length 10, all cannabis use variables (with the exception of 
amount used in the last 30 days) with updating at list length 8, and two cocaine use 
variables (amount used in the last 30 days, total lifetime dose) with updating at list length 
6. These effects were quite robust for each drug and only one drug was significantly 
correlated with each aspect. What may the reason be for this dissociation? One reason (as 
mentioned in the introduction to Chapter 6) is the possibility that this reflects a difference 
in strategies adopted to update the contents of working memory. Research on running 
memory and serial position of updated items suggests that many participants do not adopt 
an updating strategy, relying instead on a phonological recency strategy. Ruiz et al. 
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(2005) analysed serial position data from a letter-updating task and found a clear recency 
effect. Moreover, the recency effect increased sharply with increasing list length 
indicating that a recency strategy was more likely to be adopted for the longer list 
lengths. 
In terms of the results of Chapter 6 this has a few possible interpretations. One 
such interpretation is that while deficits in the shorter list lengths (6 and 8 items) may 
reflect a genuine updating deficit, deficits in longer list lengths (10 and 12 items) may be 
related to impairments in recency strategies. In Chapter 6 correlations revealed that while 
chain length 6 and 8 performance were related to indices of cocaine and cannabis use 
respectively, chain length 10 performance was related to indices of ecstasy use. As 
mentioned above Ruiz et al. (2005) found that the use of recency strategies increased with 
increasing list length, which raises the possibility that while the use of cannabis may 
impair memory updating, and cocaine may impair performance on span measures, the use 
of ecstasy impairs effective utilisation of recency strategies which are related to rehearsal 
and in the case of verbal information (as in Chapter 6) the phonological loop (although if 
this were the case, it would be expected that ecstasy users would be impaired in simple 
span tasks. Such deficits are not typically observed). This would be in line with studies 
reporting verbal working memory deficits in ecstasy users (e. g. Parrott et at. 1998; 
Thomasius et al. 2003). This poses the question as to why ecstasy users in particular may 
be impaired in this aspect of memory. All participants were instructed to use an updating 
strategy as per Morris and Jones' (1990) procedure: "dropping the "oldest" item and 
adding the most recent to the string" (page 113). As it was particularly ecstasy use that 
was related to chain length 10 performance (which is supposedly more likely to recruit a 
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recency strategy) it may be that ecstasy users were either unable to follow the updating 
instructions adequately, or found the procedure too difficult to follow. Although 
admittedly this is a tenuous link, previous research in ecstasy users provides some 
support. For example, Rodgers et al. (2001) showed that errors made while completing a 
questionnaire were predicted by ecstasy use (not cannabis) indicating that the ecstasy 
users were unable to follow the instructions adequately. Similarly, Fox et al. (2002) found 
that ecstasy users performed worse on more difficult aspects of some tasks indicating that 
they found these parts harder than the nonusers did. 
If all users of ecstasy adopted an updating strategy (and we have no reason to 
believe that they did not) then there are a number of inferences that can be made. As 
cocaine use was associated with performance at 6 items, cannabis at 8 items and ecstasy 
at 10 items, it may be that cannabis use gives rise to impairment in memory updating 
prior to ecstasy use. However we cannot rule out the possibility that the significant 
correlations are a function of polydrug use with drug use in general being associated with 
deficits. More research is needed to ascertain the precise nature of memory updating in 
each group of drug users. If Ruiz's account of updating memory is to be followed then it 
is possible that no participants adopted an updating strategy and while cocaine mildly 
impairs phonological rehearsal, and cannabis moderately impairs rehearsal, the use of 
ecstasy has severe effects on rehearsal. Ruiz et al. maintain that their pattern of results 
from letter and word updating tasks indicate that participants do not generally adopt an 
updating strategy even when instructed to do so. Furthermore when list length is 
uncertain as in Chapter 6, it has been postulated that no updating may occur at all. 
Hockey and co-workers (Hamilton & Hockey 1974; Hockey 1973) postulate that 
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updating strategies cannot be started retrospectively. In the case of the'running memory 
task used in this thesis, the cue for a participant to start updating is the appearance of a 
new item (letter) on the screen after the sixth item has been presented. Thus the updating 
would have to be self-initiated retrospectively after presentation of letter 7. However it 
does not necessarily follow that individuals would wait until their span was reached to 
initiate updating. As most of the sequences in the updating task used in this thesis require 
updating, the participants is likely to approach the test with the expectation that updating 
will be required rather than initiating the process retrospectively. However, this 
interpretation would depend on Ruiz's account of memory updating and recency being 
accurate; Baddeley and Hitch (1993) maintain that recency is a phenomenon of short- 
term memory which would suggest that the executive process of updating would not be 
subject to recency effects. 
Although the preceding two paragraphs suggest that aspects of ecstasy use may 
not be associated with updating function deficits at shorter sequence lengths, Chapters 8, 
9 and 11 found that ecstasy users performed worse than nonusers on the computation 
span task, an established measure of memory updating (Fisk & Sharp 2004; Miyake et al. 
2000). While this implies that ecstasy users are impaired in memory updating, the results 
of Chapter 6 may reflect the relative difficulty of the letter-updating task. All participants 
were required to remember the last 6 letters of each chain, regardless of their letter span, 
and after control for letter span the main effect of ecstasy use on memory updating was 
reduced to below statistical significance. Nevertheless ecstasy-related differences in chain 
length 8 and 10 updating remained significant after control for letter span suggesting that 
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simple span was not an important factor in ecstasy-related performance decrements on 
this task. 
To summarise, it appears that ecstasy users are impaired on a memory-updating 
task either due to inappropriate strategy use, inability to follow instructions, or a genuine 
updating function deficit. 
Moving the focus to task switching, mean scores showed that ecstasy users and 
nonusers had similar switch costs on the plus-minus and number-letter tasks. This was 
reflected by non-significant multivariate and univariate analyses. It was predicted in 
Chapter 7 that users and nonusers would perform comparably on these tasks, inline with 
previous research (e. g. McCardle et al. 2004). Two established tasks were used to assess 
task switching. The plus-minus task is a key indicator of Miyake et al's conceptual 
framework and requires participants to switch between adding 3 and subtracting 3 from a 
list of two digit numbers. It has been suggested that ecstasy users may have exhibited 
deficits in arithmetic processing rather than a deficit in task switching: Wareing et al. 
(2004b) found that ecstasy users were impaired on the computation span task but not the 
reading span task. However no between group differences were observed on the plus 
minus task in Chapter 7. This could mean one of two things. Firstly, it could be that 
ecstasy users are not actually impaired in arithmetic processing or task switching, and 
therefore the results of Chapters 8,9, and 11 reflect an actual working memory updating 
deficit indexed by lower computation span scores. This is quite plausible considering that 
Chapter 6 revealed that ecstasy users were impaired on a memory-updating task that did 
not require arithmetic processing. Secondly, the plus-minus task may not recruit 
executive switching resources to the extent that an ecstasy-related deficit would be 
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evident i. e. the function of adding/subtracting three from a two digit number is not 
cognitively demanding enough. Previous research also supports this proposal. In a more 
complex serial add and subtract task that additionally required participants to identify the 
least significant digit (lowest number) of an arithmetic problem, and if negative add 10 to 
it, McCann et al. (1999) found that ecstasy users performed worse than nonusers. Fox et 
al. (2002) also found that on the 3D-IDED switching task, the user group by task 
difficulty interaction approached significance indicating that the ecstasy users performed 
worse on the more difficult task switches. 
The number-letter task requires participants to switch between making letter 
judgements (is the letter a vowel or a consonant? ) and number judgements (is the number 
odd or even? ) and is also a key indicator of Miyake et al's conceptualisation of executive 
processes. As with the plus-minus task, ecstasy users and nonusers performed 
comparably. This task incorporates both numerical and verbal components and hence 
provides further support for the absence of specific numerical processing deficits in 
ecstasy users. Both switching tasks required mental set switches to be internally driven. 
Research has shown that switch cost latencies are higher when switches are internally 
driven as opposed to when they are cued. For example using the plus-minus task Spector 
and Biederman (1976) found that switch costs were high when participants had to 
generate switches internally, but when cues were given (e. g. 51 + 3,76 - 3) switch costs 
were reduced. It is possible that inline with the data in Chapter 7, both the ecstasy users 
and nonusers found it equally difficult to generate internal set switches as both groups 
had similar switch cost latencies. 
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In Chapter 7, subsequent stimuli were presented immediately after the previous 
one had been responded to (in the plus-minus task, all stimuli were printed in a list, and in 
the number-letter task stimuli appeared on a computer screen immediately after response 
to the preceding stimulus). Rogers and Monsell (1995) suggest that in the task-switching 
paradigm, more time is needed for participants to reconfigure task set. In their study 
Rogers and Monsell found that when response-stimulus latency was increased, the switch 
cost latency dissipated somewhat (although importantly a large amount of switch cost 
latency, the "residual switch cost", did not dissipate). It may also be that if longer time 
was allowed before presentation of the next stimulus in the present study, the residual 
switch cost would become apparent as task difficulty for both groups had been reduced. 
Previous research in ecstasy users has shown that ecstasy users give more perseverations 
on the Wisconsin Card Sort Task (e. g. Alting von Geusau et al. 2004; Thomasius et al. 
2003), which can also be interpreted as an inability to reconfigure task set before 
responding to subsequent stimuli. 
Contrary to the results of Chapter 7, Chapter 10 found that ecstasy users gave 
more perseverative responses on an associative learning task indicating an inability to 
reconfigure task set as in Alting von Geusau et al. (2004) and Thomasius et al. (2003). 
Verdejo-Garcia et al. (2005) provided support for the proposal that recreational drugs 
differentially affect aspects of executive functioning, with cannabis use being related to 
task switching (termed "cognitive flexibility" in Verdejo-Garcia's study). In agreement 
with the separable effects of drugs on switching, Morgan et al. (2002) found that although 
ecstasy users performed worse on the TMT-B task, performance was more related to the 
use of LSD and Psilocybin mushrooms. The ecstasy users in this thesis did not report 
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frequent use of psilocybin or mushrooms, although they did report use of cannabis, 
cocaine and amphetamine. Unlike Morgan's study no indices of drug use were 
significantly correlated with switch cost latencies on either task, somewhat curious 
considering previous research. Perseverative errors on the associative learning task 
(Chapter 10) were related to indices of ecstasy and cocaine use. In view of this it is 
possible that deficits in task switching in the present sample are related to ecstasy and/or 
cocaine use. With the exception of the categorical cocaine user/nonuser variable, 
correlations with perseverative errors were generally higher for ecstasy use than for 
cocaine use, although all cocaine users on whom these analyses were based were also 
ecstasy users. Thus perseverative responses in ecstasy users may be related to some 
aspect of ecstasy-cocaine polydrug use. 
To summarise, this thesis found that ecstasy users did not display longer switch 
cost latencies on two switching tasks, although they did give more perseverative errors on 
an associative learning task. 
Moving on to the next target function of response inhibition, it was predicted that 
ecstasy users would perform comparably to nonusers. A random letter generation task 
was used in which participants had to generate 100 letters at three production rates, one 
letter every 4-seconds, 2-seconds, and 1-second. Contrary to expectations there was a 
main effect of ecstasy use on inhibition due to the ecstasy users generating more letters 
than nonusers. There were no group differences on the alphabetical sequences, repeat 
sequences or redundancy scores indicating that ecstasy users were not impaired in these 
aspects of random letter generation. In an early study by Wareing et al. (2000) in which 
participants were instructed only to generate consonants, the ecstasy users performed 
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worse than nonusers on this task. However Fisk et at. (2004) found that ecstasy users did 
not perform worse than nonusers on this task when required (as in Chapter 7) to select 
any letter from the alphabet (vowels and consonants). The lack of consensus between 
these two studies may reflect the increased task difficulty of constraints in the consonant 
only generation and the much larger lifetime ecstasy dose in Wareing et al's study. While 
it is likely that these three measures on which no deficits were found load solely on the 
inhibition component (Fisk & Sharp, 2005), this may not be the case for number of letters 
generated. The surplus evident on the number of letters produced may reflect increased 
impulsivity on the part of the ecstasy users: while nonusers try and concentrate on using 
the correct generation strategies, ecstasy users try and concentrate on using non-random 
strategies such as spelling out words (which would not show up in performance 
measures) to try and attain the maximum possible. As mentioned in Chapter 2, poor 
performance (through increases in errors) in some tasks has been related to heightened 
impulsivity. For example Morgan et at. 2002 found that errors on the MFF20 were 
associated with ecstasy use (interpreted as heighten impulsivity), and Parrott found that 
ecstasy users had increased impulsivity (SCL-90). It is noteworthy that other tasks that 
supposedly load on to Miyake et al's conceptual framework e. g. the Stroop test appear 
not to be affected by ecstasy use (e. g. Croft et at. 2001a; Morgan et at. 2002). Likewise, 
according to Miyake et al. the Tower of Hanoi/Tower of London tasks load on the 
inhibition component, and these also appear to be unaffected by ecstasy use. For example 
Fox et al. (2002) found that only one aspect of TOL performance was adversely affected 
by ecstasy use while Morgan (1998) found no evidence of ecstasy-related impairment on 
the TOL task. Since Chapter 7 failed to find between group differences on the three 
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established random generation measures, the available evidence suggests that ecstasy 
may not be associated with any substantial impairment in this aspect of executive 
processing. 
Number of alphabetical sequences, repeat sequences and redundancy were not 
related to any indices of drug illicit drug use. Number of letters produced was 
significantly correlated with frequency of ecstasy use, average ecstasy dose and amount 
used in the last 30 days suggesting that the increased number of letters generated is 
actually a function of ecstasy use and not merely a coincidence. 
To sum up, ecstasy users actually performed better than nonusers on the task of 
response inhibition, which may reflect heightened impulsivity or the adoption of other 
non random generation strategies which do not show up in the traditional measures of 
task performance. This should however be treated with some caution as it is not 
supported by previous research. 
Moving on to the fourth executive function, it was expected that ecstasy users 
would perform worse on all three measures of access, but that deficits would be most 
pronounced on the harder aspects i. e. ecstasy users would be worst on the constrained 
"C" letter category, then the "S" letter category, then the semantic fluency task. It was 
also possible that deficits in word fluency were mediated by the group differences evident 
in Chapters 6 and 7 in updating and inhibition. Mean scores showed that the ecstasy users 
performed worse on all three access measures although this was only significant for "S" 
and "C" letter fluency. This remained significant after control for verbal IQ scores and 
years spent in education, as it was possible that both of these aspects may have influenced 
available word knowledge. This supports previous research showing that ecstasy users 
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retrieved fewer words than nonusers (e. g. Bhattachary & Powel 2001; Fox et al. 2002; 
Heffernan et al. 2001 a). 
One aim of this thesis was to study the separability of ecstasy-related deficits in 
access. Earlier Chapters (6 & 7) show that ecstasy users are impaired in the updating 
aspect of executive functioning and perform better than nonusers on the inhibition 
component, although no differences were observed in switch cost latencies. Accordingly, 
it was possible that differences in access might be mediated by group differences in these 
two aspects of executive functioning. Control for differences in random letter generation 
did little to modify the deficits in word fluency. After control for differences in memory 
updating via computation span, the main effect of ecstasy use on access and the effects on 
"S" and "C" letter fluency were slightly attenuated but remained significant. Firstly this 
indicates that updating is related to access as control for updating attenuated deficits in 
access. Secondly as deficits in access remained significant after removal of the variance 
due to updating, it suggests that access is a clearly separable executive function, and 
provides further support for Fisk and Sharp (2004). 
It has also been suggested that attention may affect performance on this task. In 
Chapter 9, attention was assessed via the digit span task (digit span has been used as an 
indicator of attention in other studies in ecstasy users e. g. Semple et al. 1999). Attention 
exhibited a suppressor effect on access performance with both the main effect and "C" 
letter performance being intensified. Cohen and Stanczak (2000) found that performance 
on the Chicago Word Fluency Test loaded on the same factors as working memory 
capacity and attention. In the introduction of Chapter 9, it was postulated that ecstasy 
users may exhibit deficits on the CWFT due to decreased working memory capacity or 
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attention, as this word fluency task is longer than those previously used in research in 
ecstasy users. In support of Cohen and Stanczak's work, the results of Chapter 9 suggest 
that performance on access, working memory, and attention tasks are all interrelated (the 
former attenuated and the latter intensified ecstasy-related deficits in access), although 
clearly separable. This raises the possibility that maybe those studies that did not find a 
deficit in access did not use a long enough version of the task. With reference to which 
task ecstasy users may have found most difficult, the group differences were most 
pronounced on the constrained "C" letter category, supporting Heffernan et al. (2001 a) 
where ecstasy users retrieved fewer household items beginning with "T", while group 
differences on the "S" letter task were also significant. Contrary to expectations, ecstasy 
users did not perform worse on the semantic fluency task (as in Heffernan et al. 2001a). 
One possible reason for this could be the specific semantic category chosen. As 
mentioned in the introduction to Chapter 9, Baldo and Shimamura (1998) found that 
"animals" is one of the most easily retrieved semantic categories (in their study normal 
participants retrieved 23 animal names in a minute, and those with frontal lobe damage 
only 14 animals in a minute). In light of this it would be expected that as ecstasy use may 
also cause lesions in the frontal lobes (See Chapter 3 for review) ecstasy users would also 
retrieve fewer words than nonusers. Obviously ecstasy use does not impair frontal lobe 
function to the same extent as the lesions in Baldo and Shimamura's study. Having said 
this, Cohen and Stanczak (2000) performed a meta-analysis of studies utilising the CFWT 
to assess frontal lobe damage. It was found that though the CWFT was ineffective at 
discriminating left vs. right, and anterior vs. posterior regions of damage, and global vs. 
diffuse lesions, it was very effective at discriminating brain damaged vs. normal 
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participants. Thus the results of Chapter 9 provide further support for the idea that ecstasy 
use damages the brain, giving rise to potential problems that are unrelated to working 
memory capacity, attentional deficits, or verbal IQ. 
Moving on to indices of drug use, a number of ecstasy use variables were 
significantly correlated with performance on "C" and "S" letter fluency. More 
specifically total lifetime dose, average dose, and having ever used ecstasy with "S" letter 
fluency, and total lifetime dose, average dose, frequency of use, amount used in the last 
30 days and having ever used ecstasy were all significantly correlated with "C" letter 
fluency. Indices of cocaine use also emerged as particularly important predictors of 
performance, with frequency of use being significantly correlated with semantic fluency; 
total use, frequency of use, average dose, and having ever used cocaine with "S" letter 
fluency; and total use, frequency of use, average dose, amount used in the last 30 days, 
and having ever used cocaine with "C" letter fluency. In order to compare the relative 
magnitude of ecstasy and cocaine effects on access, further analyses were performed with 
cocaine user/nonuser as the sole independent variable. Effect sizes for the multivariate 
and semantic analyses were larger for cocaine than for ecstasy. However, effect sizes for 
"C" and "S" letter fluency were larger for ecstasy suggesting that these two aspects of 
access tasks are more related to ecstasy use. Referring back to the literature review 
chapters (Chapter 2 and 4) it appears from previous research that while ecstasy users may 
be impaired in access tasks (e. g. Bhattachary & Powel, 2001; Fox et al. 2002; Heffernan 
et al. 2001a) the same is not true for cocaine use (e. g. Berry et al. 1993; Butler & Frank, 
2000; Goldstein et al. 2004). Indeed studies in cocaine abusers indicate that even chronic 
cocaine-only users (using for an average of 5.83 years) are not impaired on this task 
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(Butler & Frank, 2000). What may this mean in terms of the results of the present study? 
As all the participants who felt that they were able to accurately estimate patterns of 
cocaine use were also ecstasy users, one possible explanation is that the strong 
correlations with indices of cocaine use actually reflect some aspect of ecstasy use. Part 
correlations between ecstasy use and fluency scores were calculated following control for 
indices of cocaine use. A number of these were reduced to marginal non-significance 
following control for cocaine use. However many remained significant (mostly those 
between ecstasy use and "C" letter fluency) reflecting hat it is likely that the use of 
ecstasy is related to this aspect of performance. Another explanation could be that 
concomitant use of cocaine along with ecstasy may increase the neurotoxic potential of 
ecstasy (see Chapter 4), and thus correlations with both ecstasy and cocaine are strong. 
To summarise the discussion thus far, it is evident that ecstasy users are impaired 
in the executive functions of updating and access, although the use of other recreational 
drugs also emerged as important contributors. Outside the field of psychopharmacology, 
this provides further support for Miyake et al's conceptualisation of executive processes 
and highlights the importance of studying the central executive as a divergent structure. 
The first part of this discussion has shown that ecstasy users are impaired in sonic 
executive tasks. The second part will discuss the contribution of executive tasks to 
performance in syllogistic reasoning (Chapter 9), associative learning (Chapter 10), and 
everyday memory (Chapter 11) tasks. Taking Chapter 9 first, previous research had 
shown that ecstasy users are impaired in logical thinking (e. g. Alting von Geosau et al. 
2004; McCann et al. 1999) and planning (e. g. Fox et al. 2001; Schifano et al. 1998). It 
was expected that ecstasy users would be impaired on a syllogistic reasoning task, and 
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that the deficit would be most evident on the harder three-model/No-Valid-Conclusion 
(3-m/NVC) syllogisms. Mean scores showed that ecstasy users performed worse than 
nonusers on both levels of difficulty, although this was only significant for the one-model 
problems. The user group by difficulty interaction was significant, however this reflected 
the absence of group differences on the more difficult syllogisms where both groups 
generally performed at around chance. Therefore as previous research has suggested (e. g. 
Gouzoulis-Mayfrank et al. 2000; McCann et al. 1999) ecstasy users are impaired on a 
"pure" reasoning task. Updating and access were identified as executive functions that 
may have contributed to performance on a syllogistic reasoning task. After control for 
memory updating (computation span) via ANCOVA, the main effect of ecstasy use and 
the user group by difficulty interaction were both reduced to below statistical 
significance. When the three access measures were incorporated into ANCOVA, the user 
group by difficulty interaction was again reduced to below statistical significance, 
although the main effect of ecstasy use remained significant. In terms of which aspects of 
executive functioning may affect performance, updating and access deficits in ecstasy 
users both appear to be particularly important. In the case of updating, this is supported in 
previous literature where working memory performance slightly attenuates syllogistic 
reasoning deficits (e. g. Fisk and Sharp, 2002) and provides further support for syllogistic 
reasoning being reliant on working memory capacity. Although comparisons have been 
drawn between the effects of ecstasy and the effects of cognitive ageing on the brain 
(Morgan 1998), this may not be the case for reasoning deficits. Fisk and Sharp (2002) 
found that control for reading and computation span (both indicators of updating 
function) did little to attenuate age-related differences in syllogistic reasoning implying 
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that in ageing, unlike in ecstasy use, updating is not an important contributor to changing 
performance on reasoning tasks. This is not to minimise the implications of the group 
differences observed in reasoning in Chapter 9. Even if it is the case that underlying 
reasoning competence remains intact in ecstasy users, given that they lack the executive 
resources to make full use of this capacity, they are still likely to exhibit impairments in 
the capacity for rational thought. With reference to access, it is possible that word 
knowledge and linguistic abilities may differentially affect performance on syllogisms. 
Beyond working memory, syllogistic reasoning is also believed to utilise other resources, 
for example relations between linguistic concepts such as `all', `some' and the logical 
operator `not', as well as spatial representations of class inclusion relationships (e. g. 
Ford, 1995). As a result access may mediate syllogistic reasoning deficits via linguistic 
competence in ecstasy users. 
It was predicted in Chapter 9 that the performance deficit between ecstasy users 
and nonusers would be most pronounced on the more difficult syllogisms, consistent with 
Johnson-Laird's (1983) mental models theory. However, the absence of group differences 
on the NVC and three-model syllogisms is difficult to reconcile with Johnson-Laird's 
(1983) account of mental models theory. While Johnson-Laird (1983) postulates that 
individuals construct a number of mental models to solve syllogisms, testing each new 
model against the conclusion that they have formed, Evans and co-workers (Evans, , 
Handley, Harper & Johnson-Laird 1999; Handley, Dennis, Evans & Capon 2000; 
Newstead, Handley and Buck 1999; Newstead, Thompson & Handley 2002) maintain 
that individuals generally only construct one mental model and fail to search for 
alternatives. In both Evans' and Johnson-Laird's perspectives, for complex and simple 
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syllogisms the premises need to be retained so that alternative possible conclusions can 
be accepted or rejected in the context of the initial mental model and the contents of 
working memory can be updated as necessary. In Chapter 9 the ecstasy-related group 
differences evident on the one-model syllogisms appear to be consistent with some 
degree of impairment in this process. On three-model/NVC syllogisms, in which 
according to Evans et al's theory only a single mental model is constructed, this single 
model does not itself constitute an exhaustive representation of the premises, and thus 
conclusions derived from this model (for users and nonusers) are likely to be erroneous. 
Consistent with the findings of Chapter 9, group differences would not be expected on the 
three-modeUNVC syllogisms. This suggests that nonusers were better able to construct a 
single mental model than ecstasy users, but that both groups performed equally poorly on 
the three-model/NVC problems. Consistent with this, a recent paper from our laboratory 
(Fisk, Montgomery, Wareing & Murphy, 2005) observed that ecstasy users made more 
non-responses (i. e. did not indicate a response) than nonusers on the easier one-model 
syllogisms. In addition the nonusers made more erroneous responses on the three model 
and NVC syllogisms. These findings suggest that ecstasy users with their reduced 
executive functioning are less able to retain the premises in working memory and as a 
consequence experience difficulty in forming the initial model necessary to draw a 
conclusion. 
Unlike chapters 6,7, and 8, indices of cocaine and cannabis use were not 
significantly correlated with performance on either type of syllogism (although having 
ever used amphetamine was significantly correlated with performance on one-model 
syllogisms). Having ever used ecstasy, total lifetime dose and average dose were all 
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significantly correlated with performance on one-model syllogisms, which may in turn 
reflect some aspect of memory updating performance, as ecstasy-related differences in 
one-model syllogisms were reduced to below statistical significance following control for 
updating. By way of summary, the results of Chapter 9 suggest that ecstasy-related 
deficits are most apparent in the aspect of executive functioning captured by computation 
span (updating) and that these deficits in turn produce secondary deficits in reasoning 
performance. 
Chapter 10 assessed the contribution of executive processes to a paired associate 
learning task, and examined the processes underpinning associative learning deficits in 
ecstasy users. While previous research suggested that ecstasy users might exhibit 
impairments in learning, this thesis used a number of different measures of associative 
learning performance, notably initial learning, trials to completion, perseverative 
responses, and indices of forgetting well-learned and less well-learned responses. It was 
expected that ecstasy users would perform worse than nonusers on all these measures. 
Ecstasy users had lower mean scores on all indices of associative learning, and both the 
main effect and all univariate analyses were significant (with the exception of forgetting 
at levels 2 and 4). After control for memory updating and access all significant group 
differences remained significant, although slightly attenuated in most cases (with the 
exception of group differences in forgetting at level 4 which were intensified after control 
for updating). Like syllogistic reasoning, associative learning seems to be related to 
deficits in executive functions. However, unlike syllogistic reasoning the group 
differences in associative learning remained significant after control for executive 
functions. Thus it appears that ecstasy related deficits in associative learning are 
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relatively independent of deficits in executive processes and that the two functions are at 
least in part reliant on distinct cognitive systems that are susceptible to different sources 
of impairment. 
As with updating, inhibition and access (in chapters 6,8 and 8 respectively) there 
appears to be a dissociation between the effects of recreational drugs on aspects of 
associative learning performance. While ecstasy use was significantly correlated with 
trials to completion and perseverative errors, indices of cannabis use were significantly 
correlated with the number of correct responses on trial one, and indices of cocaine use 
with forgetting. Implications with reference to perseverative errors have been discussed 
previously in this chapter. The significant correlations between indices of ecstasy use and 
trials to completion indicated that as severity of ecstasy use increased (indexed by total 
lifetime dose, average dose, frequency of use, amount used in the last 30 days) trials 
taken to learn all the associations also increased. Deficits of the same nature have been 
observed in ecstasy users in list learning tasks (e. g. Gouzoulis-Mayfrank et al. 2000), 
although this is the first study on drug use to find that ecstasy users take longer on a 
paired associates learning task. With reference to cannabis, indices of cannabis use were 
significantly negatively correlated with the number of correct responses on trial one 
indicating that as severity of cannabis use increased, number correctly recalled decreased. 
Deficits in short-term memory have been observed in cannabis users (e. g. Solowij et al. 
1992) so it could be that the significant correlations reflect some aspect of cannabis- 
related impairment in immediate recall. However, Rodgers (2000) and Croft et al. 
(2001 a) both found that cannabis users did not differ from controls on this task (although 
in Rodger's study, the ecstasy users were worse than the cannabis users on the delayed 
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recall of word pairs). Indices of cocaine use were significantly positively correlated with 
forgetting at level 1 indicating that as cocaine use increased, there was a tendency to 
forget responses that were not well learned. 
With reference to the structure of associative learning processes in ecstasy users, 
it was revealed that ecstasy-user group accounted for -2210 of the total variance in trials 
to completion. In the regression analysis all of the component measures of learning 
performance substantially reduced the ecstasy-group related variance in trials to 
completion. The greatest degree of attenuation was achieved by the level of initial 
learning (correct responses on trial one). The various measures of forgetting each reduced 
the ecstasy-group related variance by about one half while for perseverative responses the 
degree of attenuation was around 40%. Thus the ecstasy-group related effect appears to 
be mediated through all of the learning sub-processes. Taken together with the results of 
the MANOVA and correlations, this is consistent with an ecstasy-mediated effect in trials 
to completion. 
Chapter 11 assessed the contribution of executive processes to self-reported 
incidences of everyday memory failures. Ecstasy users scored significantly higher than 
nonusers on a number of everyday memory measures: the CFQ, EMQ, two subscales of 
the PMQ (long-term episodic and internally cued PM) and significantly lower on a 
measure of memory updating and a measure of access. Ecstasy users were also rated 
significantly higher by friends on the CFQ-for-others. The interaction between CFQ and 
CFQ-for-others scores and ecstasy use was non-significant, indicating that ecstasy users 
do realise their cognitive slips. Surprisingly, although there was a main effect of ecstasy 
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use on most of the measures, cannabis use variables emerged as the most significant 
predictors of everyday memory scores. 
The findings of Chapter 11 support and extend previous research. Firstly, we 
found that ecstasy users rated themselves higher on the CFQ, indicating increased 
incidence of cognitive slips. This provides further support for Fox et al. (2001), who 
reported a higher incidence of cognitive slips in ecstasy users than in nonusers. However, 
Rodgers (2000) and Heffernan et al. (2001a) did not find any ecstasy-related differences 
on this version of the questionnaire. This may be due to differences in lifetime drug 
consumption. While both studies report that the ecstasy user group had used ecstasy 20 
times over a 5-year period, Heffernan et al. (2001 a) also report that the average dose was 
one tablet per session. As the average dose in the present study was 346.5 tablets, this 
raises the possibility that the types of slip assessed by the cognitive failures questionnaire 
are relatively preserved until a certain threshold of ecstasy use is reached. 
Ecstasy users were also rated higher by friends on the CFQ-for-others. The 
percentages of reported slips for the CFQ and CFQ-for-others were relatively similar 
(45.42 and 45.79 for ecstasy users; 38.58 and 33.47 for nonusers). The interaction 
between ecstasy use and self- and other-reported slips was non-significant. It has been 
suggested that the absence of a deficit on this task in previous research may reflect a 
metacognitive deficit in ecstasy users, which renders them unable to monitor their 
cognitive state accurately. However, the results of the present study suggest that ecstasy 
users do realise their cognitive slips, which is consistent with Heffernan et al's findings 
(2005) that self-reported PM and objective PM slips in ecstasy users were similar. 
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Ecstasy users also scored significantly higher on the EMQ indicating increased 
incidences of slips in everyday memory. Rodgers et al. (2003) found that frequency of 
cannabis use was the most important predictor of everyday memory scores (discussed 
below). 
Ecstasy-related differences were also observed on two sub-scales of the PMQ: 
long-term episodic PM and internally cued PM. This provides some support for 
Heffernan et al. (2001b) in which ecstasy users reported a greater number of prospective 
memory slips on the internally cued subscale than the long term subscale (however, the 
main effect and short-term PM in the present study were non-significant). Heffernan et al. 
(2001 a) also found evidence for prospective memory deficits in ecstasy users: Short-term, 
long-term and internally cued PM were all related to ecstasy use. In Rodgers et al's 
(2001b) study, LT-PM was also negatively associated with ecstasy use. The effects of 
ecstasy on LT-PM may be due to similar mechanisms as those associated with deficits in 
recall, where ecstasy users generally perform worst on recall tasks in the delayed 
condition (as suggested by Rodgers et al. 2001). 
Control for access and updating attenuated or reduced the everyday memory 
deficits to below statistical significance. Heffernan et al. (2001 a) suggested a link 
between executive functioning and prospective memory deficits in ecstasy users (as 
ecstasy users performed worse on both a word fluency task and PM task in their study), 
although they did not investigate such an interaction. Thus the present study provides 
further support for the mediating role of executive functioning in prospective memory 
deficits in ecstasy users. This is also seen in older adults, who perform worse on PM tasks 
partly due to decreased working memory capacity (e. g. Martin & Schuman-Hengsteier, 
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2001); thus unlike the syllogistic reasoning deficits observed in Chapter 9, the nature of 
everyday memory deficits in ecstasy users is similar to that of older individuals and 
further supports the notion that ecstasy-polydrug use may facilitate premature ageing of 
the brain (Morgan 1998). 
The focus of Chapter 11 was intended to be ecstasy use. There was a main effect 
of ecstasy use on most of the everyday memory measures, and indices of ecstasy use 
were associated with EMQ scores (ever used, average dose), CFQ scores (ever used, 
average dose), and CFQ-for-others scores (ever used, total lifetime dose). However, a 
number of other illicit drugs consumed by the participants tested here appear to have 
produced effects on the measures that were administered. Indices of cannabis use seem to 
be particularly important predictors of everyday memory deficits. Indeed, having ever 
used cannabis, total lifetime dose and average weekly dose were significantly correlated 
with all everyday memory measures. Given that 40 (maximum 43) of the ecstasy users 
and 26 (maximum 5 1) of the nonusers had ever tried cannabis, with 30 and 18 
respectively being able to estimate lifetime consumption, it is entirely possible that the 
ecstasy-related group differences in ratings of everyday memory reflect some aspect of 
ecstasy-cannabis use, or cannabis only use (e. g. Schwartz et al. 1989). Studies which 
have attempted to adequately control for cannabis use via ANCOVA and regression 
analysis have found a dissociation between the two drugs in terms of their impact on 
aspects of everyday memory functioning, suggesting that the effects observed in the 
present study on prospective memory at least may be accurate. Rodgers et al. (2003) 
found that while cannabis use predicts self-reports of failures in everyday memory, long- 
term prospective memory deficits were related to ecstasy use. Rodgers et al. (2001) also 
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found that cannabis use was related to self-reports of "here and now" (ST and internally 
cued PM) memory deficits, while ecstasy use was associated with long-term PM deficits. 
Heffernan et al. (2001a; 2001b) also found that ecstasy-related deficits in PM remained 
significant after control for alcohol, cannabis and cocaine, and a cannabis only group did 
not report more cognitive failures compared to ecstasy users and controls (2001 a). 
Cannabis use thus appears to be a particularly important contributor to everyday 
memory deficits. In addition to the many significant correlations between cannabis use 
and everyday memory, separate analyses were performed with cannabis user (two levels: 
user/nonuser) as the independent variable. Effect sizes were larger in all cases (with the 
exception of the CFQ-for-others) for cannabis use than ecstasy use indicating that deficits 
in everyday memory are more related to the use of cannabis. Unlike the analyses with 
ecstasy use, all cannabis use analyses remained significant following control for updating 
and access. In terms of the components of everyday memory, this may imply that 
decrements in users of ecstasy and users of cannabis are apparent for different reasons. It 
may be that while cannabis users exhibit genuine everyday memory deficits which may 
or may not dissipate somewhat with prolonged abstinence, ecstasy users exhibit deficits 
in aspects of executive functioning (access and updating in this thesis) which render them 
unable to efficiently utilise their everyday memory skills. Hence the everyday memory 
deficits in ecstasy users are not as strong as those in cannabis users and are reduced to 
below statistical significance following control for working memory capacity. 
To recapitulate, it appears that while associative learning deficits in ecstasy users 
are relatively independent of updating and access, the same is not true for everyday 
memory and syllogistic reasoning deficits. Ecstasy-related group deficits in reasoning and 
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everyday memory were reduced to below statistical significance following control for 
memory updating, and in some cases for access also. Additionally cannabis emerged as a 
more important predictor of everyday memory performance than ecstasy use. 
The next section of this discussion will focus on the results of this thesis in terms 
of the neural areas that may be associated with such deficits. Focusing primarily on 
updating, Salmon, van der Linden, Collette and Delfiore (1996) used a letter-updating 
task adapted from Morris and Jones (1990) requiring participants to recall the most recent 
six items from strings of eight, nine and ten consonants. Brain activation during the 
updating task was compared to that during a phonological short-term memory task. For 
the updating task only, an increase in activation was seen in the mid-dorsal prefrontal 
cortex (BA 9), left middle frontal regions (BA 46 and BA 10) and in the right frontal pole 
(BA 10). In a more recent study using PET imaging Van der Linden et al. (1999) required 
participants to remember the most recent 4 items in letter strings of varying length and it 
was found that the most significant increases in activation occurred in the left frontopolar 
cortex (BA 10) spreading to the left middle frontal area (BA 46). Utilising ERP and 
neural imaging techniques, Postle and co-workers provide further support for the role of 
the dorsolateral prefrontal cortex in updating tasks (e. g., Postle, Berger, Goldstein, Curtis, 
& D'Esposito, 2001). Thus it appears that these areas of the prefrontal cortex may be 
especially sensitive to the effects of ecstasy use. Ecstasy users were also impaired in 
access to long-term memory. Similarly, it appears that access19 also recruits resources in 
the DLPFC: Lesion studies have implicated the left dorsolateral prefrontal cortex in 
impaired letter and category-based fluency (Stuss et al. 1998) and also in impaired 
19 The Chicago Word Fluency Task, as mentioned earlier in the discussion, is very effective at identifying 
brain damaged individuals compared to non brain damaged, although it is not believed to be as effective at 
identifying the site of damage. Such studies refer to other access tasks. 
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fluency among children (Levine et al. 2001). In a PET study of word finding, also using a 
word fluency task (Frith, Friston, Liddle & Frackowiak, 1991), performance was 
associated with an increase in left dorsolateral prefrontal cortical activity specifically 
BA46. Taken together these results suggest that ecstasy use may adversely affect the 
DLPFC. In this thesis ecstasy users were not impaired in switching tasks or inhibition 
tasks. Given that performance on both of these tasks has also been linked to functioning 
in the left prefrontal lobes (e. g. Petrides. Alivastos, Evans, & Meyer, 1993a and b; Rogers 
et al. 1998; Stuss & Benson, 1998) the lack of group differences on these tasks is 
surprising. It may be that ecstasy-related deficits in updating and access do not reflect 
degradation of the serotonin system in the prefrontal cortex, although this seems unlikely 
(see below). Moving on to syllogistic reasoning the pattern of neural correlates is rather 
more diverse, indeed syllogistic reasoning even in its abstract form is very complex and 
relies on numerous cognitive capabilities including executive functioning. Such 
capacities are likely to be distributed in different areas of the brain: the process of 
integrating premises is associated with increased activation in the DLPFC (BA46 
bilateral, BA8 left hemisphere), the left inferior prefrontal cortex (BA 10 and 44) and the 
right inferior/medial prefrontal cortex (BA46). The key aspect of syllogistic reasoning 
(i. e. evaluating the conclusion) is associate with increased activation in the inferior 
frontal lobe (BA45 bilaterally, left BA44), bilateral cerebellum and basal ganglia, 
bilateral fusiform gyrus (BA18), and the left superior parietal lobe (BA7, Goel, Buchel, 
Frith & Dolan, 2000). 
What support is there for the proposition that the deficits observed in this thesis 
may be related to decrements in the serotonin system caused by ecstasy use? Evidence 
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suggests that the prefrontal cortex in general and the DLPFC in particular are especially 
sensitive to the effects of ecstasy (See Chapter 3 for a review of the human ecstasy 
neuroimaging literature). In terms of neurotransmitters, Robbins (2000) highlights the 
contrasting roles of dopamine and serotonin in underpinning different aspects of 
cognitive functioning, especially the role of dopamine in spatial working memory 
functioning. To further support this Dopamine is also involved in modulating DLPFC 
activity (BA46) in non-human primates (Henze, Gonzalez-Burgos, Urban, Lewis & 
Barrionuevo, 2000). In terms of serotonergic functioning Luciana, Collins, and Depue 
(1998) found that fenfluramine (a serotonin agonist) impaired visuo spatial working 
memory performance while bromocriptine (a dopamine agonist) generally facilitated 
performance. 
There are a number of important implications of this thesis outside the area of 
Psychopharmacology. Firstly, one aim of this thesis was to study the separability of four 
executive processes in ecstasy users. Until recently it was believed that the central 
executive of working memory was a unified structure. However recent theoretical models 
postulate that although some executive functions are inter-correlated, they are also clearly 
separable (Fisk & Sharp, 2004; Miyake et al. 2000). This thesis therefore provides further 
support for the fractionation of executive processes into four sub categories: updating, 
shifting, inhibition and access. Secondly this thesis provides further support for Evans et 
al's (1999) theory of syllogistic reasoning. In Chapter 9 both groups performed 
comparably on the three-model/NVC syllogisms suggesting that individuals generally 
only construct a single mental model of premises and fail to search for alternatives. This 
is consistent with cognitive ageing literature (e. g. Fisk & Sharp, 2002). Thirdly this thesis 
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provides a framework for the nature of associative learning processes which may apply to 
non-ecstasy users as well as the ecstasy-using group in the present study. Fourthly it is 
also suggested that syllogistic reasoning and everyday memory functioning may be 
reliant on working memory resources (providing further support for e. g. Gilhooly et al. 
1993). Although deficits in syllogistic reasoning performance appear unrelated to 
working memory performance in older populations (e. g. Fisk & Sharp 2002) this was not 
true of ecstasy users. Equally it appears that everyday memory performance is related to 
executive and working memory functioning in a number of populations (e. g. Marsh & 
Hicks, 1998). 
There were a number of limitations with the research in this thesis. While the 
results of Chapters 6-10 emphasize the importance of ecstasy use in accounting for the 
observed deficits (and in the case of Chapter 11, cannabis use), the possibility that the use 
of other recreational drugs may have contributed to such deficits cannot be entirely ruled 
out. The use of ANCOVA was not deemed appropriate as it would not have been possible 
to test for homogeneity of regression in the case of cocaine use, which would have 
rendered the ANCOVA result difficult to interpret. Accordingly correlations and where 
appropriate part correlations were used to try and ascertain relationships between drug 
use and performance. In the case of updating, ecstasy generally emerged as the most 
significant source of variance, although it is possible that for word fluency cocaine or 
ecstasy/cocaine polydrug use were important contributors. Likewise, cannabis emerged as 
the most significant predictor everyday memory deficits. Even where statistical controls 
were implemented, the reliance on self-report data can be potentially problematic. The 
indices of drug use that were calculated for each chapter were based on the individual 
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being able and willing to provide an accurate indication of their drug use. Additionally, 
there is no guarantee that the substances that were consumed always contained the drug 
in question, although a recent review of the contents of amnesty bin contents from 
nightclubs suggests that ecstasy tablets mostly contain MDMA (Parrott, 2004a). Due to 
limitations in available resources, it was not possible to use urine, saliva or hair samples 
to confirm recent patterns of drug use. However, this thesis is not alone in this respect. 
Most published studies assessing cognitive deficits in ecstasy users (e. g. Fox et al. 2002; 
Heffernan et al. 2001a and b; Morgan 1998; Parrott and Lasky, 1998; Rodgers 2000; 
Rodgers et al. 2001) have not resorted to these objective measures of drug use. 
While subjective measures of prospective and everyday memory have been used 
in ecstasy research investigating this area to date (e. g. Heffernan et al. 2001a; Heffernan 
et al. 2001b; Rodgers et al. 2001; Rodgers et al. 2003), such subjective measures are not 
without their limitations. Although the everyday memory measures such as the PMQ 
seem to correlate well with more objective measures of PM (Hannon et al. 1995; 
Heffernan et al. 2005), there are obvious benefits to the use of objective PM tasks (not 
least that they are not reliant on subjective perceptions of memory, in a group of 
supposedly memory impaired individuals). Therefore perhaps future research should aim 
to use more objective measures of PM for example the Cambridge Prospective Memory 
Test (CAMPROMT) which contains 4-event based and 4-time based situations, and can 
be used in a laboratory setting (Wilson, Emslie, Foley, Shiel et al. 2005). In addition, 
Heffernan et al. (2001b) note that subjective memory ratings can be affected by 
depression. Research in clinical populations has shown that both objective and subjective 
cognitive deficits are heavily related to depression (in one study differences between 
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groups were reduced to below statistical significance following control for depression- 
Chamelian & Feinstein, 2006). Some studies in ecstasy users show that users of the drug 
report higher levels of depression (Curran & Travill, 1997; Parrott and Lasky, 1998) and 
consequently it remains a possibility that the group deficits in prospective and everyday 
memory observed in this thesis may reflect increased depressed mood in ecstasy users. 
However, a recent meta-analysis concluded that there is little evidence for ecstasy-related 
depression, and incidences of such are not likely to be clinically relevant (Sumnall & 
Cole, 2006). To summarise, the research in this thesis may be limited by the use of some 
subjective measures and future research should seek to use more objective measures and 
investigate the link between subjective reports of memory slips and depressed mood in 
ecstasy users. 
While established and validated tests have been used in every chapter, the results 
of such laboratory measures may have limited generalisability to the real world. This is 
not however to minimise the implications of this thesis. Tests such as the PMQ, EMQ and 
CFQ could have very serious real-world implications for ecstasy users. These tests 
contained items such as "I forgot an important appointment"; "I forgot what I went in to a 
room for". Such lapses in memory could have serious implications for users of the drug 
(especially for example in a university setting, or an occupational setting where 
individuals are required to keep appointments). More worryingly, the results showed that 
ecstasy users did not implement more strategies than nonusers although they did exhibit 
more slips in prospective memory. Therefore the results of this thesis could be used to 
educate individuals who have used/consider using ecstasy, and make them aware of 
strategies that can aid memory. 
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It was also possible that the groups differed in some aspect other than their use of 
illicit drugs. In each Chapter data were collected on indices of sleep quality, alcohol 
consumption, premorbid and fluid intelligence, age, gender and other lifestyle variables. 
In a number of Chapters the groups did not differ significantly on background variables 
(Chapters 7 and 10). In those chapters where there were significant group differences on 
background measures, such differences mainly acted to intensify ecstasy-related effects. 
In Chapter 6 (updating) where alcohol use, ESS scores and gender were entered into 
ANCOVA both the main effect and the univariate analyses were intensified, and the 
previously non-significant 12-letter list length difference became significant. In Chapter 8 
(access) after Raven's Progressive Matrices scores, Alcohol use and ESS scores were 
entered into ANCOVA, the main effect and the univariate effects for all three-word 
fluency scores were intensified, with the previously non-significant Semantic category 
now becoming significant. In Chapter 9 (syllogistic reasoning), although control for 
alcohol use reduced the interaction between ecstasy use and problem type to below 
statistical significance, the main effect was once again intensified. The results of these 
ANCOVAs suggest that although ecstasy users and nonusers may differ on some lifestyle 
variables, these are not responsible for the ecstasy-related deficits observed in this thesis. 
Indeed after removing the variance due to background variables the ecstasy-related 
deficits were actually intensified. Nonetheless, it is possible that the groups differed on 
some other pre-existing factors that we have not controlled for. 
Finally there are a number of suggestions for future research arising from this 
thesis. Chapters 6 and 10 revealed that ecstasy users exhibit deficits in memory updating 
and associative learning respectively. In Chapter 2 section 2.11.3 a number of studies 
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show that ecstasy users are impaired is aspects of visuo-spatial working memory (e. g. 
Wareing et al. 2004a). Both of the tasks used in Chapters 6 and 10 were verbally based, 
and it would therefore be interesting to see if ecstasy users are also impaired in visuo- 
spatial memory updating and visuo-spatial associative learning. Although some studies 
have already looked at the updating of visuo-spatial information (e. g. Alting von Geusau 
et al. 2004) it would be of great benefit to use an established memory updating paradigm 
such as that Fisk & Sharp (2003). Similarly visuo-spatial associative learning has also 
been assessed in ecstasy users (e. g. Croft et al. 2001a; Fox et al. 2002). However, once 
again it would probably be beneficial to look at other measures of learning similar to 
those used in Chapter 10, for example, trials to completion, initial learning, 
perseverations, forgetting at various levels, and to further explore the relationship 
between them in the context of ecstasy-related effects. Chapter 8 revealed that ecstasy 
users were impaired in access to long-term memory. Research so far in ecstasy users has 
mainly assessed this executive function via word fluency tasks (see Chapter 2, section 
2.3.2). It would be interesting to see if this deficit in access to long-term memory is 
restricted to performance on word fluency or if other tasks that are also supposedly reliant 
on access (e. g. verb generation) are also susceptible to the effects of ecstasy. Finally, one 
obvious limitation is the reliance on opportunity sampling. Due to the method of 
recruitment and the nature of the sample it was not possible to recruit a group that solely 
used ecstasy, a group that solely used cannabis and a group that solely used cocaine. Thus 
it is possible that some of the observed deficits were attributable to the concomitant use 
of other recreational drugs. Future research should focus on trying to recruit such groups, 
although most published studies in this area contain an ecstasy-polydrug using group. 
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There is alarming evidence that suggests that individuals are starting to use 
ecstasy at a younger age now (e. g. British Crime Survey 2004-05). Therefore future 
research could focus on possible deficits in such age groups. While it would also be 
useful to perform a longitudinal study with such age groups, securing funding for such 
projects remains potentially problematic. This thesis attempted to control for possible 
lifestyle/background factors that may have affected the results (e. g. sleep quality, 
intelligence). Nonetheless it still remains a possibility that the groups differed in some 
other factor than their ecstasy use, such as diet (e. g. Curran & Robjant, 2006), lifestyle 
(e. g. dancing for long periods of time in crowded clubs e. g. Parrott, 2004b). Thus future 
research could perhaps focus on protective factors such as adequate diet, the importance 
of regular rest breaks, and possible functional differences between groups of ecstasy users 
with/without adequate diets and with/without regular rest breaks. As well as drug-taking 
situations such as dancing and hyperthermia, other drug-taking factors may also be 
important in functional differences. It has long been reported that higher dosage groups of 
ecstasy users exhibit more severe cognitive deficits than low dosage groups (e. g. Halpern 
et al. 2004). In addition to this, it is likely that those who ingest a higher number of 
tablets per occasion ("bingeing") are more likely to be subject to possible neurotoxicity. 
Thus it would be expected that such individuals would present worse psychological 
profiles. This would be an interesting area for future research. 
Thesis Summary 
This thesis sought to evaluate executive function deficits in a sample of 
recreational ecstasy users using recent theoretical models of executive functioning. It was 
found that ecstasy use differentially impairs executive functions with updating and access 
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to long-term memory being affected and inhibition and switching being relatively 
preserved. Access and updating were then evaluated as potential mediators of syllogistic 
reasoning, associative learning and everyday memory in ecstasy users. It was found that 
reasoning and everyday memory deficits are dependent on executive resources 
(particularly updating) while ecstasy-related differences in associative learning are 
relatively independent of these processes. In most cases deficits appear to be related to 
the use of ecstasy. However cocaine emerged as an important predictor of access deficits 
and cannabis of everyday memory deficits. Outside the area of psychopharmacology this 
thesis has important implications for the structure of executive processes, the nature of 
associative learning and syllogistic reasoning processes. 
In conclusion, the results of this thesis raise a number of important issues 
concerning future research, and recommendations are made. The results suggest that the 
use of ecstasy may be harmful to the human brain, possibly through degradation of the 
serotonergic system, and thus the results should be used in the education of individuals 
considering using the drug. 
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Appendix I 
The table below shows the overlap of participants in Chapters 6-11. 
Ch 6 Ch 7 Ch 9 Ch 8 Ch 10 Ch 11 
Chapter 6 (updating) - - - --- 
Chapter 7 (Switching & Inhibition) 8U - - --- 
11NU 
Chapter 9 (Syllogisms) 27 U 15 U - --- 
35NU 35 NU 
Chapter 8 (Access) 11 U 15 U 17 U --- 
19NU 18 NU 39 NU 
Chapter 10 (Associative Learning) 27 U 14 U 17 U 33 U-- 
35 NU 34 NU 38 NU 62 NU 
Chapter 11 (Everyday Memory) 29 U 8U 24 U 28 U 27 U- 
35 NU 11 NU 32 NU 39 NU 39 NU 
U= Ecstasy Users 
NU = Nonusers. 
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I 
Participant Number Height 
Weight 
Gender 
Age 
I. Have you ever used the drug ecstasy? YesINo* 
`No' please move on to Question 16) 
2. How long have you been taking ecstasy? Months Years 
3. How aware are you that using the drug ecstasy may have harmful long 
term effects on your health? 
(Please fick relevant answer) 
Very aware 
Quite aware 
Unsure 
Quite unaware 
Very unaware 
Can you explain below what these harmful effects may be? 
4. Are you concerned about the possible dangers of using ecstasy? 
(Please tick relevant answer j 
Extremely Concerned 
Very Concerned 
Concerned 
Slightly Concerned 
Not Concerned 
4 
a 
5. How do you find out information about ecstasy? 
(Please tick all relevant answers) 
TV-News Radio 
N-Specialist Drug Agencies 
Daily News ar Drug Leaflets 
Music M azines Friends 
Magazine Clubs 
Other 
6. Where do you usually take ecstasy? 
(Please tick relevant boxes) 
Pubs/Bars 
Ni ht-clubs 
Rave Events 
Private House/Flat 
Patties 
Own Home 
Friends Home 
Other 
7. What acüvities do you participate in when under the influence of ecstasy? 
(Please tick relevant boxes) 
Do you take any sort of precautions when using ecstasy? YesWo 
(E. G. Vitamins) 
If yes please give details 
9. Are you aware that medical advice suggests that Yes_, _,, 
No 
you should take precautions when using ecstasy? 
If yes can you explain below what precautions should be taken and why 
t3 
10. When under the influence of ecstasy: 
(a) Do you take regular rest-breaks when dancing Yes- No- 
(b) Do you monitor your fluid intake Yes- No-- 
(c) Is there anything else you do Yes-- No- 
If yes please give details 
11. Is there a maximum number of ecstasy tablets 
you will take in one session? Yes- No- 
If Yes, what is the maximum number 
12. What factors decide when you have taken enough ecstasy tablets in one session? 
(Please give details below) 
a 
L 
13. Do you believe that since using ecstasy you have changed in any way? 
Please look at the following list very carefully 
(For example, if you believe that since using ecstasy you have become more caring then tick 
caring under the heading MORE. If however you feel that you have become less caring then 
tick caring under the heading LESS. If you feel that you have not become any more or less 
caring the tick caring under the heading NO CHANGE) 
MUCH 
MORE 
MORE NO 
CHANGE 
LESS MUCH 
LESS 
CARING 
PARANOID 
ALERT 
DEPRESSED 
SOCIABLE 
AGGRESSIVE 
HAPPY 
HEALTHY 
MOODY 
PATIENT 
IRRITABLE 
CONFIDENT 
SAD 
LOVING 
CONFUSED 
Any other changes 
1 
s 
. 1,6 1, I.. 0 
14. What has stopped you taking ecstasy in the past? 
(Please tick relevant boxes) 
"i. 
15. From the following list, please indicate what type of other drugs you use at the same time 
as ecstasy and the frequency of use. 
(Please tick all relevant boxes) 
Drug Always Frequently Occasionaliv Never 
Alcohol 
Amphetamine 
Cannabis 
Cocaine 
Crack 
DMT 
GHB 
Herbal E 
Heroin 
Ketamine 
LSD 
Acid'Blotters 
LCB 
Mushrooms 
Poppers 
Prozac 
Salvia 
Divindrum 
Tranquillisers 
Tobacco 
Viagra 
Other 
-9 
16. From the following list, please indicate what type of other drugs you have used in the last 
three months use and the frequency of use. 
(Please tick all relevant boxes) 
17. From the following list, please indicate which types of drugs you have used in the past. 
Please indicate when you first began using and when you last used the drug. 
When did When did you as use? 
Drug you first (Please cirde one only) 
use? 
mmfyr. Hours Days Previous Weeks Months Years Previous 
Previous Previous Previous 
123456 123456789 
Ecstasy (MDMA) 0123466 123 789 10 11 10 
123456 123456789 
Alcohol 0123456 123 789 10 11 10 
123456 123456789 
Amphetamine 0123456 123 789 10 11 10 
123456 123456789 
Cannabis 0123456 123 789 10 11 10 
123456 123456789 
Cocaine 0123456 123 789 10 11 10 
1 234 56 123456789 
Crack 0123456 123 789 10 11 10 
123456 123456789 
DMT 0123456 123 789 10 11 10 
123456 123456789 
GHB 0123456 123 789 10 11 10 
123456 123456789 
Herbal E 0123456 123 789 10 11 10 
123456 123456789 
Heroin 0123456 123 789 10 11 10 
123456 123456789 
Ketamine 0123456 123 789 10 11 10 
12 34 56 123456789 
LSD 0123456 123 789 10 11 10 
acid\Blotters 
123456 123456789 
LCB 0123456 123 7891011 10 
123456 123456789 
Mushrooms 0123456 123 789 10 11 10 
123456 123456789 
poppers 0123456 123 789 10 11 10 
123456 123456789 
proms 0123456 123 789 10 11 10 
123456 123456789 
Salvia Divindium 0123456 123 789 10 11 10 
12 34 56 123456789 
Tranquillisers 0123456 123 789 10 11 10 
123456 123456789 
Tobacco 0123456 123 789 10 11 10 
123456 123456789 
Vagra 0123456 123 789 10 11 10 
123456 123456789 
Other 0123456 123 789 10 11 10 
If less than a day, indicate hours previous 
ý` 
. 
18. Please list any controlled substances, prescription medications, and alcohol you have 
consumed in the last 10 days? Please list ALL occasions during the last 10 days. 
Daysthours Amount taken 
Substance previous Grams Cost Units Dose 
e. g. bags/wraps e. g. joints, line 
.n 
19. How would you describe you current pattern of ecstasy use? 
times per week OR 
times per month OR 
times per year OR 
previous user (more than 6 months since last used) 
Please estimate your pattern of use from the first year of taking the drug to present use 
" Fill in the year you began taking ecstasy 
" Select an average month of use within that year 
" Estimate the total number of ecstasy tablets you would normally have 
taken during one session 
" Indicate frequency of use, e. g., number of times per weekhronthlyear 
Continue to fill in each consecutive year regardless of whether you used 
ecstasy or not. If you have not used for a particular year, continue to enter the 
year and specify a month, and then enter zero in the space provided for the 
total number of tablets taken. 
Total number of 
tablets taken in Frequency Route of 
Year Month one session of use Administration 
e. g. Year 1 
1993 June 1 One a Week e. g. swallow, sniff Inject 
, This year Last 30 Now many limos? 
days , 
04 
3ý 
ý` 4a 
20. How would you describe you current pattern of Amphetamine use? 
times per week OR 
times per month OR 
times per year OR 
previous user (more than 6 months since last used) 
In what form do you take amphetamine? 
Powder (amphetamine sulphate) 
Tablets (please indicate type) 
Other 
Please estimate your pattern of use from the first year of taking the drug to present use 
" Fill in the year you began taking amphetamine 
" Select an average month of use within that year 
" Estimate the total number of amount of powder you would normally 
have taken during one session 
" Indicate frequency of use, e. g., number of times per week/monthlyear 
Total amount 
taken in Frequency Route of administration 
%I R 
21. How would you describe you current pattern of Cannabis use? 
times per week OR 
times per month OR 
times per year OR 
previous user (more than 6 months since last used) 
In what form do you fake Cannabis? 
Joints 
Other 
Please estimate your pattern of use from the first year of taking the drug to present use 
" Fill in the year you began taking Cannabis 
" Select an average month of use within that year 
" Estimate the total number of joints you would normally 
have taken during one session 
" Indicate frequency of use, e. g., number of times per week/month/year 
Total number 
of joints in Frequency Route of administration 
Year Month one session of use 
e. g. Year 1 
1993 June e. g. I One a Week e. g. Smoke, Swallow 
This year Last 30 Now Many Limos? 
days 
"w 
22a. Other drug regularly used: Please estimate your pattern of use from the first year of 
taking the drug to present use. 
times per week OR 
times per month OR 
times per year OR 
previous user (more than 6 months since last used) 
Which Drag? 
In what form? 
Please estimate your pattern of use from the first year of taking the drug to present use 
" Fill in the year you began taking the drug 
" Select an average month of use within that year 
" Estimate the total amount you would normally 
have taken during one session 
" Indicate frequency of use, e. g., number of times per week/month/year 
Total 
amount in Frequency Route of administration 
Year Month one session of use 
e. g. Year 1 
1993 June e. g. I One a Week e. g. Smoke, Swallow, 
Inject, Snort 
This year Last 30 
days 
How many times? 
4. 
22b. Other drug regularly used: Please estimate your pattern of use from the first year of 
taking the drug to present use. 
times per week OR 
times per month OR 
times per year OR 
previous user (more than 6 months since last used) 
Which Drug? 
In what form? 
Please estimate your pattern of use from the first year of taking the drug to present use 
" Fill in the year you began taking the drug 
" Select an average month of use within that year 
" Estimate the total amount you would normally 
have taken during one session 
" Indicate frequency of use, e. g., number of times per week/monthlyear 
Total 
amount in Frequency Route of administration 
Year Month one session of use 
e. g. Year 1 
1993 June e. g. 1 One a Week e. g. Smoke, Swallow, 
Inject, Snort 
This year last 30 Howmany temps? 
days 
0. 
23. How many years of full time education have you completed from primary school to 
date? 
Years 
24. From the following list, please indicate if you have obtained any of the 
following educational qualifications? 
Qualification Y1N Details 
CSE 
GCE 
GCSE 
A LEVEL 
NVQ 
GOV. EMPLOYMENT 
TRAINING SCHEME 
CRAFTITRADE (EG CITY & 
GUILD) 
'HND 
DEGREE 
OTHER 
NONE 
25. Do you have any convicäons for drugs Yes- No-- 
If yes, would you please give details below? 
E. g. year of conviction, We of drug, We of offence 
26. Do you have any other convictions Yes- No- 
If yes, would you please give detail below? 
E. g. year of conviction, type of offence 
4e 
Appendix 3 
Adjusted Means for Chapter 6 following ANCOVA. 
Below is a table showing the adjusted means for the letter updating task following 
ANCOVA for Epworth Sleepiness Scale, Alcohol consumption and gender. The means 
show that the scores are in the direction predicted in the original hypothesis. 
Ecstasy Users Nonusers 
Length 6 2.54 2.87 
Length 8 1.99 2.51 
Length 10 1.86 2.46 
Length 12 1.96 2.35 
Appendix 4 
Supplementary analyses for Chapter 8 
The data for Chapter 8 were analysed via MANOVA. However, it was suggested 
that semantic fluency may be the easier part of the task, with the "S" letter fluency being 
intermediate in difficulty and the constrained "C" letter fluency being the hardest 
category. If this were the case, we would expect ecstasy users and nonusers to perform 
comparably on the semantic fluency task, with performance differences increasing with 
increasing task difficulty. To see if word fluency deficits were qualified by a ecstasy-user 
group by difficulty interaction, the data were analysed via profile analysis. Ecstasy user 
group was the sole independent variable and level of difficulty (three levels: semantic 
fluency --+ "S" letter fluency -+ "C" letter fluency) was the dependent variable. The 
interaction between user group and difficulty was non-significant, F(2,95) = 0.90, p>. 05 
for Pillai's trace. 
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Syllogistic Reasoning Performance in MDMA (Ecstasy) Users 
Catharine Montgomery, John E. Fisk, and Michelle Wareing and Philip N. Murphy 
Russell Newcombe Edge Hill College of Higher Education 
Liverpool John Moores University 
Previous research has demonstrated working memory and executive deficits in recreational 
users of MDMA (3,4-methylenedioxymethamphetamine; Ecstasy). In turn, both of these 
constructs have been implicated in syllogistic reasoning performance. Twenty-two MDMA 
users (mean age = 21.36) and 26 MDMA nonuser controls (mean age - 21.31) were tested 
on syllogisms of varying difficulty and on measures of working memory and executive 
functioning. MDMA users were significantly impaired in aspects of syllogistic reasoning, and 
the effect remained significant after the authors controlled for the use of other drugs. 
However, the MDMA-related variance was reduced to below statistical significance follow- 
ing control for group differences in working memory span. The results are consistent with the 
possibility that MDMA-related deficits in aspects of executive functioning result in impaired 
reasoning performance among MDMA users. 
Syllogistic reasoning performance in populations of those 
not using drugs has been shown to rely on working memory 
and executive resources (Fisk & Sharp, 2002; Gilinsky & 
Judd, 1994). The purpose of the present study was to estab- 
lish whether MDMA-related deficits in these aspects of 
cognitive functioning (Curran & Travill, 1997; Morgan, 
McFie, Fleetwood, & Robinson, 2002) might give rise to 
syllogistic reasoning deficits. Because syllogistic reasoning 
is generally regarded as an indicator of the capacity for 
rational thought, MDMA-related deficits on this measure 
raise the possibility that extensive use of MDMA might be 
associated with impaired rational thinking. 
A key construct in cognitive psychology is Baddeley's 
(1986) model of working memory. The model consists of 
phonological and visuospatial components and an executive 
system that coordinates these and is responsible for manag- 
ing goal-directed behavior and reconciling processing con- 
flicts. The working memory system is believed to underpin 
a wide range of key cognitive processes, for example, 
learning to read (Hitch, Towse, & Hutton, 2001), the devel- 
opment of arithmetic competence (Hitch et al., 2001; Trbo- 
vich & LeFevre, 2003), knowledge and skill acquisition 
(Head, Raz, Gunning-Dixon, Williamson, & Acker, 2002), 
and thinking and reasoning (Stanovich & West, 2000). 
Previous and current MDMA users have been found to 
exhibit impairments in working memory functioning. For 
example, Wareing, Fisk, Murphy, and Montgomery (2004) 
found that MDMA users were impaired on the computation 
span measure. Computation span is an established indicator 
of working memory functioning loading on both the pho- 
nological and executive components (Salthouse & Babcock, 
1991). Wareing, Fisk, et al. (2004) observed that MDMA 
users were impaired specifically on the executive compo- 
nent of the task. MDMA-related deficits have also been 
found in other aspects of executive functioning, for exam- 
ple, the subtracting serial sevens task (Curran & Travill, 
1997) and the Tower of London task (Fox et al., 2002). 
An important area of cognitive functioning that has not 
been directly addressed with regard to MDMA users is 
reasoning. Of the broad range of intellectual abilities that 
has been investigated, reasoning is perhaps the most cogni- 
tively demanding. There is cause to believe that among the 
many illicit drugs commonly in use, MDMA in particular 
has the potential to disrupt reasoning processes. The drug is 
believed to have long-terni adverse effects on the serotonin 
system (Morgan, 2000). In turn, the serotonin system is 
believed to underpin the operation of working memory 
processes through its modulation of the dopaminergic sys- 
tems that support prefrontal executive processes (Luciana, 
Collins, & Depue, 1998; Robbins, 2000), Indeed, in his 
review of the literature, Morgan (2000) noted that "it has 
been proposed that it [serotoninj may play an orchestrating 
role in cognition" (p. 234). However, the possibility that 
MDMA users might be impaired in reasoning, and more 
specifically in syllogistic reasoning, has not yet been 
investigated. 
Syllogistic reasoning requires a participant to draw valid 
inferences from a set of premises. For example, 
Catharine Montgomery, John E. Fisk, and Russell Newcombe, 
School of Psychology, Liverpool John Moores University, Liver- 
pool, United Kingdom; Michelle Wareing and Philip N. Murphy, 
Department of Social and Psychological Sciences, Edge Hill Col- 
lege of Higher Education, Lancashire, United Kingdom. 
Correspondence concerning this article should be addressed to 
John E. Fisk, School of Psychology, Liverpool John Moores Uni- 
versity, 15-21 Webster Street, Liverpool L3 2ET, United King- 
dom. E-mail: j. e. tisk@livjm. ac. uk 
Given that: Some A are D. 
and 
No B are C 
It follows that: Some A are not C. 
Johnson-Laird (1983) maintained that reasoning involves 
constructing mental models of the premises and testing 
conclusions against these models. Constructing a single 
model may solve some problems, but other problems may 
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require up to three models. ' The more complex the problem, C 
the greater number of models required and the greater the 
load on working memory and executive resources. Syllo- 
gistic reasoning is also believed to utilize resources outside 
of working memory, for example, relations between linguis- 
tic concepts such as "all, " "some, " and the logical operator 
"not, " as well as spatial representations of class inclusion 
relationships (see, e. g., Ford, 1995). 
Among the different measures of reasoning competence, 
syllogistic reasoning is perhaps one of the best known. It 
was central in the development of Johnson-Laird's mental 
models theory (Evans, Handley, Harper, & Johnson-Laird, 
1999; Johnson-Laird, 1983). Within a developmental con- 
text, it has been used as a key indicator of reasoning 
competence in early childhood (Lourengo & Machado, 
1996) and over the adult life span (Fisk & Sharp, 2002; 
Gilinsky & Judd. 1994). Syllogisms have also featured 
prominently in the debate on human rationality (e. g., 
Stanovich & West, 2000). Given that MDMA use has been 
associated with impaired working memory and executive 
functioning and that these cognitive constructs are believed 
to underpin syllogistic reasoning performance (e. g., see Fisk 
& Sharp, 2002; Gilhooly, Logie & Wynn, 1999), it seems 
reasonable to expect MDMA users might be impaired on 
this measure of reasoning ability. 
In evaluating the potential effects of MDMA, controls for 
the effects of other drugs, especially cannabis, are neces- 
sary. Cannabis has been found to adversely affect several 
aspects of executive functioning, including the organization 
and integration of information (Hall & Solowij, 1998), 
verbal fluency performance (Croft, Mackay, Mills, & Gru- 
zelier, 2001; Klugman, Hardy, Baldeweg, & Gruzelier, 
1999), and among heavy users, perseveration errors on the 
Wisconsin Card Sorting Test (Pope & Yurgelun-Todd, 
1996). Although there is no direct evidence that cannabis 
affects syllogistic reasoning, because the drug appears to 
impair certain executive processes, it is possible that rea- 
soning might be affected as a consequence. In the present 
study, we therefore attempt to control for the effects of 
cannabis and other drugs. 
In summary, we expected MDMA users to perform worse 
compared with controls in a syllogistic reasoning task and 
the MDMA-related deficit to be most pronounced on the 
two- and three-model syllogisms because these load most 
heavily on working memory and executive resources. Anal- 
ysis of covariance (ANCOVA) was used to investigate the 
extent to which MDMA-related differences in syllogistic 
reasoning are related to group differences in working mem- 
ory capacity and executive functioning. Working memory 
and executive functioning were assessed through a compu- 
tation span task and through random letter generation. 
Method 
)gy joint students. Subsequently, word-of-mouth referral 
was 
ised, with most participants being recruited by this means. 
Partic- 
pants were requested to refrain from MDMA use 
for at least 7 
lays and ideally 10 days prior to testing (the mean period of 
abstinence was actually 4.61 weeks). Participants were also re- 
quested not to use any other illicit drugs for at least 
24 hr and 
ideally for 7 days prior to testing. 2 Participants were paid U. 
K. £l5 
(U. S. $27) in store vouchers for their participation. 
Materials 
Fluid intelligence was measured through Raven's progressive 
matrices (Raven, Raven, & Court, 1998). Premorbid intelligence 
was assessed through the National Adult Reading Test 
(NART, 
Nelson, 1982). A background questionnaire used by Montgomery. 
Fisk, and Newcombe (2004) assessed the use of MDMA and other 
drugs as well as age, years of education, general health, and other 
lifestyle variables. In relation to other drugs, among other things, 
participants were asked to indicate their frequency of use and the 
last time that they had used each drug. Cigarettes smoked per day 
and units of alcohol consumed each week were also assessed. 
Participants were also questioned concerning their history of 
drug 
use. Using a procedure developed by Montgomery et al. (2004), 
we used these data to estimate total lifetime use for each drug. 
Syllogistic reasoning. The syllogisms were presented in ab- 
stract form as in the example set out above. Participants attempted 
to generate solutions for 4 one-model syllogisms, 4 three-model 
syllogisms, and 4 syllogisms for which there was no valid conclu- 
sion (NVC). The syllogisms were the same as those used by Fisk 
and Sharp (2002). Scores were based on the number of correct 
solutions, or in the case of the NVC syllogisms, a response was 
deemed correct when the participant indicated that no valid con- 
clusions were possible. According to Johnson-Laird (1983), NVC 
syllogisms require either two or three mental models in order to 
derive the correct solution. In the present study, 2 of the NVC 
syllogisms were two-model and 2 were three-model. Therefore, in 
terms of the number of models required, three-model and NVC 
syllogisms were the hardest, and one-model syllogisms were the 
easiest. The syllogisms used in the study were presented in random 
order. The test was administered following the procedure outlined 
by Fisk and Sharp (2002). 
Working memory and executive functioning. The computation 
span measure and random letter generation were used to assess 
these aspects of cognitive functioning. Computation span has been 
used as an indicator of working memory functioning in the cog- 
nitive aging literature (Fisk & Warr, 1996; Salthouse & Babcock, 
1991), and it is similar to the operation span measure used by 
Miyake et al. (2000) in their investigation of executive processes. 
Participants were required to solve a number of arithmetic prob- 
lems (e. g., 4+7= ?) by circling one of three multiple-choice 
answers as each problem was presented. They were also required 
to simultaneously remember the second digit of each presented 
problem. At the end of each set of problems the second digits had 
to be recalled in the order in which they were presented. The 
number of arithmetic problems that the participant had to solve 
while remembering each second digit gradually increased as the 
Participants 
Twenty-two MDMA users (11 men, 11 women) and 26 MDMA 
nonuser controls (10 men, 16 women) between the ages of 18 
and 25 were recruited. Participants were initially recruited through direct approach to Liverpool John Moores University undergrad- 
uate students, including psychology majors and psychology-biol- 
1 Although a full description of the distinction between one-, 
two-, and three-model syllogisms is beyond the scope of the 
present article, such a description can be found in Fisk and Sharp 
(2002, pp. 1274-1275) and Johnson-Laird (1983, pp. 98-100). 
'For those persons using other illicit drugs, the mean period of 
abstinence in weeks was 62.24 for amphetamine, 4.55 for canna- 
bis, 6.47 for cocaine, 62.98 for magic mushrooms, and 17.71 for 
poppers. 
SYLLOGISTIC REASONING IN MDMA USERS 
test proceeded. For each of the first three trials only a single 
problem was presented. For the next three trials, two problems 
were presented. Subsequently, the number of problems presented 
per trial increased by one every third trial. In order to proceed, the 
participant was required to be correct in at least two of the three 
trials at the current level. Computation span was defined as the 
maximum number of end digits recalled in serial order, with the 
added requirement that the corresponding arithmetic problems had 
been solved correctly. Because computation span is reliant on both 
phonological and executive processing resources, a simple digit 
span task (Fisk & Warr, 1996) was also administered so that it 
could be ascertained that any observed MDMA-related deficits 
were not simply a result of lower level nonexecutive impairments 
(i. e., the phonological loop). 
Random generation is an established measure of executive func- 
tioning. For example it features prominently in both Baddeley's 
(1996) and Miyake et al. 's (2000) accounts of executive processes, 
and by use of the dual task methodology, it has been studied 
directly in relation to syllogistic reasoning performance (Gilhooly 
et al., 1999). We used the procedure developed by Baddeley 
(1966). However, a computer display and concurrent auditory 
signal were used to pace responses. Participants were asked to 
speak aloud a letter every time the signal was presented. They were 
told to avoid repeating the same sequence of letters, to avoid 
producing alphabetical sequences, and to try to speak each letter 
with the same overall frequency. Individuals attempted to produce 
three sets of 100 letters: one set at a rate of I letter every 4 s, a 
second set at 1 letter every 2 s, and a third set at I letter every I s. 
The order in which the sets were generated was randomized. The 
experimenter recorded the responses on an answer sheet. The test 
yields four scores: first, the number of alphabetically ordered pairs; 
second, a repeat sequences score, corresponding to the number of 
times that the same letter pair is repeated; third, a redundancy 
score, which measures the extent to which all 26 letters of the 
alphabet are produced equally often (0% being truly random); and 
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fourth, the number of letters produced. In the first three cases, 
higher scores indicate poor performance; in the fourth the opposite 
is the case. The scores for each separate variable at each of the 
three generation rates were standardized. A single random gener- 
ation score for each participant was produced by averaging the 
standardized scores and reversing the sign for the number of letters 
generated so that for the overall measure a positive score was 
indicative of poor performance. 
Sleep quality. Research has shown that MDMA users exhibit 
altered sleep patterns, with less total sleep time and qualitative 
changes in the characteristics of Stage lI sleep (Allen, McCann, & 
Ricaurte, 1993). It has been suggested that apparent MDMA- 
related cognitive deficits might simply be due to the fact that 
MDMA users get less sleep (Cole, Sumnall, & Grob, 2002). To 
assess this possibility, we used a screening questionnaire and the 
Epworth Sleepiness Scale (Johns, 1991) to investigate any group 
differences in sleep quality and wakefulness. The Epworth Sleep- 
iness Scale measures subjective daytime sleepiness. It contains 
eight items, which a participant has to score on a scale of 0 (would 
never doze off in this situation) to 3 (high chance of dozing off in 
this situation). Summing the responses to all eight items produced 
an overall total score. The screening questionnaire contained a 
number of questions on sleep quality, as detailed in Table 1. 
Procedure 
Informed consent was obtained. The tests were administered 
under controlled laboratory conditions. A computer using MS- 
DOS was used for the digit span, computation span, and random 
letter generation tests. Tasks were administered in the following 
order: health-education questionnaire, MDMA background qucs- 
tionnaire and sleep questionnaire, random letter generation. digit 
span test, computation span test, syllogistic reasoning test, NART, 
and Raven's progressive matrices, The order of the random gen- 
Table 
Performance of MDMA Users (n - 22) and Nonusers (n = 26) on Background Variables 
Variable M 
MDMA user 
SD Mdn. %M 
MDMA nonuser 
SD Mdn. % 
Age (years) 21.36 1.67 21.31 1.69 
Education (years) 15.05 2.84 15.96 1.89 
Raven's total score' 47.43 6.53 48.28 5.52 
NART 27.95 7.60 30.19 6.07 
Digit span 6.52 1.21 6.88 1.21 
Computation span 3.00 1.58 4.88 1.63** 
Random generation 0.05 0.38 -0.09 0.28 
Self-report health 4 4 
Epworth Sleepiness Scale (total score)" 5.33 2.67 6.50 2.53 
Screening questionnaire 
Sleep (hours per night) 8.09 1.49 8.10 0.85 
Sleep refreshed` 2 2 
Sleep quality' 2 2 
Sleep morning/evening type (neutral/morning type)' 23 46'" 
Sometimes miss out a night's sleep 86 73 
Note. t tests were used to analyze age, education, Raven's total score, digit span, computation span, and random generation. Mann-Whitney U tests were used to analyze self-report health, sleep refreshed, sleep quality, and sleep morning/evening type. Chi-square 
tests were used to analyze sometimes miss out a night's sleep. NART - National Adult Reading Test (Nelson, 1982). 
u Raven et at. (1998). b Johns (1991). ° Sleep refreshed represents "How refreshed do you feel in the morning? " Response options are 
1= very alert, 2= fairly alert, 3= fairly tired, and 4= very tired. "s Sleep quality represents "}tow well do you normally sleep at 
nights? " Response options are I= very well, 2- satisfactory, 3- not very well', and 4- very badly. ' Sleep morninglevening type 
represents "We hear about people who feel better In the morning or who feel better in the evening. Which of these two types do you think 
you are? " Response options are I= definitely a morning type, 2= more morning than evening, 3- neither one nor the other, 4 more 
evening than morning, and 5= definitely an evening type. 
wp<. 05. r*wp<. 001, 
'. 
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Bration, computation span, and syllogistic reasoning tests was 
rotated to eliminate order effects. Overall, testing took between 2 
hr and 3 hr, at the end of which the participant was debriefed and 
provided with drug education leaflets. The study was approved by 
the Ethics Committee of Liverpool John Moores University and 
was administered in accordance with the ethical guidelines of the 
British Psychological Society. 
Design 
A mixed design was used with MDMA user group (with two 
levels, user and nonuser) as the between-participants variable and 
level of difficulty of the syllogism (again with two levels, low and 
high) as the within-participants variable. Level of difficulty was 
based on the number of models required to derive a solution. Thus, 
one-model syllogisms were low in difficulty. Because the NVC 
and three-model syllogisms require a similar number of models to 
produce a solution, responses for these types were combined to 
fonn the high difficulty level. The dependent variable was the 
number of correct solutions for the low and high difficulty syllo- 
gisms (maximum score was eight in both cases). We also sought to 
determine whether the main effect of user group was qualified by 
a User X Difficulty interaction. In common with established prac- 
tice, ANCOVA was used to statistically control for group differ- 
ences in potentially confounding or moderating variables (e. g., see 
Fisk & Sharp, 2002; Morgan, 1999; Verkes et al., 2001; Wareing, 
Murphy, & Fisk. 2004). Thus, where appropriate, indices of other 
drug use, sleep quality, and working memory measures were 
included as covariates. 
Results 
Background Variables 
Average age, years of education, fluid intelligence, pre- 
morbid intelligence, and other background variables for the 
two groups are set out in Table 1. Statistical tests (analysis 
of variance, t test, Mann-Whitney U, and chi-square) re- 
vealed that there were some significant group differences 
among the background variables. MDMA users performed 
worse than did nonusers on the computation span test, F(I, 
45) = 15.92, p< . 001. With regard to wakefulness, most 
users considered themselves to be evening types, whereas 
nonusers made neutral responses or stated that they were 
morning types (Mann-Whitney U= 181.50, p< . 
05). 
Inspection of Table 2 reveals that the use of other drugs 
was commonplace among MDMA users, whereas among MDMA nonusers, drug use was mainly limited to alcohol, 
cannabis, and tobacco. There were large differences be- 
tween MDMA users and MDMA nonusers in the total 
number of cannabis joints smoked, the mean period of 
abstinence from cannabis, and the frequency of cannabis 
use. For total number of joints smoked and period of absti- 
nence these differences were nonsignificant, 420) = 0.92, 
and t(11) = -1.53, respectively, p> . 
05 in both cases, In both cases standard deviations were large and Levene's test 
was significant in relation to period of abstinence. Clearly, 
these nonsignificant results need to be treated with caution 
given the relatively small number of cannabis users among the MDMA nonuser group. The group difference 
was significant for frequency of cannabis use. 
1(14.98)=2.94, p<. 05. 
Syllogistic Reasoning: Main Analysis 
Table 3 reveals that MDMA users performed worse than 
did nonusers on both the one-model and three-model/NVC 
syllogisms, although in the latter case the group difference 
was less pronounced. Mixed analysis of variance yielded a 
significant Models X User interaction, F(l, 46) = 5.56, p< 
. 05, with an effect size of 
10.8% (i. e., partial q2= . 108). 
Subsequent analyses revealed that MDMA users performed 
significantly worse on the one-model syllogisms, F(1, 
46) = 11.24, p< . 
01, but there was little difference between 
the groups on the three-model/NVC problems (F < 1). 
Covariate Analyses 
Working memory and executive functioning. It is pos- 
sible that the observed MDMA-related deficit in syllogistic 
reasoning might be mediated by working memory compo- 
nents. MDMA users performed significantly worse than did 
nonusers on the computation span measure. ANCOVA with 
computation span as a covariate generated a significant 
result with respect to computation span, F(1,44) = 7.23, 
p< . 
05. Consistent with this, the interaction effect between 
MDMA user group and models on syllogistic reasoning was 
reduced to below statistical significance after we controlled 
for differences in computation span, 3 F(1,44) = 2.41, p> 
. 
05, and the effect size was reduced to 5.270, approximately 
half its original magnitude. The main effect of user group 
was also reduced to below statistical significance° (F < 1). 
By way of contrast, ANCOVA with random letter genera- 
tion as a covariate generated a nonsignificant result with 
respect to random generation (F < 1). The interaction effect 
between group and models on syllogistic reasoning re- 
mained significant after we controlled for random genera- 
tion, F(l, 45) = 4.59, p< . 
05, and at 9.3% the effect size 
was barely reduced at all. In both analyses the Group X 
Covariate interactions were nonsignificant (F < 1), indicat- 
ing that homogeneity of regression was obtained. 
Sleep quality. As noted above, with regard to whether 
individuals viewed themselves as morning or evening types, 
relative to nonusers MDMA users were more likely to see 
themselves as evening types. To establish whether this 
outcome had any effect on group differences in reasoning 
performance, we entered each participant's ordinal response 
for the sleep type variable (ranging from 1= definitely a 
morning type to 5= definitely an evening type) as a covari- 
ate, and the main analysis was repeated. This produced a 
nonsignificant result with respect to the covariate (F < 1), 
and the Groups X Models interaction effect on syllogistic 
reasoning remained significant, F(1,45) = 4.52, p< . 
05. 
3 Control for digit span produced no substantial degree of at- 
tenuation. The interaction between group and models remained 
significant, F(l, 44) - 6.03. p< . 03, with the effect size 12.0%. Prior to the inclusion of computation span as a covariate, the 
main effect of user group yielded F(1,46) 6,41, p< . 
05. 
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Table 2 
History of Drug Use 
MDMA user MDMA nonuser 
History M SD nm SD np 
MDMA 
Lifetime use 
Tablets consumed 303.30 374.04 22 
Length of use (weeks) 164.82 99.58 22 
Current use 
Weeks since last use 4.61 6.82 22 
Frequency of use (times/week) 0.47 0.40 22 
Other drugs 
Lifetime use 
Amphetamine (g) 102.20 220.14 5 
Cannabis (joints) 4,700.44 7,040.93 16 1,986.00 1,883.40 6 ns 
Cocaine (g) 56.84 79.26 11 - - -- 
Current use 
Cigarettes (number/day) 9.62 4.19 13 11.50 4.87 5 ns 
Alcohol (units/week) 21.82 11.14 22 11,83 8.19 26 *** 
Cannabis (times/week) 2.58 2.54 15 0.63 0.31 6* 
Cocaine (times/week) 0.76 0.54 11 - - -- 
Weeks since last use 
Amphetamine 62.24 92.89 10 
Cannabis 1.68 4.64 18 9,23 15.99 11 ns 
Cocaine (times/week) 6.75 15.53 16 2.00 t 
Mushrooms 62.98 66.75 7 - - -- 
Poppers 15.91 18.17 19 52.00 1 
History % of MDMA users % of MDMA nonusers 
Other drugs used during 3 months 
prior to testing 
Alcohol 100 100 
Amphetamine 14 0 
Cannabis 86 46 
Cocaine 50 4 
Mushrooms 9 0 
Poppers 46 4 
Tobacco 55 23 
Note. Means and standard deviations relate only to those individuals taking the drug in question. Dashes indicate either cases in which 
individuals were only occasional users and were unable to provide an accurate estimate of their lifetime use or cases in which there were 
no users of the illicit drug in question. 
*p<. 05. ***p<. 001. 
Homogeneity of regression was obtained (F < 1) for the 
Group X Covariate interaction. Thus, it appears that group 
differences in aspects of sleep quality were not responsible 
for the MDMA-related impairments in syllogistic reasoning 
performance. 5 
Other drugs. It was necessary to establish whether the 
prevalence of polydrug use, especially among the MDMA 
user group (see Table 2), contributed to the MDMA-related 
differences in reasoning performance. ANCOVA with fre- 
quency of cannabis use as a covariate6 reduced the interac- 
tion between group and models to below statistical signifi- 
cance, F(1,45) = 2.15, p> . 05, The main effect of user 
group was also reduced to below statistical significance, 
F(1,45) = 2.57, p> . 05. Homogeneity of regression was 
obtained (F < 1) for the Group X Covariate interaction. 
However, subsequent ANCOVA with the number of correct 
one-model syllogisms as the sole dependent variable, user 
group as the between-participants independent variable, and 
frequency of cannabis use as the covariate left the main 
effect of group statistically significant, F(1,45) - 4.64. p< 
. 05, and homogeneity of regression was obtained, F(1, 44) = 1.75, p> . 05, for the Group X Covariate interaction. The possibility that prolonged cannabis use might pro- 
duce a cumulative decrement in syllogistic reasoning per- 
formance was also evaluated. An estimate of lifetime can- 
It is possible that MDMA-related differences in the morning or 
evening type ratings may have played some role in producing the 
computation span group differences, thereby indirectly accounting 
for some of the syllogistic reasoning deficits. I lowever, ANCOVA 
with computation span as the dependent variable, MAMA user 
group as the independent variable, and the sleep measure as a 
covariate left the group difference in computation span and the 
corresponding effect size intact, F(l, 44) - 17.05, p< . 001. Thus, it appears that the sleep measure plays no role, either direct or 
indirect, in accounting for the syllogistic reasoning deficit. - "A value of zero was entered for those persons who had never 
consumed cannabis. 
ý1 
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Table 3 
Average Number of Correct Responses for One-Model 
Syllogisms and Three-Modet/NVC Syllogisms for MDMA 
Users (n = 22) and Nonusers (n = 26) 
MDMA Users MDMA nonusers 
Syllogisms M SD M SD 
One model 3.45 2.13 5.27 1.61** 
Three modelNVC 1.45 1.99 1.81 1.58 
overall % correct 30.62 44.25 
Note. For the 4 one-model problems (for which there were two 
valid conclusions per syllogism) and the 8 three-model/NVC syl- 
logisms (for which there was one valid conclusion per syllogism), 
the maximum possible score was eight. NVC = no valid conclu- 
sion. 
** p< . 01. 
nabis use was included as a covariate 7 and the main anal- 
ysis was repeated. The interaction between groups and 
models was reduced to just below significance, F(1, 
45) = 3.71, p= . 
061. However, the main effect of user 
group remained significant, F(1,45) = 3.77, p< . 
05, 
one-tailed, Homogeneity of regression was obtained (F < 1) 
for the Group X Covariate interaction. Again, subsequent 
ANCOVA with the number of correct one-model syllo- 
gisms as the sole dependent variable, user group as the 
between-participants independent variable, and lifetime 
cannabis use as the covariate left the main effect of group 
statistically significant, F(1,45) = 7.15, p< . 
05, and 
homogeneity of regression was obtained (F < 1) for the 
Group X Covariate interaction. 
In view of the fact that some of the participants, both 
MDMA users and nonusers, had smoked cannabis during 
the week prior to testing, for all cannabis users, time since 
last use of cannabis was correlated with performance on the 
syllogisms. This yielded nonsignificant correlation coeffi- 
cients of . 05 and . 07 for the one-model and three-modelt NVC syllogisms, respectively (p > 05, n= 29, in both 
cases). 
Thus, on balance it appears that the MDMA-related def- 
icits in syllogistic reasoning remain significant following 
statistical controls for various measures of cannabis use. Nonetheless, the possibility that cannabis exerts an influ- 
ence cannot be entirely excluded. The correlation coeffi- 
cient between lifetime use of cannabis and performance on 
the one-model syllogisms was -0.36 (p <. 05). This com- 
pares with a correlation of -0.40 (p < . 01) between life- time use of MDMA and performance on the one-model 
syllogisms (for the three-model/NVC syllogisms neither of 
the equivalent correlations were statistically significant). Whereas 55% of MDMA users smoked cigarettes, only 23% of nonusers were smokers, Therefore it is possible tha 
users might have been more susceptible to nicotine depri 
vation during testing. Furthermore, whereas both group 
consumed alcohol regularly, MDMA users consumed al 
most twice as many units per week compared with nonuser; To evaluate the potentially confounding effects of then 
variables, the number of cigarettes consumed per day an the units of alcohol per week were entered as covariate The interaction between groups and models was reduced t 
just below significance, F(I, 44) = 3.54, P =-- 067. How- 
ever, the main effect of user group remained significant, 
F(l, 44) = 7.45, p< . 01, and homogeneity of regression 
was obtained (F < 1) for the two Group X Covariate 
interactions. 
With regard to the use of other illicit drugs, Table 2 
reveals that MDMA users had previously consumed am- 
phetamine and "mushroorns, " In addition, they were cur- 
rently also consuming "poppers" and cocaine. It would have 
been desirable to statistically control for the effects of these 
other drugs; however, there were insufficient users of them 
among the MDMA nonuser group to perform ANCOVA 
because it was not possible to properly test for homogeneity 
of regression, To try to distinguish the effects of the indi- 
vidual drugs, we conducted multiple regression analysis, 
Two separate regressions were run, the first with the number 
of correct responses on the one-model syllogisms as the 
dependent variable and the second with the number of 
correct responses on the three-model/NVC syllogisms as the 
dependent variable. For both regressions, independent vari- 
ables were estimates of lifetime consumption of amphet- 
amine, cannabis, cocaine, and MDMA. 8 For the one-model 
syllogisms the regression model accounted for a significant 
proportion of the variance, R2 = 243, F(4,43) = 3.45, p< 
. 05, However, the regression model failed to reach signifi- 
cance for the three-model/NVC syllogisms (R' = . 063, 
F< 
1). Examination of Table 4 reveals that for the one-model 
syllogisms, total lifetime use of MDMA was the only Sig- 
nificant predictor, uniquely accounting for around 7% of the 
variance, With the exception of total use of cannabis, the 
standardized beta coefficients were negative for all of the 
predictors, indicating that performance on the one-model 
syllogisms declines as lifetime consumption of each of the 
predictors increases. 
In situations in which ANCOVA cannot be used and as 
an alternative to regression analysis, a further method to 
control for the potentially confounding effects of these other 
drugs is to exclude all users of each drug in turn and 
reanalyze the data. Although this technique has its limita- 
tions in that it ignores the likelihood that there are correla- 
tions between the use of these other drugs, nonetheless it 
does provide at least some degree of control for their use. 
Therefore the main analysis, with user group as the be- 
tween-participants variable and models as the within-partic- 
ipant variable, was repeated, excluding all those who had 
used a particular substance during the last 3 months. This 
was done with respect to amphetamine, cocaine, mush- 
rooms, poppers, and tobacco, 
In all but one case this reduced the Group X Models 
interaction to below statistical significance, Specifically, F 
t values for the models by user group interaction were as follows: F(I, 43) = 3.46, p= . 07, excluding amphetamine users; F<1, excluding cocaine users, F(l, 44) = 6.69, p< 
1A value of zero was entered for those persons who had never 
consumed cannabis, 
e It is difficult to meaningfully quantify lifetime consumption of 
poppers; so this substance was not included in the regression 
analyses. 
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Table 4 
Results From Regression Analysis With Number of 
Correct Syllogism Responses as Dependent Variables and 
Measures of Lifetime Use of Other Drugs as Independent 
Variables 
independent Standardized Squared semipartial 
variable beta weight t(47) correlation coefficient 
Correct one-model syllogisms 
Total lifetime use 
Amphetamine -. 260 -0.65 . 007 Cannabis . 197 0.66 . 008 Cocaine -. 175 -0.55 . 005 MDMA -. 408 -2.03* . 072 
Correct three-model/NVC syllogisms 
Total lifetime use 
Amphetami nc -. 639 -1.43 . 045 Cannabis . 179 0.54 . 006 Cocaine . 445 1.25 . 034 MDMA -. 246 -1.10 . 026 
Note. NVC = no valid conclusion. 
*p< . 05. 
. 
05, excluding mushroom users; F(1,35) = 1.75, p> . 
05, 
excluding poppers users; and F<1, excluding tobacco 
users. However, in each of the analyses the main effect of 
MDMA user group remained statistically significant, with 
MDMA users obtaining fewer correct responses compared 
with nonusers. F values were as follows: F(1,43) = 4.39, 
p< . 
05, excluding amphetamine users; F(1,34) = 12.31, 
p< . 
01, excluding cocaine users; F(1,44) 5.3 1, p< . 
05, 
excluding mushroom users; F(1,35) = 10,29, p< . 
01, 
excluding poppers users; and F(1,28) = 4.92, p< . 
05, 
excluding tobacco users. For MDMA users and MDMA 
nonusers sample sizes were 19 and 26, respectively, exclud- 
ing amphetamine users; 11 and 25 excluding cocaine users; 
20 and 26 excluding mushroom users; 12 and 25 excluding 
poppers users; and 10 and 20 excluding tobacco users. 
Thus, by way of summary, in relation to the possible 
confounding effects of these other drugs, the main effect of 
MDMA user group remained significant when the analyses 
were rerun excluding users of each of the other drugs in 
question. Furthermore, in the regression analyses, among 
the total use variables that were included as independent 
variables, only MDMA proved to be significant as a pre- 
dictor of performance on the one-model syllogisms. 
Discussion 
As expected, the present results demonstrate an MDMA- 
related deficit in syllogistic reasoning. Furthermore, because 
the average reported period of abstinence was 4.61 weeks, 
the results observed are unlikely to be a short-term conse- 
quence of using the drug. Contrary to expectations, there 
was no group difference between the NVC and three-model 
syllogisms. MDMA users did, however, perform signifi- 
cantly worse than did nonusers on the one-model syllo- 
gisms. The absence of group differences on the NVC and 
three-model syllogisms is difficult to reconcile with John- 
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son-Lai'rd's (1983) account of mental models theory. It does 
however provide further support for Evans et al. (1999), 
who maintained that individuals generally construct only a 
single mental model of the premises and fail to search for 
alternatives. From either perspective, for both one-model 
and more complex syllogisms, the premises need to be 
retained so that alternative possible conclusions can be 
accepted or rejected in the context of the initial mental 
model and the contents of working memory can be updated 
as necessary. The MDMA-related deficit evident in the 
one-model context appears to be consistent with soine de- 
gree of impairment in this process, In the three-modeVNVC 
situation, in which according to Evans et al. (1999) only a 
single model is constructed, this model does not itself con- 
stitute an exhaustive representation of the implications of 
the premises, and for both users and nonusers, most infer- 
ences derived from it are therefore likely to be erroneous. 
Therefore, consistent with the findings reported here, group 
differences would not be expected on the three-model/NVC 
problems. Apart from the present findings, other evidence 
has been obtained consistent with Evans et al, 's (1999) 
conceptualization of reasoning processes, For example, 
Newstead, Thompson, and Handley (2002) have demon- 
strated that many individuals do not proceed beyond the 
initial model of the premises, relying solely on it when 
constructing their inference (Newstead,. Handley, & Buck, 
1999; Newstead et al., 2002). Similar findings have been 
repoiled also by Handley, Dennis, Evans, and Capon 
(2000). 
It is possible that any group differences in syllogistic 
reasoning were due to reduced working memory and exec- 
utive resources rather than a specific deficit in underlying 
reasoning competence. Computation span was significantly 
lower in MDMA users, and when included as a covariate, 
this measure accounted for half of the MDMA-related vari- 
ance in syllogistic reasoning. This' suggests that the 
MDMA-related deficit in syllogistic reasoning might be 
attributable to executive impairment rather than a conse- 
quence of some fundamental deficit in underlying reasoning 
competence. However, this is not to minimize the implica- 
tions of the present findings, Even if it is the case that 
underlying reasoning competence remains intact in MDMA 
users, given that they lack the executive resources to make 
full use of this capacity, they are still likely to exhibit 
impairments in the capacity for rational thought. 
It is worthy of note that although there were MDMA- 
related differences in computation span, no such trend was 
evident in the random letter generation scores, and inclusion 
of the latter as a covariate did not attenuate the group 
differences in reasoning performance. In fact, previous rc- 
search has shown that performance on the two working 
memory executive measures is not invariably correlated 
(Lchto, 1996; Miyake et al., 2000), and it has been argued 
that each measure loads on a qualitatively different aspect of 
executive functioning (Fisk & Sharp, 2004; Miyake et al., 
2000). Thus, the present results suggest that MDMA-related 
deficits are most apparent in those aspects of executive 
functioning captured by the computation span measure and 
that these deficits produce secondary effects on reasoning 
performance. 
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A number of background variables were considered in the 
present study, including various measures of sleep and t 
wakefulness. These appear to play no part in the group I 
differences in syllogistic reasoning that were obtained. 
However, the measures that were used were largely self- I 
reported, and it remains possible that more physiologically i 
based measures might have produced a different outcome. I 
Therefore the possibility that sleep impairment mediates 
some or all of the MDMA-related effects cannot be totally 
excluded. 
An important aspect that was addressed in the present 
study was the potentially confounding effect of other drugs. 
The use of other drugs was much more common among the 
MDMA user group, and with a few exceptions, the use of 
other drugs among the MDMA nonuser group was limited 
to alcohol, tobacco, and cannabis, ANCOVA with various 
measures of alcohol, tobacco, and cannabis use as covari- 
ates were conducted, and in all cases, at least in relation to 
the one-model syllogisms, MDMA users remained signifi- 
cantly impaired. Furthermore, regression analysis revealed 
that measures of total use of cocaine and amphetamine were 
not significant predictors of performance on the one-model 
syllogisms; indeed, total use of MDMA was the only sig- 
nificant predictor. Although these results highlight the im- 
portance of MDMA in accounting for the results obtained, 
the possibility that other drugs might exert some impact 
cannot be totally excluded. For example, total cannabis use 
among the whole sample was significantly and negatively 
correlated with performance on the one-model syllogisms. 
It remains unclear whether this potential cannabis-related 
effect is mediated through executive or nonexecutive pro- 
cesses. We find it interesting that in the population of those 
not using drugs, Fisk and Sharp (2002) found that syllogis- 
tic reasoning performance was positively correlated with 
word fluency scores. In turn, it has been suggested that word 
fluency taps an important aspect of executive functioning- 
access to semantic memory (Fisk & Sharp, 2004). Although 
there is little evidence to link MDMA with impaired word 
fluency performance, cannabis use has been found to pro- 
duce such an effect (e. g., Croft et al., 2001; Klugman et al., 1999). Thus, it is possible that cannabis impairs this aspect 
of executive functioning, thereby producing a detrimental 
effect on syllogistic reasoning. However, it must be ac- knowledged that this possibility is speculative and requires further investigation. 
A number of limitations were evident in the present 
study; for example, we were reliant on individuals being 
willing and able to provide an accurate account of their 
previous drug use. Furthermore, it was not possible to 
quantify the amounts of each psychoactive drug present 
within the tablets or joints consumed, in addition, because 
of limited resources, we were unable to use urine, saliva, or hair samples to confirm recent patterns of drug use. How- 
ever, the drug use questionnaire was designed to check the internal consistency of the information provided. It is 
equally worthy of note hat most of the published studies 
that have probed cognitive deficits among MDMA users have not resorted to urine, hair, or saliva testing (e. g., Fox 
et al., 2002; Morgan, 1999; Parrott & Lasky, 1998; Rodgers, 
2000). 
Aside from the issue of drug testing, other limitations of 
he present study need to be acknowledged. 
For example, 
ifestyle differences and premorbid factors cannot 
be ex- 
cluded as possible sources of group differences 
in studies of 
this nature. MDMA users may neglect their diet and phys- 
ical health. Studies have reported that they suffer 
from a 
range of subclinical conditions, including depression, anx- 
iety, paranoia, and phobias (Morgan et at., 2002). 
Depres- 
sion and anxiety have been shown to impair cognitive 
functioning (Eysenck & Calvo, 1992; Murphy, Michael, 
Robbins, & Sahakian, 2003), and so it is possible that these 
aspects of psychological affect may have mediated some 
of 
the effects observed in the present study. This 
is clearly a 
possibility that needs to be addressed in future research. 
Furthermore, it has also been suggested that MDMA users 
are subject to a heightened state of impulsivity 
(Morgan, 
1998). In the present study, this may have resulted in 
responses being produced before their logical necessity 
had 
been thoroughly probed. It is also important not to over 
generalize from the present findings. For example, given 
that word-of-mouth referral was used as the primary means 
of recruiting participants, our MDMA user group may not 
be entirely representative of all MDMA users, especially 
those who consume the drug in settings that are unlike those 
frequented by those individuals constituting the present 
sample. 
In conclusion, the results of the present study show that 
syllogistic reasoning is impaired among MDMA users. 
This 
impairment may be a consequence of an MDMA-related 
decline in aspects of working memory and executive 
func- 
tioning. Furthermore, although the impairment appears tobe 
associated with MDMA use, it remains possible that other 
drugs, including cannabis, may also exert an influence either 
independently or in conjunction with MDMA. 
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Abstract Rationale%objectives: Research has revealed 
associative learning deficits among users of ecstasy; the 
present study explored the component processes under- 
lying these deficits. Methods: Thirty-five ecstasy users 
and 62 non-ecstasy users completed a computer-based, 
verbal paired-associates learning task. Participants at- 
tempted to learn eight sequentially presented word pairs. 
After all eight had been presented, the first member of 
ehch pair was displayed and participants attempted to 
recall the second. Eight trials were administered. Correct 
responses on each trial, forgetting at various levels of 
learning, perseveration errors and the rate at which the 
associations were learned (trials to completion) were all 
recorded. Results: MANOVA revealed that ecstasy users 
performed worse overall and subsequent ANOVAs showed 
that users performed significantly worse on virtually all 
measures. Regression analysis revealed that over half of 
the ecstasy-group related variance in trials to completion 
was attributable to group differences in initial learning 
and forgetting. In relation to forgetting, it appears that 
cannabis use may be an important determinant. In rela- 
tion to rate of learning (trials to completion) and initial 
learning, both ecstasy and cannabis may be implicated. 
Conclusions: There appears to be abundant evidence of 
associative learning deficits among ecstasy users. How- 
ever, it appears that a range of illicit drugs including 
cannabis and ecstasy may contribute to these deficits. 
Keywords Ecstasy " MDMA " Learning " Paired associate 
learning " Cannabis 
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Introduction 
Developing an understanding of relationships between 
concepts is a fundamental aspect of human learning. One 
key aspect of this is associative learning, which involves 
forming appropriate links between previously unrelated 
phenomena. The working memory system in general, and 
the executive in particular are essential components in 
learning new skills before they become automatic, so that 
learning and the acquisition of knowledge is dependent 
on working memory (Tanji and Hoshi 2001). The term 
associative learning describes the process by which an 
organism develops or reinforces connections between stim- 
ulus representations (Rose et al. 2001). Ecstasy users have 
been shown to exhibit deficits in aspects of working mem- 
ory functioning (e. g. Fisk et al. 2004; Wareing et al. 2004) 
and in view of the role of working memory and executive 
processes in supporting associative teaming it is possible 
that users might also experience impairments in learning 
processes. 
Much of the research in this domain has focussed on 
animal learning and to date the results have been equiv- 
ocal. While some studies have found MDMA-related 
deficits in aspects of learning (Broening et al. 2001; 
Frederick et al. 1995; Taylor and Jentsch 2001; Williams 
et al. 2003) others have not (Frederick and Paule 1997; 
Ricaurte et al. 1993; Romano and Harvey 1993; Winsaeur 
et al. 2002). In a study examining learning in rats, 
Robinson et al. (1993) found that the extent of 5-1IT dener- 
vation (72.6%) was not sufficient to produce marked def- 
icits (this may be a sign of neurocompensatory changes). 
More generally, it is possible that the apparent lack of 
MDMA-related deficits in some animal studies is because 
the tasks are too simple, and they do not mirror teaming in 
humans. 
Although some studies in humans have investigated 
associative teaming, this is an area that is still under in- 
vestigated as a number of tasks used relate more to 
immediate and delayed recall, rather than the learning of 
associations. Gouzoulis-Mayfrank et at. (2003) used the 
word-pair teaming test of the LGT-3 test battery, which 
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requires participantý to 
I memorise 20 word pairs consisting non-uscrs. Ecstasy-reWed deficits were also observed on ' 
'6 of a Turkish word and it's German translation. In the trial 1, the total number of words recalled and trials " retrieval phase, participants had to identify the correct tvc con- and 8 in ex-ecstasy users compared to drug-na 
Turkish word corresponding to each German word (out of trols (Thomasius et al. 2003). 
five possible answers). Heavy ecstasy users performed A problem with research in this area is that the ecstasy- tvib- worse than non-users in the delayed recall of the word 
pairs, but not the immediate recall component. However, 
related dcricits observed may be, at least in Part, a 
utable to cannabis or the concomitant use of other drugs- 
the effect was reduced to below statistical significance Croft et al. (2001) used a battery of neuropsychological, 
after control for general knowledge scores. tests to compare a group of cannabis only users, a com- 
control group. No d Croft et al. (2001) studied the relative contributions of 
ecstasy and cannabis to spatial and non-spatial Paired 
a bined ecstasy and cannabis group, an 
signif scant differences were observed between the lccstasyl- 
Associates Learning (PAL). Participants were required 
to team associations between six spatial pairs (spatial) and 
cannabis and the cannabis only groups. However, a cOM' 
bined drug-using group (merging the cannabis Only and 
six colour pairs (non-spatial). The task began with the 
i 
ecstasy/cannabis group) performed worse than controls On it span), d di k part cipant guessing, then teaming the prompted associa- 
ti h 
g war working memory (forward and bac d recognition i on t rough feedback from the experimenter (yeeno). The ng an information processing, and learn 
task finished when the participant correctly reported 18 memory. The authors concluded that cannabis, not ccstisY, 
consecutive associations, and the number of guesses re- 
quired to get to this point was the score (maximum allowed 
was responsible for the deficits. However, the lifetime 
ecstasy dose of Croft ct al., s participants was only, 41.9 , was 180). No significant differences were observed be- ther tablets, which is relatively modest compared to 0 
tween the ecstasy/cannabis group and the cannabis only 
rou A bi d 
studies (e. g. Morgan et al. 2002 study in which users 
l C ft t al s Tcsults g p. com ne drug-user group performed significant- lY worse than controls on the non-spatial PAL. ANCOVA 
consumed over 500 tablets). Whi e ro C - 
appear to implicate cannabis use, Gouzoulis-May 
revealed that this effect was more due to cannabis than et al. (2000) found an ecstasy/cannabis group (with arý' 
ecstasy. However, the average cannabis abstinence period average lifetime dose of 93.4 tablets) to be impai rel 
was only 17 h so it was possible that participants were still tive to a cannabis-only and a non-user group in sclccti C intoxicated- Also, Croft et al. s participants only had a attention, a verbal teaming task, inunedi3tc visual, I 
modest lifetime dose of ecstasy. logical thinking and general knowledge. However. T110'e'-, Fox et al. (2002) also used a spatial PAL task in which recently Daftcrs et al. (2004) found that combined ecstasy--- 
Participants were required to learn the spatial locations of cannabis users, although worse than drug free controls abstract patterns. In the test trials, participants were first on various measures of episodic memory (free recall and required to learn six pattern-location pairs and then in the story recall), did not differ significantly from cannabis only, ' next trial eight pairings. No significant group differences . -,, users an any of the rneasures that were administered. were observed in the number of errors, the number of 
Presentations required per trial, or the memory score (total 
Furthermore, unlike Croft et al. 's study, Dafters et al-'ý 
included both a heavy and light ecstasy user group, both ()f: number of patterns successfully located on initial presen- which performed similarly and did not differ from the tatiOn). The group by trial interaction approached sig. 
nificance, and post-hoc tests revealed that the ecstasy 
cannabis-only users. This being the case, Dafters, ei al . 
(2004) maintain that the memory impairments Obt3 , 
ined 
group made a greater number of errors on the eight pair trials. Rodgers (2000) found that ecstasy users were un- 
were due to cannabis rather than ecstasy. In relation to the 
h f to consider the i d impaired during the initial learning phase of the verbal and 
ere ore , present stu t is important t y. 
extent to which cannabis and other drugs might contribUte, visual Paired associates sub-tasks of the Wechsler Memory Scale- However, subsequent deficits in the dela ed re ll 
to any apparent ecstasy-group related deficit in associative, 
l i y ca of the verbal and visual Paired associates were apparent 
earn ng. 
Thus the aim of the pre=t study is to determine'ifuscis among ecstasy users but not among cannabis-only users. In additi of ecstasy exhibit 
deficits in associative learning while- on to deficits in associative learning, basic attempting to control for the potentially confounding cl; verbal teaming deficits have also been observed using fects of other elicit drugs. In addition to the measures used the Rey Auditory Verbal Leaming Test (RAVLT). During by other researchers (mainly inu-nediate and delayed Mail trials 1-5, a list of 15 words is read to ParticiPantsý and of words). the test used in the present study assesses var-,, they are then required to recall as many words as possible io and the : us measures of forgetting, persevcrative errors, in any order, in trial 6 this is repeated with a new list of speed with which all associations are learned (trialS'10ý words (interference) Trial 7 i i . requ res part cipants to again completion) that have not yet been systematically inVes'_ recall the original list. Finally, participants are given a list tigated in ecstasy research The number of pairs rc e3tid', T . _-ý of words containing those from the first list with phonemic correctly on trial one gives a measure of initial. learning, and semantic distracto d i rs, an requ red to circle words that and the number of trials rcquircd for a participant to team, appeared in the first list. McCardle et al. (2004) f ound that all associations V'trials to completion") gives an overall ecstasy users Performed significantly worse than non-users indication of speed of learning. Forgetting at each IeVil'ý` on delayed recall (trial 7ý and R l eneman et a . (2000) found will also be recorded, whereby forgetting a response that that ecstasy users recalled signif IcantlY fewer words than had previously been recalled correctly once would indicate 
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Table I Age, years of educa- Ecstasy users Non-ecstasy users `i 3 
tion, intelligence, and sleep 
quality for ecstasy users and non Mean SD 
Mean SD =t 1, 
ecstasy users 
Age (years) 21.66 1.64 21.30 1.79 
Years of education 15.77 1.88 15.36 
2.12 
Ravens progressive matrices (maximum 60) 49.94 4.55 48.13 5.27 
NART (maximum 50) 28.91 5.98 29.76 5.80 
Hours sleep per night 8.11 1.56 8.01 1.27 
'The self-report health measure Epworth Sleep Scale (maximum 24) 6.38 3.38 5.97 3.03 
scores range from I (very poor) Self-report health' 3.74 0.74 3.84 0.81 to 5 (very good) 
1.0! 
After each presentation, the participant was prompted 
with the first member of each pair and required to recall 
the second member. Eight such trials were administered. 
The order of presentation was randomised and changed for 
each trial. Measures included the number of correct re- 
sponses in trial I (a measure of initial learning), forgetting 
at various levels, the number of trials required to learn 
all associations, and the number of perseverative errors 
(giving the same incorrect answer consecutively). 
Sleep quality A screening questionnaire and the Epworth 
Sleepiness Scale (ESS; Johns 1991) were used to in- 
vestigate any group differences in sleep quality. The ESS 
is a measure of subjective daytime sleepiness and contains 
eight items, which a participant has to score on a scale 
of 0 (would never doze off in this situation) to 3 (high 
chance of dozing off in this situation). A total score of 
all eight items was used in the analysis. The screening 
questionnaire contained a number of questions on sleep 
quality, e. g. hours per night, "how refreshed do you feel in 
the morning", in addition to relevant lifestyle questions 
relating to cigarette and alcohol consumption. 
Procedure 
Ir 
The tests were administered under controlled laboratory 
conditions. A computer running on MS-DOS was used for 
Jet 
the associative learning task. Tasks were administered in 
dý" 
the following order: health/education questionnaire, ecst? 
sy and drug use background questionnaire, sleep qu' "c 
tionnaires, associative learning, NART and finally Ravi 
nc 
Progressive Matrices. Overall, testing took 2-3 h ps.. V, 
person. The study was approved by the Ethics Committee 
dy 
of Liverpool John Moores University, and was adminis- 
tered in accordance with the ethical guidelines of the 
British Psychological Society. 
Table 2 Indicators of drug use Ecstasy users Non-ecstasy users among ecstasy users and non- 
ecstasy users Mean SD Number Mean SD Number 
Total use 
Ecstasy (tablets) 315.30 330.10 35 
Amphetamine (g) 4.00 3.86 8 4.00 -i 
Cannabis (joints) 2,128.71 2,401.96 26 1,082.54 1,439.33 18 
Cocaine (g) 18.96 22.03 15 -- Frequency of use (times per week) 
Ecstasy 0.40 0.34 35 
Amphetamine 0.04 0.04 5 -- Cannabis 2.45 2.40 25 0.77 0.90 18 
Cocaine 0.26 0.23 15 - Amount used during previous 30 days 
Ecstasy (tablets) 3.38 3.58 34 
Amphetamine (g) 1.20 2.68 5 -- Cannabis (joints) 17.52 18.26 24 7.91 11.03 16 
Cocaine (g) 1.23 1.77 13 -- Average weekly dose 
Ecstasy (tablets) 1.67 1.31 35 
Amphetamine (g) 0.10 0.20 8 0.01 -1 Cannabis (joints) 7.75 8.73 25 5.11 9.94 18 
Cocaine (g) 0.14 0.24 15 -- 
t 
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3 Performance on asso- 
+fr e learning measures for 
Cestas users Nnn-cest, axy uwro l"i, aw 
Y users and non-ecstasy Mean SD Mean SD 
Trials to completion 6111 1.94 4,32 1.46 26.540"" 
Number of correct responses in trial 1 2.97 2.01 4.32 2.01 10.1404 
` 
Number of pcrseverative responses 0,69 1.16 0.16 0.66 RA" " 
Number forgotten at 
Level I 0.86 1.03 0.39 0.75 6.610 
&; %, 
p 0 001 
Level 2 0.26 0.66 0.10 0.35 2.47 
, ý . `V 
Level 3 0.14 0.36 0.00 0.00 10.12 
. OI 
-OS 
Level 4 0.06 0.24 0.00 0,00 3.68 
: r'Oge age, years of education, fluid intelligence, pre- 
4ý"? id intelligence and other background variables for the 
41roups are set out in Table 1. Statistical tests (ANOVA, 
revealed that there were no significant differences 
6141 wen the groups regarding these variables, so they are discussed further. 
spection of Table 2 reveals that the use of other drugs 
commonplace among the ecstasy group, but was 
cted mainly to the use of cannabis among the control 
P. The Ecstasy users had a lifetime dose of cannabis 
y twice that of the controls (2,128 joints compared 
t. 082 joints), in addition to using it more frequently 
`ýiy S times per week, compared to 0.77 times), and 
ng smoked more in the last 30 days (17.52 joints 41 
tr pared to 7.91 joints). There were significant group * erences in the amount smoked in the last 30 days 
'k=2.07, and the frequency of use t32, s6=3.20, p<0.05 
týtý' 
bath 
cases. However, the difference in lifetime use 
not statistically significant: 141,31=1.80, p>0.05. (As 
ene's test was significant, degrees of freedom have 
been adjusted accordingly. ) The ecstasy group reported 
an average total lifetime dose of ecstasy of 315 tablets; of 
amphetamine, 4g (nv8); and of cocaine, 111.96 g (n-15). 
The average frequency of use for ecstasy was 0.4 times 
per week, and for cocaine, 0.26 times per week (n*15). 
Ecstasy users performed worse on all measures of as- 
sociative learning. Users required more trials to learn 
the pairings; they scored lower on the measure of initial 
learning (the number of correct responses on Trial 1); 
and they made more perseverative responses. I towever, 
Table 3 reveals that the group differences were less pro- 
nounced for the measures of forgetting. Indeed, the means 
reported in the table indicate that once the material had 
been learned to a moderate degree, forgetting was a rare 
event among both users and non-users. Thus, for example, 
once a response had been successfully learned for four or 
more consecutive trials, there was no occurrence of for- 
getting in the non-user group and only seven of the 35 
users forgot a previously learned response. RIANOVA 
revealed that the ecstasy-related group difference on the 
measures of associative learning was statistically signif- 
icant, F7, sq, 1.64, p<0. OO1. Furthermore, subsequent uni- 
ý4 Ecstasy user group e''e' fecF values) on measures of associative learning following statistical control i Eiar various measures of Betamine, 
cannabis, and cocainuse 
Covariate measures 
Total use Times used Amount consumed in Average weekly dose Ever used' 
per week the previous 30 days 
\tivariate effect (dr7,85) 3.16" 4.16"+' 5,300+« q 10100 3 64«« its to completion 18.71 18,06""" 21.78""« 23.764'0 13.4$""" 
ber of correct responses in trial 1 6.21' 2.65 4.270 7.70" 0.73 4, -r% of perseverative responses 4,17' 7.54"" 12.26«+0 8.1300 4.32« -i 
NN 
etting: number forgotten at level 1 2.30 5.80' 6,9500 3,75 71340 
etting: number forgotten at level 2 2.26 5.98" 4,94+ 2.74 6.050 
NN-Ittting: number forgotten at level 3 3.534 16.76«00 18,8314« 7,2800 7,7200 
ersing: number forgotten at level 4 3.39 0.73 0.53 3,92 6.94' 
Into measures relating to the use of each of the three drugs were entered as covariates in each analysix, For all univariate analyse, 1,91. Unless otherwise noted, the units were as follows: cannabis, number of joints; amphetamine and cocaine, grams. Nun-uacru of the in question were coded as zero on the particular measure concerned egorical variable coded: 0 user, I non-user 
. 
00l 
`, 
` 0.01 - 
I 
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Table 5 Correlations betwebn 
various measures of learning 
performance and measures of 
illicit drug use 
Trials to 
completion 
rd 
Initial 
learning 
Perseverative 
responses 
Forgetting 
level 1 
Forgeting levels 
2-7 
[a 
92 
92 
Total use 
Ecstasy 0.193 -0.226 0.162 0.146 --0.045 
Cannabis 0.281 * -0.242" -0.039 0.309* 
0.360* 
Cocaine 0.092 -0.155 0.274 0.047 -0.012 
`pc 
Amphetamine 0.085 0.058 0.172 0.093 
0.074 
Frequency 
Ecstasy 0.218 -0.173 0.004 0.189 
0.066 is 
Cannabis 0.165 -0.320" -0.102 -0.016 
0.057 
01 
Cocaine 0.169 -0.248' 0.139 0.148 -0.014 o-i 
Amphetamine 0.143 0.107 0.331 * 0.085 -0.058 
Use in last 30 days 
Ecstasy 0.226 -0.127 0.075 . 
0.154 0.082 ? 9` 
Cannabis 0.198 -0.279* -0.052 -0.037 
0.00 0 
Cocaine 0.092 -0.154 0.036 0.109 -0.038 
Amphetamine -0.054 0.106 -0.040 0.051 -0.035 
Average weekly dose 
Ecstasy 0.234 -0.260* 0.149 0.100 -0.038 to 
Cannabis 0.235 -0.230 -0.032 0.266* 
0.305" 
Cocaine 0.042 -0.107 0.113 0.005 
0.014 It 
Amphetamine -0.033 0.103 -0.002 0.057 -0.025 
User/non-user 
N=97. A Bonferroni corrected Ecstasy -0.466** 
0.310* -0.281 * -0.259' -0.281 
* 
significance level of a=0.01 was Cannabis -0.221 0.245' 0.013 -0.075 -0.100 
used Cocaine -0.302' 0.345' -0.202 -0.075 -0.078 *p<0.01, one tailed 
**p<0.001, one-tailed Amphetamine -0.167 
0.184 -0.072 -0.078 -0.143 
variate analyses revealed significant group differences on 
each of the measures with the exception of forgetting at 
levels 2 and 4 (see Table 3). 
It is possible that some or all of these effects might have 
been attributable to the effects of other drugs. To address 
this possibility, the preceding analysis was repeated five 
times with different measures of amphetamine, cannabis, 
and cocaine use as covariates. In the first analysis, mea- 
sures of lifetime use of each of these other drugs were 
included; in the second, the number of times each drug 
was consumed each week; in the third, the amount of 
each drug consumed within the last 30 days; in the 
fourth, the average weekly dose (i. e. total amount con- 
sumed divided by the length of use in weeks); and in the 
fifth, categorical variables in which users and non-users 'S 
of each individual drug were coded as 0 or 1, resPec- 
S 
tively. Thus each of the analyses contained specific mea- 
sures of amphetamine, cannabis, and cocaine use as 
t 
covariates. This was done for the multivariate data yield- 
five multivariate outcomes and for each of the seven ing 
measures of associative learning yielding 35 univariatc 
analyses in total. The results are set out in Table 4. It, the 
analyses, the multivariate effect of ecstasy user group and 
the univariate ecstasy user group effects on trials to 
completion and perseverative errors remained statistically 
significant. The same was true in relation to forgetting at 
level three although this result needs to be treated with 
caution as all non-ecstasy users scored zero on this 
Table 6 Performance on asses High lifetime Low lifetime Non-ecstasy Ft, s- 
s_ 
ec taslusrs measures for 
ecstasy dose >200 ecstasy dose <_200 user ecstasy users with th high high and low ecstasy lifetime dose and non-ecstasy tablets' tabletsb 
users 
Mean SD Mean SD Mean SD 
***p<O. OOI 
**p<0.01 
*p<0.05 
`n-18; mean lifetime number of tablets consumed, 520; range 219-1,682 
"n= 17; mean lifetime number of 
tablets consumed, 98; range 15- 
192 
Trials to completion 5.67 1.28 6.59 2.40 4.32 1.46 14,92"** 
Number of correct responses in trial 1 2.67 1.81 3.29 2.20 4.32 2.01 5.49** 
Number of perseverative responses 0.67 1.28 0.71 1.05 0.16 0.66 4.03* 
Number forgotten at 
Level 1 0.72 0.83 1.00 1.22 0.39 0.75 3.75* 
Level 2 0.06 0.24 0.47 0.87 0.10 0.35 4.75* 
Level 3 0.00 0.00 0.29 0.47 0.00 0.00 16.15** 
Level 4 0.00 0.00 0.12 0.33 0.00 0.00 5.17** 
7 in 
týinf; uniquel 
Variancey 
edt1Ye ingh ecstasy user group follow- 'etiestatistical controls for the 
"ý? ý'1rits of other independent ablcs 
4 
ý''ý0.001 
t 147 
Regression Independent variables in the model prior to the Total R squared increment associated 
model inclusion of ecstasy user group R2 with Ecstasy user group 
None 0.218 0.218*** 
I Number of correct responses in Trial 1 0.454 0.086*** 
2 Number of perseverative responses 0.304 0.134*** 
3 Number forgotten at level 1 0.445 0.109*** 
4 Number forgotten at levels 2,3 and 4 0.405 0.091 *** 
_Nj 
'%ure. Somewhat less reliable were the group differ- 
1, S in initial learning where measures of the frequency 
lli4 'ýýIther drug use and the categorical other drug use/ 
. 
k; ý'Iise covariates reduced the ecstasy-relatcd group dif- 
ces to below statistical significance. Similarly, ecstasy- 
P related differences in forgetting were reduced to 
statistical significance following control for total 
17me use and averag6 weekly dose of the other drugs. 
relation to the cannabis measures that were included [4t, ý4ch of the 35 ANCOVA analyses referred to in the 
, 
thi "'iOus paragraph, homogeneity of regression was ob- 
iý 
t' ltýtd in 31 out of 35 cases, p>0.05 for the covariate by 
-sY user group interaction. The exceptions were: (1) in tion to the cannabis user group covariate, for the initial 
ing measure; (2) again in relation to the cannabis user 
'ý'IXIP covariate, for the forgetting at level 4 measure; (3) 
, -'%t, 
4rding the average weekly dose of cannabis covariate, 
fý_Ntý t1he forgetting at level 3 measure; and (4) in relation to 
4t frequency of cannabis use covariate, for the forgetting 
-vel I measure. For these exceptional cases, the co- 
-_ýi% 
N; ate by ecstasy user group interactions were all sta- leall i ificant; p<0.05 in all cases. y sign 4iýlnce the number of cocaine and amphetamine users 
-brj"ýjng the non-ecstasy user group was small, it was not 
to properly test for homogeneity of regression in 
to the cocaine and amphetamine measures, Given 
limitations, we cannot entirely rule out the possibility ýt4t Other drugs may have played a part in accounting for the 
obtained here. Indeed the correlations set out in 
e5 reveal that various aspects of other drug use were 
lated with associative learning processes. Assuming a 
e of 0ý-_0.01, forgetting, both for well-learned and for 
Well-learned material, was significantly correlated with I lifetime dose and average weekly dose of cannabis. "I'-1, 
everative responses were significantly correlated with 
ýIi frequency of amphetamine use. Initial learning was ificantly correlated with lifetime cannabis use, the 
411ency of cannabis and cocaine use, cannabis use during 
Previous 30 days, and the average weekly dose of 
sy. Consistent with the results of the MANOVA, the 
tasy user group variable was significantly correlated 
all measures of learning performance. In relation to possible ecstasy dosage effects, Table 6 
ý-h Cals that for the most part while both ecstasy user groups 1ýtfori-ned 
worse than non-users, there is little difference 'tween the high lifetime ecstasy dose and the low lifetime ýMasy dose user groups. MANOVA with level of ecstasy 
as the independent variable (high lifetime dose n= 18, 
low lifetime dose n=17, non-user n=62) and the seven 
measures of teaming performance as dependent variables 
yielded a significant multivariate effect of level of ecstasy 
use F14.178=5,199 p40.001- Table 6 reveals that significant 
differences were also obtained for each of the component 
teaming measures. Pairwise comparisons revealed that non- 
users performed significantly better than both user groups 
in trials to completion, p<0.05 via Tukey's test, Equally 
non-users were significantly better than heavy users on the 
initial teaming measure, p<0.05. Non-users were also sig- 
nificantly better than light users on all of the forgetting 
measures, p<0.05. The only significant differences be- 
tween the two ecstasy user groups were for forgetting at 
levels 2,3, and 4 where paradoxically light users performed 
significantly worse then heavy users, p<0.05, via Tukey's 
test. 
Regarding the ecstasy-group related variance in trials to 
completion, it is important to cmphasise that the ecstasy- 
group related variance potentially arises from a range of 
sources. In addition to using ecstasy, a range of other drugs 
was also used and there may also be pre-morbid differ- 
enccs between the two groups, as well as differences in 
psychological affect. Thus the ecstasy-group related var- 
iance might have arisen from any one of these sources. 
The focus here is to establish which sub-processes were 
responsible for the ditTerence in overall teaming perfor- 
mance among this group of poly-substance abusers. 
Table 7 reveals that the ecstasy-group related variance 
amounted to 21.8% of the total variance in associative 
learning (as indicated by the R2 increment of 0.218). In 
subsequent analyses, ecstasy use was entered in the 
regression equation following the inclusion of each spe- 
cific teaming sub-process. This makes it possible to es- 
tablish how much of the ecstasy-group related variance 
was accounted for by each of the teaming sub-processcs. 
Inspection of Table 7 reveals that following statistical 
control for group differences in initial teaming (as mca- 
sured by the number of correct responses in Trial 1), the 
residual ecstasy-group related variance amounts to 8.6%. 
Thus over half of the ecstasy-group related variance is 
accounted for by individual differences in the level of 
initial teaming. Three other regression models were eval- 
uated. Prior control for group differences in persevcrative 
responses reduced the ecstasy-related variance from 21.8 
to 13.4%. Inclusion of forgetting at level one and at higher 
levels in the first stage of the hierarchy removed at least 
half of the ccstasy-group related variance in both cases. 
ýz ; 
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Discussion 
As expected, the results demonstrated an ecstasy-group 
related deficit in associative teaming. The ecstasy user 
group performed worse on all measures of associative 
teaming, they required more trials to team the associa- 
tions, achieved fewer correct responses on trial one, pro- 
duced more perseverative responses, and demonstrated a 
greater propensity to forget previously learned responses, 
especially those that were not well learned. Furthermore, 
when indices of cannabis, cocaine, and amphetamine use 
(lifetime dose, frequency of use, average weekly dose, 
amount consumed in the last 30 days, and a categorical 
variable of user/non-user) were included as covariates, the 
ecstasy-group related deficits in trials to completion and 
perseverations remained significant. However, differences 
in initial teaming fell to below statistical significance with 
control for other drug use (frequency of use, user/non- 
user). In addition, group differences in forgetting were 
reduced to below statistical significance following control 
for lifetime, and average weekly dose of other drugs. 
As some of the apparent ecstasy-group related effects 
were reduced to below statistical significance following 
controls for the use of other drugs and since homogeneity 
of regression was not obtained in all cases or could not 
be tested, the possibility that other drugs might affect 
associative teaming performance cannot be excluded. Indeed, the correlations obtained in the present study 
suggest that cannabis use may affect a number of aspects of teaming performance. However, the correlations set out in Table 5 do need to be treated with caution. Most of them 
were modest in scale so that the variables in question 
shared only a relatively small amount of variance with 
the teaming measures. Furthermore, the Bonferroni cor- 
rection that was used is based on the assumption that it is appropriate to consider expectations for each illicit drug separately; hence the procedure is based on a total 
of 25 comparisons where both the outcome variables 
and the predictor variables were intercorrelated. If a more 
conservative Bonferroni correction procedure was em. 
ployed, then with 100 1 independent correlations, a value f6i 
oc--0.0005 would be appropriate. At this level only two oj the corTelations would be statistically significant, specifi. cally, perseverative responses with the frequency of am. phetamine use and the ecstasy user/non-useT variable witt trials to completion. 
It was noteworthy that the apparent ecstasy-group effec does not appear to be directly related to the level o lifetime ecstasy use, since MANOVA revealed that, rel ative to non-users, heavy ecstasy users were no mor impaired than light ecstasy users. This outcome is nc readily explained. It may be that no straightforward re lationship exists between the total number of tablets take and the risk of a neurotoxic dose (O'Shea et al. 1998' Rather the likelihood of MDMA related impairment i associated with the co-occurre . nce of a number of factor which are not necessarily related to the total number ( tablets consumed such as the number of tablets ingested c a single occasion and the conditions (ambient temperatur 
level of hydration, baýkground sound level) prevailing at 
the time (O'Shea et al. 1998). Thus an individual who 
typically consumes a modest dose, relatively infrequently 
but over a long period of time may have a high lifetime 
dose but not demonstrate any substantial learning deficits. 
Turning to the results of the regression analysis, it was 
revealed that ecstasy user group accounted for -22% 
of the total variance in trials to completion. All of the 
component measures of learning performance substantially 
reduced the ecstasy-group related variance. The greatest V 
degree of attenuation was achieved by the level of initial 61 
learning (number correct in trial 1). The various measure 
of forgetting each reduced the ecstasy group related var- Ij 
iance by about one half while for perseverative responses C 
the degree of attenuation was around 40%. Thus the ec- It 
stasy-group related effect appears to be mediated throug 
IC 
all of the learning sub-proccsses. Taken together with ýP 
the results of the MANOVA, the robustness of the group It, 
difference in trials to compIction following the various 
ANCOVA analyses is consistent with an ecstasy-mediated iu 
effect in relation to this aspect of learning. However, it is 
at least possible that some of the attenuation produced by 
the level of initial leaming and by forgetting may have ij 
been due to other drugs such as cannabis. Such a poss* 
bility would be consistent with the results of Dafters et 
(2004) and Croft et al, (2001) linking cognitive deficit 
cannabis use rather than ecstasy. However, in relation to th%. 
other leaming measures, statistical controls for group dif- 
ferences in various measures of cannabis consumption did 
not eliminate the overall ecstasy related group difference. 
There are a number of limitations of the present study that I, 
need to be acknowledged. In a quasi-experimental design 
such as that adopted in the present study, it is pogsible that 
the groups may have differed on some variable other than 
ecstasy. Some possibilities can be excluded such as in- 
telligence (NART and Raven's) and aspects of sleep quality. 
However, others such as general health, nutfition, or some 
pre-morbid condition cannot be ruled out. Furthennore, we 
relied on self-reports of drug use and so it is possible that 
there were inaccuracies in this data. There is also no 
r guarantee of the purity of drugs used, and the quantitative 
f amounts per tablet, gram, etc. (Cole ct al. 2002). Fur- 
thermore, due to limited resources, we were unable to 
provide an objective measure of recent drug use (e. g. from 
1 hair and urine samples). However, most published studies 
testing cognitive deficits among ecstasy users have not 
t used these techniques (e. g. Fox et al. 2002; Morgan 1998; f Morgan 1999; Parrot and Lasky 1998, Rodgers 2000; 
- Wareing et al. 2000). All participants reported being drug 
,e free for 24 h, and ecstasy-free for at least 7 days (average 
A abstinence period was actually 12 weeks), and we have no 
- reason to believe this information to be false (participants 
n were not informed that they would be excluded prior to ). testing). 
is In conclusion, the present study further supports evi- 
S, dence for cognitive deficits in ecstasy users. Individual 
af differences in initial learning, perseverative responses and 
)n forgetting all appear to be important determinants of ver- 
C, bal associative learning deficits in these individuals. How- 
IN 
ý 45'ýo erg while some of these impairments appear to be relate 
n dY! ý+uckstasy use, others may be attributable to other drug sb 
ro as cannabis. 
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